Yale Medicine : Alumni Bulletin of the School of Medicine, Autumn 2008- Spring 2009 by Yale University. School of Medicine
Yale University 
EliScholar – A Digital Platform for Scholarly Publishing at Yale 
Yale Medicine Alumni Newsletters, Bulletins, 
and Magazines 
Yale School of Medicine, Office of 
Communications 
Fall 2008 
Yale Medicine : Alumni Bulletin of the School of Medicine, Autumn 
2008- Spring 2009 
Yale University. School of Medicine 
Follow this and additional works at: https://elischolar.library.yale.edu/yale_med_alumni_newsletters 

YALE 
UNIVERSITY 
CUSHINGAVHITNEY 
HISTORICAL LIBRARY 

Digitized by the Internet Archive 
in 2017 with funding from 
Arcadia Fund 
https://archive.org/details/yalemedicinealum4320yale 
Ya e Medicine 
A fallen student’s 
endearing legacy 
4 
Paul MacLean’s 
triune brain theory 
16 
A Yale alumna in 
the rain forest 
30 
autumn 2008 

CONTENTS 
ON THE COVER 
Illustration by Jeffrey Fisher 
Letters 
Chronicle 
Rounds 
Findings 
Books & Ideas 
Capsule 
Mapping the future of medicine 
With its largest grant ever, Yale is assembling resources 
to help clinical scientists focus on ideas—and leave 
the red tape to others. 
By Jill Max 
Is the straight road too narrow? 
Demands for cures and a flat NIH budget are putting 
pressure on scientists to produce findings that go 
right to the bedside. Still, there’s value in finding what 
you’re not looking for. 
By Pat McCaffrey 
A life’s work in Indonesia 
Even as a medical student, Kinari Webb knew where she 
wanted to practice medicine. Now, she and her ecologist 
husband are working to bring health care to Borneo— 
while preserving the rain forest. 
By Jill Max 
Faculty 
Students 
Alumni 
In Memoriam 
Follow-Up 
Archives 
End Note 
On the Web 
yalemedicine.yale.edu 
On our website, readers can submit class notes or a change of address, 
check the alumni events calendar, arrange for a lifelong Yale e-mail alias 
through the virtual Yale Station and search our electronic archive 
2 
4 
8 
io 
12 
16 
18 
24 
30 
35 
38 
46 
62 
64 
64 
65 
Y
al
e 
M
e
d
ic
in
e
 
a
u
tu
m
n
 
20
08
 
Letters 
Yale Medicine 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or less) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style and content. 
We should expect our 
students to be literate 
It was with some sadness that I 
read of the teaching of ethics by 
my colleague, Alan A. Stone, M.D. 
'55, to his students at Harvard 
Law School. ["A Passport to the 
Young," Yale Medicine, Spring 
2008] Stone felt obliged to turn 
to the movies because "few stu¬ 
dents had read Sophocles or 
Dostoevsky, Austen or Flaubert.” 
I was reminded of how startled 
I was some years ago to discover 
that one of my patients, a gradu¬ 
ate student in literature at Yale 
and a magna cum laude gradu¬ 
ate of Yale College, had never 
read a work by Shakespeare. 
Should our top law and 
medical schools be admitting 
people who haven’t even a 
rudimentary reading knowl¬ 
edge of the Western canon? 
Perhaps what is needed is not 
a "new passport to the young,” 
but a reactivation of the old 
one. And perhaps we cannot 
absolve ourselves of some of 
the blame for the illiteracy of 
the young until we make it 
clear to them that we expect 
them to be literate. 
Victor A. Altshul, M.D. '60 
Associate Clinical Professor 
of Psychiatry 
VISIT US ON THE WEB 
yalemedicine.yale.edu Med school missing 
from cover 
I find an interesting example 
of the complex relationship 
between the School of Medi¬ 
cine and the main campus 
represented by the absence of 
the topography of the medical 
campus on the cover of last 
spring’s issue of Yale Medicine. 
Robert B. Duckrow, M.D. '75, HS ’79 
Associate Professor of Neurology 
and Neurosurgery 
Online: Yale Netcasts 
Additional content for articles 
in this issue of Yale Medicine 
is available online at iTunesU, 
or by pointing your browser to 
yalemedicine.yale.edu. 
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Basic science vs. translational research, 
and medicine and rain forests 
In the autumn of 2006, Yale became one of a handful of 
medical schools to receive a ctsa grant from the National 
Institutes of Health (nih), a boon to translational research 
here and around the country. Once the program was up 
and running we asked writer Jill Max to take a look at the 
new Yale Center for Clinical Investigation, created and 
: funded with the goal of supporting clinical research. This 
enhanced emphasis on translational research also prompted 
us to explore the tension between basic-science research- 
knowledge for knowledge’s sake—and the bench-to-bedside 
goals of those who start out with a cure or treatment in 
mind. Boston-based science writer Pat McCaffrey talked to 
scientists at Yale and found that, largely due to a flat nih 
budget, scientific research is going through hard times. 
But some scientists also worry that basic research is taking 
a back bench to translational research. 
More than two years ago, in May 2006, we heard 
from Kinari Webb, m.d. ’02, who asked if we’d be interested 
in an article about her work in Indonesia. Four years out 
of medical school, Webb had laid the groundwork to open 
a clinic in a remote area of Borneo. In addition to her desire 
to provide medical care to an underserved area, she and 
her husband, a Harvard ecologist, wanted to link that to pre¬ 
serving the region’s rain forests. For more than a year Jill 
Max has been in contact with Webb, following the progress 
of the clinic, which opened in the summer of 2007. Her 
report begins on page 30. 
John Curtis 
Managing Editor 
SECOND OPINION BY SIDNEY HARRIS 
"Ltrs sire nIowc." 
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4 chronicle news from cedar street 
The death of Mila Rainof, a month before her 
graduation, sent a shock throughout the medi¬ 
cal school. Her classmates posted her photo and 
left flowers at the site of the accident. 
A student’s warm heart 
and “amazing” smile 
Mila Rainof’s embrace of others 
has inspired an enduring memorial 
at the medical school. 
As the 96 members of the Class of 
2008 processed to Old Campus for 
Commencement on May 26, they 
paused at the corner of York Street and 
South Frontage Road. One by one, each 
graduate placed a carnation in memory 
of Mila Rainof, a classmate who was not 
with them in the procession. 
On April 19 Rainof was struck by a 
car as she crossed the intersection. She 
died the next day of her injuries. At a 
medical school town meeting called by 
Dean Robert J. Alpern, m.d., on the 
Monday after Rainof died, Alpern said, 
“The medical school family has lost a 
member way too young in age.” 
In the wake of her death, Rainof’s 
friends and classmates have found many 
ways to honor her. Her close friends 
stood by Rainof’s parents and sister 
when they came to New Haven and 
organized a memorial service in the 
medical school’s Rose Garden. Others 
began collecting photos and remem¬ 
brances for a book to be given to her 
family. Students have organized efforts 
to improve safety at intersections near 
the medical school. (See sidebar.) A 
memorial scholarship and award fund is 
being established at the School of Medi¬ 
cine to honor and perpetuate Rainof’s 
memory, in particular her compassion¬ 
ate spirit and humanistic approach to 
medicine. Students also planted a cherry 
tree in her honor on Harkness Lawn. 
Rainof’s parents have shared with 
Merle Waxman, director of the Office 
for Women in Medicine and a mentor 
to Rainof, that their daughter loved Yale 
and was happy here. Her phone calls, 
they told Waxman, were always filled 
with her enthusiasm for her classmates, 
teachers and patients. 
What friends remember best about 
Rainof is her warm and welcoming 
smile. “Like everyone else,” her 
boyfriend and classmate James Troy 
said at the Rose Garden memorial, 
“I was instantly won over by her amaz¬ 
ing smile.” A friend and classmate, 
Ellen House, recalled sharing clinical 
rotations with Rainof and all the 
patients asking for “the smiley one.” 
Margaret A. Drickamer, m.d., associ¬ 
ate professor of medicine, recounted a 
trip to Seattle with Rainof to attend a 
conference. They walked all over the 
city, she said, talking and telling stories. 
“We laughed, we cried—and we did 
go to some poster sessions.” Beyond 
Rainof’s warm and friendly demeanor, 
Drickamer said, was a determination 
to help people. “Mila really cared 
about people, especially when she felt a 
responsibility for their welfare, and she 
steadfastly refused to let anything get in 
the way of that caring,” Drickamer said. 
Karen J. Jubanyik, m.d., assistant 
professor of surgery (emergency medi¬ 
cine), described a difficult shift at 
Yale-New Haven Hospital the day after 
Rainof died. “I just thought, ‘What 
would Mila do?’ ” Jubanyik said. “She 
would contribute any way she could. 
She would go to the patient’s side, 
hold their hand and genuinely listen 
to them.” Friend and classmate Maggie 
Samuels-Kalow said, “Mila was the per¬ 
son that you wanted at your side when 
the patient was getting sicker and you 
didn’t know what to do.” 
Kristina Zdanys, one of the class co¬ 
presidents, said that the students in the 
Class of 2008 are a close-knit group and 
would have felt the loss of any of their 
members, but that Rainof was special. 
“Whenever she walked into a class or 
Marigolds, she was always smiling or 
had something nice to say,” Zdanys said. 
“If you asked people to think of a 
person in the class who always made 
people feel good ... she would be the 
first person,” said Rachel Wattier, who 
has been leading a committee that has 
met with city and university officials to 
improve traffic safety. 
A few days before Commencement, 
students, faculty and others gathered 
at the intersection where the accident 
occurred. Bearing signs that read “Yield 
4 Walkers,” and “No Turn on Red,” the 
group asked drivers to slow down and 
respect the traffic lights. 
“There was really no one to blame,” 
Gregory L. Larkin, m.d., professor of 
surgery (emergency medicine), said at a 
meeting in The Anlyan Center the day 
after Rainof died. Larkin had been the 
attending in the emergency room when 
an ambulance delivered Rainof. The day 
before the accident, Larkin had been her 
teacher, instructing her in the use of 
ultrasound. Rainof was scheduled to 
begin a residency in emergency medi¬ 
cine in Oakland, Calif., after graduation. 
On the morning of April 19 Rainof 
was on her way back to her York Street 
apartment after working out in the gym 
in Harkness Dormitory. A truck was 
leaving the loading dock of Yale-New 
Haven Hospital against a red light. As 
Rainof crossed South Frontage Road, 
also against the red light, the truck 
cleared the intersection and cars in the 
three oncoming lanes moved forward. 
Two swerved to avoid her, but a third 
struck her when she was just a yard 
away from the curb and safety. She died 
the next day of severe head injuries. 
—John Curtis 
After a tragedy, the medical 
school community mobilizes 
around traffic safety 
On the afternoon of May 22, about 
two dozen students, faculty and staff 
from the School of Medicine marched 
from Cedar Street to the corner of 
York Street and South Frontage Road, 
where Mila Rainof, a fourth-year medi¬ 
cal student, died after being struck by 
a car a month earlier. 
Pedestrians have long dreaded this 
and other intersections near the medi¬ 
cal school. Drivers in a hurry to reach 
the Route 34 Connector feeding into 
Interstate 91 and Interstate 95 rou¬ 
tinely run red lights and ignore pedes¬ 
trian crossing signals. 
Students have organized a Traffic 
Safety Group since Rainof’s death— 
their goal is to make the streets safer 
for pedestrians. 
“It is important that we honor Mila 
and keep the traffic safety effort in the 
spirit of what she would have done,” 
said Rachel Wattier, a fifth-year medical 
student who is leading the traffic group. 
“A lot of people have deep-seated con¬ 
cerns about traffic that they were never 
able to act on. People see an opportunity 
to have their concerns addressed.” 
Plans are already under way to 
improve four intersections adjacent to 
the medical school area. They are 
part of a larger plan for street improve¬ 
ments as part of a deal struck between 
Yale-New Haven Hospital and the 
city for the construction of the Smilow 
Cancer Hospital. The model will be 
the intersection at Cedar Street and 
Congress Avenue, which has pedes¬ 
trian crossing lights that flash and 
count down the seconds remaining 
for a safe crossing. 
The hospital will also relocate a truck 
loading dock at South Frontage Road 
and York Street under the adjacent Air 
Rights Garage. Traffic that now leaves 
the garage onto South Frontage Road 
will leave through a roundabout to be 
built where the Route 34 Connector 
meets the garage. 
In light of the planned improve¬ 
ments, the safety group is developing 
materials to promote pedestrian 
and cycling safety, petitioning the city 
government to enforce the city’s 25 
mile-per-hour speed limit, and calling 
for strict enforcement of traffic 
regulations governing stop lights and 
signs, cell phone use, bicycle lanes 
and crosswalks. 
-J.C. 
A few days before Commencement, students, 
faculty and staff at the medical school rallied at 
the intersection of York Street and South Frontage 
Road to urge drivers to respect traffic rules. 
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6 chronicle 
School of Medicine goes green 
as it aims for lower carbon 
emissions by 2020 
The Yale School of Medicine’s sustain¬ 
ability campaign is ambitious and costs 
a little extra, but it’s perfectly willing to 
accept hand-me-down jeans—in fact, 
that’s part of the point. 
Denim discarded in the jean manu¬ 
facturing process, which now helps 
insulate the Sterling Hall of Medicine’s 
C wing, is one of many recycled materi¬ 
als that are lightening the university’s 
carbon footprint. The building’s recently 
renovated lab casework, ceiling tiles and 
wall insulation also come from such 
recycled materials as wheat straw board 
and soy-based spray foam. In total, the 
sustainability campaign squeezes more 
light from the sun, diverts trash from 
landfills and conserves water and heat. 
Adding such features to previously 
planned renovations costs more— 
between 1 and 2 percent of the $8.2 
million price tag of the Sterling renova¬ 
tions that were completed in 2006— 
but Yale can’t afford not to do it, said 
Virginia Chapman, director of construc¬ 
tion and renovation for the School of 
Medicine’s facilities office. “We’re saving 
the university money as a by-product of 
reducing carbon emissions,” she said. 
Still to come, Chapman added, are 
renovations to the second and third 
floors of Sterling’s I wing, the Brady 
Memorial Laboratory, the Hunter 
Building, the sixth and seventh floors 
of the Laboratory for Epidemiology and 
Public Health and the Laboratory for 
Surgery, Obstetrics and Gynecology, all 
of which will incorporate green features. 
Yale’s overall sustainability strategy 
began with the student-initiated 
“Yale Green Plan” in 1998. In 2002, the 
university’s Advisory Committee on 
Environmental Management proposed 
a set of environmental principles, and 
in 2005 President Richard C. Levin 
committed the university to reducing 
greenhouse gases to 10 percent below 
1990 levels by the year 2020. 
Implementing a sustainable labora¬ 
tory renovation that could be bench- 
marked and measured by a national 
standard would not come easily. Success 
is measured by the U.S. Green Building 
Council’s Leadership in Energy and 
Environmental Design (leed), but the 
organization had not set standards for 
lab renovations, “leed was designed for 
new buildings or full-building renova¬ 
tions but not laboratories nor smaller- 
scale renovations of the kind we do here 
at die medical school,” Chapman said. 
The work on the third floor of the 
C wing created a yardstick in 2006 
when it became the first laboratory 
renovation project in the United States 
to gain leed gold certification for its 
sustainable features. Among those fea¬ 
tures, said Robert Skolozdra, an associ¬ 
ate at the architectural firm Svigals & 
Partners, which designed the renova¬ 
tions, are sensors that switch lights 
on only when a person is in the room. 
“Daylight harvesting”—adding win¬ 
dows—maximizes available light. The 
project eased the strain on landfills 
by recycling 85 percent of construction 
and demolition debris. Lab faucets 
have reduced their output from 2 to 1.5 
gallons per minute, and low-flush toilets 
and urinals have been installed. Water 
use is now down 35 percent overall. 
As green renovations continue at 
the medical school, officials know that 
the older buildings will pose a chal¬ 
lenge, but The Anlyan Center, which 
opened in 2003, is also “a big energy 
user,” Chapman said. When it was 
designed, “other concerns outweighed 
concerns for the environment.” The 
building is undergoing an energy audit 
to determine how to address the high 
energy use, she said. 
—John Dillon 
New financial aid policy 
geared toward middle-income 
families and students 
Some students opening acceptance let¬ 
ters from the School of Medicine this 
spring had another reason to celebrate. 
While their colleagues in the Class of 
2008 graduated with an average debt 
of $115,000, a new financial aid formula 
should ease that burden for middle- 
income families. 
Dean Robert J. Alpem, m.d., Ensign 
Professor of Medicine, announced the 
new policy in April. Formerly, parents 
with a combined income over $45,000 
were expected to help pay the costs 
of their child’s medical education. 
Beginning this academic year, that 
threshold has been raised to $100,000. 
The “base loan” (the amount students 
are expected to borrow before receiving 
scholarship funds) has been raised from 
$17,000 to $18,000, keeping it among 
the lowest in the country. The new 
formula applies to all current students. 
“What we were expecting was 
not realistic,” said Richard Belitsky, 
m.d., the Harold W. Jockers Associate 
Professor of Medical Education and 
deputy dean for education. 
The change was made possible after 
Yale’s endowment income added $1.1 
million to the medical school’s finan¬ 
cial aid budget. The school’s financial 
aid committee then decided that stu¬ 
dents from middle-income families 
needed the extra funds most. Especially 
needy families did not need to borrow 
more than the base loan, as School of 
Medicine scholarships make up the 
difference, while affluent families were 
less burdened by tuition costs. The 
resources of students from middle- 
income families, though, consistently 
fell short of the old financial aid for¬ 
mula’s estimate, and these students 
were forced to borrow above the base 
loan to pay what the school required. 
“They should have been borrowing 
$68,000—four times the unit loan— 
but the average debt was $115,000,” 
said Alpern. 
Another reason for the change, said 
Belitsky, was that high debt often influ¬ 
ences specialty choice. For example, 
primary care physicians are in critically 
short supply nationwide, perhaps in part 
because they are less well reimbursed 
than their colleagues in some specialties. 
Of tire 97 Yale students who matched 
this year, only four entered primary care, 
and another three entered family medi¬ 
cine. The American Medical Student 
Association has stated that the current 
American model of financing medical 
education harms efforts to improve 
physician diversity and patients’ access 
to care. 
Richard Silverman, director of ad¬ 
missions, speculates that the change 
may also affect the diversity of the appli¬ 
cant pool. “If another school is widely 
perceived to be generous or liberal in 
its financial aid policy, it might get more 
applications from candidates who 
assume that Yale, because of the name, 
is only for the wealthy,” he said. Tuition, 
fees and expenses at the School of 
Medicine this year are expected to range 
from $62,000 to $69,000. 
Other medical schools are also 
changing their financial aid policies. 
In March, citing concerns about debt 
and specialty choice, Harvard Medical 
School raised its parental-income 
threshold to $120,000. 
“If a student wants to be a neurosur¬ 
geon instead of going into primary 
care,” said Alpern, “I’d hate for them to 
do it just because of the loans they had.” 
—Jenny Blair 
0 
Online: Yale Netcasts 
Richard Belitsky: A Great Doctor Is Not What 
You Know but Who You Are. 
PROVOST LEAVES FOR OXFORD 
Provost Andrew Hamilton, ph.d., is leaving 
Yale after 11 years to become the next 
vice chancellor of the University of Oxford 
in England. 
“As a noted scientist, a successful depart¬ 
ment chair, university citizen and provost 
these past four years, Andy has had a remark¬ 
able impact on Yale since joining our faculty 
in i99l" said President Richard C. Levin. 
Hamilton helped create the Yale Center 
for Genomics and Proteomics and the Yale 
Institute for Nanoscience and Quantum 
Engineering. He has been instrumental in 
developing plans for research programs and 
core facilities for Yale’s new West Campus. 
Hamilton also helped to create the new 
interdisciplinary Humanities Program and 
has supported Yale’s investments in the arts. 
After joining Yale, Hamilton became 
chair of the chemistry department in 1999. 
He became deputy provost for science and 
technology in 2003 and provost in 2004 
after then-Provost Susan Hockfield, ph.d., 
was appointed president of mit. 
In September, Peter Salovey, ph.d., dean 
of Yale College was named provost. 
—John Curtis 
62 YMG MEMBERS IN TOP DOCS LIST 
New York Magazine’s 2008 list of the 
region’s top physicians includes 62 physi¬ 
cians from Yale Medical Group (ymg). 
Yale's “top docs” are in 40 specialties and 
serve patients of all ages. 
The list, which appeared in the magazine’s 
June 16 issue, is based on the Top Doctors 
New York Metro Area guidebook, published 
annually by Castle Connolly Medical Ltd. 
The publishers ask doctors throughout the 
region which of their colleagues they would 
recommend to a friend or relative. The 
guidebook includes the top 10 percent of the 
metro area’s physicians. New York 
Magazine publishes a shorter list—the top 
quarter of the top 10 percent. 
“Our strong representation in the New 
York metro area highlights the fact that ymg 
is a regional and, in some cases, national 
practice,” said David J. Leffell, m.d., ceo 
of ymg. “Patients throughout New York and 
New England are coming to see ymg as a 
medical destination of choice.” 
—J.C. 
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Rounds MEDICINE AND HEALTH AT YALE 
A stroke of luck saves 
New London patient 
A new telemedicine initiative 
brought a potentially lifesaving drug 
to a patient 50 miles away. 
When Jeanne Munnelly went for a 
swim at a high school in East Lyme 
one August morning, she could not 
have known she was about to have 
a stroke—and make medical history 
in Connecticut. 
At about 8:15, as she swam in the 
school’s pool, Munnelly became weak 
on her right side and unable to speak. 
Lifeguards pulled her out and emer¬ 
gency personnel based at the fire station 
across the street arrived within five 
minutes. She reached New London’s 
Lawrence and Memorial Hospital in 
just 15 minutes. 
That’s when Munnelly, 67, became 
the first patient to benefit from the Yale- 
New Haven TeleStroke Network, a pro¬ 
gram modeled on a similar initiative at 
Massachusetts General Hospital. The 
TeleStroke Network allows area hospi¬ 
tals to call upon Yale neurologists’ 
expertise in assessing stroke victims. 
Using high-speed network videoconfer¬ 
encing and image-sharing technology, 
neurologist Joseph Schindler, m.d., eval¬ 
uated Munnelly via computer from Yale- 
New Haven Hospital (ynhh), then gave 
the “green light” to physicians in New 
London to use the clot-busting drug 
tissue plasminogen activator (tPA). 
Munnelly received the drug only 37 
minutes after reaching the hospital— 
much more quickly than if she had 
been transported to ynhh first. 
Schindler said the process of evalu¬ 
ating a stroke patient via TeleStroke is 
the same as when he sees a patient in 
ynhh’s emergency department. “It’s 
no different; it’s just the use of tech¬ 
nology to do it remotely,” he said. 
Speed and decisiveness are critically 
important in treating stroke victims. 
Most blood clots that cause ischemic 
strokes can be dissolved by tPA, a 
thrombolytic agent. But this medica¬ 
tion can also cause bleeding in the 
brain, and that risk increases beyond 
three hours after the onset of symp¬ 
toms. To meet that three-hour deadline 
and try to prevent this complication, 
doctors must ensure that a patient is 
an appropriate candidate for tPA. Yet in 
most hospitals, neurologists are not 
always available to assist emergency 
physicians with the evaluation and 
treatment decision. As a result, many 
patients who might benefit from tPA 
do not receive it. 
With telemedical technology, a 
neurologist need not be physically pres¬ 
ent. While seated at a computer 50 
miles away from the patient, Schindler, 
the clinical director of the Yale-New 
Haven Stroke Center, used a high-speed 
Internet connection to speak with 
the patient, family and clinical staff 
and review Munnelly1 s medical his¬ 
tory, blood tests and CT scan. He also 
examined her using a camera with a 
zoom feature. She was, he determined, 
a good candidate to receive tPA. Shortly 
after receiving the drug, Munnelly 
regained the use of her right leg as 
well as some ability to speak. 
Schindler, who is optimistic that 
Munnelly’s condition will continue to 
improve, was pleased not only that the 
technology worked but also that he and 
the team in New London could act so 
quickly. “We’ve done it at Yale when 
the entire team was already in the ED; 
we [assessed and treated the patient] 
in a similar time. But to have that done 
remotely, it’s wonderful.” (See related 
story, page 9.) 
—Jenny Blair 
From a console in New Haven, neurologist 
Joseph Schindler evaluated a stroke patient 
50 miles away in New London. 
9 
With virtual lives on the line, 
simulations help responders 
assess triage systems 
Imagine being the first paramedic on 
the scene after a tanker truck has 
plowed into a city bus. Traffic is snarled, 
cars are honking and people are scream¬ 
ing. Who needs your attention most— 
the man on the concrete holding his 
bloodied knee or the woman on her 
back with closed eyes? What about the 
people inside the overturned bus? And 
what is that white vapor drifting from 
the truck’s tank? 
In emergencies, prioritizing care 
for victims is called triage. The word 
comes from the French trier, “to select” 
or “to sift,” a usage that goes back to 
Dominique Larrey, the chief surgeon of 
Napoleon’s armies. A victim might be 
color-coded as red, meaning he needs 
help immediately; yellow, meaning he 
will need help soon; green, meaning 
he has minor injuries; or black, mean¬ 
ing he cannot be helped with available 
resources. But sorting human lives in 
this way is still more art than science. 
This uncertainty persists because, 
although many rules exist to help res¬ 
cuers, it is hard to evaluate whether 
those rules actually save lives. The 
decades-old Simple Triage and Rapid 
Treatment (start) system color-codes 
patients as described above. But like 
other such systems, said David C. Cone, 
m.d., associate professor of surgery 
(emergency medicine) and of epidemi¬ 
ology, “we have no idea if it works.” 
Cone has spent his career thinking 
about disasters and mass-casualty triage. 
He studies emergency medical services 
and plans for chemical, biological and 
nuclear terrorist incidents. Fie has run 
disaster simulations at Tweed-New 
Haven Airport complete with volunteers 
smeared with fake blood. But triage 
research is inherently difficult. For one 
thing, said Cone, “we don’t even know 
what we want a mass-casualty triage 
system to do.” Is the best system the 
one that’s easiest to teach? Quickest to 
apply? Is the most important goal to get 
patients into ambulances as quickly as 
possible? Or to save the greatest num¬ 
ber of lives? The complexities mount 
when one considers that every disaster 
is unique—it is almost impossible to 
compare triage systems in the real 
world. Now, though, Cone has begun 
working with a new tool to study 
start and other triage systems: a 
virtual-reality (VR) simulator. 
While studying in Italy for a mas¬ 
ter’s degree in disaster management in 
2004, Cone saw a VR simulator used to 
train Dutch firefighters and realized that 
the software could be adapted for triage 
research. Developed by tire Dutch com¬ 
pany E-Semble, the simulator looks like 
the highly realistic video game Grand 
Theft Auto. Learners at a laptop “walk 
around” a vivid scene, assessing and 
triaging victims. Dangers and distrac¬ 
tions, like toxic spills or television 
reporters, can be added to the scenario. 
The learners are timed and their 
actions exported into a database that 
can then be analyzed. 
Working with emergency medicine 
resident John Serra, m.d., and sup¬ 
ported by the Centers for Disease 
Control and Prevention and tire Laerdal 
Foundation, Cone plans to teach para¬ 
medic students two different triage 
systems several months apart, then 
compare how they did with each system 
in identical VR scenarios. “Once we get 
the software tuned, then we can design 
the larger studies,” said Cone. He plans 
eventually to use the tool to explore 
whether rules for triage are even neces¬ 
sary, or whether victims are better off 
being triaged by experienced rescuers 
who rely on clinical gestalt. 
VR may one day allow researchers 
around the world to collaborate, 
exchange scenarios and compile 
“libraries” of standardized victims. 
Cone hopes the controlled VR environ¬ 
ment will allow for real progress in 
triage research and ultimately save 
more lives during real disasters. 
-J-B. 
CHOCOLATE AND PRE-ECLAMPSIA 
Eating chocolate may lower the risk of pre¬ 
eclampsia, a dangerous condition in preg¬ 
nancy characterized by increased blood 
pressure and proteinuria, according to a Yale 
study published in the journal Epidemiology 
in May. But the study is not a free pass for 
chocoholics. Eating too many sweets can 
cause health problems, said Elizabeth W. 
Triche, ph.d., of the Yale Center for Perinatal, 
Pediatric and Environmental Epidemiology, 
who led the study. 
Triche’s team wanted to find out whether 
chocolate—especially dark chocolate 
with antioxidants that confer cardiovascular 
benefits—would protect pregnant women 
against pre-eclampsia. The study found that 
women who had more than five servings a 
week had a lower risk of pre-eclampsia; those 
who had high levels of theobromine, a by¬ 
product of chocolate consumption, were 
nearly 70 percent less likely to develop pre¬ 
eclampsia than women who had low levels. 
“This looks promising, but we need to 
do more research into how much and what 
type of chocolate is the most beneficial,” 
Triche said. 
—John Curtis 
A VIPER’S VENOM AND STROKE 
What does snake venom have to do with 
stroke? Depending on the results of a study 
in which Yale-New Haven Hospital (ynhh) 
is participating, possibly a lot. 
Doctors at ynhh are administering 
ancrod, a drug derived from the venom of 
the Malayan pit viper, to eligible patients 
who enter the hospital with symptoms of 
acute ischemic stroke. 
In such cases doctors may administer a 
dot-breaking agent—tissue plasminogen acti¬ 
vator, or tPA—but it must be given no more 
than three hours after symptoms appear. 
Ancrod has an anticoagulant effect and can be 
administered up to six hours later. “If ancrod is 
safe and effective,” said Joseph Schindler, m.d., 
assistant professor of neurology and neurosur¬ 
gery and clinical director of the Stroke Center 
at ynhh, “it will double the time frame during 
which stroke patients can be treated.” 
ynhh is the only Connecticut hospital 
in the trial, which is expected to last one to 
two years. 
—Charles Cershman 
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10 Findings from the bench 
In this image of a developing embryonic rat 
spinal cord, the purple marks show grow¬ 
ing commissural axons before they cross to 
opposing hemispheres. Yellow marks show 
a receptor called dscam, which is necessary 
to guide axons to their destinations. 
Biologists find molecule 
that guides axons 
A receptor implicated in Down 
syndrome and fruit fly development 
also charts a path for nerve fibers. 
Like a complex electronic device, the 
“wiring” of the nervous system has 
no tolerance for error. As an embryo 
develops, wirelike axons sprout from 
cells, elongating to form networks of 
neurons in the brain and spinal cord. 
Some axons cross the body from one 
side to the other, while others stay put. 
Neuroscientists have long wondered 
how axons migrate to form trillions of 
connections among neurons. How do 
they know where to travel and when 
to cross? Molecular signals are at the 
heart of the puzzle. 
The first such signal, a guidance 
molecule called netrin-i, was identified 
about 20 years ago. Since then, 
researchers have found receptors on 
the axons that help them steer toward 
their targets. Now Yale researchers have 
found another molecule that guides 
axons on their intricate journey. 
A team led by Elke Stein, ph.d., 
assistant professor of molecular, cellular 
and developmental biology and of cell 
biology, reported in June in the journal 
Cell that it had discovered that a gene 
linked to mental retardation in Down 
syndrome is also essential for axons in 
the spinal cord to cross from one side of 
the body to the other. 
The protein made from that gene is 
a receptor called dscam, which stands 
for Down Syndrome Cell Adhesion 
Molecule, dscam is already familiar 
to researchers. Its genetic instructions 
are on chromosome 21, and people 
with Down syndrome have three copies 
of the chromosome rather than the 
normal two. 
The Yale scientists found dscam 
through studies of nerve fibers called 
commissural axons that cross at the 
midline of the spinal cord, which 
divides the body into its right and left 
halves. Cells at the midline instruct 
axons by secreting attractive and repul¬ 
sive molecules. Netrin-i, the guidance 
molecule identified 20 years ago, is 
one such molecule. It attracts and 
guides commissural axons over long 
distances to the midline of the central 
nervous system. Researchers had previ¬ 
ously found that netrin-i signals dcc, a 
receptor that steers commissural axons 
to their targets. But they noted that 
some axons migrate even when dcc is 
absent. There had to be another recep¬ 
tor involved, and scientists searched 
for it for more than 10 years. 
The missing receptor, Stein’s lab 
found, was dscam, which was known to 
regulate nervous system development in 
fruit flies. But in humans it had only 
been known to help neural cells adhere 
to each other, and was thought to con¬ 
tribute to mental retardation in people 
with Down syndrome. In collaboration 
with scientists from Genentech, Stein 
and graduate student Alice Ly found 
that dscam at the tips of migrating 
axons is required in order to cross the 
midline in response to the attractant, 
netrin-i, which activates dscam and ini¬ 
tiates directional growth of commissural 
axons in much the same way that a key 
turns the ignition and starts a car. 
The researchers showed that com¬ 
missural axons that lack dscam lose 
their “sense of direction,” fail to grow 
and don’t reach the midline. The Stein 
laboratory is now investigating whether 
dscam plays a key role in wiring other 
parts of the nervous system and its 
contributions to mental retardation in 
Down syndrome. 
—Jenny Blair 
METASTASIS AND A HYBRID CELL 
Bacteria disable immune 
cells by exploiting a 
genetic similarity 
The bacteria that cause Legionnaires’ 
disease and Q fever, both of which are 
linked to pneumonia, use a clever form 
of mimicry to survive inside host cells, 
according to a team of Yale scientists. 
Both bacteria use genes that have 
evolved in tandem with genes in their 
hosts and that disarm the immune 
system cells that are trying to kill them, 
the researchers reported in the journal 
Science in June. 
“Because of their lifestyle, trying to 
identify how these organisms cause 
disease has been really difficult,” said 
Craig R. Roy, ph.d., associate professor 
of microbial pathogenesis, referring to 
the fact that the bacteria live inside 
their host cells. Roy’s team knew that 
some disease-causing bacteria inject 
proteins into human cells. What those 
proteins are and what they do, though, 
was unknown. 
Previous research on the genomes 
of the bacteria, Legionella and Coxiella, 
had turned up many genes with areas 
called anks (ankyrin repeat homology 
domains). These genes bear a strong 
resemblance to important genes in 
eukaryotic cells, those cells with a 
nucleus that are found in humans and 
other advanced life forms. Legionella 
and Coxiella appear to have “hijacked” 
genes from their hosts in order to sur¬ 
vive in the cell. In fact, some species of 
these bacteria cannot exist outside a 
eukaryotic cell. 
Roy’s lab showed that ank proteins 
are secreted into macrophages— 
immune system cells—and once inside, 
the proteins turn off mechanisms 
designed to destroy the bacteria. The 
macrophage ordinarily kills bacteria by 
exposing them to a destructive acidic 
environment, but the ank proteins pre¬ 
vent the acidic compartment from being 
transported to the bacteria by mimick¬ 
ing a natural process that occurs during 
cell division. 
Roy believes that more such survival 
tricks of gram-negative pathogens will 
be found, and that the diseases may one 
day be preventable with a vaccine that 
disables the ank protein and allows 
macrophages to complete the job of 
destruction. “This study at least gives us 
a foothold,” he said. 
-J.B. 
This image of a cell infected with Legionella 
shows host cell microtubules, which have 
been labeled using green fluorescent protein 
to show the bacterial compartments closely 
aligned on the microtubule network. 
Metastasis, the spread of cancer throughout 
the body, may be caused by a hybrid cell 
that takes on the most dangerous features 
of two different cell types, according to 
a review by Yale scientists in the May issue 
of Nature Reviews Cancer. 
According to dermatology researchers 
John M. Pawelek, ph.d., and Ashok K. 
Chakraborty, ph.d., the natural hybrids 
take on both the white cell’s migratory 
ability and the cancer cell’s tendency to 
divide uncontrollably. The hybrid can travel 
to other organs and seed new cancer sites. 
“This is a unifying explanation for 
metastasis,” said Pawelek. “We expect this 
to open new areas for therapy based on 
the fusion process itself.” So far, one case 
of fusion in humans and many cases in 
mice have been reported. Pawelek said 
more research is needed to be certain that 
fusion accounts for metastasis in humans. 
—J.B. 
A CLUE TO EVOLUTION 
After 16 years of research, Yale scientists 
have produced the first images of a group II 
intron, a cellular molecule whose ancestor 
may have opened the door to the evolution 
of higher organisms. 
Anna Marie Pyle, ph.d., professor of 
molecular biophysics and biochemistry, and 
her team crystallized the intron of a salt- 
tolerant bacterium that lives in the Sea of 
Japan. High-resolution images of the crys¬ 
tal, which appeared in Science in April, 
support the hypothesis that the intron 
shares a close evolutionary heritage with 
the human spliceosome, a complex molecu¬ 
lar machine found in higher organisms that 
allows many proteins to be made from one 
stretch of the genome. 
“The molecules showed us their struc¬ 
ture, their active site and their activity,” said 
Pyle. “We were even able to visualize their 
associated ions.” Pyle hopes the introns may 
be developed into agents for gene therapy. 
—J.B. 
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Books & ideas bookshelf 
When the doctor is the patient 
Robert Klitzman’s resistance to his own depression led 
him to explore what happens when doctors get sick. 
Robert L. Klitzman, m.d. '85, expected the grief that followed 
the death of his sister Karen, who died at the age of 38 in 
the World Trade Center on September n, 2001. But he did 
not expect that he would be unable to sleep and would 
suffer from persistent flu. Or that he would stop listening to 
music and take no pleasure in reading. 
When friends told Klitzman that he was depressed, 
he rejected the idea. As a psychiatrist, of course, he knew 
that emotional depression often manifests itself in the body. 
“I’d read it in textbooks,” he acknowledged. Eventually 
Klitzman did recognize that it was depression, not flu, that 
was making him feel that his body had “given way” beneath 
him. “Going through it myself made me realize how much 
I didn’t know about what it was to be a patient,” he said. 
That realization, he said, was “a defining moment.” 
Klitzman, a research scientist and associate professor 
of clinical psychiatry at the hiv Center for Clinical and 
Behavioral Studies at the New York State Psychiatric 
Institute and Columbia University, had already written five 
books. In fact, he’d gotten his start as a writer by reviewing 
books while a medical student at Yale—a starting point 
he recommends to students today. His role models included 
Richard A. Selzer, m.d., hs ’61; Sherwin B. Nuland, m.d. 
’55, hs ’61; and Howard M. Spiro, m.d.—Yale physicians 
who are also prominent authors. Klitzman had already con¬ 
templated writing a book about doctors as patients. Now, 
however, “It was no longer an academic question.” 
When Doctors Become Patients is the product of inter¬ 
views with 70 physicians of all ages who were facing 
cancer, heart disease, Huntington disease, bipolar disorder, 
hiv and other illnesses. Klitzman analyzes such common 
themes as denial of illness, doctors choosing doctors, 
“self-doctoring,” going public about one’s disease, over¬ 
working, coping and the role of spiritual beliefs. 
Klitzman found that the doctors viewed themselves 
either as patients or as doctors, “as if individuals had a 
zero-sum identity.” In reality, Klitzman said, “They’re not 
entirely doctors and they’re not entirely patients.” Klitzman 
called this “odd hybrid form” the “doctor-patient”—one 
doctor-patient with a foot infection brought his own bag of 
opiates to the hospital. And as patients, Klitzman’s inter¬ 
viewees were often upset by the carelessness with which 
their doctors addressed their fears. A surgeon told one doc- 
tor-patient that a procedure carried a 5 percent chance of 
dying. The patient would rather have heard that he had a 
95 percent chance of living. 
Just as Klitzman resisted the notion of his own depres¬ 
sion, his colleagues also denied that they were sick. They 
told him, “I feel like I have a magic white coat. Illness hap¬ 
pens out there—not to me.” Klitzman noted that magical 
thinking is part of our everyday lives: “When we blow out 
the birthday candles, we all make a wish.” But doctors 
deny their irrationality, contending, “We do not engage in 
magical thinking. We’re trained scientists.” 
Perhaps because doctors see themselves as scientists, 
they are reluctant to discuss religion or spirituality with 
their patients, as Klitzmarfs research suggests. Yet “when 
patients are lying in bed, that’s what they’re thinking 
about,” he said. He advocates adding at least a lecture on 
the topic during medical school. 
A reviewer wrote in the New England Journal of Medicine 
that Klitzmarfs book “goes to the very heart of the question 
of what a physician is.” In addition, When Doctors Become 
Patients serves as a lasting memorial to Karen Klitzman. 
—Cathy Shufro 
Robert Klitzman’s depression 
after the loss of his sister on 9/11 
led him to explore what he 
calls the “odd hybrid” of doctors 
who become patients. 
Bookshelf focuses on books and authors at the School of Medicine. 
Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
BOOK NOTES 
Polarities of 
Experience 
Alan E. Kazdin, Ph.D.. 
n, KAZDIN METHOD 
for Parenting the 
Defiant Child 
Polarities of Experiences: 
Relatedness and Self-Definition 
in Personality Development, 
Psychopathology and the 
Therapeutic Process 
by Sidney J. Blatt, ph.d., profes¬ 
sor of psychiatry and psychology 
(American Psychological Associa¬ 
tion) The author proposes that 
psychological development is a 
lifelong personal negotiation 
between two dimensions: relat¬ 
edness, which he terms the 
anaclitic dimension; and self¬ 
definition, or the introjective 
dimension. He contends that 
emphasis on one developmental 
line at the expense of the other, 
however, can lead to a variety 
of mental disorders. Within this 
framework, Blatt sees mental 
disorders as compensatory exag¬ 
gerations of the normal polarities 
of relatedness and self-definition 
rather than clusters of present or 
absent symptoms. Blatt discusses 
research indicating that anaclitic 
and introjective persons respond 
differently to psychotherapy. He 
then argues that this conceptu¬ 
alization of personality devel¬ 
opment has clear implications for 
refining approaches to therapy. 
The Kazdin Method for Parenting 
the Defiant Child: With No Pills, 
No Therapy, No Contest of Wills 
by Alan E. Kazdin, ph.d., the 
John M. Musser Professor of 
Psychology, and director of the 
Yale Parenting Center and 
Child Conduct Clinic (Houghton 
Mifflin) In this book and DVD, 
Kazdin lays out his science-based 
program for using praise and 
rewards to alter children’s behav¬ 
ior. Kazdin provides a step-by-step 
method that relies on positive 
reinforcement and a reward sys¬ 
tem for dealing with behavior 
problems.The book describes 
approaches for children of differ¬ 
ent ages; discusses ways to 
involve siblings; and provides 
scenarios for coping with such 
commonplace difficulties as 
tantrums, dawdling, resisting 
homework and delaying bedtime. 
Saving Sickly Children: The 
Tuberculosis Preventorium in 
American Life, 1909-1970 
by Cynthia A. Connolly, R.N., 
ph.d., assistant professor of nurs¬ 
ing and the history of medicine 
(Rutgers University Press) The 
author provides an analysis of 
public health and family welfare 
viewed through the institution 
of the tuberculosis preventorium 
of the early 20th century. This 
facility was intended to prevent 
TB in indigent children at risk for 
developing the disease or who 
came from families labeled as 
irresponsible. Connolly further 
explains how the child-saving 
themes embedded in the preven¬ 
torium movement continue to 
shape contemporary pediatric 
health care delivery and family 
policy in the United States. 
Attachment and Sexuality 
edited by Sidney J. Blatt, ph.d., 
professor of psychiatry and psy¬ 
chology; Diana Diamond, ph.d., 
and Joseph D. Lichtenberg, m.d. 
(The Analytic Press) Each paper 
featured in this text forms a 
separate narrative strand that 
clarifies different configurations 
of the relationship between 
attachment and sexuality. The 
unifying thread is the notion 
that the attachment system, and 
particularly the degree of felt 
security—or lack thereof—in 
relation to early attachment 
figures, provides a paradigm for 
relationships that forms a scaf¬ 
fold for the developmental 
unfolding of sexuality in all its 
manifestations.These manifesta¬ 
tions include infantile and adult, 
masturbatory and mutual, and 
normative and perverse sexuality. 
Apoptosis and Cancer: 
Methods and Protocols 
edited by Gil Mor, m.d., ph.d., 
associate professor of obstetrics, 
gynecology and reproductive sci¬ 
ences, and Ayesha B. Alvero, m.d., 
associate research scientist in 
obstetrics, gynecology and repro¬ 
ductive sciences (Humana Press) 
This book, a collaboration 
between academics and industry- 
based scientists, describes the 
performance of contemporary 
techniques for studying the 
biology of apoptosis and its role 
in cancer. The protocols described 
within will aid both academic 
laboratory workers interested in 
further characterizing the 
mechanism of apoptosis and 
industry-based researchers con¬ 
cerned with identifying new tar¬ 
get molecules or screening for 
new compounds with potential 
clinical use. The text covers the 
newest methods as well as basic 
conventional techniques. 
Robert Edward Kennon, M.D. 
The Future of Medicine: 
Megatrends in Health Care That 
Will Improve Your Quality of Life 
by Stephen C. Schimpff, m.d. 
’67, hs ’69 (Thomas Nelson 
Publisher) This book describes 
and evaluates health care inno¬ 
vations in areas including 
genomics, imaging, pharmaceu¬ 
ticals, the operating room, and 
alternative and complementary 
medicine. The author combines 
scientific fact with personal 
stories and experiences to 
describe the tools, techniques 
and treatments that are mak¬ 
ing a difference in health care. 
These innovations include vac¬ 
cines that prevent cancer and 
chronic disease; surgery simula¬ 
tion and robots in the operat¬ 
ing room; and smaller, more 
powerful medical devices that 
help a patient’s heart beat, 
relieve depression and replace 
failing organs. 
Hip and Knee Surgery: A Patient’s 
Guide to Hip Replacement, Hip 
Resurfacing, Knee Replacement 
and Knee Arthroscopy 
by Robert E. Kennon, m.d., hs 
’04 (Lulu Publisher) This book 
contains information for patients 
considering treatment for hip or 
knee arthritis and related condi¬ 
tions.The author explains what 
to expect before, during and after 
hospitalization; describes postop¬ 
erative exercises; and offers rec¬ 
ommendations for rehabilitation. 
Illustrated sections discuss hip 
and knee surgeries; nonoperative 
treatment options; surgical 
approaches, the latest minimally 
invasive surgery techniques; 
implant materials and designs; 
and potential complications of 
joint surgery. 
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14 Books & ideas book notes IN CIRCULATION 
A Yale librarian upgrades Internet access for 
physicians in Uganda 
Neuroinformatics (Methods 
in Molecular Biology) 
edited by Chiquito J. Crasto, ph.d., 
m.s., associate research scientist 
in neurobiology (Humana Press) 
This book describes advances in 
data sharing and the use of 
computational models in neuro¬ 
science. It provides expert sum¬ 
maries of specific computational 
models and simulations as 
well as approaches to data min¬ 
ing.The authors also discuss 
informatics representation and 
approaches to the structural 
complexity of the brain using 
a variety of both traditional and 
noninvasive imaging methods. 
The book’s final section con¬ 
siders the value of using neuro¬ 
informatics to understand such 
complex mental disorders as 
dementia, schizophrenia and 
Alzheimer disease. 
Comfortably Numb: How 
Psychiatry Is Medicating a Nation 
by Charles M. Barber, m.f.a., 
lecturer in psychiatry (Pantheon) 
The author argues that without 
an industry to promote them, 
nonpharmaceutical approaches 
to reducing emotional distress 
are overlooked by a nation that 
sees drugs as instant cure-alls. 
He argues that Americans are 
under increasing pressure to self- 
medicate. In analyzing these 
influences, Barber cites direct- 
to-consumer advertising; the 
promise of the quick fix; and 
the blurring of the distinction 
between mental illness—for 
which medication might be 
appropriate—and everyday emo¬ 
tional problems. Barber then 
offers therapeutic alternatives 
to prescription antidepressants. 
Seldin and Ciebisch’s The Kidney: 
Physiology and Pathophysiology, 
4th ed. 
edited by Robert J. Alpern, m.d., 
dean of the School of Medicine 
and Ensign Professor of Medicine 
(nephrology), and the late Steven 
C. Hebert, m.d., former c.n.h. 
Long Professor of Cellular and 
Molecular Physiology and profes¬ 
sor of medicine (nephrology) 
(Academic Press) This edition 
has more than 40 new chapters 
and 1,000 illustrations, provid¬ 
ing comprehensive coverage 
of renal physiology and patho¬ 
physiology. The topics move 
from the molecular biology 
of the kidney and its cell physi¬ 
ology to clinical issues sur¬ 
rounding renal function and 
dysfunction. 
Before You Take That Pill: 
Why the Drug Industry May Be 
Bad for Your Health 
by ). Douglas Bremner, m.d., 
former associate professor of 
diagnostic radiology and psychia¬ 
try (Avery of PenguinGroup) The 
author offers an inside look at 
the pharmaceutical industry as 
well as a scientifically backed 
assessment of the risks of more 
than 300 prescribed medications, 
vitamins and supplements.This 
book distinguishes between the 
pharmaceuticals that are essen¬ 
tial to the health of consumers 
and those whose benefits may 
not outweigh their potential 
side effects. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, ct 06511, or via e-mail 
to cheryl.violante@yale.edu 
When librarian Mark Gentry, m.a., m.l.s., set out to expand 
Internet access at a hospital in Uganda, he experienced 
deja vu. “The speed of the Internet took me back 15 years to 
the beginning of the Web, when we had dial-up modems,” 
said Gentry, the clinical support librarian at the Cushing/ 
Whitney Medical Library. 
Gentry learned about the idiosyncrasies of satellite- 
based Internet service in Uganda when he joined the 
Yale-Makerere collaboration, a partnership that includes the 
School of Medicine, Makerere University and Mulago 
Hospital in Kampala. Since 2006 Yale attendings and resi¬ 
dents have traveled to Kampala for rotations at Mulago 
Hospital, and Ugandan residents are now coming to Yale 
for clinical training. 
While visiting Mulago Hospital in the spring of 2008, 
Gentry streamlined Internet use for physicians by setting up 
a home page that links directly to such often-used functions 
as e-mail and online journals. “Click: you go right to it. 
Because every time you get an intermediate page, you have 
to wait from 10 to 30 seconds,” said Gentry. Meanwhile a 
Yale resident compiled CDs that allow Ugandan colleagues 
to bypass the Internet—the disks contain copyright-free 
information on diseases such as hiv, tuberculosis and malaria. 
Gentry next began building up the library for the 
Department of Medicine at Mulago Hospital, where 
the medical textbooks were 20 years old. Gentry collected 
50 essential texts that were hand-delivered to Kampala. 
Up-to-date books are a godsend, said Ugandan resident Fred 
Okuku, m.d. During a five-month rotation at Yale last 
spring, Okuku discovered journal articles about research 
done in Uganda that he’d been unable to access at home. 
While in Uganda, Gentry promoted a free Internet 
service called hinari; sponsored by the World Health 
Organization for health care workers in developing coun¬ 
tries, it provides links to nearly 4,000 journals. 
Gentry said the Makerere collaboration has been a natu¬ 
ral extension of his work on Cedar Street. “Part of my job 
as a clinical support librarian is to do what I can to support 
our people wherever they are.” 
—Cathy Shufro 
In Circulation focuses on activities at the Cushing/Whitney Medical 
Library. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
ON CAMPUS 
Lawsuits could bankrupt 
vaccine program 
A program that encourages child¬ 
hood vaccinations could collapse 
under unproven allegations that 
the shots cause disease, an expert 
warned at grand rounds for the 
Department of Pediatrics in May. 
Paul Offit, m.d., chief of infec¬ 
tious diseases at Children’s 
Hospital of Philadelphia, said that 
the fallout from a 2008 court 
decision would discourage vac¬ 
cine makers from continuing 
production. Since 1955, when a 
bad batch of polio vaccine killed 
10 people, testing and regulation 
of vaccines have improved. But 
subsequent court rulings that 
vaccine makers could be held 
liable without being negligent 
led to "a flood of lawsuits” in 
the 1970s. 
In 1986 Congress created the 
National Vaccine Injury Com¬ 
pensation Program to protect 
vaccine makers while compen¬ 
sating those harmed by faulty 
vaccines. But Offit said that the 
program took "a sad turn” in 
2008 when a special "vaccine 
court” composed of epidemiolo¬ 
gists and clinicians ruled that 
claims can be granted even if 
it’s only possible—with no epi¬ 
demiological evidence—that 
vaccines are responsible. 
About 5,000 children who 
claim to be harmed as a result of 
vaccination await a decision 
that could bankrupt the vaccine 
program. If the decision allows 
for monetary compensation, 
"it could eliminate the program,” 
Offit said. 
—John Dillon 
A gene to protect bone marrow 
from chemotherapy 
In a new approach to cancer 
treatment, researchers are study¬ 
ing a form of gene therapy that 
may make bone marrow more 
resistant to chemotherapy, 
allowing for higher doses and 
better outcomes. 
"We are turning the tables,” 
said Joseph R. Bertino, m.d., 
interim director and chief scien¬ 
tific officer of the Cancer Insti¬ 
tute of New Jersey, at Yale Cancer 
Center grand rounds in May. "This 
therapy will allow for safer use of 
drugs and an increase in dosage. 
If we do this we can protect 
patients from a wide variety of 
chemotherapy drugs.” 
Bertino, who was director of 
the Yale Comprehensive Cancer 
Center from 1973 to 1975, said 
this approach calls for introduc¬ 
ing a drug-resistant gene into 
hematopoietic progenitor cells. 
That could limit the drugs’ tox¬ 
icity and preserve the marrow’s 
ability to produce infection¬ 
fighting white blood cells. 
Oncologists would then be able 
to prescribe higher doses of 
chemotherapy, potentially lead¬ 
ing to improved outcomes. 
Bertino said two clinical 
trials—one for lymphoma and 
another for pancreatic and 
breast cancer—are in the plan¬ 
ning stages. 
—.John Curtis 
Children, foster care 
and orphanages 
When Nicolae Ceau§escu took 
power in Romania in 1965, he 
believed that his country needed 
a larger work force. He decreed, 
said Charles H. Zeanah Jr., m.d., 
Sellars-Polchow Professor of 
Psychiatry at Tulane University, 
that all women must bear 
five children. 
The economy didn’t improve, 
Zeanah told an audience at pedi¬ 
atric grand rounds in May, but 
more children entered the coun¬ 
try’s orphanages."Children with 
a history of institutional rearing 
have a high risk of psychological 
and social problems,” Zeanah 
said. In 2000, Zeanah and Charles 
Nelson, ph.d., of Harvard and 
Nathan Fox, ph.d., of the 
University of Maryland began a 
four-year study of 136 children 
who ranged in age from 7 to 33 
months, and found that their 
development lagged in most 
areas. Half of the 136 children 
were then placed in foster 
care, previously unavailable in 
Bucharest, and half remained 
in institutions. 
Foster care enhanced devel¬ 
opment in most areas, but 
complete recovery was rare. For 
cognitive development and 
attachment, recovery seemed 
to have more to do with the 
timing of interventions than 
their duration. Children who 
entered foster care before their 
second birthday, Zeanah said, 
were more likely to recover 
from the severe deprivations 
of Romanian orphanages. 
—J.C. 
Bolero, dementia and 
the creative process 
In 1930, when Maurice Ravel 
composed Bolero, his best-known 
work, he may have been in the 
throes of frontotemporal demen¬ 
tia (ftd), a neurodegenerative 
disease that usually affects 
people in their late 50s. Ravel’s 
meticulous handwriting had 
become irregular, he had lost his 
bags and tickets on a concert 
tour and, while conducting one 
of his works, he had uncharacter¬ 
istically skipped from the open¬ 
ing movement to the coda. 
In a talk at neuroscience grand 
rounds in May, Sarah C. Janicki, 
m.d., m.p.h., hs ’08, said Ravel’s 
case is not unusual—ftd has 
been linked to strong bouts of 
creativity. “Over time a series 
of patients were coming to light, 
patients with ftd developing 
creative skills,” she said. 
Although the reasons for 
this connection are not clear, 
the brain’s left temporal lobe 
appears to be involved. And 
the disorder appears to release 
artistic inhibitions—artists 
move from representational to 
more abstract forms of expres¬ 
sion. But as the disease pro¬ 
gresses, that process reverses 
itself. "As [the patients’] lan¬ 
guage skills declined, their art 
became fairly representational 
instead of a creative manipula¬ 
tion to generate new thought," 
Janicki said. 
—J.C. 
i6 capsule 
The Dragons of Eden, a book by the 
astronomer Carl Sagan that explored the 
evolution of the human brain. Dragons 
won the 1978 Pulitzer Prize for general 
nonfiction and helped to launch Sagan’s 
celebrity as a spokesman for science in 
the 1980s. 
The real star of the book, however, 
was a theory of human neural organi¬ 
zation that took root some 30 years 
earlier in writings by Paul D. MacLean, 
m.d. ’40. MacLean, who died last 
December at age 94, was a highly 
original—some say eccentric—thinker 
whose model of the triune brain, 
though now discredited, has had a last¬ 
ing cultural impact. 
“Paul never traveled with the herd,” 
said Thomas R. Insel, m.d., director of 
the National Institute of Mental Health, 
who worked alongside MacLean for 
10 years at the Laboratory of Brain 
Evolution and Behavior in Poolesville, 
Md. Insel remembers his colleague 
as irreverent and uninhibited. MacLean 
once roamed through a room, Insel 
recalled, feeling the scalps of visiting 
scientists to ascertain the presence 
or absence of a skull protuberance he 
had deemed an important factor in 
the evolution of human intelligence. 
The beginnings of MacLearis theory 
appeared in a 1949 paper just as 
he joined the faculty of the School of 
Medicine as an assistant professor of 
physiology with a joint appointment in 
psychiatry. After conducting electro- 
encephalographic recordings in patients 
In Paul MacLean’s triune brain, primitive emotions 
overruled conscious thoughts. 
with psychosomatic illnesses and 
I epilepsy at Massachusetts General 
; Hospital, MacLean had become 
convinced that the emotional compo¬ 
nents of these disorders were seated 
in deep brain structures that he called 
the visceral brain (and renamed the 
limbic system in 1952), which included 
the hippocampus, amygdala and 
cingulate gyrus. 
Since all mammals possess variants 
of these structures, MacLean concluded 
that they are phylogenetically ancient 
and that the emotional responses they 
produce are only weakly regulated by 
such newer, human structures as the 
neocortex. “Our affective behavior con¬ 
tinues to be dominated by a relatively 
: crude and primitive system,” he wrote. 
Twenty years later, MacLean rounded 
| out his picture of the triune (three 
in one) brain by adding what he termed 
the R-complex (for “reptilian”)—struc¬ 
tures in the brain’s core and brain stem 
that govern basic survival functions— 
to the neocortical and limbic systems he 
had defined previously. 
The theory saw its fullest expression 
in MacLearfs 1990 magnum opus, The 
' Triune Brain in Evolution, which was 
based on wide-ranging anatomical stud¬ 
ies of brains in animals as diverse as 
alligators and monkeys. In its casting of 
a cognitively sophisticated neocortex 
unable to fully restrain the primal emo¬ 
tional responses of the limbic system, 
MacLearfs model was a neuroanatomi- 
cal cousin to Freud’s tripartite view of 
the mind, with its warring superego, 
ego and id. The theory’s conceptual 
beauty and intuitive appeal lent it enor¬ 
mous staying power; it is still covered 
in many textbooks and course lectures 
in biological psychology. 
But according to Terrence Deacon, 
ph.d., an expert on the evolution 
of human cognition at the University 
of California, Berkeley, subsequent 
research has revealed that MacLean’s 
basic premise—his ‘“hats on top of 
hats’ view” that brain systems were 
added by accretion over the course of 
evolution—was mistaken. “Adding 
on is almost certainly not the way the 
brain has evolved,” said Deacon. 
“Instead, the same structures have 
become modified in different ways in 
different lineages.” 
Nonetheless, Deacon said, the force 
of MacLean’s personality gave his 
ideas a special resonance. “His death 
represents the passing of an era, 
because he was really the model of 
the move towards understanding the 
brain in evolutionary terms,” said 
Deacon. “A lot of our contemporary 
advances ride on top of his work, 
even though in hindsight it was mis¬ 
leading. That happens a lot in the 
sciences, and we don’t often give credit 
to the false starts that really push us 
along the way.” 
Peter Farley is the managing editor of the 
bimonthly newsletter Medicine&Yale. 
opposite Paul Maclean believed that the 
neocortex was a relatively late development 
in the mammalian lineage, but there is now 
a consensus that homologues of this structure 
exist in simple fish, and even in insects. 
BELOW In MacLean’s triune brain (top), the 
neocortex has only partial dominion over 
the emotional responses of the more primitive 
limbic system (bottom). "This situation,” 
he wrote, “provides a clue to understanding 
the difference between what we ‘feel’ and 
what we ‘know.’ ” 
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Mapping 
the future 
of medicine 
Medical schools are relatively new to the game of large-scale clinical 
research; however, they are sponsoring studies to test new therapies 
with increasing frequency. With its largest grant ever, Yale is plunging 
headlong into human trials and assembling resources to help clinical 
scientists focus on ideas—and leave the red tape to others. 
By Jill Max 
Illustrations by Jeffrey Fisher 
19 
About six years ago, Thomas O. Carpenter, m.d., professor of 
pediatrics (endocrinology), wondered why he was seeing an 
increasing number of infants with nutritional rickets. He 
examined some of the infants’ medical records and found that 
although rickets is presumed to be caused by a vitamin D defi¬ 
ciency, fewer than half of the infants had low levels of the vita¬ 
min. Many appeared to be calcium-deficient as a result of 
being weaned from breast milk to juices and soda. With fund¬ 
ing from the Gerber Foundation, Carpenter began a large- 
scale three-year study in 2005 that involved 800 babies from 
inner-city New Haven health clinics and the Primary Care 
Center at Yale-New Haven Hospital. By screening infants at 
their well-child visits, Carpenter aims to define the prevalence 
of early rickets in New Haven, determine how much of it is 
due to vitamin D deficiency versus calcium deficiency and 
look for changes in biomarkers that can be spotted before 
bone disease is evident. The study is already showing results: 
Carpenter found that elevated levels of parathyroid hormone, 
which is used to diagnose rickets, can also be used to predict 
who may eventually develop the disease, so that doctors can 
begin to treat children to ward off the disorder before symp¬ 
toms are present. He is also searching for other genetic factors 
that may represent an increased susceptibility to the disease. 
Such clinical research is not a novelty at Yale. But these 
efforts are now being organized and supported on a much 
broader scale under the umbrella of the Yale Center for 
Clinical Investigation (ycci). The center was launched in 
early 2006 to coordinate research programs among Yale’s 
health science schools and the surrounding community. It is 
also intended to support faculty research efforts while at the 
same time ensuring that patients are protected and receive 
high-quality care, ycci’s mission dovetails with the National 
Institutes of Health (nih) Roadmap for Medical Research, 
which was implemented in 2002 near the end of a five-year 
period in which Congress doubled the nih budget. The 
Roadmap helped garner public support for NiH-supported 
research and provided a framework for bringing medical 
knowledge from the laboratory to the patient. In October 
2006 the School of Medicine was one of 12 institutions 
around the country to receive a Clinical and Translational 
Science Award (ctsa); at $57.3 million the five-year award is 
by far the largest nih research grant in the school’s history 
(see related story, page 24). When fully implemented in 2012, 
the ctsa initiative is expected to provide $500 million annu¬ 
ally to 60 academic health centers working in concert, nih 
Director Elias A. Zerhouni, m.d., said that ctsa will “trans¬ 
form how clinical and translational research is conducted.” 
Yale has traditionally been strong in basic science and 
has been successful in identifying drug targets and such 
other methods of combating disease as tissue engineering or 
large-scale public health interventions aimed at disease pre¬ 
vention. But until recently a center for translating basic sci¬ 
ence discoveries into clinical practice had never taken hold. 
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20 Mapping the future of medicine 
“We just never had the necessary resources to set up the 
infrastructure we’re able to have now,” said Robert S. 
Sherwin, m.d., the c.n.h. Long Professor of Medicine and 
director of ycci. The center is a one-stop shop that provides 
the support investigators need to translate their work from 
the bench to the bedside, ycci is accomplishing this task 
through a mix of such initiatives as helping investigators 
implement their own clinical trials, nurturing a new genera¬ 
tion of physician-scientists and clinical investigators, and 
supporting collaborations with local organizations to pro¬ 
mote public health. 
Expertise and an online database 
No one is more cognizant of the difficulties of negotiating 
the clinical trial maze than Christopher K. Breuer, m.d., 
assistant professor of surgery (pediatrics) and pediatrics. 
Breuer and Toshiharu Shinoka, m.d., ph.d., director of 
pediatric cardiac surgery at Yale-New Haven Children’s 
Hospital, have developed a technique for engineering blood 
vessels to connect the inferior vena cava to the pulmonary 
artery. Known as Fontan surgery, the technique corrects a 
single-ventricle anomaly—a heart defect in which a patient 
has a weakened or single ventricle instead of the usual two. 
Breuer starts by seeding mononuclear cells isolated from a 
patient’s bone marrow onto a tube made from a synthetic 
material similar to that used to make absorbable sutures. 
The cells attach to the synthetic scaffold and form new tissue; 
as the tissue forms the scaffold degrades, leaving a purely 
biological vessel. Blood vessels grown from a patient’s own 
cells are less prone to infection than the artificial vessels 
that have traditionally been used in this surgery. The natural 
vessels are biocompatible and—perhaps most important 
for pediatric applications—they grow with the child, preclud¬ 
ing the need for further surgery. 
When Breuer began experimenting with tissue engi¬ 
neering in the early 1990s, he broke down a blood vessel 
into its cellular components in order to grow a new one. 
But this approach required additional surgery to procure the 
blood vessel and up to four months to grow the cells in 
culture and allow them to attach to the scaffold. He can 
now perform a bone marrow aspiration, isolate a special 
fraction of stem cells, seed them onto the scaffold, and 
implant the engineered vessel into the patient in a single 
procedure that lasts about six hours. 
Breuer is about to begin a Phase I study to test the 
procedure’s safety. He plans to try it in six patients over the 
next three years, staggering enrollment so that each patient 
can benefit from the one before. Although Shinoka has suc¬ 
cessfully performed the procedure on 23 patients in Japan, 
the regulatory requirements in the United States are more 
demanding. “One of the biggest challenges is the regulatory 
requirements,” said Breuer. “ycci has offered a lot of help 
and expertise.” 
21 
Breuer is now well versed in running a clinical trial. 
For other researchers who lack the experience to put together 
an effective study, however, ycci offers expertise in trial 
design, regulatory issues, protocol development, biostatistics 
and epidemiology, budget and recruitment. The center also 
offers research nursing support, data management, laboratory 
services, and both inpatient and outpatient facilities to conduct 
trials. A new online database at yaletrials.org provides detailed 
information about all clinical trials at Yale, so that patients 
interested in a specific disease can search for a trial related to 
it. ycci also integrates the efforts of Yale’s institutional review 
boards (irbs) into the process. These panels, comprising 
clinicians, faculty, students and members of the community, 
must approve every research project that involves humans, 
even a paper-and-pencil survey. Tire medical school’s two irbs 
meet weekly to discuss the several hundred new proposals 
and more than 1,500 requests to renew ongoing studies that 
come their way each year. 
In the world of clinical trials, some studies, such as 
Breuer’s work, attempt to treat an existing condition, while 
others try to answer basic questions about the course of dis¬ 
eases or ways to prevent them. Carpenter’s work does both. 
His nutritional rickets study is helping doctors treat the dis¬ 
ease before it can do damage, but he also conducts research 
on X-linked hypophosphatemia (xlh), the most common 
form of inherited rickets in the United States, xlh can lead to 
deformed bones and debilitating arthritis. Carpenter estab¬ 
lished the Yale Center for xlh, an NiH-sponsored Center of 
Research Translation (cort), one of eight in the country that 
serve as a model of translational research in academic medical 
centers. Some of the center’s projects interface with ctsa, 
such as clinical trials studying the effect of a medication 
specifically aiming to suppress the hyperparathyroidism that 
occurs with xlh. Carpenter is also conducting an observa¬ 
tional study to characterize the disease in patients past child¬ 
hood and he is trying to determine the chemical and skeletal 
features of xlh in older patients. “Understanding the disease 
has opened up a whole new mechanism of how minerals are 
regulated in the body,” said Carpenter. That area of research 
includes new therapies applicable not only to xlh but also to 
other disorders in which the body’s handling of phosphate has 
gone amiss, such as chronic renal failure. 
Focus on training 
Perhaps the single most important aspect of the ctsa—and 
by extension ycci-—is training young researchers to con¬ 
duct clinical studies. “In the past, most physicians learned 
on the job, sort of like an apprenticeship,” said ycci Director 
Sherwin. “But the kind of sophistication that’s now required 
to do clinical research and the kind of mentorship background 
you need to do research today are much more involved than a 
simple apprenticeship.” The Investigative Medicine Program, 
which serves as the administrative home for the educational 
component of ycci, was developed at the School of Medicine 
in 1999 to award the ph.d. to physicians training in clinical 
research. Under the ctsa it has expanded to offer courses 
to medical, nursing and public health students. In addition, 
20 junior faculty members and senior fellows who are com¬ 
mitted to careers in clinical or translational research have 
received 18-month grants for salary and research support 
through ycci’s Scholar program. Drawn from the three Yale 
health schools, the grant recipients are pursuing research 
projects under the guidance of individualized mentorship 
committees. “We’re investing in them like we invest in 
training a ph.d., which involves having people from diverse 
backgrounds looking at their work from different perspec¬ 
tives,” said Sherwin. 
The work of Mary E. Tinetti, m.d., director of the 
Yale Program on Aging, serves as an example of the kind 
of research the program strives to advance. While training 
in geriatrics more than 20 years ago, she recognized that 
a slew of health conditions—such as incontinence, delir¬ 
ium and injuries caused by falls—were neglected by the 
health care system yet have a major impact on quality of life 
and functioning. 
Tinetti identified characteristics linked to an increased 
risk of falls and conducted a study to determine whether 
interventions targeting these risk factors would prevent 
falls and injuries. Until that time, most clinical trials 
focused on a single intervention; however, Tinetti and her 
colleagues developed a new multifactorial trial design in 
which patients receive a combination of interventions tailored 
to their particular risk factors. For example, the intervention 
for patients who experience a drop in blood pressure when 
moving from lying or sitting to standing consists of 
increased hydration, specific exercises to do before getting 
up, and a reduction in medications likely to affect blood 
pressure changes on standing. In the mid-1990s, Tinetti and 
colleagues followed a group of 320 patients and controls for 
two years and found that patients who received such inter¬ 
ventions reduced their risk of falling by about 30 percent. 
The next step was to see whether this reduction in falls would 
also occur when real-world clinicians, rather than investiga¬ 
tors, were responsible for carrying out the interventions. For 
the past eight years, she and colleagues have been conducting 
a study in the greater Hartford area to train health care prac¬ 
titioners to incorporate components of fall prevention into 
their practice. The real-world trial was funded by the West 
Hartford-based Donaghue Medical Research Foundation, said 
Tinetti, the Gladys Phillips Crofoot Professor of Medicine 
(geriatrics) and professor of epidemiology (chronic diseases) 
and investigative medicine. 
In an article published in the New England Journal of 
Medicine in July, Tinetti and her colleagues reported that the 
fall prevention programs resulted in an 11 percent reduction in 
falls compared to the control group, and 10 percent fewer 
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22 Mapping the future of medicine 
fall-related hip fractures and head injuries. The reduced injury 
rate translated into some 1,800 fewer emergency room 
visits over a two-year period and health care savings esti¬ 
mated at $21 million. 
“The research is done,” Tinetti said. “The next step is 
to put it into practice, by making physicians, nurses and physi¬ 
cal therapists everywhere more conscious of fall risks among 
their patients and what can be done to prevent falls.” 
From bedside to community 
Tinetti s application of her research to clinical practice ties in 
with another major goal of ycci—forging research relation¬ 
ships with the local community to improve public health. 
The Community Alliance for Research & Engagement (care), 
supported in part by ycci, fosters community-based research 
and translates these findings for the benefit of New Haven- 
area residents. “The specific goal of care is to go from bed¬ 
side to the community,” said Jeannette R. Ickovics, ph.d., 
deputy director of care and professor of epidemiology 
(chronic diseases) and public health and of psychology. The 
first major initiative of care was to sponsor a consensus 
conference in 2007 with more than 70 leaders from New 
Haven and Yale, care has awarded five grants totaling 
$110,000 for pilot research projects—including childhood 
obesity and violence prevention, care also publishes 
a quarterly newsletter highlighting community-based 
health information about how research is conducted, and 
“CAREtips”—easily accessible recommendations based on 
faculty findings. “There are so many important discoveries 
at Yale that land in the major medical journals but never 
benefit our neighbors right here in New Haven,” said 
Ickovics. “We’re looking to take the work of excellent Yale 
scientists and really give the science away. Our goal is 
to improve health in New Haven.” 
Even when investigators reach the point where they 
are conducting trials with study participants, they often 
continue working in the lab. For example, as Breuer pre¬ 
pares for the clinical trial to implant tissue-engineered 
blood vessels in children, he is experimenting with mice 
to discover the mechanism that forms the new tissue. 
Working with colleagues in biomedical engineering, he has 
isolated the protein responsible for maintaining the vessel’s 
lumen (inner cavity), a finding that may eliminate the 
need for bone marrow aspiration in the next generation 
of tissue-engineered grafts for humans. Every investiga¬ 
tion has the potential to advance the prevention and treat¬ 
ment of disease. The structure provided by ycci is helping 
clinical investigators from different disciplines to pool 
their efforts, learn from one another, and take advantage 
of their collective expertise. “That’s how progress is,” 
said Breuer. “Everyone adds their own tiny step, and in the 
end you’ve gone a long way.” ym 
Jill Max is a freelance writer in Trumbull, Conn. 
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Patient-volunteers help 
find cures on medicine’s 
front lines 
Every day at the medical school, 
patients and control subjects 
undergo imaging tests, hop on 
treadmills and swallow medica¬ 
tions in the name of advancing 
knowledge. Some do it to con¬ 
tribute to society and research, 
some are lured by the payments 
offered, and some hope to help find 
a cure and ease a loved one’s suf¬ 
fering or that of future patients. 
That last consideration is what 
motivated Kriste Gill to enroll her 
newborn twins in a study on early 
indications of autism. A speech 
pathologist with a professional 
interest in the study. Gill also has 
a 22-year-old brother with autism. 
“I get to give back to research for 
a disability that's very near to us,” 
she said. For the past two years, 
Gill’s babies have undergone 
developmental assessments.The 
exams are not physically invasive, 
and Gill has learned much about 
the twins’ development. And if 
any signs of autism should surface, 
she’s confident the research team 
would flag them and recommend 
next steps for further evaluation. 
A different concern brought 
Jan Davey into the Kronos Early 
Estrogen Prevention Study (keeps), 
a study to determine whether early 
menopausal hormone therapy 
prevents or delays heart disease. 
Davey, 61, has a 27-year-old daugh¬ 
ter and sees the need for research 
that may benefit future genera¬ 
tions of women. Participants 
commit to taking hormones or a 
placebo as well as undergoing 
periodic lipid profile tests and vagi¬ 
nal ultrasounds for four years. As 
a clinical research nurse in Cardio¬ 
vascular Medicine and at Yale 
Cancer Center, Davey understands 
the demands and rewards of 
clinical trials but had never before 
participated in one. “It’s a very 
important part of what we do in 
health care,” she said. 
Some participate in hopes of 
obtaining treatment for a disease 
from which they or a loved one 
suffer. Terri Rathbun’s 16-year-old 
daughter, Molly, has childhood 
absence epilepsy—short seizures 
in which the person appears to 
blank out. Her condition has not 
responded to medication. To assess 
Molly’s brain function, she under¬ 
went mri scans while performing 
cognitive tasks. Her mother is hop¬ 
ing the study will benefit other 
children; in the meantime, it has 
helped her recognize how well 
Molly has coped while living with 
seizures. According to her mother, 
Molly hopes that participating in 
this study “will open up opportuni¬ 
ties for other kids so that seizures 
don’t define their lives.” 
For cancer patients Kathy Willie 
and Geralyn Spollett, a trial for 
treatment of HER2-positive breast 
cancer was a chance to receive 
chemotherapy that might have 
reduced or eliminated their tumors 
before surgery. Willie initially didn’t 
want to undergo chemotherapy, 
but her decision paid off; during a 
partial mastectomy her surgeon 
found no trace of the tumor. 
Although the treatment didn’t 
change the course of Spollett’s 
treatment—she ended up needing 
a mastectomy as well as chemo¬ 
therapy and radiation—she 
believes it was a positive experi¬ 
ence. "I felt lucky to be in the trial 
because of the consultation and 
support," said Spollett, who will 
have follow-up blood work in 
September. 
Social responsibility also moti¬ 
vates patients. Jean O’Brien, 65, and 
her daughter Stephanie, 32, have 
X-linked hypophosphatemia (xih), 
the most common form of inher¬ 
ited rickets in the United States. 
They joined in a study designed to 
define the features of the disease in 
adults. “It’s a few days out of my 
life that could change someone 
else’s life,” said Stephanie, referring 
to two days of bone scans, X-rays 
and ultrasounds at Yale-New Haven 
Hospital. “My generation is writing 
the textbook on this disease,” said 
Jean, who hopes the study will 
benefit her grandson and future 
grandchildren. 
Clinical trials require not only 
sick but also healthy subjects. 
One 76-year-old woman partici¬ 
pates in the Alzheimer Disease 
Neuro-imaging Initiative even 
though she is healthy. As part of 
the three-year study she gets mri 
and PET scans every six months 
so that researchers can compare 
the mental changes that occur 
in normal aging, mild cognitive 
impairment and Alzheimer dis¬ 
ease. She hopes that the trial 
will lead to a cure that will help 
family members and friends 
who have the disease. 
Because he has a family history 
of heart disease, 27-year-old Niall 
McComiskey agreed to a stress 
test on a treadmill, administra¬ 
tion of adenosine to increase 
his heart rate and a pet scan. 
McComiskey also said that the 
$200 he was paid didn’t hurt, and 
for some people, financial com¬ 
pensation is reward enough. For 
others, it’s a combination of fac¬ 
tors that spur them to partici¬ 
pate. One 40-year-old veteran, 
a recovering alcoholic and addict 
who suffers from post-traumatic 
stress disorder, had two reasons 
for undergoing pet scans as part 
of a study to measure the levels 
of neurotransmitters in brain tis¬ 
sue. He wanted to understand 
the chemical imbalances in his 
brain; he was also paid about 
$700 to participate in the study. 
Thomas O. Carpenter, M.D., pro¬ 
fessor of pediatrics (endocrinol¬ 
ogy), offers a $25 grocery card 
to participants in his nutritional 
study, which he said is an effect¬ 
ive incentive. 
Such are the rewards of clinical 
studies that patients often repeat 
the experience. Jan Davey, who is 
participating in the keeps study, 
has also signed up for three ancil¬ 
lary studies. “We wouldn’t be 
where we are in health care if we 
hadn’t been doing clinical research 
all these years,” she said. 
—Jill Max 

Is the straight road too narrow? 
Congressional demands for cures and accountability-™combined with 
a flat nih budget-—have increased pressure on scientists to produce 
findings with direct application to disease. Nonetheless, there's great 
value in cultivating the art of finding what you're not looking for. 
By Pat McCaffrey 
Illustrations by Jeffrey Fisher 
The stereotype of the basic researcher—driven by curiosity, 
absorbed in the arcane, immune to practical considerations— 
is only half right. The need to unravel a puzzle, to uncover 
the beauty and order in biological systems, or simply to 
follow one’s nose, asking and answering questions, is both 
the initial impulse and sustaining force for many a career 
in basic research. Yet these scientists are not indifferent to 
the practical applications of their work. They are just not 
starting out with that particular end in mind. 
Take structural biologist Thomas A. Steitz, ph.d., 
Sterling Professor of Molecular Biophysics and Biochemistry. 
Beginning with his doctoral work more than 40 years ago, 
Steitz has fixated on one question: How do proteins and 
nucleic acids carry out their diverse jobs in cells? For Steitz, 
that question is best answered by looking at the macro¬ 
molecule’s shape; he is a leader in charting the topology of 
proteins and nucleic acids at the atomic level. 
Steitz and his team were the first to see one particu¬ 
larly important biological machine eight years ago when 
they solved the molecular structure of the large subunit of 
the ribosome, the protein-making factory inside all cells. 
That discovery, coming after five years of effort, a few dead 
ends and a little luck, has turned out to have practical 
benefits. Many antibiotics work by interfering with the func¬ 
tions of bacterial ribosomes. Steitz’s lab was soon busy 
looking at the ways in which antibiotics recognize and bind 
to the bacterial large ribosomal subunit and shut it down. 
Hard data about molecular interactions are like gold to sci¬ 
entists looking to design new antibiotics—as they are now 
doing in a company that Steitz helped found. 
“When I started solving protein structures as a gradu¬ 
ate student, I had no idea, nor did anyone else, that this 
would ever be of any practical benefit whatsoever,” Steitz 
says. “We just wanted to know, how does this machine 
work? ... Our work has led to translational research, but 
it wasn’t the goal. I never thought that I would end up build¬ 
ing a pharmaceutical company around the study of the 
structure of the ribosome.” 
It is a cliche of scientific exploration that even the 
most esoteric work can yield unexpected benefits. From 
synthetic insulin, the first biotech drug (a result of studies 
of bacteria) to the latest frontier of RNA-based therapies 
(started by work in worms), Steitz posits that every single 
medical discovery of major importance made over the last 
30 years has its roots in basic research. “If you trace back 
through the history of molecular biology, which made bio¬ 
technology possible, you find that it all came from basic 
research,” he says. 
So why are Steitz and his colleagues so worried about 
the future of creative, idea-driven biological research? He 
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26 Is the straight road too narrow? 
and researchers like him are proof that investments in ideas 
and individuals can and do pay off handsomely for human 
health. Nonetheless, these days a combination of painfully 
lean budgets at the government agencies that fund basic 
research, coupled with a current fashion for applied, disease- 
oriented studies (see related story, page 18) have basic 
researchers asking where their next grant—not to mention 
the next generation of like-minded scientists—will come from. 
Risk management 
“What really gets me excited is a brand new project,” says 
fruit fly researcher Lynn Cooley, ph.d., professor of genetics 
and cell biology. 
Cooley is fascinated by egg production in female fruit 
flies, a process that reveals the ways in which the flies’ cells 
communicate and cooperate in order to form nurturing envi¬ 
ronments for developing eggs. Although her work has some 
application to the growth and spread of human cancers, 
Cooley’s research is guided by her team’s latest experiments. 
“When a set of experiments opens doors to unexplored 
areas of biology, that’s the fun part,” she says. “That’s what 
makes it exciting to go into the lab every day.” 
The harder part is finding the funding to support her 
quest. The bedrock of basic biomedical research in the 
United States has long been the investigator-initiated research 
grant from the National Institutes of Health (nih), known 
as an ROi. These grants cover salaries and laboratory expenses 
for an investigator and a few junior scientists to work 
on projects of their own design. ROi grant applications are 
25-page proposals that are reviewed by committees of 
researcher’s peers, who judge their merits and recommend 
the best for funding. The system has worked well for years 
to cull out the most promising new research for nih support. 
And that research has been well supported. With 
a total nih budget of $29.5 billion in 2008, the United 
States leads the world in its funding of basic research 
m the biological sciences. Half of all federal funds devoted 
to scientific research are funneled to biomedical research 
through the nih. That money pays for 80 percent of 
biomedical research done in the United States. Support 
for basic research boomed during the years between 1998 
and 2003, when Congress oversaw the doubling of the 
nih budget. The ROi program was a major beneficiary 
of the increase. 
“The fact is that the nih has put us far ahead of the 
curve in biomedical research,” says Cooley. “And we have 
seen a huge payoff from research at the extremely basic 
level. Look at the examples of therapeutic rnas or stem cells. 
In both cases, the researchers were driven by curiosity as 
to how organisms develop from single cells to complicated 
systems. Who would have known that their work would 
become the underpinnings of some of the biggest therapeu¬ 
tic advances well see over the next decades?” 
But what Congress gives, it can also take away. Since 
peaking in 2004, nih funding has flatlined at $29.5 billion, 
and next year’s proposed budget looks to be more of the 
same. While Congress often kicks in a little more money to 
keep programs from further cuts, the effects of inflation 
mean that the nih is operating with 13 percent less buying 
power than it had in 2004. 
On top of that, the demand for ROi funding is higher 
than ever. During the doubling period, the whole research 
enterprise grew as universities and academic medical cen¬ 
ters expanded basic research facilities and faculties. That 
expansion takes time, so the nih saw only modest growth in 
the number of grant applications received during the dou¬ 
bling years. As a result, a larger proportion of grant applica¬ 
tions were funded. In the first two years of flat budgets, 
however, the number of grant applications doubled as new 
researchers came on line, and success rates in obtaining 
grants plummeted. 
There is no relief in sight. According to a budgetary 
analysis by the American Association for the Advancement of 
Science, under the proposed 2009 nih budget, the number 
of new grants, the average size of a grant, and the expected 
success rate for grant applications are all expected to fall. 
“I have two new projects I’m really excited about but 
also kind of nervous,” admits Cooley. “The most exciting 
projects are the ones that are hardest to fund because they 
tend to be the risky ones—ones where our lab has no track 
record — and there’s not a big field of established work to 
point to and show where we fit in.” 
Lean times force funding agencies like the nih to be 
more conservative and favor surefire bets. That means that 
finding support for innovative science can go from difficult 
to impossible as budgets shrink, says Richard A. Flavell, 
ph.d., chair and Sterling Professor of Immunobiology, pro¬ 
fessor of biology and an hhmi investigator. “Grant reviewers 
still recognize research that is new and exciting and worth 
taking a chance on. But in a super-competitive environment, 
those off-the-wall, risky, creative projects lose out,” he says. 
Enter the Roadmap 
Money, or lack of it, is not the only threat basic researchers 
perceive. Many report a growing unease with the wider 
world’s view of their work, and with what some think is a 
mistaken assessment of its value. Among researchers, there 
is a palpable feeling that a recent and highly visible growth 
in support for clinically oriented translational research 
programs means less funding for basic research. In this 
regard, some re-searchers blame a set of programs collec¬ 
ted), under the direction of Robert S. Sherwin, m.d., the 
c.n.h. Long Professor of Medicine, received a $57.3 million 
grant in 2006—the largest single nih grant ever given to 
Yale. That grant included existing grants to Yale of $25.8 mil¬ 
lion, so the net increase to Yale was $31.5 million. Another 
recent nih award supports the training of medical students 
to carry out clinical research. 
No matter the merit of those programs, they create 
a perception problem, says Carolyn W. Slayman, ph.d., 
Sterling Professor of Genetics and deputy dean for academic 
and scientific affairs. Compared to an average ROi grant 
of about $1 million over four years, the new awards were 
eye-popping. “To starving scientists who are worrying about 
TAe NIH is not the Academic Scientist, Employment Act. 
ItS a imnMe from Congress to create a biological basis 
for improved therapies ajid for improving health care! 
- Immunologict Jordan Yoher 
tively called the nih Roadmap for Medical Research for 
draining support from their labs. 
The Roadmap had its start at the end of the period of 
rapid budget growth. Anticipating that the public and its 
representatives in Congress would be looking for payoff on 
their investment, the then-new nih director, Elias Zerhouni, 
m.d., initiated a mass consultation in 2002 with hundreds 
of scientists to identify gaps in nih programs. Over the 
course of a year, Zerhouni identified areas in which the nih 
might do a better job of supporting multidisciplinary teams 
as well as translational and clinical research. The process 
was dubbed the Roadmap; its first projects began in 2004. 
There was controversy about the Roadmap from 
the beginning. Just as ROi funding was tightening, basic 
researchers watched money flow to translational research, 
multi-investigator grants and clinical research. 
The School of Medicine has certainly benefited from 
that funding stream. The Yale Center for Clinical Investigation 
their own ROi, it’s hard to see Roadmap grants awarded in 
huge and very visible chunks of $20 or $40 or $50 million,” 
Slayman says. “Their immediate reaction is, how many 
laboratories like mine could be kept going very happily for 
years with that money?” 
Even so, the idea that the Roadmap is a drag on basic 
science funding is exaggerated, says Jordan S. Pober, m.d., 
ph.d., professor of immunobiology, pathology and dermatol¬ 
ogy and vice chair of the Section of Human and 
Translational Immunology. 
The numbers support his view. Taken together, 
Road-map projects account for less than 2 percent of the 
total nih budget; moreover, fully half of Roadmap fund¬ 
ing goes to individual researchers in the form of ROi 
or similar grants. The real culprit, Pober says, is the stag¬ 
nation of the overall budget. His message: “There is 
pain, to be sure. But don’t blame the Roadmap, blame 
the budget.” 
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28 Is the straight road too narrow? 
Moreover, the activities championed by the Roadmap 
are necessary for the nih to fulfill its goal to improve 
people’s health, Pober says. “The nih is not the Academic 
Scientist Employment Act. It’s a mandate from Congress 
to create a biological basis for improved therapies and for 
improving health care.” 
The Roadmap initiative just happened to come at the 
same time as the nih budget stagnated and the chances 
to obtain ROi funding decreased dramatically, says feremy 
M. Berg, ph.d., the director of the nih’s National Institute 
of General Medical Sciences, which primarily supports 
basic, nondisease-targeted research and is heavily involved in 
over the rocks in the field of biology and see what is under¬ 
neath. And that means an investigator in a lab working 
steadily over years and decades. That means Steitz tinkering 
with the ribosome. It means Cooley finding out how flies 
make eggs. 
That theme—the long and winding road from disease 
to cure—was echoed in a recent editorial in the journal 
Science. Editor in chief Bruce Alberts, ph.d., argued elo¬ 
quently for the importance of basic research in spurring 
medical progress. 
“We have all been taught that the shortest distance 
between two points is a straight line," Alberts writes. “But 
We have all been taught that the shortest distance between, 
two points is a straight line.hut the same idea, has repededhj 
proven not to he true for progress in medical research. 
-ScttfflCC ediW Bruce Alberts 
Roadmap activities. “That does not mean those events are 
causally related.” 
On the contrary, Berg says, the Roadmap has been a 
very good thing for basic research. The idea of setting aside 
a relatively small amount of money for new kinds of pro¬ 
grams and approaches was a key provision of the Roadmap 
and has paid off by becoming quite popular in Congress. 
“In my opinion the Roadmap has been quite successful with 
Congress in terms of their seeing the value in what we’re 
doing. My sense is that the nih would have been substan¬ 
tially worse off than we are right now if we had not had 
the Roadmap.” 
Shortest distance between two points 
Money talk aside, researchers still worry that the hoopla sur¬ 
rounding new clinical and applied programs that began 
under the Roadmap may divert attention from the fact that 
successful medical research relies on a foundation of 
basic knowledge about the functioning of healthy cells and 
organisms. The only way to get that information is to turn 
the same idea has repeatedly proven not to be true for 
progress in medical research.” The reason, he says, is that 
we understand so little of what there is to know about 
the basic functions of cells that researchers tracing a path 
from disease to cure must navigate largely uncharted 
terrain. Scientists continue to rely on lessons learned from 
simple organisms—yeast, bacteria, plants, fruit flies, 
worms—to guide progress through the terra incognita of 
human disease. 
John Carlson, ph.d., the Eugene Higgins Professor 
of Molecular, Cellular and Developmental Biology, has been 
looking for answers in the fruit fly’s sense of smell for 
20 years. Carlson has spent that time figuring out the work¬ 
ings of odor receptors and the olfactory system of flies, 
which use their sense of smell primarily to navigate the world. 
He and his colleagues mapped out the chemical receptors 
and brain pathways involved in the uncanny ability of these 
pests to appear out of nowhere in response to the aroma of 
a banana left outside to ripen on a warm day. On the way, he 
has found both beauty and some unanticipated applications. 
“The same way that fruit flies find bananas, mosqui¬ 
toes find humans,” Carlson explains. “They both depend 
on their sense of smell.” That insight propelled him into 
the field of malaria, a disease that infects hundreds of 
millions of people around the world each year. Carlson is 
working with European and African colleagues to find 
chemical compounds that confuse the sensory receptors on 
a mosquito’s nose and prevent them from finding humans. 
In the future, he foresees using a similar approach to 
keep crops free of agricultural pests. Carlson says the work 
may also be adapted to use odor receptors as detection 
devices for explosives. 
For two decades, Carlson has been able to keep his 
research program on track with an uninterrupted stream of 
funding from nih. His applied research draws support from 
private foundations, including the Bill and Melinda Gates 
Foundation for the malaria work. Nonetheless, he says, 
“I do worry about the nih dropping support for individual 
labs exploring questions that excite their curiosity about 
basic science.” 
The long view 
The Nobel Prize-winning biologist Arthur Kornberg, m.d., 
liked to tell a story that starts with a surgeon out for his 
morning jog. While passing a lake, the doctor sees a man in 
the water about to drown. So he dives in, pulls the man 
out, resuscitates him and continues running. 
A bit farther down the path, another man is flailing in 
the water in another part of the lake. The surgeon saves 
him, and no sooner sets off jogging again than he sees two 
more people in trouble in the water. He notices his friend, 
a neuroscience professor, loitering nearby and calls out for 
him to save one person while the surgeon rescues the other. 
When the neuroscientist does not move, the exasperated 
surgeon shouts at him, “Why aren’t you doing something?” 
The neuroscientist answers calmly, “I am doing 
something. I’m desperately trying to figure out who’s throw¬ 
ing all these people in the lake.” 
The point is, of course, that the fight against human 
disease occurs on several fronts. Someone has to rush in and 
save today’s victims. Solving fundamental problems, how¬ 
ever, requires other people with different skills and interests. 
Neither group is more important than the other. That is 
one message that researchers fear is being lost on lawmakers 
and the public, and even on budding young scientists as the 
funding freeze continues. 
Pietro De Camilli, m.d., Eugene Higgins Professor 
of Cell Biology and co-director of the program for Cellular 
Neuroscience, Neurodegeneration and Repair, sees this 
loss of perspective in his experience with up-and-coming 
researchers. “There is a perception I see in young people 
that if they want to be a scientist and successfully compete 
for funding, they have to work on applied problems. 
A career in basic research seems less and less attractive.” 
The boom-and-bust cycle of congressional appropria¬ 
tions to nih over the last decade has left some senior re¬ 
searchers struggling to maintain long-term projects. When 
young investigators see their mentors not being funded, 
they get the message, says stem cell researcher Diane 
Krause, m.d., ph.d., professor of laboratory medicine and 
cell biology and associate director of the Yale Stem Cell 
Center. “This is dissuading people from trying to succeed 
as academic researchers. We certainly make it look difficult 
to our students and postdoctoral fellows.” 
At current levels, the nih budget overall is a prescrip¬ 
tion for slowing medical progress in the future, not speed¬ 
ing it up, according to immunologist Flavell. He supports 
the Roadmap but cautions that any success depends on 
maintaining a healthy basic research environment and push¬ 
ing forward with applied and clinical programs. One without 
the other makes no sense, yet increasingly he sees outstand¬ 
ing researchers unable to win grants. Unless something 
changes soon, he says, we may find ourselves 20 years down 
the road with an impressive clinical and translational infra¬ 
structure but few new basic findings to translate, ym 
Pat McCaffrey is a freelance writer in Boston. 
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A life’s work in Indonesia 
ByJil1 Max Kinari Webb came to medical school knowing how and where she 
Photographs by Erick Danzer wanted to practice medicine. Now, she and her ecologist husband 
are working to bring health care to a remote corner of Borneo while 
preserving the rain forest. 
Kinari Webb, a 2002 graduate of 
the School of Medicine, visits 
with a family in the town of Suka- 
dana in a remote corner of the 
Indonesian island of Borneo. Webb 
has opened a clinic that serves 
the local population. She and her 
husband are also working to 
preserve the rain forest of nearby 
Cunung Palung National Park. 
Webb spent a year traveling 
throughout Indonesia to find the 
right place to launch her clinic. 
Sukadana is next to a national 
park with a rain forest under siege 
from logging, and the region’s 
three clinics and 60,000 people 
shared a single physician. 
Pak Rudi, a 40-year-old 
from a remote corner of the 
island of Borneo, Indonesia, 
was in bad shape. Walking 
even a few steps left him 
short of breath. In the fall 
of 2007, with his wife and 
several family members, he 
traveled for eight hours by 
motorboat and motorcycle 
taxi to reach the coastal 
town of Sukadana, where 
he had relatives who urged 
him to seek help at the 
local clinic. By the time his 
family carried him into the Alam Sehat Lestari clinic, known 
as asri, Pak Rudi was close to death. Although the clinic 
lacks an X-ray machine, the medical staff diagnosed Pak Rudi 
based on a physical exam and the medical history he and 
his family provided. Dilated cardiomyopathy due to a viral 
infection a decade earlier was causing his heart to fill almost 
his entire chest cavity—it was only later, after the doctors 
saw an old X-ray, that they realized how swollen the heart 
had been. 
In Indonesia, which has 16 physicians per 100,000 
people, 12 times lower than the ratio in the United States, 
medical care is a scarce commodity. In rural areas, the ratio 
is even worse: where Pak Rudi lived—in West Kalimantan— 
three clinics and 60,000 residents shared one doctor. That 
changed when asri opened in June 2007 as the newest 
clinic in the area. A small house with three exam rooms 
and a lab for basic tests, the clinic is run by Kinari Webb, 
m.d. ’02, who also led Pak Rudi’s medical team. 
“I figure there are not very many humans on the 
planet who are crazy enough to do something like this,” says 
Webb, who spent a decade preparing to open her clinic 
in the rain forest. “Something like this” refers to her dual 
dreams of bringing health care to Borneo and promoting 
forest conservation. It’s no accident that her clinic is next to 
Gunung Palung National Park—558 square miles of forest, 
swamps and mountains that contain 5,000 species of trees, 
wild orangutans, sun bears, agile gibbons, proboscis mon¬ 
keys, wild boars and hundreds of bird species. This pristine 
habitat is in danger from logging companies and poachers 
who eke out a living by harvesting lumber. In the 1960s, 
rain forest covered 82 percent of Indonesia—now it covers 
49 percent. Since the 1980s more than half the rain forest 
in Borneo, one of the largest of Indonesia’s 17,500 islands, 
has been destroyed. 
Webb first visited the island as an undergraduate at 
Reed College in Portland, Ore., and was both entranced 
by the beauty of Gunung Palung, with its mangrove forests 
and verdant mountains shrouded in gentle mists, and 
horrified by the extent of the region’s illegal logging. While 
the government has tried to protect the rain forests through 
mass tree plantings and international carbon-trading 
schemes, villagers have few ways to earn a living. Some 
work on rubber and oil palm farms. Others earn a few dol¬ 
lars a week breaking boulders and selling the rocks to road¬ 
building crews. More than 7 percent of the former Dutch 
colony’s 245 million people live on less than a dollar a day. 
In asri’s catchment area, many households survive on 
about $15 a month, and for many families, a shared weekly 
egg is the sole source of protein. Tree poaching, although 
it pays less than $2 a day, remains an attractive option. 
A life-changing experience 
In a sense, Webb’s journey to Indonesia began during her 
childhood in Dixon, N.M., a small town about an hour 
from Santa Fe. Her parents, both of whom have ph.d.s in 
psychology, were hippies who had joined the back-to-the- 
land movement and taught Webb and her sister a love of 
animals and nature. Webb majored in biology at Reed, 
where she focused on orangutans. She pursued her studies 
with a determination that would serve her well later: she 
went to the library, looked up articles on orangutans and 
asked every author for a job. In 1993, between her junior 
and senior years, she worked at a research station in Gunung 
Palung National Park, one of the world’s few remaining 
orangutan habitats. 
One day a research assistant approached her with a 
cut on the palm of his hand, and although the wound was 
not serious, he acted as if it were life-threatening. It dawned 
on Webb that for people living in remote areas a seemingly 
routine injury could have dire consequences. Since she 
had no medical training, Webb whipped out her copy of the 
health care manual Where There Is No Doctor, by David Werner, 
cleaned the cut and closed it with improvised butterfly 
y
al
e 
M
ed
ic
in
e 
a
u
tu
m
n
 
20
08
 
32 
below Webb examines a woman 
in Sukadana. With limited resources 
and frequent power failures, Webb 
often improvises her treatment. She 
has used honey to treat a diabetic 
ulcer; cardboard to make inserts for 
shoes; and mucuna beans, with 
their high L-dopa concentration, to 
treat Parkinson disease. 
middle A family relaxes on their 
front porch in Sukadana. Webb 
has engaged the townspeople in 
a dialogue about conservation and 
offers health care credits at her 
clinic for those who promise not 
to engage in illegal logging. 
bandages made of adhesive tape. The cut healed and Webb 
was hooked; she knew that she wanted to become a physi¬ 
cian and that she wanted to help people in rural Indonesia. 
Her experience at Gunung Palung was life-changing 
for other reasons as well. She met Campbell Webb, ph.d., 
a biologist and ecologist who was pursuing his doctorate at 
Harvard. At first they resisted romance in an isolated setting 
under the scrutiny of their colleagues. But candlelit dinners 
(there was no electricity), bathing in waterfalls (there was no 
plumbing) and two months alone at their camp weakened 
their resolve. They were married as soon as Kinari graduated 
from Reed. 
In Gunung Palung the idea of the interconnectedness 
of living things took hold in Kinari Webb’s mind. For 
several species of trees, for example, propagation depends 
on orangutans that eat their fruit and defecate the seeds. 
On a more global level, Webb realized that timbering not 
only reduced rainfall and lengthened the dry season, but 
also contributed to global warming. Webb decided to focus 
her energy on a new project: she would provide health care 
to a population in desperate need, but she would also 
use it as an incentive for villagers to stop cutting down trees. 
A decade of preparation 
More than 10 years passed before she 
could bring her vision to life. During 
that time she laid the groundwork 
for asri, whose name means “beauti¬ 
ful and harmoniously balanced.” She 
came to Yale knowing exactly where 
she wanted to practice medicine. When 
it was time to apply for her residency, 
Webb looked for a family medicine 
program that would provide the best 
training for practicing medicine in a 
developing nation. At Contra Costa 
Regional Medical Center in Martinez, 
Calif., she delivered more than 
250 babies and performed enough 
C-sections to qualify for privileges 
at any hospital in the United States. 
“She got this incredible preparation 
to be out in the middle of nowhere 
and be the first person to do whatever has to be done,” 
said Nancy R. Angoffi m.p.h. ’81, m.d. ’90, hs ’93, associate 
dean for student affairs. 
In early 2005, just before completing her residency, 
Webb returned to Indonesia to help in the aftermath of the 
tsunami that devastated coastal areas of more than a dozen 
countries on the Indian Ocean in December 2004. She was 
distressed to see that the efforts of many of the agencies 
and organizations were ineffective and little of the aid was 
reaching those who needed it most. This only fueled her 
right Webb and her husband, 
Cam, make their home in Suka¬ 
dana, but the couple spend as 
many as five months of each year 
apart. Campbell Webb, a Harvard 
ecologist, travels throughout 
Indonesia and Malaysia for his 
work with the Arnold Arboretum. 
determination to open her own clinic. After her residency, 
she set up Health in Harmony (healthinharmony.org), 
a nonprofit organization to manage fundraising. Cam Webb 
moved to Bogor, West Java, which his wife used as a base 
while she searched for a location that was both close to 
a rain forest and in an area with few health care resources. 
“The whole process was like stepping off a cliff,” she said. 
After almost a year of searching, Kinari Webb realized 
that Sukadana, just outside Gunung Palung, was the perfect 
spot. It’s two airplane flights and a two-hour drive through 
mangrove swamps from Jakarta, Indonesia’s capital. The 
heart of the park’s forest is still uncut, so there is conserva¬ 
tion work to be done, and the local population has unmet 
medical needs. The location also worked for Cam Webb, 
who got a job as a senior research scientist with Harvard and 
is working with the Center for Tropical Forest Science, the 
world’s largest tropical forest research program. His work 
takes him from his home base in Sukadana to his office in 
Bogor, and to sites throughout Indonesia and Malaysia 
where he does research in plant biodiversity and teaches 
a Harvard field course on Bornean ecology. 
Before she set up shop, Webb recruited college and 
medical school classmates to help raise start-up money 
through a combination of Indonesian and American grants 
and private donations. Despite support from the Indonesian 
government, Webb faced innumerable delays in securing 
permits to open her clinic. Every time she produced a docu¬ 
ment, bureaucrats demanded yet another. Even worse, officials 
had their hands out for bribes, which she refused to give. 
On June 12, 2007, asri opened its doors. A five- 
minute walk from an undeveloped beach, asri is on the out¬ 
skirts of Sukadana (population 12,000), a sleepy town with 
a pungent fish market and several stores packed with flip- 
flops, rattan baskets and plastic buckets. A forest stretches 
up the hills surrounding the village, and gibbons can be 
heard calling through the trees. Orange with a bright blue 
roof, the six-room clinic is surrounded by houses, rice fields 
and gardens. It has three exam rooms, a dental exam room 
and a room for patients to sleep overnight, plus a lab for 
malaria and TB smears, blood work and urinalysis. There is 
a small pharmacy with a refrigerator, but Webb would like 
to have a solar-powered model since the electricity blacks out 
as often as five times a day. When that happens Webb lights 
candles, and if an emergency requires electricity she turns 
on a generator. She would like to add an X-ray machine to 
the ultrasound, ekg machine and other equipment on hand. 
The staff of 15 includes two Indonesian doctors, a den¬ 
tist, three nurses, a pharmacy assistant, a conservation direc¬ 
tor and an organic farm manager. “Kinari has surrounded 
herself with a system that can support this project and she’s 
sort of the spark in the middle, the lifeblood of the project,” 
said Roger Barrow, m.d., associate clinical professor of 
family medicine at the University of California, Davis, who 
Gunung Palung National Park is 
one of the world's last habitats for 
orangutans, but logging, legal and 
illegal, has led to deforestation of 
more than 70 percent of Borneo’s 
rain forest since 1980. 
worked with Webb in the aftermath of the tsunami and 
visited asri in April 2007. 
“What they were able to accomplish in four months is 
almost impossible to imagine in a country that moves that 
slowly,” said Jeremy Sussman, m.d., who spent a few weeks 
at asri in November 2007 as part of the Johnson & Johnson 
Physician Scholars in International Health Program at 
Yale, which sends residents to underserved areas around the 
world. Webb appreciates the opportunity to tap into the 
expertise of volunteers like Sussman. “It’s good for my doc¬ 
tors to have someone else teaching them besides me,” 
she said. “It helps to have a wider variety of opinions and 
ways of doing medicine.” 
The clinic is already bursting at the seams—asri 
treated 3,000 patients in its first nine months and is booked 
three weeks in advance. Webb has started to think about a 
new building and plans to open a hospital. The nearest 
hospital is two hours away and anything more than minor 
surgery requires a seven-hour journey to Pontianak, the 
regional capital. 
Because her resources are limited, Webb finds inno¬ 
vative ways to treat her patients, some of which she has 
picked up from visitors like Werner. Webb has used honey to 
treat a diabetic ulcer on a hand, fashioned cardboard shoe 
inserts for a boy who had trouble walking, and used mucuna 
beans from the clinic’s organic garden (they have a high con¬ 
centration of L-dopa, which increases dopamine levels) to 
treat Parkinson disease. She and her staff treated Pak Rudi 
with aspirin, diuretics and blood pressure medications. In 
June 2008, Webb learned that Pak Rudi had died; he went 
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34 dor 
With donations from the United 
States, Webb has been able to offer 
eyeglasses to villagers in Borneo. 
On a single day last year she 
handed out 93 pairs in one village. 
off his medicines for a month, in part because of the difficul¬ 
ties of transportation from his village. 
Patients with cancer, diabetes, high blood pressure, 
severe diarrhea and a variety of other ills come to asri, 
but the area’s biggest health problem is tuberculosis. More 
than 20 percent of the local population has TB, Webb esti¬ 
mates, and she has trained and hired workers to institute a 
Directly Observed Therapy program, in which they visit 
patients to monitor them while they take their medications. 
Poverty plays a major role in many of the diseases 
Webb treats and is also a barrier in receiving treatment, but 
Webb doesn’t believe in free health care. “It’s reasonable 
that you pay for it, but it’s also reasonable that you pay for it 
in a way you can actually afford,” she said. “It gives patients 
dignity.” That’s why health care credits are a key component 
of her program. Patients and their families can pay for 
their treatment by cleaning the clinic, doing laundry, wash¬ 
ing equipment or providing manure for the organic garden. 
They can also undertake conservation work, as Pak Rudi’s 
family did. During the month he spent recuperating at a 
nearby relative’s house, his family worked in the organic gar¬ 
den next door to the clinic. Area villagers are learning organic 
farming, and vegetables from the garden feed the clinic 
staff and patients. Webb expects to have produce to sell in the 
local market to help pay for medicine and other supplies. 
Linking health care to ecology 
Getting the local population to understand why they should 
worry about the environment pervades almost everything 
Webb does. When asked why she and her colleagues bicycle 
instead of driving to the clinic, she says, “Because biking is 
healthier, cheaper and better for the environment." The 
clinic’s staff held a series of meetings in villages surround¬ 
ing Gunung Palung to discuss tire connection between health 
and the environment and identify incentives that would 
motivate the villagers to protect the park from logging. It is 
here that Webb’s effervescent yet soft-spoken demeanor 
works its charm. Indonesia is the largest Muslim nation in 
the world, but in West Kalimantan there are no restrictions 
on women’s social liberties, and she engages villagers in 
lively discussions, asri’s staff and local residents came up 
with a plan: communities would work toward a “green” con¬ 
servation status, meaning no illegal logging in the previous 
month. In return, they receive one month of free ambulance 
service, mobile clinic visits and clinic discounts. No one is 
ever denied health care, but Webb would like to provide 
incentives for the long-term health of both the community 
and the environment. “We don’t know yet whether the 
incentive is strong enough on an individual level or on 
a community level for people to actually change their behav¬ 
iors,” said Cam Webb, “but even if it doesn’t work we’re 
doing a lot of education. If we get even a portion of forest 
restored, then it’s having a positive effect.’’ 
Although the program is still in its infancy, its reputa¬ 
tion is spreading. The managers of an elephant conservation 
project on the Indonesian island of Sumatra have approached 
Webb about replicating tire asri model. She hopes that other 
organizations around the world will also recognize its poten¬ 
tial. Meanwhile, each day brings satisfaction that her vision 
is working. “I’m feeling kind of like a parent whose child has 
just started to toddle around,” she said. 
At the end of a long day treating patients, Webb will 
sometimes provide an evening meal to village children 
who stop by her thatched-roof house. Many of their neigh¬ 
bors consider the Webbs’ house, with its cement floor and 
no plumbing, quite modest, but the couple finds it charm¬ 
ing. A pump from their well fills a water tank on a hill 
that drains to a sink and they use a squat toilet which they 
flush with water from a bucket. 
When Cam Webb is home, the two often paddle their 
dugout canoe to a small island, where they watch the sunset 
or go for a swim. When she’s on her own, Kinari writes 
thank-you notes to donors and answers e-mail before falling 
into bed, where she may be awakened by a raucous serenade 
from gibbons camped out in the trees behind her house. 
If she had any doubts about the course her life was 
taking, a recent boat ride into the park, where miles of grass¬ 
land have replaced the once-majestic forests, convinced her 
that this is exactly where she wants to be and where her 
future lies. She plans on spending the next few decades in 
this remote corner of the world, but her patients hope 
the clinic will be around even longer, so that they won’t have 
to worry whether a simple cut on the hand might end in 
tragedy. As one village leader put it, “We hope that asri will 
be forever and ever.” ym 
Jill Max is a freelance writer in Trumbull, Conn. 
Erick Danzer is a freelance photographer based in Indonesia. 
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James Rothman 
Leading cell biologist 
to head department 
JAMES E. ROTHMAN, PH.D. ’71, 
one of the world’s leading cell 
biologists, has been named chair 
of the Department of Cell Biol¬ 
ogy and the Fergus F. Wallace 
Professor of Biomedical Sciences, 
Rothman will also launch the 
new Center for High-Throughput 
Cell Biology at Yale’s West 
Campus, formerly the site of 
Bayer Healthcare. 
Rothman came to Yale from 
Columbia University’s College of 
Physicians and Surgeons, where 
he was a professor in the Depart¬ 
ment of Physiology and Biophysics, 
the Clyde and Helen Wu Professor 
of Chemical Biology and director 
of the Columbia Genome Center. 
Under Rothman’s leadership 
Yale’s Department of Cell Biology 
will be significantly expanded 
and will be co-located at the 
West Campus along with its pres¬ 
ent location at the main campus 
of the School of Medicine. 
At the Yale Center for High- 
Throughput Cell Biology, Rothman 
will lead multidisciplinary teams 
of scientists to develop tools and 
techniques to rapidly decipher the 
cellular functions of the 25,000 
known protein-coding genes in 
the human genome, providing 
fresh insights into disease and 
identifying new molecular targets 
for therapy. For more than two 
decades, Rothman has performed 
seminal research on membrane 
trafficking. 
Rothman graduated summa 
cum laude from Yale College in 
1971 with a degree in physics. His 
research interests were inspired 
by cell biologist and Nobel laure¬ 
ate George E. Palade, M.D., who 
founded Yaie’s Department of 
Cell Biology. 
Joan Steitz 
Rothman earned a ph.d. in 
biological chemistry from Harvard 
Medical School in 1976. He then 
spent two years as a postdoctoral 
associate in the laboratory of 
Harvey F. Lodish, ph.d., a pre¬ 
eminent biochemist at the Massa¬ 
chusetts Institute of Technology. 
In 1978, Rothman moved to the 
Department of Biochemistry at 
Stanford School of Medicine as an 
assistant professor. He continued 
his research at Princeton Univer¬ 
sity from 1988 until 1991, when 
he became the founding chair of 
the Department of Cellular 
Biochemistry and Biophysics at 
Memorial Sloan-Kettering Cancer 
Center in New York and vice chair 
of the Sloan-Kettering Institute. 
Rothman succeeds cell biolo¬ 
gist and immunologist Ira S. 
Mellman, ph.d., who was chair 
and Sterling Professor of Cell 
Biology at the School of Medicine 
until 2007, when he joined the 
biotechnology company 
Genentech as vice president for 
oncology research. James D. 
Jamieson, M.D., professor of cell 
biology and director of the medi¬ 
cal school’s m.d./ph.d. program, 
served as interim chair of the 
department. 
Yale professor receives 
Albany prize 
joan A. steitz, ph.d.,Sterling 
Professor of Molecular Biophysics 
and Biochemistry, is one of the 
first two women scientists to 
receive the Albany Medical Center 
Prize in Medicine and Biomedical 
Research, America’s top award in 
medicine. She shared the award 
with Elizabeth H. Blackburn, ph.d., 
fw ’77, SC.D.H. '91, the Morris 
Herzstein Professor of Biology 
and Physiology at the University 
of California, San Francisco. The 
two will share the $500,000 
award. Now in its eighth year, the 
prize is the largest in medicine in 
the United States and the second 
largest in the world outside of 
the Nobel Prize. 
Steitz is best known for her 
pioneering work in rna. She dis¬ 
covered and defined the function 
of small ribonudeoproteins 
(snRNPs) in pre-messenger rna— 
the earliest product of dna tran¬ 
scription—and was the first to 
learn that these cellular complexes 
(snRNPs) play a key role in process¬ 
ing messenger rna by excising 
noncoding regions and splicing 
together the resulting segments. 
Her breakthroughs into the previ¬ 
ously mysterious splicing process 
have clarified the science behind 
the formation of proteins and 
other biological processes, includ¬ 
ing the intricate changes that 
occur as the immune system and 
brain develop. 
Steitz earned her ph.d. from 
Harvard in 1967. After completing 
postdoctoral work in Cambridge, 
England, she joined the Department 
of Molecular Biophysics and 
Biochemistry at Yale as an assist¬ 
ant professor and later became 
an associate and full professor, as 
well as chair of the department. 
Pasko Rakic 
Kavli Prize for a Yale 
neuroscientist 
PASKO RAKIC, M.D., PH.D., chair 
and the Doris McConnell Duberg 
Professor of Neurobiology, profes¬ 
sor of neurology and director of 
the Kavli Institute of Neuroscience 
at Yale, was named one of the 
inaugural recipients of the Kavli 
Prize, given for the first time 
this year. The 2008 laureates 
were selected for groundbreaking 
research that has significantly 
advanced understanding of the 
unusual properties of matter on 
an ultra-small scale, the basic 
circuitry of the human brain and 
the nature of quasars. Rakic, 
one of seven scientists to receive 
the $1 million prize, was honored 
for a pioneering series of anatomi¬ 
cal studies carried out over the 
past three decades that revealed 
how neurons in the developing 
cerebral cortex are generated and 
how they assemble themselves 
into interconnected circuits that 
direct higher-order sensory and 
motor functions. The seven win¬ 
ners will receive a scroll, a medal 
and a share of the overall prize 
for each area. 
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36 Faculty NOTES 
Jack Elias Andrew 
Hamilton 
Seven faculty members of the 
School of Medicine were elected 
to the Connecticut Academy of 
Science and Engineering.They 
are Jack A. Elias, m.d., Waldemar 
von Zedtwitz Professor of Medi¬ 
cine and chair of the Department 
of Internal Medicine; Andrew D. 
Hamilton, ph.d., provost of the 
university and the Benjamin 
Silliman Professor of Chemistry; 
Diane S. Krause, M.D., PH.D., profes¬ 
sor of laboratory medicine and 
cell biology; Harlan M. Krumholz, 
m.d., the Harold H. Hines Jr. 
Professor of Medicine and pro¬ 
fessor of epidemiology and 
public health and investigative 
medicine; Nancy H. Ruddle, 
ph.d., the John Rodman Paul 
Professor of Epidemiology and 
Public Health and professor of 
immunobiology; Michael P. Snyder, 
ph.d., the Lewis B. Cullman 
Professor of Molecular, Cellular 
and Developmental Biology and 
professor of molecular biophysics 
and biochemistry; and Mary E. 
Tinetti, m.d., the Gladys Phillips 
Crofoot Professor of Medicine 
and professor of epidemiology 
(chronic diseases) and investiga¬ 
tive medicine. 
Amy F.T. Arnsten, ph.d., professor 
of neurobiology, was selected 
by narsad in April to receive 
its prestigious Distinguished 
Investigator Award, narsad 
will provide a one-year grant of 
$100,000 to advance her research 
on schizophrenia. Arnsten’s 
past work on prefrontal cortex 
and executive function has con¬ 
tributed to the development of 
new treatments for attention 
deficit disorder. 
Michael Snyder Henry Cabin Diane Krause Harlan Krumholz 
In April two faculty members 
were awarded 2008 Young 
Investigator Awards from 
narsad, the world’s leading 
charity dedicated to funding 
research on psychiatric disor¬ 
ders. They are among 220 early- 
career scientists in the United 
States and 11 other countries 
who will receive funds this year 
from narsad to advance their 
research on mental illnesses. 
Each will receive $60,000 over 
the next two years. Savita C. 
Bhakta, m.b.b.s., plans to gain a 
better understanding of how 
cannabinoids (chemical com¬ 
pounds found in marijuana) 
induce schizophrenia-like behav¬ 
ioral and cognitive effects in 
healthy people and exacerbate 
symptoms in patients with 
schizophrenia. Fes Wang, PH.D., 
will use multimodal aari tech¬ 
nology to study adolescents 
with bipolar disorder. The study 
will identify abnormalities in 
the structural integrity of con¬ 
nections in brain circuitry serv¬ 
ing the emotional processing 
that are implicated in the illness, 
as well as associated disruptions 
in circuitry function. 
Henry S. Cabin, m.d., professor of 
medicine (cardiology), has been 
named medical director of the 
Yale-New Haven Hospital (ynhh) 
Heart and Vascular Center. Cabin 
will be responsible for day-to-day 
operations associated with the 
cardiovascular service line, includ¬ 
ing inpatient services, and diag¬ 
nostic and interventional 
catheterization laboratories. In 
addition, Cabin will participate on 
an executive council and work 
collaboratively with other multi¬ 
disciplinary physician leaders in 
medicine, radiology and surgery 
to build a comprehensive cardiac 
and vascular center. Since 1994, 
Cabin has been associate section 
chief of cardiology at ynhh and 
associate chair, Department of 
Internal Medicine. 
David C. Cone, M.D., associate 
professor of surgery (emergency 
medicine) and of epidemiology, 
has been appointed editor in 
chief of Academic Emergency 
Medicine, the journal of the 
Society of Academic Emergency 
Medicine. 
Stephen C. Edberg, ph.d., profes¬ 
sor of laboratory medicine and 
director of the Yale-New Haven 
Hospital microbiology labora¬ 
tory, has been awarded the 
American Society for Micro¬ 
biology's BD Award for Research 
in Clinical Microbiology.This 
award honors a clinical micro¬ 
biologist for outstanding 
research accomplishments lead¬ 
ing to or forming the foundation 
of important applications in 
clinical microbiology. Edberg’s 
contributions to clinical micro¬ 
biology range from basic science, 
through applications and tech¬ 
nology transfer, to critical analy¬ 
sis of current microbiologic 
findings and principles as 
applied within the context of 
public health problems. His 
research has resulted in more 
than 180 publications. 
Richard L Edelson, M.D., director 
of Yale Cancer Center, has been 
named the inaugural Aaron B. 
and Marguerite Lerner Professor 
of Dermatology. Edelson has 
made fundamental contribu¬ 
tions to the study of cutaneous 
T-cell lymphoma (ctcl), a dis¬ 
ease caused by malignantT 
lymphocytes that affects the 
skin. He identified and charac¬ 
terized this cancer and his 
research group played a central 
role in deciphering the basic bio¬ 
logic properties of ctcl cells, 
both in delineating the patho¬ 
genesis of the malignancy and 
in developing effective thera¬ 
pies for it. Along with his 
research team, Edelson devised 
and implemented the first FDA- 
approved selective immunother¬ 
apy for any cancer, a treatment 
now referred to as transimmu¬ 
nization. This treatment has 
been administered worldwide 
to patients with ctcl and has 
proven to be a safe and clinically 
effective cellular "vaccine" for 
ctcl patients. Since 2003 Edelson 
has been director of Yale Cancer 
Center. In January he announced 
he would step down once a 
successor is appointed. 
Christine Jacobs-Wagner, PH.D., 
the Maxine Singer Associate 
Professor of Molecular, Cellular 
and Developmental Biology, has 
been designated a Howard 
Hughes Medical Institute inves¬ 
tigator. She is one of 17 Yale sci¬ 
entists who now hold the 
prestigious appointment. 
Jacobs-Wagner is one of the 
world’s leading experts on the 
internal cellular workings of 
bacteria. Her descriptions of the 
inner mechanisms of bacteria 
have led to an appreciation of 
the survival strategies of these 
ancient organisms and new 
insights into how to study mod¬ 
ern human illnesses. 
37 
David Cone Richard Edelson 
Ruslan Medzhitov, ph.D., received 
the Howard Taylor Ricketts 
Award from the University of 
Chicago in May. The Howard 
Taylor Ricketts Award is given in 
memory of Ricketts, the scientist 
for whom the Rickettsia genus of 
microorganisms is named.The 
award recognizes an individual 
who has made an outstanding 
contribution in a field of the 
medical sciences. 
Curtis L. Patton, ph.d., professor 
emeritus in the School of Public 
Health, was one of 13 people to 
receive a Seton Elm/Ivy Award 
this spring. Patton was honored 
for bringing previously unrecog¬ 
nized African-Americans to public 
light. Yale’s recognition of Edward 
A. Bouchet, a distinguished 
New Havener, Yale College’s first 
African-American graduate and 
the first African-American to earn 
a ph.d. anywhere in the nation, is 
due in part to Patton. He also cel¬ 
ebrated the work and legacy of 
Cortlandt Van Rensselaer Creed, 
m.d., another distinguished New 
Havener and the first African- 
American graduate of Yale Uni¬ 
versity. In 2007, on the occasion 
of the 150th anniversary of 
Creed’s graduation from the School 
of Medicine, Patton and his col¬ 
leagues organized a series of 
events culminating in the dedica¬ 
tion of a new memorial to Creed 
at the Grove Street Cemetery. 
Joel L. Rosenbaum, ph.d., professor 
of cellular and molecular biology, 
received an honorary degree from 
Christine Brian Smith 
Jacobs-Wagner 
the University of Siena in Italy, in 
May. Rosenbaum has been 
studying the ultra-structure of 
the intraflagellar transport (1 ft) 
process at the University of 
Siena with his colleagues there. 
ift was discovered in the 
Rosenbaum laboratory in 1992 
and was shown to be respon¬ 
sible for the formation and 
maintenance of almost all cilia 
and flagella. Analysis of the 
genes underlying the ift process 
have led to new insights into 
the role of cilia and flagella in 
polycystic kidney disease and 
other human diseases. 
Brian R. Smith, M.D., professor 
and chair of laboratory medi¬ 
cine, has been elected president 
of the Academy of Clinical 
Laboratory Physicians and 
Scientists, the major academic 
society for laboratory medicine. 
Edward L. Snyder, M.D., professor 
and associate chair for clinical 
affairs in the Department 
of Laboratory Medicine, has 
been voted president-elect of 
the National Marrow Donor 
Program. He will begin his two- 
year term in January. 
Scott A. Strobel, PH.D., professor 
of molecular biophysics and 
biochemistry, has been awarded 
the Schering-Plough Research 
Institute Award. The award is 
given by the American Society 
of Biochemistry and Molecular 
Biology to recognize outstand¬ 
ing scientific contributions 
made by young researchers early 
in their careers. Strobel gave 
the award lecture,"Three Views 
of rna Catalysis: Ribozymes, 
Ribosomes and Riboswitches,” 
at the society’s annual meeting 
in San Diego in April. 
Ronald Vender 
Ronald J. Vender, M.D., ’77, HS ’80, 
fw ’82, a nationally recognized 
gastroenterologist who special¬ 
izes in therapeutic endoscopy 
and inflammatory bowel dis¬ 
ease, started on June 1 as chief 
medical officer (cmo) for Yale 
Medical Group (ymg) and associ¬ 
ate dean for clinical affairs at 
the School of Medicine. He 
reports to David J. Leffell, m.d., 
chief executive officer of ymg 
and deputy dean for clinical 
affairs. Vender, a clinical profes¬ 
sor of medicine, built a clinical 
practice in the New Haven area 
and has held leadership and 
teaching roles at Yale-New 
Haven Hospital, the Hospital of 
Saint Raphael and Milford 
Hospital. He chaired the 
National Affairs Committee of 
the American College of Gastro¬ 
enterology and currently serves 
on the board of trustees. He has 
published numerous research 
papers with colleagues on the 
Yale faculty. One of the appeals 
of his new position is the 
chance to return to his alma 
mater and work with colleagues 
he’s known since he was a stu¬ 
dent. “There are a number of 
people with whom I was a resi¬ 
dent who are on the faculty. 
Some of my teachers and men¬ 
tors are still here,” Vender says. 
“I am being very warmly and 
generously received by my col¬ 
leagues and former mentors. I 
feel that I am coming back to a 
place I never left.” 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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38 students commencement 2008 
Liza Goldman Huertas, James Troy, Amy Meadows 
and Alexander Diaz de Villalvilla before the 
Commencement ceremony at Old Campus. 
6 i ^ f rt ^ ^ f1 
above Class co-president Kristina Zdanys 
received her degree from Dean Robert Alpern. 
right Zofia Piotrowska, Karl Laskowski, 
Lu Anne Dinglasan and Kevin Lau on their 
way to Old Campus. 
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Celebration, loss and an 
exhortation to dream 
Marking their own graduation, 
students in the Class of 2008 
remembered a fallen classmate. 
Commencement was a day of mixed 
emotions for graduates in the Class 
of 2008. As they celebrated their own 
passage from students to physicians, 
they also mourned the loss of their 
classmate Mila Rainof, who died on 
April 20 after being struck by a car. 
(See related story, page 4). 
Rainof’s absence was palpable 
throughout the day’s events. As the 
medical and public health students 
marched to Old Campus, each left a 
carnation at the site of the accident at 
York Street and South Frontage Road. 
During the ceremony on Harkness 
Lawn, Merle Waxman, m.a., associate 
dean, ombudsperson and director 
of the Office of Women in Medicine, 
accepted Rainof’s posthumous medi¬ 
cal degree. And the class gift was 
a donation to a scholarship fund in 
Rainof’s memory. 
Maggie Samuels-Kalow and Ellen 
House took the podium to offer their 
reflections. They recalled Rainof’s com¬ 
mitment to her friends and patients 
as well as her seemingly boundless 
warmth and compassion. Samuels- 
Kalow urged her classmates to find 
other ways to remember Rainof. “We 
honor her memory in less tangible 
ways, in the ways we treat each other 
and our patients,” she said. 
“Let’s celebrate today, as Mila would 
have wanted us to,” said House. 
Commencement speaker Alfredo 
Quinones-Hinojosa, m.d., offered 
as inspiration his own life story, 
recounting how he packed his few pos¬ 
sessions into a bag 20 years ago and, 
with $65 to his name, crossed the border 
illegally from Mexico to California. The 
same hands that now probe “the most 
beautiful organ in the human body— 
the brain” were once bloody and raw 
from pulling weeds on the farms of the 
San Joaquin Valley. After an industrial 
accident almost killed him, Quinones- 
Hinojosa’s father told him, “You have 
been given a gift. Life is short.” 
Quinones-Hinojosa went on to 
graduate from a California community 
college and Harvard Medical School. 
While at Harvard he became a U.S. 
citizen. He is now a neurosurgeon at 
the Johns Hopkins School of Medicine. 
(For the full text of the address, visit 
medicine.yale .edu/ysminfo / top_story / 
2008/05/commencement-speech.html) 
Commencement awards 
This year’s Bohmfalk Prizes for excel¬ 
lence in teaching went to Leigh V. 
Evans, m.d., hs ’02, assistant professor 
of surgery (emergency medicine), for 
clinical sciences, and to Aldo J. Peixoto, 
m.d., associate professor of medicine 
(nephrology), for basic science. 
Thomas P. Duffy, m.d., professor of 
medicine (hematology), received the 
Leonard Tow Humanism in Medicine 
Award. The Leah M. Lowenstein 
Awards went to Nina Horowitz, m.d., 
assistant clinical professor of surgery, 
and to Andres S. Martin, m.d., 
m.p.h. ’02, associate professor in the 
Child Study Center and of psychiatry. 
Eve R. Colson, m.d. ’89, associate 
professor of pediatrics, received the 
Alvan R. Feinstein Award. Lynn D. 
Wilson, m.d., m.p.h. ’86, professor of 
therapeutic radiology and of dermatol¬ 
ogy, received the Francis Gilman Blake 
Award. And the Betsy Winters House 
Staff Award went to Vikram Reddy, m.d. 
—John Curtis 
above Deans Nancy Angoff and Richard 
Belitsky before the procession to Old Campus. 
LEFT Former Beatle Sir Paul McCartney was 
among those who received an honorary 
doctorate from Yale this year. 
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40 students commencement 2008 
Diane Martinez received a dean’s prize for 
outstanding thesis from Dean Paul Cleary. 
Public health grads urged to 
develop skills beyond science 
as leaders and advocates 
The 108 graduates of the School of 
Public Health’s Class of 2008 have 
their work cut out for them: defeating 
the aids virus, reducing obesity and 
eliminating health care disparities— 
to name just a few of the tasks cited 
by Dean Paul D. Cleary, ph.d. And 
they’ll face one more challenge, said 
Commencement speaker Georges 
C. Benjamin, m.d., director of the 
American Public Health Association: 
“Nobody’s going to know what you 
do,” he told the graduates gathered in 
Battell Chapel on May 26. 
Benjamin offered an analogy: Two 
people rescue a drowning person who 
drifts by their picnic spot. The next day 
they save two more people; and as the 
numbers steadily increase, they estab¬ 
lish an elaborate rescue system using 
boats, ambulances and helicopters. 
When the rescuers finally address the 
above Graduate Daina Barauskas with faculty 
member Annette Molinaro. 
right Public health students proceed to 
Old Campus. 
cause of the problem—a curve in an 
upstream road—and solve it with a 
guardrail and speed limit, the flow of 
victims ends. 
To achieve this sort of prevention, 
Benjamin told the graduates they’d 
need skills as leaders, administrators 
and advocates and good relationships 
with policy-makers. “Science is neces¬ 
sary but not sufficient,” Cleary said, 
noting that students on the medical 
campus are pressing New Haven offi¬ 
cials to improve traffic safety at nearby 
intersections. In April a medical stu¬ 
dent was killed (see related story, page 
39); in October 2006 a public health 
student was seriously injured. Both 
were struck by cars. 
Public health awards 
This year’s excellence in teaching award 
went to Annette M. Molinaro, ph.d., 
assistant professor of public health 
(biostatistics). “If you can generate 
enthusiasm for core biostatistics, you 
are some teacher,” Cleary quipped. 
Sharing the Dean’s Prize for Out¬ 
standing m.p.h. Thesis were Rupak 
Datta, Ling-I Hsu, Diane Martinez and 
Stephanie Smith. The Henry J. (Sam) 
Chauncey Jr. Inspiration Award went to 
Heather McPheron, and Ashley Fields 
won the Cortlandt Van Rensselaer 
Creed Award. Student speaker Rebecca 
Boulos offered warm memories of 
her classmates. 
—Cathy Shufro 
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PA students don white coats 
in new ceremony marking 
their entry to medicine 
Second-year students in the Physician 
Associate (pa) program helped their 37 
first-year colleagues in the Class of 
2009 don the white coats that symbol¬ 
ize the medical profession on the after¬ 
noon of March 20. Medical students 
have long participated in this tradition, 
but it is only the second time that Yale 
pa students have joined in tire ritual. 
And unlike their medical colleagues, 
they celebrated not the beginning of 
their training, but a different milestone. 
The donning of the white coat in the 
Medical Historical Library marked the 
transition from learning in the class¬ 
room to learning on the wards from 
I real patients. 
“We wanted to incorporate into a 
ceremony the idea of trying to instill in 
the students the ethical responsibility 
of being health care providers and the 
reverence with which they should prac¬ 
tice,” said Mary L. Warner, m.m.sc., 
pa-c, director of the pa program. 
“The White Coat Ceremony is a rite 
of passage, serving as a reminder of 
your need to balance excellence in the 
medical sciences with demonstrated 
compassionate care,” said keynote 
speaker Cynthia B. Lord, pa ’91, direc¬ 
tor of the Quinnipiac University pa 
program and president-elect of the 
American Academy of Physician 
Assistants. “The white coat should 
never be a symbol of status, hierarchy 
or power.” 
—Melinda Tuhus 
above At the White Coat Ceremony for stu¬ 
dents in the Physician Associate Program, 
second-year students helped first-years don the 
coats that symbolize their entry into clinical 
medicine. In turn, the first-year students placed 
School of Medicine pins on the coats of the 
second-years. Thea Cogan-Drew, president of 
the first-year class, right, put a pin on Karen 
Edwards’ coat. 
top Michelle Smith smiled as she got help 
from Tamara Brining. 
above Jason Fleury helped Megan Dieterich 
don her white coat. 
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42 students 
Students present their 
findings at 22nd Student 
Research Day 
At this year’s Student Research Day, 
the 22nd Annual Scientific Poster 
Session featuring research by students 
in medicine and public health, 58 stu¬ 
dents presented their findings on topics 
ranging from the soon-to-be-personal 
(Depression and Resilience During the 
First Six Months of Internship) to the 
practical (Educational and Behavioral 
Interventions to Reduce Exposure to 
Isocyanates in Auto Body Shops) to the 
profound (Beyond Patient Satisfaction: 
Physician Ambivalence, Authenticity 
top Jennifer Dominguez,center, with colleagues 
from the Yale Program for Women’s Reproductive 
Behavioral Health, where Dominguez did her 
thesis research. 
above Amanika Kumar, a student from Stony 
Brook University Health Sciences Center School of 
Medicine, who was at Yale on a fellowship, with 
David G. Nathan, who delivered the Farr Lecture. 
and The Challenges to Patient-Centered 
Medicine). 
Some projects reflected the notion 
that the most common expression in 
science is not “Eureka!,” but “Huh?” 
As medical student Kiera S. Levine 
analyzed her findings—patients 
expressed satisfaction with physicians 
whose manner was cold and imper¬ 
sonal—she asked, “That’s interesting. 
What’s going on?” Her conclusion: 
“The idea of satisfaction is complicated 
and tremendously ambivalent. Looking 
for simple assessments doesn’t reflect 
the patient’s circumstances.” 
Medical student Ayal Aizer— 
Radical Prostatectomy Versus Intensity- 
Modulated Radiation Therapy in 
the Management of Localized Prostate 
Adenocarcinoma—reviewed the records 
of about 800 patients treated for 
prostate cancer at Yale over a 10-year 
period to see whether they fared better 
with surgery or radiation therapy. For 
patients with a favorable prognosis, 
there was no difference in outcomes 
between patients who had surgery 
and those who had radiation. Patients 
with a poor prognosis tended to do 
better with the radiation therapy, as did 
patients with the most advanced cancers. 
Allison Arwady, who graduated with 
a degree in medicine this year, studied 
an old disease that is on the rise again 
in New Haven and elsewhere. In her 
project, The Uses of Rickets: Race, 
Technology and the Politics of Preventive 
Medicine in The Early 20th Century, she 
found that in the century’s early 
decades, as higher rates of the disease 
were observed in people with darker 
skin, it was erroneously concluded that 
the disease must be the result of poor 
sanitation. A large-scale study in New 
Haven in the 1920s found that the dis¬ 
ease, now known to be caused by a 
vitamin D deficiency, was widespread 
and afflicted people of all races and 
ethnic groups. Only then, Arwady said, 
did the public stop blaming the victims. 
She believes there’s a lesson to be 
learned from this rush to judge and 
stereotype, as she sees that reaction 
reflected in the response to some 
public health issues we face today, 
such as hiv/aids. 
Following the poster session, five 
students who won prizes for their re¬ 
search gave oral presentations. Lu Anne 
Dinglasan discussed “The role of matrix 
metalloproteinases in axon guidance 
and neurite outgrowth”; Ryan Kaple 
wrote his thesis on “The axial distribu¬ 
tion of lesion-site atherosclerotic plaque 
components: An in vivo volumetric 
intravascular ultrasound radiofrequency 
analysis”; Jason Roh’s talk was “The 
chemokine mcp-i is an essential media¬ 
tor in tissue engineered blood vessel 
development”; Andrew Simpson 
researched “The utility of plain radiogra¬ 
phy in the evaluation of degenerative 
spine disease”; and Nandakumar 
Narayanan’s paper was titled “While 
they wait: Rodent frontal cortex and 
delayed-response performance.” 
The day ended with the annual 
Farr Lecture, delivered this year by 
David G. Nathan, m.d., president 
emeritus of the Dana-Farber Cancer 
Institute. His talk, “A voyage in clinical 
research,” focused on his pioneering 
investigations into blood disorders. 
—Jennifer Kaylin 
MATCH DAY 2008 
Sarah Frasure, right, got a congratu¬ 
latory hug from classmate Lindsay 
McGuire at Match Day in March. 
Match Day 2008 
Nationally, this year’s match was the 
I largest ever—more than 28,000 appli- 
\ cants competed for 22,240 slots asfirst- 
II year residents. At Yale, 97 students 
matched. And for the third time in the 
last four years, all students found a 
match. “1 couldn’t he happier," said 
Nancy R. Angoff, m.p.h. ’81, m.d. ’go, 
hs ’93, associate dean for student 
affairs. This year’s match also saw 
a high number of students entering 
psychiatry—nine chose the field, the 
most ever at Yale. 
California 
Alameda County Medical Center, 
Oakland 
Mary Hatcher, emergency medicine 
| Mila Rainof, emergency medicine 
California Pacific Medical Center, 
San Francisco 
Sean McBride, medicine-preliminary 
Santa Clara Valley Medical Center, 
San Jose 
Jenelle Jindal, medicine-preliminary 
Maulik Shah, medicine-preliminary 
Stanford University Programs 
Louis Salamone, general surgery 
Sutter Medical Center of Santa Rosa 
Rachel Friedman,family medicine 
UCLA Medical Center, Los Angeles 
Anne Ackerman, surgery-preliminary, 
urology 
University of California, San Francisco 
Jessica Beard, general surgery 
Tina Dasgupta, radiation oncology 
Rasha Khoury, obstetrics and 
gynecology 
Yunie Kim, internal medicine/primary 
Kiera Levine, psychiatry 
Maulik Shah, neurology 
Krishan Soni, internal medicine I Michael Swetye, psychiatry 
James Troy, internal medicine 
Pavithra Venkat, obstetrics and 
gynecology 
Connecticut 
Greenwich Hospital 
Claudia Castiblanco, medicine¬ 
preliminary 
Griffin Hospital, Derby 
Louvonia Boone, medicine-preliminary 
Hospital of Saint Raphael, New Haven 
Jennifer Dominguez, medicine- 
preliminary 
Keith Gipson, transitional 
Nandakumar Narayanan, medicine¬ 
preliminary 
Karen Shoebotham, transitional 
Hannah Yu, medicine-preliminary 
St. Vincent’s Medical Center, 
Bridgeport 
Scott Kennedy transitional 
University of Connecticut Program, 
Farmington 
Keith Gipson, anesthesiology 
Jeannine Ruby general surgery 
Yale-New Haven Hospital 
Mary Allison Arwady, medicine/ 
pediatrics 
Eric Arzubi, psychiatry 
Erik Carlson, orthopaedic surgery 
Claudia Castiblanco, ophthalmology 
Douglas Davis, medicine/primary- 
preliminary, diagnostic radiology 
Jennifer Dominguez, anesthesiology 
Ryan Hebert, surgery-preliminary, 
neurosurgery 
Kristin Hoffmann, medicine/primary¬ 
preliminary, dermatology 
Lily Horng, internal medicine 
Rasika Jayasekera, psychiatry 
Kimberly Johung, medicine¬ 
preliminary, radiation oncology 
Rachel Laff, Internal medicine/primary 
Tamara Lazic, medicine/primary¬ 
preliminary 
Nandakumar Narayanan, neurology 
David Peaper, clinical pathology 
Elizabeth Wahl, internal medicine/ 
primary 
District of Columbia 
Children’s Nat’l Medical Center/ 
George Washington University 
Ephat Russcol, pediatrics 
Uniformed Services University of the 
Health Sciences 
Melissa Wollan, obstetrics and 
gynecology 
Walter Reed Army Medical Center 
Amanda Sandoval, psychiatry 
Indy Wilkinson, anesthesiology 
Kimberly Schinnerer, medicine¬ 
preliminary 
Y
al
e 
M
ed
ic
in
e 
a
u
tu
m
n
 
20
08
 
44 students match day 2008 
Corinna Levine, left, shared 
the good news with classmate 
Zofia Piotrowska. 
Florida 
Jackson Memorial Hospital, Miami 
Gabriel Widi, neurosurgery-preliminary 
Mount Sinai Medical Center of 
Florida Program, Miami Beach 
Roger Goldberg, medicine-preliminary 
University of Miami 
Gabriel Widi, neurosurgery 
University of Miami/Bascom Palmer 
Eye Institute 
Roger Goldberg, ophthalmology 
Illinois 
University of Chicago Medical Center 
Jason Griffith, internal medicine/ 
M.D. scientist 
Iowa 
University of Iowa Hospitals and 
Clinics, Iowa City 
Paul Walker, otolaryngology 
Maryland 
Johns Hopkins Hospital, Baltimore 
Mohamad Bydon, surgery¬ 
preliminary, neurosurgery 
Julia Marsh, internal medicine 
Kimberly Schinnerer, anesthesiology 
Johns Hopkins University 
Alison Norris, social science 
postdoctoral fellow 
Johns Hopkins University/Bayview 
Medical Center 
Elizabeth Houle, medicine-preliminary 
Johns Hopkins University/Wilmer 
Eye Institute 
Elizabeth Houle, ophthalmology 
Massachusetts 
Brigham and Women's Hospital, 
Boston 
Candace Feldman, internal medicine/ 
primary 
Sarah Frasure, emergency medicine 
Sanaz Ghazal, obstetrics and 
gynecology 
Karl Laskowski, internal medicine 
Sean McBride, radiation oncology 
Zofia Piotrowska, internal medicine 
Jason Roh, internal medicine 
Margaret Samuels-Kalow, emergency 
medicine 
Massachusetts General Hospital, 
Boston 
Argyro Caminis, psychiatry 
Sharmin Ghaznavi, psychiatry 
Ellen House, psychiatry 
Jenelle Jindal, neurology 
Ryan Kaple, internal medicine 
Jeffrey Winer, pediatrics 
Massachusetts General Hospital/ 
Harvard Combined Program 
Dania Magri, orthopaedic surgery 
Andrew Simpson, orthopaedic surgery 
Mount Auburn Hospital Program, 
Cambridge 
Karen Shoebotham, diagnostic 
radiology 
Minnesota 
Regions Hospital/HealthPartners 
Institute, St. Paul 
Timothy Sullivan, emergency medicine 
Missouri 
Barnes-Jewish Hospital, St. Louis 
Gregory Nelson, orthopaedic surgery 
New York 
Albert Einstein College of Medicine 
(Jacobi/Montefiore), Bronx 
Kurtland Ma, emergency medicine 
Albert Einstein College/Montefiore 
Medical Center, Bronx 
Liza Goldman Huertas, family medicine 
Hospital for Special Surgery/Cornell 
Medical Center, New York City 
Peter Fabricant, orthopaedic surgery 
Memorial Sloan-Kettering Cancer 
Center, New York City 
Tina Dasgupta, transitional 
Carolyn Graeber, transitional 
Sophia Liu,transitional 
Mount Sinai Hospital, New York City 
Leon Boudourakis, general surgery 
Lindsay McGuire, medicine-preliminary 
New York-Presbyterian Hospital- 
Columbia University Medical Center, 
New York City 
Louvonia Boone, anesthesiology 
Cynthia Correll, medicine-preliminary, 
neurology 
Sophia Liu, anesthesiology 
Christopher Winterbottom, internal 
medicine 
Hannah Yu, anesthesiology 
New York-Presbyterian Hospital- 
Weill Cornell Medical Center, 
New York City 
Scott Kennedy, diagnostic radiology 
Lindsay McGuire, dermatology 
Lori Spoozak, obstetrics and 
gynecology 
New York University School of 
Medicine, New York City 
Benjamin Bowling, internal medicine 
Carolyn Graeber, ophthalmology 
Mark McRae, plastic surgery 
Kristina Zdanys, psychiatry 
St. Luke’s-Roosevelt Hospital Center 
Program 
Barbara Wexelman, general surgery 
below left Gene-Fu Liu and bottom Yunie Kim discussed 
Julia Marsh, right, celebrated. the Match with faculty member 
Cyrus Kapadia. 
below right Kristin Hoffman 
will stay in New Haven for a 
dermatology residency. 
Ohio 
Cleveland Clinic Foundation 
Al Makkouk, orthopaedic surgery 
Pennsylvania 
Children's Hospital of Philadelphia 
Kevin Lau, pediatrics 
Tamara Miller, pediatrics 
Ashley Neal, pediatrics 
Drexel University College of 
Medicine, Philadelphia 
Abby Hochberg, medicine¬ 
preliminary, dermatology 
Hospital of the University of 
Pennsylvania, Philadelphia 
Lu Anne Dinglasan, diagnostic 
radiology 
Pennsylvania Hospital, Philadelphia 
Lu Anne Dinglasan, medicine¬ 
preliminary 
University of Pittsburgh Medical 
Center 
Misaki Kiguchi, vascular surgery 
Amy Meadows, pediatrics/psychiatry- 
adult and child 
Danielle Smith, obstetrics and 
gynecology 
Rhode Island 
Rhode Island Hospital/Brown 
University, Providence 
Alexander Diaz de Villalvilla, 
medicine/pediatrics 
Roger Williams Medical Center 
Program, Providence 
Tamara Lazic, dermatology 
Tennessee 
Vanderbilt University Medical Center 
Jennifer Giltnane, pathology 
Washington 
Swedish Medical Center Program, 
Seattle 
Soledad Ayres,family medicine 
University of Washington Affiliated 
Hospitals, Seattle 
Corinna Levine, otolaryngology/ 
research 
Natalya Lopushnyan, surgery¬ 
preliminary, urology 
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46 Alumni REUNION 2008 
Reunion 2008 
The big news and main attraction of this year's 
alumni gathering was the university’s new West Campus, 
which could transform research at Yale. 
Dean Robert Alpern led alumni on a tour of 
Yale’s new West Campus, a former pharmaceuti¬ 
cal facility that straddles the neighboring towns 
of West Haven and Orange and that will provide 
the university with 1.5 million square feet of 
new office, storage and laboratory space. 
47 
This year’s reunion was a jaw-dropping 
experience for the scores of alumni 
who toured Yale University’s new West 
Campus during the weekend. On the 
three buses shuttling alumni to the 
136-acre campus in neighboring West 
Haven and Orange and in the corridors 
of one of the site’s research buildings, 
alumni marveled at the new space, 
its pristine laboratories and the low 
price. When Dean Robert J. Alpern, 
m.d., Ensign Professor of Medicine, 
led alumni down a hallway past a 
chemistry lab that seemed to stretch 
forever, the possibilities for research 
seemed equally endless. 
After a brief tour of the lab and its 
12-foot chemistry hoods followed by a 
lunch in the facility’s cafeteria, Alpern 
described the process that led to the 
university’s $109 million purchase of 
the site and its 1.5 million square feet 
of office, storage and research space, 
as well as some of the medical school’s 
plans for its use. “We don’t see this as 
a site for classroom teaching,” Alpern 
said, “but we do see this as a site for 
research, some of which will include 
student participation.” 
The first research program to be 
based at West Campus will be the new 
Center for High-Throughput Cell 
Biology, headed by the new chair of 
cell biology, James E. Rothman, ph.d. 
’71, the Fergus F. Wallace Professor 
of Biomedical Sciences. The center 
will focus on developing tools and 
techniques for analyzing the cellular 
functions of the 25,000 known protein¬ 
coding genes in the human genome. 
West Campus, Alpern said, may 
also be a site for clinical use. Yale-New 
Haven Hospital sees potential for 
building an emergency room, and Yale 
Medical Group could open clinical 
practices at West Campus, which has 
parking for 3,000 cars. “For people 
coming up from southern Connecticut, 
the thing they hate most is the last 10 
minutes, driving into New Haven and 
trying to find parking,” Alpern said. 
Bayer Healthcare, which had owned 
the site for decades, decided to close it 
down in 2006 after a corporate merger. 
The company put the property on the 
market hoping to sell it to another 
pharmaceutical firm, but the only bids 
came from developers interested in 
the land. “When it became clear that 
no pharmaceutical company was going 
to come into the bidding process ... 
they told us they would love to get a 
bid from us,” Alpern said. “The devel¬ 
opers were getting land. We were 
getting research buildings, office build¬ 
ings and land. The biggest bonus is 
the time. If I convince [Yale President 
Richard C. Levin] that we need to 
start today on a new research building, 
it is a six-year time frame. ... We have 
gotten something that would have 
taken six years.” 
West Campus was also a central 
theme in Alpern’s State of the School 
address earlier that day at the Association 
of Yale Alumni in Medicine’s business 
meeting. “We want to establish pro¬ 
grams of exceptional quality that greatly 
enrich science at Yale and outside of 
Yale,” Alpern said, explaining the vision 
for the new campus. “This needs to 
transform science at Yale.” 
West Campus was not the only topic, 
however, in Alperrfs discussion of the 
state of the school. The School of 
Medicine, he said, remains one of the 
best in the world. “It has become 
absolutely impossible to get into the 
School of Medicine. We get over 4,000 
applications for 100 spaces,” he said. 
“The top 1,000 applicants are indistin¬ 
guishable, they are so fantastic.” 
Among the new educational initia¬ 
tives is a program for clinical clerkships 
in global health, which relies on estab¬ 
lished and ongoing programs with uni¬ 
versities and hospitals abroad. “We used 
to let students pick a place in Africa and 
go there,” Alpern said. “Now we really 
try to have organized rotations.” 
The medical school is moving away 
from the traditional “see one, do one, 
teach one” methodology through the 
use of such computerized models that 
mimic the human body as SimMan, a 
portable manikin that allows students 
to practice emergency treatment tech¬ 
niques and decision-making skills. “It 
is completely real,” Alpern said. “You 
see ekg, you see vital signs, you give 
medications. You don’t know that the 
patient isn’t real.” The medical school 
has also adjusted its financial aid 
policy (see related story, page 7), in 
order to ease the burden on middle- 
income families. 
The clinical practice, Alpern said, 
is the fastest-growing area of the medi¬ 
cal school. The partnership with Yale- 
New Haven Hospital, he said, “has 
never been better.” The new liver 
transplant program had performed 33 
procedures since the summer of 2007; 
in September 2007 the program com¬ 
pleted the first split-liver transplant in 
the state. “We have overnight become 
a center for liver transplants,” he said. 
At the alumni meeting that morning 
Christine A. Walsh, m.d. ’73, a professor 
of clinical pediatrics at Albert Einstein 
College of Medicine in New York, 
received the Distinguished Alumni 
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48 Alumni REUNION 2008 
Service Award in recognition of her 
service to her profession, patients and 
family. “It is icing on the cake to receive 
an award for something you absolutely 
love to do,” Walsh said. 
Improved outcomes for autism 
Diagnosing autism these days, said 
Fred R. Volkmar, m.d., director of the 
Yale Child Study Center, is something 
like filling out a form to diagnose deaf¬ 
ness. “You’d say ‘I want a hearing test!’ 
... We’re trying to make the diagnosis 
[of autism] ... more like a hearing test.” 
Although researchers have found 
some genetic markers for autism, diag¬ 
nosis is still a complex process requir¬ 
ing far more than a simple hearing 
exam. The current diagnostic gold 
standard requires the judgment of an 
experienced clinician who looks for cer¬ 
tain behaviors in a child and discusses 
the child’s developmental history with 
his or her caregiver. Most cases aren't 
diagnosed until the child is between the 
ages of 3 and 5; however, recent advances 
have allowed clinicians to diagnose the 
disorder in children as young as 2. 
Clinicians and researchers at Yale are 
now developing ways to spot autism 
even earlier. 
Formal diagnostic criteria became 
available only in 1980, and research 
and interventions developed since then 
have led to improved outcomes. Autistic 
children now apply for college, Volkmar 
said—something unthinkable 25 years 
ago. “In a university setting,” Volkmar 
joked, the odd social behaviors typical of 
people with autism “are often more easi¬ 
ly tolerated and people can fit right in.” 
Volkmar and his colleague Ami 
Klin, ph.d., director of the Yale Autism 
Program, described new diagnostic 
techniques at this year’s reunion 
symposium. The new approaches allow 
clinicians to deduce what a child is 
thinking by tracking what she looks at. 
Klirf s team recently found that toddlers 
who were later diagnosed with autism, 
when shown a video of a woman 
speaking tenderly into the camera, 
pay attention mostly to her mouth or 
to background objects. Other children 
typically watch the woman’s eyes. 
The eye-tracking technology that 
led to this discovery has been central 
to research at the Child Study Center 
since 2000, when Warren Jones, now 
a graduate student in neuroscience, 
proposed its use to Klin. Using this 
technique, researchers found that 
autistic adults watch actors’ mouths 
or background objects during emo¬ 
tional movie scenes rather than the 
actors’ faces. Brain imaging studies 
confirmed that people with autism 
see human faces the way normal peo¬ 
ple see objects. 
The youngest subjects of eye-tracking 
technology, though, are infants. The 
team created a video of a human figure 
rendered as a series of moving dots 
along with a spoken soundtrack; they 
then showed the video to babies. Infants 
later diagnosed with autism tended to 
look at both upright and upside-down 
figures, while normal babies preferred 
the upright figures. The autistic group, 
though, were more interested in 
Ami Klin and Fred Volkmar (at lectern) 
described new techniques for studying autism 
at the reunion’s scientific symposium. 
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figures that move in time with the 
soundtrack. This preference for audio¬ 
visual synchrony may be part of the 
reason that autistic people watch lips 
so intently—they’re drawn to the syn¬ 
chronous occurrence of lip move¬ 
ments and speech sounds. The team 
showed that mouth-looking exceeds eye¬ 
looking as early as 5 months of age 
in at-risk infants. 
Volkmar and Klin hope that in the 
near future babies held on a parent’s lap 
can watch a video while eye-tracking 
technology monitors their gaze and 
offers an early diagnosis of autism. But 
little research on effective treatments 
has been done in children under tire age 
of 3. Klin told the audience that a task 
force for extending therapies to babies 
has been formed. “We need a rapid- 
response system for the very young 
children who can’t wait.” 
Telemedicine’s global reach 
At $10,000 per hour for analog satel¬ 
lite time, said Ronald C. Merrell, m.d., 
the world’s first telemedical surgery 
“was a little bit, well, unwieldy.” 
The former chair of surgery at Yale 
referred to a pioneering open-heart 
operation in Houston in 1965, when a 
satellite linkup connected legendary 
surgeon Michael E. DeBakey, m.d., to 
viewers in Geneva. More recently, a 
surgeon in New York performed the 
first fully remote surgery on a patient 
in France. The momentous event was 
underreported, said Merrell, because 
the press conference was scheduled for 
September n, 2001. 
Merrell, who left Yale in 1999 to 
become chair of surgery at Virginia 
Commonwealth University (vcu), dis¬ 
cussed the past, present and future of 
telemedicine at the Yale Surgical Society 
Spring Reunion, which was held this 
year in his honor. He now leads the 
Medical Informatics and Technology 
Applications Consortium at vcu. 
Telemedicine, he said, is “the applica¬ 
tion of telecommunications and infor¬ 
mation science to support the delivery 
of health care at a distance.” 
Telemedicine is already with us in 
many ways, he said. Picture archiving 
and communication systems, now 
common, allow radiologists to diagnose 
patients from thousands of miles away. 
Preoperative clearance can also be done 
remotely, as Merrell and a team of 
surgeons demonstrated when they 
cleared the way for patients in the 
Dominican Republic to undergo sur¬ 
gery before the surgeons had arrived. 
A satellite dish installed on the roof of 
an outbuilding provided the link for 
low-bandwidth video. 
In medical education, Merrell said, 
telemedicine can be as simple as 
Internet access in Kenya from solar- 
powered laptops, or as sophisticated 
as the class he once taught from the 
operating room for a group of medi¬ 
cal students in Russia. “Education 
can be distributed in virtual reality in 
ways that really do work,” Merrell 
said, adding that he hoped such tech¬ 
niques would reduce our “separation 
and alienation from the developing 
world.” Telemedical techniques might 
one day beam top-quality medical 
education into medical classrooms 
around the world. 
“I would make this integral to the 
training of medical students interna¬ 
tionally,” he said. “As long as it’s inter¬ 
active, I think we can do as well as we 
could in a classroom.” 
Former chair of surgery Ronald Merrell was 
honored at the Yale Surgical Society Spring 
Reunion. In his address, Merrell described 
telemedical techniques that bring medical 
education around the world. 
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A focus on ethics in public health 
As Lawrence O. Gostin, j.d., associate 
dean and the O’Neill Professor of 
Global Health Law at the Georgetown 
University Law Center, surveys the 
health landscape around the world, he 
comes to an obvious yet troubling con¬ 
clusion. “Rich countries just don’t care 
enough,” he said, calling the response 
of the United States and other affluent 
countries to health inequalities “lim¬ 
ited and quite pathetic.” 
Gostin, the keynote speaker at the 
School of Public Health's Alumni Day 
symposium, said that government 
leaders need to pay closer attention to 
health threats in other parts of the 
world. “Infectious diseases don’t respect 
national borders,” he said, noting that 
health issues pose serious ramifications 
for international commerce, trade, 
tourism and government stability. 
“States with unhealthy populations 
provide a great opportunity to harbor 
terrorists.” Even the cia, he said, 
uses infant mortality as a marker of 
political stability. 
While such headline-grabbing events 
as the recent China earthquake and the 
East Asian tsunami of December 2004 
are typically followed by a “powerful 
humanitarian response,” Gostin said 
that help to meet such basic necessities 
as sanitation, clean air and water, pest 
abatement and vaccines is more 
urgently needed in developing coun¬ 
tries. “It’s disarmingly simple and inex¬ 
pensive,” he said. “They don’t need 
state-of-the-art facilities or foreign aid 
workers parachuting in to rescue 
them; they just need basic stuff they 
can run themselves.” 
Noting that governments currently 
exist in a state of “global health anarchy,” 
Gostin proposed the creation of an 
international framework convention on 
global health modeled on the Kyoto 
Protocol, which raised the visibility of 
climate change as a global threat. The 
framework convention, an idea that is 
already being discussed by the World 
Health Organization and other interna¬ 
tional agencies, would convene key 
stakeholders for the purpose of address¬ 
ing health disparities and developing 
global health solutions. 
When it comes to health, “the poor 
suffer much more than the rich,” Gostin 
said. “Health disparities are no less 
important than global warming and 
other issues of the times.” 
The panel that followed Gostirfs talk 
also pursued the subject of ethics and 
public health. On the panel was Stewart 
D. Smith, m.a., m.p.h. ’96, a former 
Navy officer, who served in the first 
Gulf War and was in the Pentagon on 
September 11. Since leaving the military, 
Smith has made a career as a consultant 
who helps organizations prepare for 
disaster. However, he has yet to see a 
company disaster plan that includes an 
ethics analysis. “Everybody assumes 
that ethics is common sense, that they 
intuitively know the right thing to do, 
and—guess what—they really don’t. 
They need to be taught; and the time to 
do it is before disaster strikes,” he said. 
For example, a recent government sur¬ 
vey found that 73 percent of its em¬ 
ployees would not come to work during 
a flu outbreak. Would it be ethical to 
require them to? “Get real,” said Smith. 
“Ethics is real.” 
Curtis Patton presented posthumously the Award 
for Excellence in Public Health to the late Virginia 
Alexander. Her great-niece, Virginia Brown, and 
niece, Rae Alexander-Minter, accepted the award. 
Smith was one of four panelists to 
discuss the importance of ethics in 
emergency planning and public health. 
Speaking from their own experiences— 
which range from military action to 
anthrax attacks—the panelists made a 
strong case for ethics training in public 
health education and decision making. 
James L. Hadler, m.d., fw ’8o, 
m.p.h. ’82, who recently retired as 
chief of the infectious diseases section 
at the Connecticut Department of 
Public Health, often juggles benefits 
to the community and individual 
rights. (See related story, page 58.) He 
usually favors the welfare of the com¬ 
munity “when the individual can’t pre¬ 
dictably be harmed.” But determining 
the chances of harm isn’t always easy. 
During a meningitis outbreak on col¬ 
lege campuses just a few days before 
the end of a semester, for example, 
Hadler had to decide whether to vacci¬ 
nate more than 12,000 students with 
jet-injector guns that carried a small 
risk of cross-contamination with blood- 
borne pathogens or with injections that 
would take much longer to administer, 
thereby putting students at risk of 
meningitis infections. After consulting 
with an ethicist and the Centers for 
Disease Control and Prevention, and 
researching different brands, Hadler 
authorized the use of jet-injector guns. 
On a smaller scale, there are the 
problems of running an inner-city 
clinic. “Do we rob Peter to pay Paul?” 
asked Thomas J. Krause, m.p.h. ’81. 
For Krause, that question isn’t just 
hypothetical. Krause is chief operations 
officer at Southwest Community Health 
Center in Bridgeport, where most of his 
patients are self-pay or have Medicaid, 
and every year he faces budget cuts. He 
is responsible for delivering health care 
to poor people, many of them immi¬ 
grants who have never encountered 
Western medicine. And he must main¬ 
tain the morale of a staff that is ham¬ 
strung by scarcity and the difficulty of 
caring for this patient population. In 
the face of such pressures, it would be 
easy to think of ways to trim and skimp, 
Krause said. “But we never go there.” 
Bruce Jennings, m.a., a lecturer in 
ethics at the School of Public Health, 
explored the philosophical underpin¬ 
nings of the others’ real-world stories. 
The idea that society serves the individ¬ 
ual and not the other way around, he 
said, sometimes “butts heads” with pub¬ 
lic health when officials must weigh an 
individual’s liberty against the greater 
public good. Debates from the early 
days of aids provide an example. As the 
epidemic silently spread, public health 
officials pushed for greater tracking and 
surveillance of cases, while others 
argued that to do so would infringe on 
privacy rights. Since the aids era began, 
he said, “it has been impossible to take 
a purely libertarian [standpoint] and it 
has been impossible to be purely utili¬ 
tarian.” But, he added, “We have to 
figure out how to get respect for per¬ 
sons and liberty—and outcomes and 
health—together. ” 
Awards and the state of the school 
Dean Paul D. Cleary, ph.d., delivered 
good news to those gathered at Alumni 
Day 2008 at the New Haven Lawn 
Club—the School of Public Health 
has gone through a successful re¬ 
accreditation process. And, Cleary said, 
changes are in the works for the school, 
including a revamping of the global 
health program. 
TOP Christine Walsh received the Distinguished 
Alumni Service Award, for her contributions 
to the school and the profession, from Dean 
Robert Alpern. 
above Tobias Carling, Vikram Reddy and 
Walter Longo at the Yale Surgical Society 
Spring Reunion. 
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52 Alumni REUNION 2008 
“We stopped admitting students to 
global health last year,” Cleary said. 
“We dissolved the division of global 
health and created a schoolwide global 
health program.” 
In addition, he said, Elizabeth H. 
Bradley, ph.d., professor of public 
health (health policy), is developing a 
global health leadership initiative that 
will bring practitioners from around tire 
world to Yale. The school has also cre¬ 
ated an office of community health, led 
by Elaine O’Keefe, former head of the 
New Haven Health Department’s aids 
division and former health director for 
the town of Stratford. The new office 
will oversee student internships, Cleary 
said. “We will move from a less-than- 
optimal approach to a better-focused, 
more-managed program,” he said. 
The Association of Yale Alumni in 
Public Health (ayaph) presented sev¬ 
eral awards this year. 
Robert E. Steele, m.p.h. ’71, ph.d. 
’75, m.div., received the Distinguished 
Alumni Award for his contributions 
to the school and the profession. Steele 
has been on the ayaph board since 
2001 and served as president from 2004 
to 2007. He is a founder and benefac¬ 
tor of the Creed/Patton/Steele Endowed 
Scholarship Fund, which supports 
future public health professionals. “It 
is important to support the institutions 
that have supported us,” Steele said as 
he accepted the award. 
The Eric W. Mood New Professionals 
Award went to Keshia M. Pollack, 
m.p.h. ’02, ph.d., who teaches at 
Johns Hopkins Bloomberg School of 
Public Health. She also works for a 
member of the Maryland General 
Assembly and advises a Baltimore 
community coalition seeking to allevi¬ 
ate childhood obesity. 
The Award for Excellence in Public 
Health Practice was given posthumously 
to Virginia Alexander, m.d., m.p.h. ’41. 
Alexander received her medical degree 
from Woman’s College of Pennsylvania 
in 1925, but no Philadelphia hospital 
would accept Alexander, who was 
African-American, for training. Instead 
she completed her internship at Kansas 
City General Hospital, in Missouri, the 
designated hospital for people of color 
in that city. After receiving her public 
health degree from Yale, she became 
physician-in-charge of women students 
at Howard University in Washington, 
D.C. Her niece, Rae Alexander-Minter, 
ed.d., and great-niece, Virginia Brown, 
accepted the award on her behalf. 
PHYSICIAN ASSOCIATE ALUMNI HOLD REUNION 
About two dozen alumni of the Physician Associate Program 
gathered in June for their fourth annual reunion. The tradition 
started in 2005, as graduates from the program’s 35 years 
reunited over dinner at the Graduate Club on Elm Street. With 
program director Mary L. Warner, pa-c (third from left), were, 
from left, Gary Spinner, pa-c ’83; Kenneth Watkins, pa-c ’98; 
and John Cassidy, pa-c ’73. 
REUNION REPORTS 
1948 
60th Reunion 
The 60th reunion of the Class of 
1948 was a great success. As of 
' June this year 31 of the 55 of us 
who graduated in 1948 were still 
around, and 15 attended the 
reunion along with nine of the 
wives. They were a pretty vigor¬ 
ous bunch of 8o-somethings. 
Three of our five living 
women members were there. 
The prize for vigor has to go to 
Elizabeth Fuller Eisner, who spends 
the winter in Alaska where she is 
addicted to cross-country skiing. 
She had to take time off this past 
year to get a new hip but she is 
now back to her old sport. She 
spends the summer in Massa¬ 
chusetts and came down on 
Saturday morning with Nan 
Codley. Nan still does some vol¬ 
unteer work at Harvard. Sylvia 
Preston Griffiths also does volun¬ 
teer work at Columbia. 
The prize for the longest trip 
goes to Al and Ruth Fisk who 
came from California. They live 
in the Sonoma valley and until 
recently had a small vineyard. 
They also won a gold medal in 
2003 at the Cal State Fair for 
their pinot noir.They have now 
given up the vineyard and keep 
busy with duplicate bridge, gar¬ 
dening and leading environmen¬ 
tal walks. Next longest was Jock 
Bishop, who is retired from an 
academic career at Minnesota in 
internal medicine and research 
in the physiology and biochemis¬ 
try of diabetes. He now pursues a 
hobby in creating rustic furniture 
from buckhorn wood. In listing 
our longer travelers I overlooked 
Dick Buker who is the last mem¬ 
ber of our class still seeing 
patients. He is the county health 
officer of Chester, Mont., and is 
in charge of disaster planning 
for his area. He attended with 
Candace Chang. 
Bob and Mary Lempke joined 
the group on Friday from 
Indiana. The OR at the Richard L. 
Roudebush Indianapolis VA 
Medical Center was named in 
Bob’s honor. He was chief of 
surgery there for many years. 
He has taken up oil painting— 
53 
landscapes and some portraits 
and has had a showing of his 
works in Indianapolis. Dave and 
Kayoke Morton came from Pueblo, 
Colo.They have been doing a lot 
of traveling, including trips to 
Japan to see Kayoke’s relatives. 
Bud and Esther Rowland, Jack 
and Ann Strominger and Paul 
Talalay came from Columbia, 
Harvard and Johns Hopkins 
respectively. I mention them 
together because they probably 
represent the most successful of 
our academicians. Paul is the John 
Jacob Abel Professor of Molecular 
Pharmacology at Hopkins. He is 
widely known for his studies of 
vegetables like broccoli that 
induce protective enzymes in the 
body and help prevent cancer. In 
2005 he was awarded the presti¬ 
gious Linus Pauling Award in 
recognition of his work. Jack is a 
professor at the Dana Farber 
institute at Harvard. He has stud¬ 
ied histo-compatibility in man 
and other vertebrates leading to 
the understanding of mecha¬ 
nisms of immune recognition. In 
1999 he received the Japan Prize, 
the largest monetary reward for 
scientific investigation. Bud was 
chief of the department of neu¬ 
rology at Columbia’s Neurologi¬ 
cal Institute and was widely 
known for his work on stroke. 
Paul and Betty Goldstein, Paul 
and Margaret Koehler, and Dick 
Richardson represent our clini¬ 
cians who remained in the 
Northeast. Paul is the only mem¬ 
ber of the class who remained in 
New Haven and has been an 
anchor for returning alumni. He 
now spends winters in Florida. 
When he is in New Haven he 
spends one day a week in his 
clinic. Dick Peterson is now 
retired. He drove down from 
Southbury, Conn., with his 
daughter Melanie Barry. Paul 
and Margaret drove down from 
Newbury, N.H. Paul served us for 
50 years as class secretary. He’s 
still pretty active despite acquir¬ 
ing four artificial joints. 
During the spring I contacted 
almost everyone in our class. I’d 
like to mention three of our 
achievers who couldn’t come. 
They are Herold Griffith, Tom Frei 
and Betty McCleary Hamburg. 
Herold spent eight years as 
chief of plastic surgery at the 
University of Illinois medical 
school. He was made an honorary 
member of British Association 
of Plastic Reconstructive and 
Aesthetic Surgeons, of which 
there are only eight in the United 
States. Tom is the Richard and 
Susan Smith Distinguished 
Professor of Medicine at Harvard 
and a member of the Dana 
Farber Cancer Institute. In 1972 
he was given the Albert Lasker 
Medical Research Award for 
demonstrating that a combina¬ 
tion of chemotherapeutic agents 
could result in long-term sur¬ 
vival and even cures in some 
leukemias and lymphomas.This 
award is often a prelude to the 
Nobel Prize. Betty reports having 
two careers, first as a professor 
at Harvard and then as the first 
director of child psychiatry at The 
Mount Sinai Medical Center in 
New York City. After retiring from 
Mount Sinai, she began a second 
career as president of the William 
T. Grant Foundation. Herold 
couldn’t come because his wife is 
so frail. Tom couldn’t make it for 
health reasons. Betty thought she 
could come in on Saturday but 
something must have interfered. 
Looking forward to seeing all 
of you on our 65th. 
Ben Rush 
1953 
55th Reunion 
Our 55th class reunion welcomed 
10 of our members, who had 
lively discussions in many venues. 
Two of our married sets, Ed and 
Rhoda Powsner and Ora and 
Howie Smith, added greatly to 
the pleasure of the weekend. 
Attending some of the reunion 
activities were Claude Bloch, Fred 
Lane and Jose Ramirez-Rivera. Tom 
Gentsch was accompanied by 
wife Betty. Hyla and Bob Melnick 
had to leave early Sunday to wel¬ 
come a new grandchild who had 
arrived on Saturday. Maureen 
was with Hal Bornstein. Many 
of our regular attendees had 
excused absences for a variety of 
reasons from knee replacement 
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54 Alumni REUNION REPORTS 
to family conflicts. Excellent 
weather enhanced the reunion 
program, especially the tour of 
Yale’s new West Campus. 
Harold D. Bornstein 
1958 
50th Reunion 
Thirty-two members of our class 
of 72 graduates were in atten¬ 
dance. Many with their wives or 
significant others were there to 
partake of the festivities. George 
and Anne Aghajanian, Joe and 
Ann Angelo, John and Trudy Arnot, 
Gerry and Ann Burrow, Dave and 
Helen Carlson, Joe Cillo and Tina 
Callahan, John and Sheila 
Creatura, Bob and Ellen Donohue, 
Larry and Reggie Dubin, Don and 
Helen Duncan, Michael and Liz 
Fishman, Marcia Kraft Goin, Bill 
and Sue Gould, Stan and Debbie 
Harris, Ernie Hartmann, Dick 
Hinckley, Mike and Jean 
Kashgarian, Jay and Barbara 
Kislak, Ted and Dora Lieberman, 
Tom and Karen Mauro, Bill 
McClanahan and Anne Bourne, 
Andy and Lois McGowan, Richard 
and Eva Miller, Al and Judie 
Muggia, Bob Neuwirth, Carol 
Phillips, Bill and Dorothy Radcliffe, 
Paul and Sandra Rudnick, Bruce 
Sklarew and Margaret Meyer, Ray 
and Maria Turner, Jack and Pauli 
Wood. We missed Bill Schlaepfer 
who could not attend and were 
sorry to hear that Chuck Kashima 
was not doing well. Our Friday 
night class dinner was held at 
the old Fulton Mansion on 
Deepwood Drive. We were for¬ 
tunate to enlist the Union League 
Cafe as our caterers since they 
produce the best French cuisine 
in Connecticut. Dean Robert 
Alpern joined us and assured us 
that the Yale system, although 
somewhat modified by external 
influences, is still alive and well 
and is attracting the very best 
students. We started dinner with 
a toast to honor the 10 members 
of our graduating class who have 
passed on over the years. John 
Carlston, Jake Gallagher, Dick 
Gershon, Jim Greenwald, Ken 
Jimenez, Mike Lotz, Pat McKegney, 
Al Phillips, Dave Pugh, Tom Shea, 
and Bob Wroblewski. Alumni 
Day began with a symposium 
on autism that fascinated and 
enthralled all who attended.The 
afternoon was occupied by some 
with a visit to the new West 
Campus, where new programs in 
biotechnology, chemistry, physics, 
environmental sciences and art 
preservation will take place, 
while others had some moments 
of nostalgia by having pizza at 
Pepe’s on Wooster Street. The 
weekend ended with dinner with 
the Friends of the 50th at the 
Graduate Club, where old friend¬ 
ships were renewed. Mike McCabe 
did not attend and is still surfing 
in Hawaii and sends this mes¬ 
sage “I miss all of you guys. But I 
love surfing my Hawaiian waves. 
So, come visit me in Hawaii!” 
Mike Kashgarian 
Gerry Burrow 
1963 
45th Reunion 
Eleven members of the Class of 
1963, many accompanied by their 
spouses, made their way back 
to the mother ship for the 45th 
Reunion. Sending regrets but 
unable to attend because of 
illnesses, prior commitments, 
unavoidable conflicts or 
intractable lethargy were 
Wayne Brenckman, Bill Friedewald, 
Bill Lehmann, Bob Mueller, Bob 
Grummon, Seth Weingarten, Steve 
Joseph, Lee Talner, Peter Gregory, 
Judy Davis, John Mahoney, Rick 
Back, Dudley Danoff, Allen 
Flaxman, Ben Harris, Pete Tishler, 
Larry Tremonti, Jim Dalsimer, 
Gordon Cohen, John Conte, Bill 
Porter and Gene Profant. Many 
commitments were offered for 
attendance at our 50th in 2013. 
Our small but very congenial 
and talkative group lingered 
through extensive conversation 
and reminiscing at Friday’s 
clambake and a marvelous 
Saturday dinner at the O-Club. 
Art Ackerman, who has been 
bringing Western medicine to 
the backwaters of developing 
countries over many decades, 
continues to do so, most recently 
in Africa (Tanzania and Rwanda) 
and the Caribbean (Antigua). 
Colonel Craig Llewellyn, fully 
retired from his longtime Army 
career, splits his time between 
Florida and Vermont, while 
teaching and assisting in the 
establishment of emergency pre¬ 
paredness teams and procedures 
at universities. Sheldon Pinnell, a 
Duke faculty guy since 1973 and 
self-confessed workaholic, sold his 
SkinCeuticals Company (for which 
he developed research-based sun¬ 
screen and antioxidant skin pro¬ 
tection and restoration products) 
to L’Oreal, and continues to spend 
full days in his lab at Durham, 
having a good time. Dave Fulmer, 
on the other hand, has his good 
times at the front end of a fish¬ 
ing rod. Back at the turn of the 
millennium, Dave decided that he 
had had enough of managed 
care and other regulatory baloney 
and would retire from his internal 
medicine practice in Princeton, 
N.J., and start enjoying his seven 
grandkids. Alex Gaudio continues 
his full-time retinal disease prac¬ 
tice in Hartford, Conn., now with 
his son, Paul, and spends one 
day every week maintaining his 
academic connection at Mass 
Eye and Ear in Boston. Hal Kaplan 
finally retired from his gastroen¬ 
terology practice in July 2007, 
but continues in his “part-time” 
medical affairs consulting slot at 
his old hospital in Meriden, Conn., 
while finding more time to enjoy 
his io (and still counting?) grand¬ 
children. Mike Fessel, also still 
hanging out in the New Haven 
area, practices interna! medicine, 
and, along with Hal, enjoys a 
clinical appointment to the med 
school faculty, trying to teach the 
art of effective communication 
with patients and family. Andy 
Edin continues his active internal 
medicine practice in Minnesota. 
Part of a large multi-specialty 
group, he now arranges his 
patient schedule on his own 
terms, allowing him time to enjoy 
his longtime hobby of hunting 
in Minnesota (these days, with¬ 
out shooting), as well as in any 
number of remote locations. 
Alan Shapiro remains happy in 
an active urology practice in 
Tinseltown. Helen Walsh, long 
since moved on from a career in 
anesthesia to one in psychiatry, 
is quite active and happy with a 
part-time Massachusetts practice 
limited to geriatric psychiatry. 
Also still engaged in a part-time 
psychiatric practice is Jay 
Pomeranz, who in his free time 
wields a very competitive tennis 
racquet in Springfield, Mass. 
Twenty-nine classmates con¬ 
tributed to the 45th Reunion 
Booklet, providing a variety of 
long and short glimpses of their 
personal lives, with fascinating 
details beyond the limited scope 
of this article. Copies will be dis¬ 
tributed by mail to all members 
of the Class of 1963. This mailing 
will be the first phase of an 
intensive campaign to encourage 
maximum attendance at our 
50th reunion, scheduled for June 
7-8,2013. SAVE THE DATES! 
Harold Kaplan 
1968 
40th Reunion 
Seventeen members of the Class 
of 1968 came to New Haven for 
our 40th reunion. Elizabeth Short 
provided the star attraction with 
the 2008 edition of the Class 
Roster, a 139-page summary of 
the class that will be mailed to all 
who did not attend. Grace 
Jordison Boxer came with hus¬ 
band Larry from Michigan. Bob 
Dillard, who came with wife 
Laura, reminded us of his pas¬ 
sions for treating sick babies and 
for fly fishing. Alan Finesilver, who 
came with wife Cindy, is also an 
avid fly fisherman (Wisconsin 
and Montana) and works as a 
volunteer to help find housing 
for homeless people. Bill Flynn Jr. 
is still working as a general sur¬ 
geon with no intention of retiring 
any time soon. Gil Grand revels in 
his "perpetual immaturity." Len 
Grauer, who came with wife 
Betsy, was "delighted to see 
everyone." Ralph Greco came with 
wife Irene Wapnir. Peter Jokl was 
excused from the fete due to aor¬ 
tic valve surgery a few weeks ear¬ 
lier. Marc Lippman was happy 
"just to be here.” Frank Lucente, 
who came with partner Stephen 
Saikin, tells us he is now enjoying 
“minimal work.” Allen McCutchan 
and wife Emily are anticipating 
55 
semiretirement soon. Richard 
Morehead invites us all to Santa 
Fe, N.M., for next year’s West 
Coast reunion—a necessary loca¬ 
tion due to global warming (i.e., 
no more West Coast). Jim Ogilvie 
is happy to “see a happy and pro¬ 
ductive Class of '68. We're not 
done yet!” Jerry Rauch and wife 
Nancy have been traveling inter¬ 
nationally, rebuilding their house 
and volunteering at an animal 
shelter. Peter Kirkpatrick says this 
event brings back good memo¬ 
ries. And Chuck Post has been 
semiretired for 8 years, sailing 
along the East Coast and the 
Caribbean, doing surgery in the 
Third World and bicycling in 
various countries. 
Donald Lyman 
1973 
35th reunion 
Among those who made the pil¬ 
grimage were Marv Chassin and 
wife Barbara, now in Phoenix, 
where Marv practices oncology. 
Marvin Miller is the class geneti¬ 
cist; he came from Dayton, Ohio, 
with wife and children. Sesh Cole 
and wife Pat came from St. Louis, 
where Sesh is in pediatrics at 
Washington University.They left 
the next day for Dartmouth’s 
graduation. John Brown has 
retired from his surgical practice 
in Vancouver, Washington, and 
spends time in Mexico and 
Florida; he noted that John Jr. has 
presented him with grandchil¬ 
dren. Chris (Kull) Walsh arrived 
from New York with husband 
Sean. Chris is a pediatric cardiolo¬ 
gist at Einstein and has a daugh¬ 
ter in her own training program. 
I Harry Romanowitz and wife Sheila 
drove up from Stamford, Conn., 
where Harry practices pediatrics. 
Doug Maddox and wife Kathryn 
flew in from Atlanta, where Doug 
i is ent chair at Emory. 
On Saturday, Joe Eichenbaum, 
who practices ophthalmology at 
Mt. Sinai, and wife Ingrid joined 
us. Randy Zusman came from 
Boston; he has been at Mass. 
General since graduation. Tom 
Sweeney and Jim Sullivan were 
both in attendance, representing 
surgery and medicine in the 
New Haven community. Rick 
Young attended, fresh from his 
third tour of duty in Iraq. Rick is 
a pediatric neurologist and chair 
of pediatrics at the Hospital of 
Saint Raphael in New Haven. 
Neil Handel attended by phone, 
unable to make it from Los 
Angeles where he is a plastic 
surgeon and the proud father of 
three young children. I am a gas¬ 
troenterologist in Dallas, run a 
colon cancer research laboratory, 
and still work on my medical 
school thesis. 
We swapped tales about 
family and professional activi¬ 
ties, tried to exchange informa¬ 
tion about those who weren’t 
there, and made up what we 
didn’t know for certain. We 
have produced two deans (Lee 
Goldman at Columbia and Dave 
Bailey at UC Irvine); several 
department chairs (George Lister 
in pediatrics at Southwestern 
Medical Center, Bob Buchholz, 
who just stepped down from 
orthopaedics at Southwestern, 
Jerry Rosenbaum in psychiatry 
at Mass. General, and probably 
more); and many division chiefs 
and other academic leaders. 
We look forward to seeing more 
of you at future reunions. 
Richard Boland 
1978 
30th Reunion 
The Class of 1978 reconvened in 
New Haven this June for their 
30th reunion. Sightings included 
Rich Baron, Duke and Claudia 
Cameron, Howard Chase and 
Claudia McNamara, Stuart and 
Amy Forman, Bob Gelfand and 
Susan Boulware, Ken Lee and 
Ruth Daniel, Yvette Piovanetti and 
Jose Martinez, Barb and Jordan 
Pober, Seth Powsner and Elizabeth 
Yen, Mike Rogawski, Bern Shen, 
Tom Smith and Joann Bodurtha, 
Marcia Wade and David Officer, 
John Wagner and Julie Budd, 
Jonathan Weinberg, and Susan 
Wong. Dean Alpern joined our 
class for dinner at the Graduate 
Club, either because of our illus¬ 
trious record of charitable giving 
to Yale or our legacy of mischief 
... you decide. It was a heart¬ 
warming and spirited evening. 
Those not in attendance were 
missed but also well represented 
in embarrassing vignettes. 
Remember this when you 
consider your plans to attend 
the 35th! Seth and I will get to 
work on a class survey to provide 
a little more detail on everyone’s 
lives. Have a great summer. 
Duke Cameron 
Seth Powsner 
1983 
25th Reunion 
“Spectacular” describes our 
reunion. As we gathered on 
Harkness lawn, at the 333 Cedar 
St. rotunda, and in the Historical 
Library, it seemed as though just 
yesterday we were students. 
Attendees included: Mark 
Boytim and Anne Boytim, Nancy 
Crocker, Dianne Edgar, Gerri 
Goodman, Linda Grais and John 
Freund, Tammy Harris, Rob 
Homer, Ana Lamas, Judy Melin, 
Elizabeth Nolan, David Norton, 
Dan Oren and Jeanette Kuvin 
Oren, Alan Reznik and Elizabeth 
Reznik, David Schwartz, Susan 
Seward and David Seward, 
Steven Sockin and Susan Sockin, 
Michael Silverberg, Michael Tom. 
Among us are expert clini¬ 
cians, educators, chiefs, chairs, 
partners, directors, trustees, 
researchers and administrators 
throughout the country. We dis¬ 
cussed our residencies, fellow¬ 
ship training, current or prior 
practice experiences in allergy 
(Ana, Steve), ENT (MikeT.), ER 
Med (Elizabeth), ophthalmology 
(Gerri), orthopaedics (Alan, 
Mark), primary care specialties 
(Tammy-FP; Judy, Sue-IM; Dave N., 
Nancy-pedi). We talked of teach¬ 
ing, research and practice at Yale 
and in New Haven (Alan, Dan, 
Rob). We talked of clinical lead¬ 
ership roles in anesthesia (Dave 
S., Mike S.), of management/VC 
work in life sciences (Linda), in 
pharmaceutical research (Dan), 
of health care administration 
and policy work (Dave N., Judy, 
Nancy et al). Most talked of edu¬ 
cating medical students and res¬ 
idents (Ana, Dan, Dave S., Gerri, 
Judy, Rob, Sue et al.). 
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Our dinner on a sunny sum¬ 
mer day at Sage’s, formerly Chart 
House, was the ideal setting for 
our class photo on the ocean 
deck. We reviewed Alan’s copy of 
our Class Yearbook, Judy’s copy of 
our first-year Facesheet, and were 
proud to learn that it’s our class 
that revived the Yearbook tradi¬ 
tion at the School of Medicine. 
Other classmates heard from 
recently include Alan Bloom (oph¬ 
thalmology), April Hang-Miller 
(rheumatology), David Helfgott 
(id), and Eric Winer (oncology). 
Tina Young Pouissant and Valerie 
Stone led the establishment of 
the memorial fund honoring 
Yvedt Matory, M.D. ’81. We thank 
Michael Tom, for his leadership 
role in the Yale Tomorrow School 
of Medicine alumni fund cam¬ 
paign, our reunion gift volun¬ 
teers David Schwartz and Eric 
Winer, and reunion co-chair 
David Helfgott. We also extend 
our thanks to Joan Peck of 
the Association of Yale Alumni 
in Medicine for organizing 
our reunion, and to Mary 
Meehan, director of alumni 
affairs, and Claire Bessinger 
of Yale Medicine. 
For classmates not here for 
the reunion, know we talked of 
your research advances, publica¬ 
tions, teaching, leadership, and 
outstanding care you provide. 
When we next convene, we’ll 
again prove accurate the refrain 
from our fourth-year show 
theme song, that we’re "one sin¬ 
gular sensation, Yale Med Class 
of ’83.” We’ll be holding a place 
for each classmate at our next 
reunion. Do join us. 
Judy Melin 
1988 
20th Reunion 
It is hard to believe that it has 
been 20 years since we left New 
Haven, especially since everyone 
who attended looked unchanged 
from our medical school days. 
Five of us took a break from 
chauffeuring our children to their 
various activities and returned 
for this year’s reunion. 
Dave Chelmow arrived for the 
Saturday night dinner. He is the 
director of the ob/gyn residency 
program and the irb chair at Tufts 
Medical Center in Boston. He and 
wife Fay, a hospice nurse, live in 
Newton, Mass. They have two 
children, Ben, 15, and Jenny, 11. 
Nicole Davis and Alex Vukasin 
also attended the Saturday 
night dinner after driving up 
from Princeton, N.J. Nicole is a 
gynecologist in solo private 
practice and Alex is a urologist 
in a group practice.They have 
two children, Gabrielle, 16, and 
Alex, 13. 
Irene Freeman attended most 
of the reunion festivities. She is 
a pediatrician in a group prac¬ 
tice in Chicago. She lives with 
husband Bob McDonald, an 
economist at Northwestern 
University, in Evanston, III. They 
have three children, Claire, 15, 
David, 13, and Henry, 11. 
Rhonda Karol attended the 
Saturday night dinner with hus¬ 
band Cordon Berger, a managing 
director of the Bank of New York 
Mellon (and a very good sport as 
he was the only non-alum and 
non-physician present). She con¬ 
tinues working as a dermatolo¬ 
gist in Forest Hills, N.Y., in the solo 
private practice she started 13 
years ago.They live in Roslyn, N.Y., 
with their two children, Elizabeth, 
13, and William, 10. 
We reminisced about absent 
classmates and exchanged sto¬ 
ries about our last sightings of 
various class members. We also 
very much missed Martha 
Brochin, who passed away since 
our last reunion. We hope that 
more of you will return to New 
Haven for our next reunion. 
Rhonda Karol 
1998 
10th Reunion 
The Class of 1998 set another 
reunion attendance record, this 
time for our 10th. Friday night 
brought the traditional clambake 
and overtired children. Saturday 
was filled with official Yale lec¬ 
tures and touring, capped off by 
a dinner at the New Haven Lawn 
Club with dancing to the DJ’ed 
music of Richard Lyn-Cook and his 
perennial roadie/sidekick, Steven 
Williams. Along the way we got 
updates from many of our class¬ 
mates who were there. 
Senai Asefaw lives in New 
Haven, where he works as a 
hospitalist at Yale-New Haven 
Hospital and does part-time con¬ 
sulting work. Kristen Aversa lives 
with her husband and children 
in Woodbridge, Conn., and con¬ 
tinues to practice ob-gyn locally. 
Tamar Braverman and husband 
Michael brought their daughters 
Yael and Talya on Friday night. 
Tamar is an internist in Branford, 
Conn. Sydney Butts lives in 
Syracuse, N.Y., where she works 
as an ent surgeon and volun¬ 
teers her time reconstructing 
the faces of domestic violence 
victims. Kent and Shelley Chou 
flew in from Phoenix, where 
Kent is an orthopaedic surgeon. 
Pediatricians Dan Coghlin and 
Barb McGee brought children 
Molly and Henry, who look like 
clones of their parents. Dan and 
Barb work in the same practice in 
Rhode Island. Psychiatrist Caroline 
Dumont lives with psychiatrist 
husband Brian Tobin and their 
three mentally healthy children 
in the New Haven area. Lawrence 
(Lori) Etter is a dermatologist in 
Durham, N.C. Husband Jeff Welty 
and daughter Caroline were 
barely recognizable beneath lay¬ 
ers of sunscreen, hats, and long- 
sleeved shirts. ENT Mark Homicz 
and Pam Loman came in from 
California wine country, where 
they live with their two children. 
Russ Huang is married, lives in 
New York and is a spine surgeon. 
Unfortunately, he has not had 
much time to play guitar, per¬ 
haps explaining the absence of 
class band Haploid Floyd at our 
reunion. Or Scott Floyd, for that 
matter, who wasn’t at the 
reunion but who is a radiation 
oncologist in Boston. 
One of our longest-in-training 
classmates, neurosurgeon 
Hahnah Kasowski and husband 
Robert Seminara live in New York 
with their son Nathaniel. Lisa 
Lipschitz practices obstetrics and 
gynecology in San Diego, where 
she lives with husband Steve 
Montal and their two children. 
Rich Lyn-Cook treats adults and 
kids, he spins tunes as a DJ, and 
he can impersonate any human 
born in the 19th or 20th cen¬ 
turies! The versatile Rich lives in 
Houston with his wife Monica, 
who is a surgeon but was too 
busy operating to join us. 
After several years on faculty 
as a hospitalist at the University 
of Vermont, Ursula McVeigh 
recently moved to Boston to start 
a palliative care fellowship. Matt 
Mealiffe works as the director of 
clinical research at Perlegen 
Sciences in the South Bay. Ali 
Portnoy lives in Villanova, Penn., 
with husband Raphael Crawford; 
Ali works for GlaxoSmithKline as 
medical director of early phase 
clinical drug development in infec¬ 
tious disease. Ruth Potee lives in 
western Massachusetts with her 
husband Steve Martin and three 
kids; Ruth commutes once weekly 
to Boston, where she is on the 
family practice faculty at Boston 
Medical Center. Ruth is probably 
our only classmate who still sleeps 
in a call room once a week. Paul 
Pottinger lives in Seattle with 
wife Julie and children Zoe and 
Matthew. Paul is an infectious 
disease specialist, especially now 
that he has two children. Nikki 
Rabidou and her husband have a 
new baby boy; Nikki practices 
rheumatology in Torrington, Conn. 
Greg Raskin lives in New York 
City and works at Alliance- 
Bernstein. Greg occasionally 
practices medicine on his wife 
Jackie Weiss and on his children 
Daphne and Morris. 
Lisa Gale Suter, husband 
Lindsay and children Fenn and 
Halvor live near Yale, where Lisa 
is on faculty in rheumatology. 
They still have a sluice gate. 
Kimara Targoff and Josh live in 
New York with their three chil¬ 
dren. Kim is an instructor at 
Columbia in pediatric cardiology, 
and is also doing research on the 
regulation of cardiac develop¬ 
ment. Meena Thayu and husband 
Eric Keuffel have a year-old 
daughter Anna and live in 
Philadelphia, where Meena is a 
pediatric gastroenterologist at 
the Children’s Hospital of 
Philadelphia. Ricky Torres isn’t 
even in our class, but he gamely 
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showed up on Saturday night 
and danced some salsa. He’s on 
faculty at Yale. Sus Waikar is a 
nephrologist at the Brigham in 
Boston and lives with his wife 
and kids in Brookline, Mass. 
Steven Williams is a plastic 
surgeon in San Ramon, Calif., 
where he lives with his wife. 
Steve occasionally goes to 
Honduras on medical missions. 
Ashley Wivel lives with son 
Jackson in Philadelphia, where 
she works for GlaxoSmithKline as 
a pharmacovigilance specialist. 
Say that 10 times fast! 
Lori Etter 
2003 
5th Reunion 
If there had been one thing the 
20 of us in attendance agreed 
upon, it was that everyone looked 
the same and no one seemed to 
have changed a bit. On the other 
hand, words cannot adequately 
capture all we have been through 
since graduating, so I will not J attempt the impossible. Instead 
here are brief updates on those 
' who made it to the reunion: 
Severine Chavel Greenspan is 
finishing her dermatology 
residency at Yale and will begin 
private practice in Stamford, I Conn., while remaining a volun¬ 
teer attending at Yale. Severine 
and husband Mike have a 10- 
month-old girl—Sophie! Mike 
Greenspan, one of several "Yale 
lifers” in attendance, is finishing 
his psych residency after win¬ 
ning the "world’s strongest man 
competition.” He will pursue 
a forensics fellowship at Yale, of 
all places. 
Sean Christensen is begin¬ 
ning a four-year derm residency 
at Yale and proudly acknowl¬ 
edges his and Elin’s official I status as "lifers.” Elin Lisska 
Christensen is now a partner in 
an internal medicine private 
practice in Madison, Conn. Elin 
and Sean just bought a house 
in Guilford. They are also cel¬ 
ebrating their second wedding 
anniversary. 
Doug Davis has “finally” gradu¬ 
ated from the m.d./ph.d. pro¬ 
gram and is beginning his intern 
year in Yale’s primary care inter¬ 
nal medicine program. 
Nataliya Uboha is beginning 
her second year of an internal 
medicine residency at Yale. She 
and husband Doug have bought 
a home in New Haven. 
Danny Kanada had "two 
more weeks” of Yale radiology 
residency on reunion day. He’s 
headed to ucsf for a cross- 
sectional fellowship. 
Pramita Kuruvilla is in the San 
Francisco Bay Area working as a 
hospitalist and teaching family 
medicine residents at Contra 
Costa Regional Medical Center. 
Matt Goldenberg is an emer¬ 
gency psych attending and 
consultant/liaison at Dartmouth. 
He is contemplating focusing 
on refugee mental health and 
forecasts "liberation” in the 
near future. 
Namita Seth Mohta lives in 
Cambridge, Mass., with husband 
Vinay and 10-month-old daugh¬ 
ter Aanika. She is a clinical strat¬ 
egy consultant at Partners Health 
Care and a hospitalist at Brigham 
and Women’s Hospital. 
Kyeen Mesesan Andersson 
met husband Richard during 
her three years in South Africa 
completing her m.d./ph.d. 
She is now starting a postdoc 
at Yale. 
Ada Emuwa, a family medicine 
physician, is moving with | 
husband Chi to Nashville,Tenn., 
and will practice in United 
Neighborhoods-Health Service 
Core Clinics for the underserved. 
Satish Nagula finished an IM 
residency at Penn and is now liv¬ 
ing in nyc with wife Shreya, 
where he is completing his final 
year of a Gl fellowship at 
Memorial Sioan-Kettering. 
Marta Rivera is a hospitalist at 
Yale-New Haven Hospital after 
enjoying a highly recommended 
seven-month primary care stint 
in Hawaii post-residency. She has 
accepted a position in primary 
care in Virginia Beach, Va. 
Dave Ross is finishing his third 
year in the Yale adult psych- 
neuroscience research training 
program, where he continues 
researching his passion—music 
and the brain. 
Rebecca Seekamp is excitedly 
moving from Boston, where she 
is a practicing family doc, to San 
Francisco, where she will become 
a clinician-educator in Stanford’s 
family medicine department. 
Joahd Toure was found moon¬ 
lighting in the Yale-New Haven 
micu. He is finishing up a Robert 
Wood Johnson Clinical Scholars 
fellowship, moving to “the city” 
for a health care consulting posi¬ 
tion and still marveling at the 
recent purchase of a washer and 
dryer with wife Viviana. 
Sunny Ramchandani is now a 
primary care internist with the 
U.S. Navy in Bethesda, Md. He 
is looking forward to seeing his 
fellow classmates at the next 
reunion! 
Susan Rushing worked as an 
attorney before returning to 
medicine. She has two years left 
in psychiatry training at U Penn, 
where she assists with health 
law lectures at the med and 
law schools. She and husband 
Karl Richter have two children, 
Elizabeth, age 2, and Kaitlyn, 
age 2 months. 
As for me, I am working on 
childhood obesity prevention 
as a special assistant to the 
president of the Robert Wood 
Johnson Foundation and as an 
obesity medicine consultant to 
Harvard Health Publications. I 
dream of resuming clinical 
work in obesity treatment and 
lifestyle medicine in the 
Promised Land (San Francisco). 
Our goal is to have the entire 
class show up for the 10-year 
reunion. In the meantime,join 
our soon-to-be-created Facebook 
group to keep in touch and share 
news of the many bundles of joy 
brought into the world thus far 
as well as other life transitions. 
Mark Berman 
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58 Alumni faces 
James Hadler began his career as a physician, 
but switched to public health. He retired recent¬ 
ly after almost 25 years as Connecticut’s state 
epidemiologist and chief of the state health 
department’s Section of Infectious Diseases. 
A career fighting 
infectious disease 
Physician and Connecticut state 
epidemiologist James Hadler 
sees the public as his patient. 
James L. Hadler, m.d., fw '80, m.p.h. 
’82, said that his relatives, many of 
whom are physicians, sometimes tease 
him for not working at the bedside. 
“They ask me, ‘When are you going to 
be a real doctor?”’ But, he said laugh¬ 
ingly, "Tire public is my patient.” 
Hadler, who retired in June after 
almost 25 years as Connecticut’s state 
epidemiologist and chief of the state 
health department’s Section of 
Infectious Diseases, has steered the 
state through a plethora of public 
health crises, from aids to Lyme dis¬ 
ease to anthrax. Although he started 
his career as a physician while work¬ 
ing on the Navajo reservation for the 
Indian Health Service and the Centers 
for Disease Control (cdc), Hadler 
found he liked looking at health from 
the perspective of populations. The 
experience, he said, “sold me on a 
career in public health.” 
He came to the state health depart¬ 
ment in 1984, just as the aids epidemic 
was picking up speed. For the first 
four or five years, “hiv became my 
life.” High-profile debates kept him in 
the public eye. For example, Connecticut 
had one of the first cases of a school- 
aged child with aids, and under national 
media attention, Hadler developed 
safety guidelines to allow the child to 
return to school. 
The mid-1990s saw a dramatic shift 
in emphasis after the Institute of 
Medicine published a paper stating that 
the country was unprepared to com¬ 
bat emerging infectious diseases. 
In 1995, the Emerging Infections 
Program, affiliated with the cdc, was 
established in partnership with the 
state health department and the Yale 
School of Public Health. It was soon 
busy with outbreaks of Eastern equine 
encephalitis and West Nile virus 
and the re-emergence of the then rare 
tick-borne diseases babesiosis and 
ehrlichiosis. 
After September n, 2001, bioter¬ 
rorism preparedness became a priority. 
Hadler was on the front lines during 
that year’s anthrax attacks (he still 
attends an annual symposium in 
honor of victim Ottilie Lundgren, a 
Connecticut resident and one of five 
people who died from exposure to 
anthrax), and later faced a crisis of 
conscience when he was instructed to 
prepare mass smallpox vaccinations 
prior to the invasion of Iraq, which he 
strongly opposed. Reasoning that to 
do so might embolden the Bush 
administration’s threat to invade, he 
considered resigning. In the end, he 
decided that to quit or go on strike 
would not stop the war, and chose to 
stay, “although uneasily.” 
While in office, Hadler also oversaw 
an increase in childhood vaccinations 
against preventable diseases, the elimi¬ 
nation of race-based disparities in child¬ 
hood vaccination rates and the reduction 
of the rates of tuberculosis and several 
sexually transmitted diseases. 
Hadler said that what has motivated 
him, in large part, is the combination 
of Connecticut’s small size and its 
great population diversity. Its problems 
come in manageable “little packets.” 
“New Haven has its down-and-out 
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side, Hartford does, but... they’re 
all small compared to New York or 
Chicago,” he said. “To me, [Connecticut] 
is a perfect laboratory to try to take 
on the challenges of diversity and 
health disparities.” 
Hadler grew up in Bethesda, Md., 
where his father worked as a naval 
architect and international consultant. 
The family hosted exchange students 
and had friends from other countries, 
and Hadler says those experiences—and 
his stint in Pakistan as an exchange 
student—gave him and his three sib¬ 
lings a global perspective. 
He attended McGill University in 
Montreal, then went to Columbia 
University’s College of Physicians and 
Surgeons. After an internship at 
Roosevelt Hospital in Manhattan, 
Hadler joined the Indian Health Service 
in a position supported by the cdc as a 
tuberculosis control officer. He com¬ 
pleted his residency at Waterbury 
Hospital in Connecticut, did an infec¬ 
tious diseases fellowship at Yale-New 
Haven Hospital and then earned an 
m.p.h. Finally, he and his wife and two 
children spent a year in China as part 
of a School of Medicine exchange with 
Hunan Medical College. He began as 
Connecticut’s state epidemiologist the 
following year. 
The job, he said, has allowed him to 
combine diverse interests and to work 
with people from all walks of life. 
“Public health is dynamic,” he said. 
“I love that aspect of the job.” 
Hadler lives in New Haven with 
his wife, Alice, who speaks several 
languages and whose experiences 
with adult education on the Navajo 
reservation with her husband grew 
into a teaching career; she is now an 
associate dean at Wesleyan. They have 
three grown children. 
Hadler plans to work as a public 
health consultant to the state and to 
New York City. He will also write scien¬ 
tific papers, deliver talks and continue 
to teach at the School of Public Health. 
—Jenny Blair 
A primary care physician 
finds peace of mind in 
concierge medicine 
On a typical day two years ago, Steven 
Fugaro, m.d. ’8i, saw a patient in his 
solo primary care practice every io to 
15 minutes. Onerous paperwork and 
economic difficulties made it hard for 
the San Francisco-based physician to 
provide the quality of care he felt his 
3,000 patients deserved. “I was becom¬ 
ing increasingly dissatisfied with what 
I was doing,” he said, “although I was 
probably too busy to be reflective of it 
at that point.” 
Then MD2, a concierge medicine 
group, based in Bellevue, Wash., 
approached him. Would he like to join 
them as a concierge physician and 
gain the time and resources to provide 
extraordinary care for a small number 
of patients? His decision to do so 
changed his life and made him part of 
a controversial trend in primary care. 
Fugaro had opened a private practice 
after an internal medicine residency at 
the University of California, San 
Francisco, and eight years in academic 
medicine. Although he loved primary 
care, physicians in that field are under 
tremendous pressure to see patients in 
great numbers—time is tight, reim¬ 
bursement rates are stagnant and 
preventive care must take a back seat 
to immediate problems. Few medical 
students choose the field, and many 
weary primary care physicians are 
retiring early or taking jobs in industry 
or administration. These doctors are in 
short supply. 
Enter concierge medicine. In this 
model, introduced in 1996 by MD2 
founder Howard Maron, m.d., patients 
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60 Alumni faces 
Steven Fugaro traded a solo 
primary care practice for a career 
in concierge medicine. 
pay a yearly fee ranging from $15,000 
for an individual to $25,000 for a 
family of four. In return, physicians 
make themselves readily available, 
offering prompt appointments, house 
calls and other extras. 
Critics of the practice, also known 
as “boutique medicine” or “retainer- 
based medicine,” call it unethical. The 
retainer is beyond the means of many 
people and because concierge physi¬ 
cians care for fewer patients than 
other primary care doctors, the prac¬ 
tice increases colleagues’ burdens and 
may endanger access to care. But many 
concierge doctors say that they would 
have quit practicing altogether if not 
for this option. Fugaro agonized for 
months over his decision. “I was wor¬ 
ried about what my colleagues would 
think. I was worried about... leaving 
patients. I wondered if I would be 
intellectually stimulated,” he said. “On 
the plus side [was] being able ... to 
have basically unlimited time with 
[patients], to be able to care for them 
in a very holistic way and to have 
balance back in my life.” For Fugaro 
that meant more time for such pur¬ 
suits as mountain biking and spending 
time with his wife of 22 years and 
their son, who studies theater at 
Northwestern University. 
In 2007, Fugaro arranged for the 
patients in his primary care practice 
to be cared for by a successor, Allan 
Treadwell, m.d., relinquishing the 
practice free of charge. Then Fugaro 
joined MD2. 
He cares for just 50 families now, 
and on a typical day sees or speaks to 
six to 10 of his patients. The office does 
many of its own tests, with results avail¬ 
able on the spot. He makes regular 
house calls. Many of his patients have 
complex medical conditions and he 
is better able to anticipate problems 
before they arise. “I was juggling so 
many things before,” Fugaro said, “it 
was clearly possible for something to 
fall through the cracks, and that’s far 
less likely now.” He also accompanies 
patients to specialty appointments 
and the ER, and enjoys learning from 
subspecialty colleagues at such times, 
“as opposed to just communicating 
through a consult letter.” For about 
5 percent of his patients, the retainer 
fee is waived. 
Fugaro is partnered with another 
physician; neither leaves town unless 
the other can stay. Though always “on 
call,” Fugaro said he has more time 
now for nonclinical professional pur¬ 
suits. In 2007, he was elected president 
of the San Francisco Medical Society, 
where he pushes for such public health 
measures as restrictions on second¬ 
hand smoke, and partners with the 
California Medical Association to battle 
Medicaid cuts. He also has volunteered 
at a clinic in Mexico. 
Fugaro says his colleagues’ reactions 
have been mostly positive. Indeed, sev¬ 
eral are opening retainer-based practices 
of their own, including Treadwell, the 
physician who took over his old prac¬ 
tice. Fugaro acknowledged that access to 
primary care is a tremendous problem 
in American medicine. “We need to 
create a better model for primary care 
doctors to continue doing what they’re 
doing and be emotionally rewarded for 
it, as well as deriving reasonable eco¬ 
nomic compensation. And right now 
our system is broken in that regard.” 
—Jenny Blair 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, 300 George Street, Suite 
773, New Haven, CT 06511. 
NOTES 
Arthur Beaudet John Patti 
196OS 
Arthur L. Beaudet, M.D. ’67, 
the Henry and Emma Meyer 
Professor and chair of the 
Department of Human and 
Molecular Genetics at Baylor 
College of Medicine, has been 
elected to the Johns Hopkins 
University Society of Scholars. 
Beaudet and 14 other esteemed 
scientists and clinicians were 
honored during the society’s 
39th induction ceremony in May. 
His accomplishments include key 
discoveries in several genetic 
disorders, including Angelman 
syndrome, Prader-Willi syndrome 
and autism. Beaudet’s many 
honors include the March of 
Dimes/Colonel Harland Sanders 
Award for lifetime achievement 
in genetic sciences. 
1970S 
Harvey Berger, M.D. '77, and his 
wife, Chrysanthi, are ecstatic 
about the latest addition to 
their family, Isabella Grace 
Berger, born on March 6. Berger 
is the founder, chair and ceo of 
ariad Pharmaceuticals, Inc., in 
Cambridge, Mass., an oncology 
company developing molecu- 
larly targeted cancer drugs. 
John A. Patti, m.d. ’71, was elected 
vice chair of the American 
College of Radiology (acr) Board 
of Chancellors at the acr annual 
meeting in Washington, D.C., in 
May. Patti, a member of the radi¬ 
ology staff at the North Shore 
Medical Center in Salem, Mass., 
since 1975, is the immediate past 
chair of the acr Commission on 
Economics, current chair of the 
Task Force on Value Added and 
vice chair of the Commission on 
Government Relations. 
Jonathan Lewin Paul Rothman 
198OS 
Josef Bohm, m.P.h. '89, will be 
joining the faculty of City 
University’s New York City 
College of Technology as an 
assistant professor within their 
Health Services Administration 
program. Bohm is a former 
deputy principal to the Anglo- 
European College of Chiropractic 
in Bournemouth, England. He is 
a member of the adjunct fac¬ 
ulty at the State University of 
New York at Stony Brook. His 
academic interests include 
behavioral economics, health 
policy and finance. 
Jonathan S. Lewin, M.D. ’85, 
has been inducted as a fellow 
in the American College of 
Radiology. Lewin is the Martin 
W. Donner Professor and chair 
of the Department of Radiology 
at the Johns Hopkins University 
School of Medicine. He holds 
leadership positions in such 
medical societies as the Academy 
of Radiology Research, Associa¬ 
tion of University Radiologists 
and the International Society 
for Strategic Studies in Radiology. 
Troy Pappas, m.p.h. ’86, has been 
appointed to the faculty of the 
Fox School of Business at Temple 
University in Philadelphia. He 
has a dual appointment with 
Temple’s School of Tourism and 
Hospitality and will be teaching 
entrepreneurship and business 
strategy.This fall, he will teach 
entrepreneurism at Temple’s 
College of Health Professions. 
He is the founder and president 
of World Athlete, a sports and 
fitness management company 
specializing in track and field. 
Lu Anne Dinglasan 
Kevin Lau 
Steven I. Rosenfeld, M.D. ’80, is 
an assistant clinical professor 
of ophthalmology at the Bascom 
Palmer Eye Institute in Miami. 
He received two awards from 
the American Academy of 
Ophthalmology at its annual 
meeting in November 2007: 
the Senior Achievement Award 
and the Secretariat Award for 
"exceptional leadership and 
enthusiastic service.’’ He serves 
on the editorial boards of EyeNet 
Magazine, Focal Points, and the 
Basic and Clinical Science Course, 
Section 13: Refractive Surgery, 
and is an associate examiner 
for the American Board of 
Ophthalmology. 
Paul Rothman, M.D. ’84, was 
named dean of the University of 
Iowa’s Roy J. and Lucille A. Carver 
College of Medicine, effective 
June 1. Rothman has served as 
head and professor of internal 
medicine at the Ul Carver College 
of Medicine and Ul Hospitals and 
Clinics since 2004. An expert in 
rheumatology, he has provided 
clinical care for more than 20 
years, trained medical students, 
fellows, and residents,and pub¬ 
lished extensively. Rothman’s 
research on cytokines focuses on 
their role in the development of 
white blood cells, the abnormal 
development of which can lead 
to leukemia. 
2000S 
Elizabeth K. Arleo, m.d. ’04, and 
her husband, Joshua W. 
Thompson, J.D., announce the 
birth of their first child. Sophia 
Arleo Thompson was born on 
May 31 and weighed in at 8 lbs., 
3 oz. Arleo is in the final year of 
a radiology residency at New 
York Presbyterian Hospital-Weill 
Carolyn Graeber 
Robert Jahn 
Cornell Medical Center, where 
she plans to stay for a year-long 
fellowship in women’s imaging. 
Thompson is a partner at the 
New York City law office of 
Proskauer Rose. 
Lu Anne V. Dinglasan, M.D. ’08, 
and Kevin C. Lau, m.p.h., m.d. 
’08, were married on May 31 at 
the Yale Club in Manhattan. 
Dinglasan began an internship 
in June at Pennsylvania Hospital 
in Philadelphia and Lau began 
his internship at the Children’s 
Hospital of Philadelphia. 
Carolyn P. Graeber, M.D. ’08, was 
married on April 26 to Robert E. 
Jahn at St.Thomas Episcopal 
Church in Manhattan. Graeber 
began an internship in June at 
the Memorial Sloan-Kettering 
Cancer Center in New York. Jahn 
is completing an m.b.a. at the 
University of Pennsylvania. 
Mona Kotecha, M.D. ’04, was 
married on April 5 to Nikhil 
Shanbhag, j.d. ’03, in Saratoga, 
Calif. Kotecha is a fourth-year 
anesthesiology resident at the 
University of California, San 
Francisco. Shanbhag is an intel¬ 
lectual property lawyer at 
Google in Mountain View, Calif. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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in Memoriam 
Rex B. Conn Jr. M.D. ’53, died of 
Parkinson disease on March 2 
in Philadelphia. He was 80. 
Born in Cedar Rapids, Iowa, 
Conn taught at West Virginia 
University in Morgantown, 
where he established the 
pathology department and 
clinical laboratory. He served as 
a radar specialist in the Navy 
Reserve during World War II. 
Conn was subsequently named 
to advisory committees at the 
National Institutes of Health, 
Walter Reed Army Medical 
Center and the Armed Forces 
Institute of Pathology. From 
1968 to 1977 he taught at Johns 
Hopkins University School of 
Medicine. Conn ran clinical 
labs both there and at Emory 
University, where he also taught. 
In 1987 he moved to Philadelphia, 
where he taught at Thomas 
Jefferson Medical College until 
his retirement in 2003. 
Alfred Robert Cordell, M.D., H.S. 
’50, died on April 9 in Winston- 
Salem, N.C. He was 83. After 
receiving his medical degree 
and completing an internship 
at Johns Hopkins University, 
Cordell came to the Yale VA 
Surgical Services for an assistant 
residency in surgery from 1948 
to 1950. Following a stint as a 
surgeon with the Medical Corps, 
U.S. Navy Reserve, training in 
general and thoracic surgery at 
Wake Forest University, and a 
year as a visiting instructor in 
the Department of Surgery at 
the University of Buffalo, he 
returned in 1970 to Wake Forest, 
where he became a professor 
of surgery. From 1979 to 1991 he 
served as the Howard Holt 
Bradshaw Professor of Surgery 
and chair of Wake Forest’s 
Department of Cardiothoracic 
Surgery. Cordell developed 
techniques in myocardial preser¬ 
vation and blood conservation 
and established an open-heart 
program at Wake Forest’s 
Baptist Medical Center. He 
served on the board of gover¬ 
nors of the American College of 
Surgeons from 1983 to 1989. In 
September 1995, he was named 
professor emeritus at Wake 
Forest; the A. Robert Cordell 
Chair in Cardiothoracic Surgery 
was established in his honor. 
Roger W. Davis Jr., M.D. 43, died 
on March 16 in Springfield, Vt. 
He was 90. After graduation 
from medical school, Davis com¬ 
pleted internships at Hartford 
Hospital in 1943 and 1946. From 
1944 to 1946 he served with the 
U.S. Army’s 174th Engineer 
Combat Battalion. He completed 
residencies in orthopaedic sur¬ 
gery at the Hospital for Special 
Surgery in New York City from 
1947 to 1949 and at Boston City 
Hospital in 1950. He opened a 
private practice in orthopaedic 
surgery in Hartford and worked 
as assistant medical director of 
the Aetna Life and Casualty Co. 
From 1974 until his retirement 
in 1981, he served as a part-time 
physician in Springfield Hospital’s 
emergency room. 
D. Joseph Demis, PH D., M.D. ’57, 
died on March 8 in Clifton Park, 
N.Y. He was 78. After interning 
in Seattle, Demis took a fellow¬ 
ship in biochemistry at Oxford 
University. There he explained 
the biosynthetic pathway of 
adrenaline in mammalian tissue 
and performed pioneering stud¬ 
ies that showed the effective¬ 
ness of antimetabolites as 
treatment for psoriasis and simi¬ 
lar skin conditions. He received 
further training in dermatology 
at Walter Reed Army Hospital in 
Washington, D.C. His interest in 
tropical diseases, and especially 
pinta, a bacterial skin disease 
endemic to Central and South 
America, led him to the U.S. 
Public Health Service. Working 
with the Brazilian government, 
Demis helped to eliminate 
pinta in that country. Demis 
subsequently served as profes¬ 
sor and chair of dermatology at 
Washington University in St. 
Louis from 1964 to 1966; at that 
time he was the youngest chair 
of a major dermatology depart¬ 
ment in the United States. After 
accepting an appointment as 
professor and chair of dermatol¬ 
ogy at Albany Medical College, 
he collaborated to produce the 
text Clinical Dermatology. He 
also maintained a private der¬ 
matology practice. 
Frederick James Finseth, M.D., died 
in February in San Francisco. He 
was 67. A graduate of Harvard 
Medical School, Finseth com¬ 
pleted a residency in surgery at 
Massachusetts General Hospital. 
He was assistant professor in 
reconstructive and plastic sur¬ 
gery at the School of Medicine 
from 1974 to 1977. He published 
several papers on the impair¬ 
ment of blood flow in the hand 
from cigarette smoking during 
his years at Yale. From 1977 to 
1979 Finseth was an assistant 
professor in plastic and recon¬ 
structive surgery at Stanford 
University School of Medicine, 
specializing in reconstructive 
surgery of the hand. He traveled 
widely and made annual trips to 
teach at Tata Memorial Hospital 
in Mumbai, India. He also taught 
in South America, Singapore, 
China and South Asia. 
Steven C. Hebert, M.D., chair and 
c.n.h. Long Professor of Cellular 
and Molecular Physiology and 
professor of medicine, died of 
cardiovascular disease in New 
Haven on April 15. He was 61. 
Hebert was a board-certified 
nephrologist who devoted his 
career to the science of renal 
fluid and electrolyte regulation. 
He made major contributions to 
medicine, notably in the cloning 
of genes that mediate or regu¬ 
late the transport of sodium, 
potassium and calcium across 
cell membranes. His work won 
him election to the National 
Academy of Sciences in 2005, 
and his research was the basis 
for a new class of drugs used to 
treat hyperparathyroidism, a 
hormonal disorder that affects 
many of the more than 1 million 
patients worldwide with end- 
stage kidney disease. 
Hebert was born in 1946 in 
Rockford, III., and lived for part 
of his childhood on the island of 
Great Inagua in the Bahamas, 
where his father was a contrac¬ 
tor for the Morton Salt Co. In a 
profile published in 2006 in the 
Proceedings of the National 
Academies of Sciences, he 
recalled watching bulldozers pile 
dried sea salt into mountains 150 
feet high and speculated that his 
interest in metabolic salts may 
have had its genesis there. He 
entered Florida State University 
at age 15 and graduated after 
three years. 
Hebert received his medical 
degree from the University of 
Florida in 1970. Following train¬ 
ing in internal medicine and 
nephrology at the University of 
Alabama at Birmingham (uab), 
he served on the faculty at uab, 
Eastern Virginia Medical School, 
the University of Texas Medical 
School in Houston, Harvard 
Medical School, and Brigham 
and Women’s Hospital. In 1997 
he joined Vanderbilt University 
as director of the Division of 
Nephrology and the Ann and 
Roscoe R. Robinson Professor of 
Medicine. In 2000 he was 
offered the chair at Yale, which 
gave him the opportunity to lead 
a world-class department and 
continue his close collaboration 
with Gerhard Giebisch, m.d., a 
longtime friend and mentor. 
In the early 1990s, Hebert's 
laboratory made three funda¬ 
mental discoveries about the 
kidney’s processing of potassium, 
sodium and calcium. His group 
identified a channel that regu¬ 
lates potassium excretion and is 
involved in Bartter syndrome 
type II, an inherited disorder that 
causes loss of sodium and potas¬ 
sium through the urine. He and 
his colleagues also identified two 
sodium chloride transporters that 
are target sites for important 
diuretic drugs. His subsequent 
discovery of a calcium-sensing 
receptor known as casr led to 
the development of a new class 
of drugs that modulate calcium- 
receptor activity. 
Most recently, with John 
Geibel, m.d., d.sc., Hebert demon¬ 
strated in an animal model that 
diarrhea could be reversed almost 
immediately by activating the 
casr receptor. Such treatment 
would have a major impact on 
health problems in developing 
countries, where diarrheal disease 
kills some 3 million infants and 
children each year. 
Hebert was awarded numer¬ 
ous professional honors, includ¬ 
ing the Homer W. Smith Award 
from the American Society of 
Nephrology, the A.N. Richards 
Award from the International 
Society of Nephrology, and the 
Carl W. Gottschalk Distinguished 
Lectureship from the American 
Society of Physiology. 
Virginia H. Hulbert, R.N., M.P.H. ’50, 
died on January 31 in Ansonia, 
Conn. She was 97. After earning 
her degree in nursing, Hulbert 
worked for more than 30 years 
as an assistant professor of 
health at Southern Connecticut 
State University, and as head 
nurse in the school’s student 
health department. 
D. Frank Johnson Jr., M.D. '55, died 
on March 31. He was 78. After 
completing his internship, 
Johnson joined the Air Force as 
a flight surgeon. Following a 
residency in internal medicine 
at Minneapolis General Hospital, 
in 1961 he pursued a career in 
Billings, Mont. For 25 years he 
was the continuing medical edu¬ 
cation director for St. Vincent 
Hospital, where he founded and 
directed Montana’s first cardiac 
rehabilitation program. He also 
helped to develop St. Vincent’s 
icu, its weight control program 
and its Lifecare outpatient 
clinic. He was an associate clini¬ 
cal professor of medicine at the 
University of Washington School 
of Medicine in Seattle. Later in 
his career he focused on weight 
management, directing clinics in 
Billings, Helena and Bozeman, 
Mont., while continuing to serve 
airline pilots in the state as a 
senior aeromedical examiner des¬ 
ignated by the Federal Aviation 
Administration. He was a mem¬ 
ber of the North American 
Society for the Study of Obesity. 
Among other honors, Johnson 
received the American Society of 
Bariatric Physicians’ Bariatrician 
of the Year award in 2002. 
Vincent J. Longo, M.D. ’46, died on 
February 18 in Niantic, Conn. 
He was 85. During World War II, 
Longo was a member of the Army 
Specialized Training Program 
and received a commission as 
first lieutenant. Following an 
internship in surgery, gynecology 
and obstetrics, and a fellowship 
in urology, he began a urology 
practice in New London, Conn., 
in 1952. He joined the staff of 
Lawrence and Memorial Hospi¬ 
tal in New London and served 
as chief of urology there from 
1976 until his retirement in 
1986. Longo was a member of 
the American Board of Urol¬ 
ogy, a fellow of the American 
College of Surgeons, and a certi¬ 
fied sex educator and therapist 
with the American Association 
of Sex Educators, Counselors 
and Therapists. After retiring 
he served with Charles Pfizer 
Pharmaceuticals as principal 
clinical investigator in the 
Viagra program. 
Cordon V.K. Reid, M.D., H.S. ’69, 
died on April 15. He was 72. After 
receiving his medical degree 
from the University of Rochester 
and further training at Barnes 
Hospital in St. Louis, Reid served 
as U.S. Public Health Service lieu¬ 
tenant commander in the 
Epidemic Intelligence Service of 
the Centers for Disease Control 
and was sent to India to do 
smallpox eradication, in 1968 he 
came to Yale to finish his training 
in internal medicine, endocrinol¬ 
ogy and gerontology. Shortly 
after joining a New Haven prac¬ 
tice in 1970, he co-founded the 
Community Health Care Plan, 
where he practiced until 1999. 
He then co-founded Endocrine 
Associates of Connecticut. Reid 
was an associate clinical profes¬ 
sor of medicine at Yale, attending 
in internal medicine and endo¬ 
crinology, and a preceptor for 
residents from Yale-New Haven 
Hospital and the Hospital of 
Saint Raphael. 
Galon S. Rodabaugh, M.D., H.S. ’53, 
died on January 9. He was 95. 
Rodabaugh completed his medi¬ 
cal degree and internship at 
Ohio State University in 1939; 
practiced for several years in 
Basil, Ohio; and served from 1942 
to 1945 as a captain with the U.S. 
Army Medical Corps in England, 
France, Belgium, Holland, 
Luxemburg and Germany. He 
saw combat during in the Battle 
of the Bulge and received two 
Bronze Stars. After completing 
a residency at Yale in 1953, he 
served as anesthesiologist at 
the Fairfield Medical Center in 
Lancaster, Ohio, until his retire¬ 
ment in 1984. 
William G. Wysor Jr., M.D., H.S. 
’52, died on January 3 in Chapel 
Hill, N.C. He was 81. After receiv¬ 
ing his medical degree from the 
University of Virginia, Wysor 
received post-graduate training 
at Yale and the Medical College 
of Virginia. In 1953 he entered 
private practice in South Boston, 
Va. From 1957 to 1969 he served 
as associate professor of medi¬ 
cine at the University of North 
Carolina (unc) School of Medi¬ 
cine. From 1969 until his retire¬ 
ment in 1990, he practiced with 
Durham Internal Medical 
Associates. His honors included 
teaching awards from Escola 
Paulista de Medicina in Sao 
Paulo, Brazil, where he was a 
visiting professor, and from the 
unc School of Medicine. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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64 F0ll0W-Up Archives 50 and 25 years ago 
After a life in medicine, a career in show business 
Brock Lynch, m.d. ’47, had been singing and dancing with the 
Young@Heart Chorus for almost 10 years when it was written 
up in Time magazine in June of 2005, and in Yale Medicine 
[See "Tap Dancing Through Medicine,” Autumn 2005]. Since 
the documentary Young&Heart was released in April, Lynch 
and the other performers in the 27-member Massachusetts- 
based group of elderly rock singers continue to tour to even 
greater acclaim. 
"Little by little, instead of drooping, it grew,” Lynch said 
of the film, which was released only gradually in the United 
States. Word of mouth and a free showing at the Sundance 
Film Festival soon accelerated the film’s popularity, and chorus 
members have subsequently traveled not only to perform but 
to promote the film. Just prior to its release, Lynch traveled to 
Washington, D.C., and Boston with two other chorus members 
to answer questions from an audience of critics. 
Children, adolescents, and college-aged audiences, he 
has long noticed, enjoy the live shows the most, while the older 
demographic seems less appreciative. “They don’t go for that 
music—that was the music [about which] they told their chil¬ 
dren,‘Turn it down!’ ” But now that many audience members 
have seen the film, Lynch said, the group has “rabid devotees.” 
Lynch recently sang with Young@Heart in Manhattan at 
the historic Beacon Theater on Broadway, a mile from Memorial 
Sloan-Kettering Cancer Center, where he was a surgical teaching 
fellow in the mid-1950s.The “Alive and Well” concert tour also 
included stops in Boston and the group’s home base of 
Northampton, Mass.The set list included songs by the Rolling 
Stones, Nirvana and James Brown. 
The group plans next to develop a cabaret act, heavy on 
the soloists. More tours are also in the works. How do they do 
it? “With grit, guts and good medication,” said Lynch. 
—Jenny Blair 
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Report on Alumni Day 
—Alumni Bulletin 
The Case of Three 
Missing Hamsters 
May 1958 —Yale Medicine 
Fall/Winter 1983 
“In spite of a heavy snowfall the 
preceding weekend and snow flur¬ 
ries on the morning of Saturday, 
February 22, many Yale Alumni in 
Medicine turned out for the 
annual Alumni Day activities at 
the school. Almost 200 were pres¬ 
ent at the afternoon business 
meeting in Fitkin Amphitheater. 
Dr. Samuel D. Kushlan (’35) 
presided. Dean Vernon W. Lippard 
spoke briefly on recent develop¬ 
ments at the medical school. Those 
attending then heard a lively dis¬ 
cussion of coronary heart disease 
by Dr. Jeremy N. Morris, visiting 
professor of epidemiology.” 
“Three infected hamsters reported 
missing from their cage in the ani¬ 
mal containment facility on the 
ninth floor of the Laboratory of 
Epidemiology and Public Health 
became overnight celebrities — 
of a sort. ‘Infected Yale Hamsters 
Escape’ was headline news for the 
wire services, major television and 
radio networks and newspapers 
across the nation, including the 
New York Times, which devoted 
almost half a page to the story. 
“The hamsters have not been 
found, and are presumed dead. 
Although their disappearance 
caused considerable stir in the 
media and concern in the Univer¬ 
sity, the three rodents and others 
like them in the LEPH-9 facility 
are of little threat to human 
health and the likelihood that 
they escaped from the facility is 
practically nil.... 
“The hamsters were among 
several hundred research animals 
in a major study of Alzheimer’s 
disease ... [they were] infected 
with Creutzfeid-Jakob virus, a so- 
called ‘slow virus,’ which is invari¬ 
ably fatal, and causes symptoms 
of senility similar to those of 
Alzheimer’s disease. ... 
“A series of meetings has 
since been held to ascertain facts 
of the escape, and to plan reme¬ 
dial actions.” 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
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End Note 
PRETTY IN PINK 
During the academic year, the stainless steel tables in The Anlyan 
Center’s anatomy labs hold the “donors” who have offered their 
bodies for the education of future doctors and physician associ¬ 
ates. For most medical students this introduction to medicine is a 
charged and emotional experience. In May the students who com¬ 
pleted this first-year course spent two days wrapping pink fabric 
around the tables where they’d dissected the human body. Their 
inspirations were the artists Christo and Jeanne-Claude, known 
for their wrappings of such public spaces as the Pont Neuf in Paris. 
“To mark the school year’s end, student artists have this 
time wrapped the lab itself, transforming this familiar space and 
raising critical questions about our relationship to anatomy,” 
wrote Ryan Blum in the program for the installation, called Re¬ 
covering the Anatomy Lab. The installation was open to visitors 
for about two weeks in May and June. “What is hidden in the site 
of dissection? What damage have we done, and how can we make 
amends? Can and should the lab be made beautiful? What about 
ourselves is changed? How can we help future classes of anatomy 
students with this difficult practice?” 
About 50 students gathered to bind the anatomy tables in 
bolts of fuchsia cloth, said Michael Otremba, who conceived of the 
idea with classmate Lauren Graber.“lt’s a sterile, metallic environ¬ 
ment,” said Otremba, adding that students wanted to comment 
on what he called “an emotionally significant time.” The choice of 
pink was deliberate. “We wanted to be playful.” 
“I think it’s delightful,” said William B. Stewart, ph.d., 
associate professor of surgery (gross anatomy), who has been 
guiding Yale medical students through the human body for 30 
years. “Art is all about people coming to grips with their feelings.” 
—John Curtis 
Evoking the work of artists Christo and 
Jeanne-Claude, students wrapped dissection 
tables in the anatomy lab in pink cloth, an 
installation that helped them deal with their 
own reactions to the first-year course. 
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Changing premed OR test speeds The lost art of the 
education surgery physical exam 
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ON THE COVER 
The Smilow Cancer Hospital ind 
related structures are chan; ;ing 
the face of the medical cent* r 
neighborhood. 
THIS PACE 
Construction projects at the medical 
center are bringing safety and traffic 
improvements to the neighborhood. 
Photographs by Robert Lisak 
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Science and culture in a strange land 
As the world gets smaller, the Committee on International 
Health asks whether Downs fellows need to leave home to find 
a foreign experience. 
By John Dillon 
The lost art of the physical exam 
Physicians once relied on seeing, hearing and touching a patient 
to make a diagnosis. Technology has enhanced those skills, but 
many doctors lament their decline. 
By Jill Max 
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As the medical center grows, so grows the city 
The ongoing expansion of the medical centerfits in with 
New Haven’s own plans to undo past urban renewal mistakes. 
By Jenny Blair 
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Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or less) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style and content. 
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President and dean respond 
to economic downturn 
Although the university and the 
medical school remain strong 
financially, the economic down¬ 
turn requires some adjustments, 
both President Richard C. Levin 
and Dean Robert J. Alpern, m.d., 
Ensign Professor of Medicine, 
cautioned recently in separate 
messages to faculty and staff. 
The economic situation, 
described as the worst since the 
Great Depression, had reduced 
Yale's endowment by $6 billion, 
"a decline of 25 percent since June 
30, 2008,” Levin announced in 
December. Budget shortfalls of 
about $100 million are expected 
next year and more than $300 
million by 2013-14. Nevertheless, 
Levin said, "$17 billion is still a 
very large endowment.” 
"In spite of the challenges 
before us, we shouldn't forget 
that we entered this period on 
a very strong footing and we 
remain strong,” Alpern wrote on 
January 23. The school has seen 
consistent growth in nih funding 
over the past few years, as well 
as growth of 11 percent in clinical 
collections during the first half of 
the current fiscal year. Gifts and 
pledges have also been rising in 
recent years. 
The university and the medical 
school, however, must tighten 
their belts. 
Levin said that next year’s 
budgets will be reduced by an 
amount equal to 5 percent of the 
salaries and benefits of all non¬ 
faculty and staff, largely through 
attrition. Budgets for all non¬ 
salary and wage expenses will be 
reduced by 5 percent next year 
and by an additional 5 percent 
the following year. Employees 
in labor unions will receive the 
increases scheduled for the final 
year of their contracts, and non¬ 
union employees will be eligible 
for merit increases of up to 2 
percent, up to a cap of $1,500. 
He urged staff and faculty to 
save money by spending less on 
outside consultants, reducing 
travel, consuming less paper 
and decreasing energy use. New 
building and renovation projects 
under construction will continue, 
but most new construction will 
be deferred, although design 
work will continue. 
The medical school will fol¬ 
low these guidelines, Alpern said, 
while noting that its financial 
picture is somewhat different. 
The university budget draws 
44 percent of its income from 
the endowment, but endow¬ 
ment income accounts for only 
8 percent of the medical school’s 
$988.6 million budget, which 
comes largely from research grants 
and clinical income. The central 
administration budget, however, 
draws 17 percent of its revenues 
from endowment income. Tuition 
and philanthropy together 
account for 5 percent of the 
medical school’s income. 
Alpern vowed to try to "pro¬ 
tect our employees in these 
uncertain economic times,” while 
honoring commitments made 
in recent years. 
"We will maintain our com¬ 
mitment to expanded financial 
aid,” he said, referring to a new 
financial aid policy that elimi¬ 
nates parental contributions 
from families making less than 
$100,000 per year. Recruitment 
of faculty and staff will continue, 
but hiring decisions will be con¬ 
sidered carefully by the dean’s 
office and the provost’s office. 
Development of programs for 
West Campus will also continue. 
“This is no time to back off 
from our core values and goals, 
and by making well-considered, 
strategic decisions now, we stand 
to do well in the future,” Alpern 
said. "We will continue to be a 
school that seeks new knowledge 
in the service of humanity, finds 
new ways of diagnosing and 
treating illness, and produces 
new leaders in science and medi¬ 
cine. To reach these goals, I ask 
all of you to help.” 
CORRECTION: REUNION REPORTS 
Alvin B. Blaustein, m.d. 48, and 
B. Herold Griffith, m.d. ’48, wish 
to correct references to themselves 
in the reunion report of the Class 
of 1948, published in the Autumn 
2008 issue of Yale Medicine. 
Blaustein noted that there is more 
than one member of the class 
still in practice: he remains 
active in psychoanalytic practice 
in New York City. Griffith said 
that he was a professor of surgery 
and chief of plastic surgery at 
Northwestern University, not at 
the University of Illinois. 
starting point 3 
Two faculty members move on, but remain close at hand 
Eleven years ago when I started as a staff writer here at Yale Medicine, one of the first people I 
met was Michael Kashgarian, m.d. ’58, hs ’63, whose name appears on our masthead as editor in 
chief. Since then, over lunches at Mory’s, meetings in conference rooms and chats in our offices, 
we’ve discussed the direction of the magazine in both generalities and specifics. He’s suggested 
story ideas and people to talk to, as well. What Mike Kashgarian always brings to these conver¬ 
sations is a love of both Yale and Yale Medicine. He sees the two as linked, with the magazine 
providing a way to keep alumni involved with the institution. Mike officially retired as of last July 
1, but he’s staying on as a researcher until he finishes a few remaining projects, and he remains 
editor in chief of Yale Medicine. 
In those days another member of the faculty I came to know was Asghar Rastegar, m.d. 
Although he plays no direct role in Yale Medicine, time and again we turned to him as a source 
for stories about an eclectic range of topics—collaborations with medical schools in Russia and 
Uganda, a Yale delegation in Iran, the challenges of implementing the 8o-hour work week for 
residents and, for this issue, the declining art of the physical examination. It wasn’t just because 
of his role as deputy chair of internal medicine or his prominence in setting the direction of 
medical education at Yale. Nor was it his knowledge of medicine or of Yale that kept leading us 
to him. His knowledge goes beyond expertise and rises to the plateau of wisdom, which he has 
shared with us with grace and generosity. Even though he has stepped down from his adminis¬ 
trative post in internal medicine, he’ll stay on as director of the international health program that 
sends residents abroad for rotations in underserved settings. As with Mike Kashgarian, it’s reas¬ 
suring to know that Asghar Rastegar will still be close at hand. 
John Curtis 
Managing Editor 
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4 chronicle news from cedar street 
Reform of premed 
education underway 
Medical educators are taking a fresh 
look at undergraduate courses that 
may deter students from medicine. 
In 1910, Abraham Flexner’s examina¬ 
tion of the state of American medical 
education led to widespread reforms 
in the way doctors are trained. Today, 
another evaluation is under way that 
could have equally far-reaching ramifi¬ 
cations for future physicians. 
The Committee to Establish the 
Scientific Foundation for Future 
Physicians, organized by the Associa¬ 
tion of American Medical Colleges and 
the Howard Hughes Medical Institute, 
is studying the standard premedical 
curriculum to make it more relevant 
to the practice of modern medicine. 
Robert J. Alpern, m.d., dean and 
Ensign Professor of Medicine, the 
committee’s co-chair, said it took the 
committee only a single meeting to 
identify the problem: while science 
and medicine have changed dramati¬ 
cally since the days of Flexner, the 
premed curriculum has remained 
static. Organic chemistry, the bete 
noire of almost every premed student, 
is a required course although the 
relevance of some components of 
the course to medicine is marginal. 
At the same time, such crucial sub¬ 
jects as statistics, biochemistry and 
genetics aren’t required at the under¬ 
graduate level. 
Another problem, Alpern said, is 
that the premed curriculum often serves 
as a gatekeeper to weed out students. 
“I’ve actually spoken to organic chem¬ 
istry professors who pride themselves 
on being the ones who determine who 
should go into medicine,” he said. 
The 19-member committee, drawn 
from both medical schools and under¬ 
graduate institutions, has been meet¬ 
ing for about a year and a half. It’s 
working on recommendations that will 
be presented in a report this year. 
The key proposal, Alpern said, is to 
replace required courses with “scientific 
competencies”—the knowledge and 
habits of thought that a student should 
have upon entering medical school. 
“We want to get away from telling col¬ 
leges, ‘You need to have a course in 
this or a course in that,’ ” he said. “We 
want to say, ‘These are the competencies 
someone should have.’ ” 
Alpern anticipates that this approach 
will reduce the importance of organic 
chemistry in favor of biochemistry. 
Similarly, the mathematics curriculum 
will shift away from calculus and toward 
statistics. Alpern also hopes that pro¬ 
fessors will develop interdisciplinary 
courses that illuminate the medical 
relevance of premed coursework and 
that standardizing what new medical 
students should know will free medical 
school professors from having to teach 
to the lowest common denominator. 
The impetus for revisiting the pre- 
med curriculum came from the 
National Research Council’s 2003 bio 
2010 report, which found that fewer 
American students are becoming 
research biologists—in part because 
of the premed requirements. “When 
premed students got tortured in organic 
chemistry, people thinking about 
careers in research biology got tortured 
along with them,” Alpern said. 
Committee members plan to seek 
feedback from certain medical and 
undergraduate educators before dissemi¬ 
nating the report to the undergraduate 
and medical school communities. The 
committee knows it will be easier for 
wealthy colleges to revise their curricu¬ 
lum to accommodate these changes. 
In a parallel effort, a new committee 
has been formed to revise the mcat, 
the aptitude test that students take for 
admission to medical school. The work 
of these two committees must be inte¬ 
grated for change to occur as it requires 
coordinated modifications in premed 
requirements, the mcat and the under¬ 
graduate curriculum. Alpern predicts 
it will take some years before students 
see any changes, because directors of 
undergraduate programs will need to 
know how the mcat will be revised 
before they can change their curricula. 
“It’s not going to happen overnight,” 
he said, “but when it does, I think it 
will represent a major transformation 
in medical education.” 
—Jennifer Kaylin 
0 
Online: Yale Netcasts 
Robert J. Alpern: Vision for the School 
of Medicine 
Dean of Yale College 
becomes third scientist 
named as provost 
Last fall, during his final freshman 
address as dean of Yale College, Peter 
Salovey, ph.d. ’83, exhorted members 
of the Class of 2012 to go their own way, 
to “say goodbye to what is familiar, even 
to what we have grown to love, and leave 
it for uncharted waters.” 
He could have been giving himself 
a pep talk in the bathroom mirror. After 
four years as dean, a job he readily admits 
he loved, Salovey was offered the job of 
provost, the university’s chief academic 
officer after the president. “I’m delighted 
to have this new set of challenges,” he 
said, “but to walk away from something 
you love is a difficult thing to do.” 
Salovey, the Chris Argyris Professor 
of Psychology and professor of epi¬ 
demiology and public health, is Yale’s 
third consecutive provost to be cho¬ 
sen from the health-related sciences. 
He succeeds Andrew Hamilton, 
ph.d., an organic chemist who left 
Yale to become vice chancellor of the 
University of Oxford in England, and 
Susan Hoclcfield, ph.d., a neurobi¬ 
ologist who is now president of the 
Massachusetts Institute of Technology. 
Salovey doesn’t think this is a coinci¬ 
dence. “There is no doubt that for Yale 
to remain in the top tier of universities, 
we have to strengthen science and engi¬ 
neering on both sides of campus,” he 
said. “This is an area of priority and has 
been for some years.” 
The acquisition of West Campus, 
a former pharmaceutical company lab 
and office complex in neighboring 
West Haven and Orange, is critical to 
this effort, Salovey said, and he sees 
it as part of his new job to work with 
Michael Donoghue, ph.d., the vice 
president for West Campus Planning 
and Program Development, to use that 
facility as an incentive to attract world- 
class researchers to Yale. 
Noting his numerous research 
collaborations with faculty from the 
schools of medicine and public health 
(he was co-director of the Center for 
Interdisciplinary Research on aids for 
nine years), Salovey said he understands 
the challenges faced by the medical school 
faculty. “My lab has the same pressures,” 
he said. “We look for funding the same 
way. We share the same struggles.” 
Salovey joined the Yale faculty in 
1986 after receiving his undergradu¬ 
ate degree from Stanford and his ph.d. 
from Yale. He was appointed dean of the 
Graduate School of Arts and Sciences 
in 2003. A year later, he was named 
dean of Yale College, where he presided 
over growth in international programs 
and financial aid changes. His research 
has focused on human emotion and 
health psychology. With colleague John 
D. Mayer, ph.d., he developed a con¬ 
cept called “emotional intelligence,” the 
theory that just as people have a range of 
intellectual abilities, they also have mea¬ 
surable emotional skills that affect their 
success in life. 
Salovey knows his own emotional 
intelligence will be tested in his new job. 
“The stereotype of the provost’s office 
is the guy who says no,” he said. “But I 
think it’s a mistake to assume that the 
role of the provost is to frustrate all good 
ideas, intentions and creativity of the 
faculty. I would like to think of it as the 
office that helps you shape your ideas, 
clarify your goals and manage your 
expectations so that we can be saying 
‘yes’ at least as often as we say no.” 
-J.K. 
Peter Salovey 
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6 chronicle 
A physician’s gift supports 
research on pre-eclampsia 
and prematurity 
Shortly before the end of World War II, 
a dying Albert S. McKern, m.a. ’13, 
m.d., turned to lawyers—fellow pris¬ 
oners in a Japanese internment camp 
in Sumatra—and composed his will. 
His vacant land was to be developed, 
and property that he owned in Penang, 
Malaysia, where he had practiced as a 
physician and surgeon, was to be reno¬ 
vated and rented. Ten years after the 
death of his last child, the family’s hold¬ 
ings were to be sold and the money 
divided among three universities—Yale, 
where he had received a degree in 
engineering; the University of Sydney 
in Australia, where he had received his 
bachelor’s degree and studied theology; 
and the University of Edinburgh in 
Scotland, where he had received his 
medical degree. 
Born in 1885 in Sydney, McKern 
came to Yale in September 1911 after 
deciding that theology was not for him 
because of his difficulties with public 
speaking. He earned a master’s degree 
from Yale, followed by a medical degree 
from Edinburgh in 1917. McKern then 
moved to Penang, where he built up 
both a successful medical practice and 
substantial real estate holdings. During 
the Japanese invasion in 1942, McKern 
was captured in Indonesia. He died three 
years later of dysentery. 
Under the terms of McKern’s will, his 
family’s estate—$12 million—was to 
be used “for the sole and special pur¬ 
pose of establishing medical research 
scholarships for investigation into the 
ESTATE OF Dr. 
■*-/* v/f' 
3. EcKERN (PEGEASEP). 
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Albert McKern in Penang, Malaysia, circa 1937. 
In 1947, statesman Averell Harriman of the Yale 
College Class of 1913 sought McKern’s help on 
behalf of the Yale-in-China Association, only to 
learn of McKern’s death. 
causes, prevention and treatment of 
mental and physical pain and distress 
during pregnancy, labour and the puer- 
perium.” McKern’s last surviving ben¬ 
eficiary died in December 1997, and the 
trust terminated a decade later. 
Yale’s portion of McKern’s gift— 
about $4 million—will endow annual 
grants to those doing promising re¬ 
search on these issues. Charles J. 
Lockwood, m.d., the Anita O’Keefe 
Young Professor of Women’s Health 
and chair of obstetrics, gynecology and 
reproductive sciences, learned about 
the gift several years ago at a meeting 
with Andrew A. Calder, m.d., head 
of reproductive and developmental sci¬ 
ences at Edinburgh. Lockwood’s initial 
reaction was disbelief. “He’d had a few 
drinks and I thought he was exagger¬ 
ating,” Lockwood said. Eventually the 
two began a discussion of joint work 
that might fulfill McKern’s dream. 
“They have a very strong program,” 
he said of ob/gyn research at Edinburgh, 
citing the work done in prematurity and 
pre-eclampsia in particular. 
Lockwood hopes to devise a joint 
strategy for using the money from the 
bequest during this academic year. 
Given McKern’s desire and the needs 
of the field, Lockwood sees prema¬ 
turity research as an area of focus. 
“[Prematurity] is the leading cause of 
infant mortality in the United States, 
the leading cause of mental retardation, 
the leading cause of childhood blind¬ 
ness. It costs the U.S. economy around 
$28 billion a year in terms of health 
care-related resources. Preterm delivery 
is a national public health crisis.” 
Funds from the bequest may also 
support a Yale-Sydney-Edinburgh schol¬ 
arly exchange program and research on 
postpartum depression in the psychia¬ 
try department. 
—Charles Gershman 
§3 
Online: Yale Netcasts 
Charles J. Lockwood : Yale Ob/Gyn—Research 
Updates and Clinical Advances 
Yale team builds new search 
engine that retrieves images 
based on embedded text 
In July a team of Yale scientists pub¬ 
lished a paper describing an innova¬ 
tive search engine with a new way of 
finding biomedical images. Search 
engines and websites already allow sci¬ 
entists to search for images based on 
titles and captions. “We are not aware 
of a biomedical search engine that can 
retrieve images by searching the text 
within biomedical images,” Michael O. 
Krauthammer, m.d., ph.d., assistant 
professor of pathology, and colleagues 
wrote in their paper published in 
Bioinformatics. 
The Yale Image Finder (yif) lets re¬ 
searchers locate diagrams, graphs 
and other experimental figures based 
on text contained in the images, yif, 
funded by a grant from the National 
Library of Medicine and accessible at 
http://krauthammerlab.med.yale.edu/ 
imagefinder/, enables users to access 
more than 140,000 images from more 
than 34,000 papers published in open- 
access biomedical journals. 
Krauthammer calls this new tech¬ 
nology a major step in biomedical 
literature retrieval, as most important 
information exists in places other than 
image captions, which, until now, have 
been the primary targets of image 
search engines. 
yif functions by performing optical 
character recognition before making 
the images available for search. Users 
can restrict image queries to the text 
within the images, the image caption, 
the paper title, paper abstract, full text or 
any combination thereof. After submit¬ 
ting a query, yif presents users with 
TWO GRANTS ADVANCE PUBLIC HEALTH 
The School of Public Health has received a 
twofold boost in the form of an $11 million 
grant from the National Institute of Mental 
Health (nimh) and a $10.7 million grant 
from the National Institute of Child Health 
and Human Development (nichd). 
The nimh funding provides five years of 
support for hiv/aids prevention and health 
services at the school’s Center for Interdisci¬ 
plinary Research on aids (cira). The grant from 
nichd adds to a $15 million grant in 2007 to 
support Yale’s role in a national study that 
will follow 100,000 children from before 
birth to age 21 to improve understanding of 
the factors that contribute to their health 
and development. 
The grant to cira follows an October 2008 
report from the Centers for Disease Control 
and Prevention that revealed higher estimates 
of new hiv infections in the United States 
than previously calculated and emphasized 
the need for more rigorous study of interven¬ 
tions for hiv prevention. 
—John Curtis 
YALE PAYS $7.6 MILLION IN GRANTS PROBE 
Under the terms of a settlement reached in 
December, Yale will repay the federal gov¬ 
ernment $7.6 million after an investigation 
of Yale’s accounting practices for research 
grants. The probe, which began in June 2006 
and covered periods going back to 1999, was 
led by the U.S. Attorney’s Office on behalf 
of federal granting agencies, including the 
Department of Health and Human Services 
and the National Science Foundation. 
President Richard C. Levin said that the uni¬ 
versity has “a clear obligation to comply with 
all regulations pertaining to the administration 
of federal awards.” He also acknowledged that 
federal regulations are sometimes burden¬ 
some, but noted that Yale receives more than 
$400 million in federal grants each year. 
As a result of the investigation, Yale’s 
Office of Research Administration has 
developed training and education programs, 
published revised policies and procedures, 
implemented a Web-based reporting system, 
and designed procedures for the documen¬ 
tation and review of cost transfers. 
—J.C. 
Yale scientists have devised a way to search 
biomedical images based on text contained 
in the images. 
thumbnails of images. Once an image 
of interest is selected, yif provides a 
high-resolution version of the image, 
along with the abstract, full text and 
other images from the associated paper. 
“The idea is to augment text mining 
with image mining, with the idea that 
we can have a better understanding of a 
research article using automated means,” 
Krauthammer says. “I’ve felt that images 
are undervalued in terms of their repre¬ 
sentative quality and what type of infor¬ 
mation they can hold. In the future, 
we should be able to obtain even more 
information from the images, and get 
a pretty good understanding of what the 
paper is about.” 
—C.G. 
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8 Rounds MEDICINE AND HEALTH AT YALE 
Blood test in the OR 
speeds surgery 
Measuring hormone levels in 
hyperparathyroidism on the spot 
sends patients home faster. 
Since Robert Udelsman, m.d., m.b.a., 
department chair and the William H. 
Carmalt Professor of Surgery, came to 
Yale in 2001 to lead the medical school’s 
Department of Surgery, the number of 
parathyroid operations has risen from 
about 30 a year to more than 350. 
Most of these patients have primary 
hyperparathyroidism (hpth)—one or 
more of the parathyroid glands in the 
neck begins to enlarge and produce too 
much hormone. These enlarged glands 
are called adenomas, and too much 
parathyroid hormone, or pth, causes 
osteoporosis, kidney stones and other 
health problems. The adenoma needs 
to be removed, a procedure that usually 
requires general anesthesia and a stay 
of several days in the hospital. 
Udelsman, however, has combined 
existing techniques with a simple but 
radical innovation—placing a laboratory 
machine to measure hormone levels 
inside the operating room—to turn this 
into an outpatient procedure. 
“Patients can fly in on Sunday, get a 
place at the hotel and see us on Monday 
morning. Tuesday morning they come 
have surgery,” said Patricia Donovan, r.n., 
m.b.a., Udelsman’s clinical coordinator. 
“They return Friday that same week. 
They might explore New Haven, have 
their sutures removed ... and fly back.” 
Udelsman’s approach, which has 
been adopted by the other three endo¬ 
crine surgeons on the team, involves 
several steps. 
First comes pre-op preparation. In 
addition to the patient’s medical history, 
the team needs to know where the of¬ 
fending adenoma is located. Most people 
have four or more parathyroid glands, so 
figuring out which is the overactive one 
—or whether there is more than one— 
can be a challenge. Imaging studies help 
to localize it. Before the patients arrive 
for surgery, Donovan gathers relevant 
records, medical information and scan 
results, talking by phone with patients 
and their doctors to make sure that the 
surgery is appropriate for them. 
In the operating room the unique¬ 
ness of Yale’s approach becomes evident. 
Instead of patients being placed under 
general anesthesia, patients receive a 
series of injections of local anesthetic 
in the neck. A small incision is made, 
the offending adenoma is removed and 
a blood test is done to check levels of 
pth. But rather than sending the blood 
sample to a laboratory, the technician in 
the operating room tests hormone levels 
immediately. The surgical team waits 
only 12 minutes for the results—about 
a quarter of the time needed at other 
institutions, where waiting for results 
can take longer than the operation itself. 
If pth levels have dropped sufficiently, 
the surgeons can be confident that they 
removed the adenoma completely. Then 
it’s time to sew up. 
The entire procedure typically takes 
half an hour, and the patient goes home 
—or to the hotel—a few hours later, 
returning to the clinic in three days for 
a final follow-up visit. Complication rates 
are low, cure rates are about 98 percent 
and the surgery is cost-effective. But most 
of all, patients are satisfied. 
—Jenny Blair 
As doctors hand off patients, 
miscommunication at sign-outs 
can cause errors 
“Sign-out,” the conversation at shift 
change when hospital patients’ informa¬ 
tion is handed off from one team of doc¬ 
tors to another, is the delicate hinge on 
which much medical communication 
turns. But this commonplace event can 
be fraught with miscommunications 
that frustrate doctors and pose a hazard 
to patients. 
That’s because doctors don’t have a 
standard approach for sign-out—unlike 
those for the formal history and physical 
presentation—nor are they supervised 
when first doing it. “We have no train¬ 
ing at all; there’s nothing,” said Leora 
I. Horwitz, m.d., assistant professor of 
medicine. Instead, residents wing it: 
they might painstakingly explain the 
team’s reasoning for each patient’s plan 
of care—or they might simply read 
names and diagnoses to a colleague and 
append a few comments to the list. 
Because much of what is known 
about sign-out is anecdotal, Horwitz 
decided to study the practice. She and 
her team studied eight teams’ hand-offs 
over 12 days, audiotaping evening 
sign-outs and collecting doctors’ print¬ 
outs, then asking the covering team 
in the morning if there had been any 
sign-out-related problems overnight. 
There certainly had been. In 88 sign- 
out sessions, 24 sign-out-related problems 
came up. Fifteen related to inefficient 
care—the covering team had to dupli¬ 
cate work or research—but there were 
five episodes of delayed diagnosis or 
care and four close calls. In one case of 
miscommunication, a patient was trans¬ 
ferred to intensive care in part because 
the covering team had not been warned 
about her bronchospasm. 
These results, published in the 
September 8 Archives of Internal 
Medicine, will surprise few physicians 
who have had to start from scratch 
while caring for a colleague’s patients. 
But with reductions in residents’ work 
hours, a rising hospital census and a 
national impetus to reduce medical 
errors, sloppiness at sign-out is evolving 
from nuisance to pressing concern. 
How should clinicians sign out? They 
might start by looking outside medicine. 
Other groups involved in high-risk or 
error-prone work, including the nuclear 
power, automotive and airline indus¬ 
tries, have developed effective methods 
of handoff. “They teach it, they train it, 
they concentrate on it—which we don’t 
do,” Horwitz said. “What you want to 
hand off in person or on paper is the 
higher-order stuff, the clinical reason¬ 
ing part, the synthesis, the judgment. 
Handoff is about understanding.” 
Based on these results, the internal 
medicine department began a sign-out 
curriculum for residents that is now 
in its third year. Horwitz often teaches 
it, and she has also developed sign-out 
templates for hospital residents in other 
specialties. She plans next to study sign- 
out during hospital discharge. 
“We just haven’t thought about 
[sign-out] as part of our job,” she said. 
“We don’t prioritize this as a safety 
issue, and that’s part of what [our team 
is] trying to change by pointing out what 
goes wrong.” 
-J.B. 
NEW APPROACH TO THYROID SURGERY 
Over the last two years the Yale Pediatric 
Thyroid Center has treated 30 patients by 
using a new approach—the pairing of pediat¬ 
ric and adult surgeons in the operating room. 
The center may be the only facility in the 
United States exclusively devoted to the care 
of children with thyroid conditions. 
“The right surgical expertise is important 
for optimizing outcomes, because the area 
by the neck is delicate, especially in young 
children,” said Scott Rivkees, m.d., professor 
of pediatrics and director of the center. 
Since far more thyroid surgeries are per¬ 
formed on adults than on children, Yale 
physicians combined the expertise of Robert 
Udelsman, m.d., m.b.a., department chair and 
the William A. Carmalt Professor of Surgery, 
a high-volume adult endocrine surgeon, with 
the skills of Christopher Breuer, m.d., a pedi¬ 
atric surgeon versed in the challenges of treat¬ 
ing thyroid disorders in young patients. 
“We can tell parents, ‘You’re going to have 
one of the world’s most experienced endo¬ 
crine surgery teams working on your child,’ ” 
Udelsman said. 
—Jennifer Kaylin 
PREVENTING FALLS IN ELDERLY PATIENTS 
Teaching clinicians and older patients how 
to prevent falls can reduce the likelihood—by 
up to 11 percent—of falls that lead to hospi¬ 
talization or an emergency room visit, Yale re¬ 
searchers reported in The New England Journal 
of Medicine in July. 
The researchers compared injury rates in 
a 58-zip code area in and around Hartford 
—where clinicians incorporated fall risk assess¬ 
ment and management into their practices— 
to those in a control region. Their analysis also 
showed some 1,800 fewer emergency depart¬ 
ment visits or hospitalizations; and health care 
savings estimated at $21 million over two years. 
“The next step is to put [the research] into 
practice,” said senior author Mary E. Tinetti, 
m.d., the Gladys Phillips Crofoot Professor of 
Medicine and professor of epidemiology and 
of investigative medicine, “by making physi¬ 
cians, nurses and physical therapists every¬ 
where more conscious of fall risks... and of 
what can be done to prevent falls.” 
—Michael Fitzsousa 
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10 Findings from the bench 
Yale scientists have designed an artificial version 
of the energy-generating cells in electric eels that 
could power medical implants. 
Yale scientists model 
artificial energy cells 
Chemical engineers design an artificial 
electrocyte that could be a power source 
for medical implants. 
Researchers at Yale University have cre¬ 
ated a blueprint for artificial cells that 
are more powerful and efficient than 
the natural cells they mimic and could 
one day power tiny medical implants. 
Their findings were published online in 
Nature Nanotechnology on September 21. 
The scientists began by exploring 
whether an artificial version of the 
electrocyte—the energy-generating cells 
in electric eels—could be designed as a 
potential power source. “The electric eel 
is very efficient at generating electricity,” 
said Jian Xu, ph.d., a postdoctoral asso¬ 
ciate in the Department of Chemical 
Engineering. “It can generate more elec¬ 
tricity than a lot of electrical devices.” 
Xu came up with the first blueprint 
that shows how the electrocyte’s dif¬ 
ferent ion channels work together to 
produce the fish’s electricity while he 
was a graduate student under David 
A. LaVan, ph.d., a former assistant 
professor of mechanical engineering 
now at the National Institute of Stan¬ 
dards and Technology. 
But the scientists didn’t stop there. 
“We’re still trying to understand how the 
mechanisms in these cells work,” said 
LaVan. “But we asked ourselves: ‘Do we 
know enough to sit down and start think¬ 
ing about how to build these things?’ 
Nobody had really done that before.” 
Using the new blueprint—based 
on a mathematical model—as a guide, 
LaVan and Xu set about designing 
an artificial cell that could replicate the 
electrocyte’s energy production. “We 
wanted to see if nature had already 
optimized the power output and energy 
conversion efficiency of this cell,” said 
Xu. “And we found that an artificial cell 
could actually outperform a natural 
cell, which was a very surprising result.” 
The artificial cell LaVan and Xu 
modeled is capable of producing 28 per¬ 
cent more electricity than the eel’s own 
electrocyte, with 31 percent more effi¬ 
ciency in converting the cell’s chemical 
energy—derived from the eel’s food—■ 
into electricity. 
While eels use thousands of electro- 
cytes to produce charges of up to 600 
volts, LaVan and Xu have shown that it 
would be possible to create a smaller 
“bio-battery” using several dozen arti¬ 
ficial cells. The tiny bio-batteries would 
need to be only about a quarter-inch 
thick to produce the small voltages used 
to power such tiny electrical devices as 
retinal implants or other prostheses. 
Although the engineers came up 
with a design, it will still be some time 
before the artificial cells can be built— 
they will still need a power source. 
LaVan speculates that the cells could be 
powered in a way similar to their natural 
counterparts. Bacteria, he suggested, 
could be employed to recycle atp—the 
molecule that transfers energy within 
cells—using glucose, a common source 
of chemical energy derived from food. 
With an energy source in place, 
the artificial cells could one day power 
a medical implant and would provide 
a big advantage over battery-operated 
devices. “If it breaks, there are no toxins 
released into your system,” said Xu. 
“It would be just like any other cell in 
your body.” 
—Suzanne Taylor Muzzin 
11 
A gene that helps blood 
vessels feed tumor growth also 
aids in brain plasticity 
A gene that typically helps rogue blood 
vessels feed tumor growth also appears to 
play a helpful role in the body—in brain 
development. Slight genetic variations 
in the vascular endothelial growth factor 
(vegf) gene sequence correlate with 
changes in the size of the hippocampus, 
the brain structure involved in memory, 
emotion and learning. These changes 
may be linked to a slew of neuropsychiat¬ 
ric disorders including major depression, 
schizophrenia and dementia. 
“There may be subsets of individ¬ 
uals, for example with mood disorder or 
bipolar disorder, who have hippocampal 
differences, and they may be the ones 
who carry these variations in vegf,” 
explained Hilary Blumberg, m.d., asso¬ 
ciate professor of psychiatry, director of 
the Mood Disorders Research Program 
and lead author of a paper published on¬ 
line in Biological Psychiatry on August 14. 
The researchers used magnetic 
resonance imaging to determine hippo¬ 
campus volumes in a group of healthy 
volunteers who had slight differences in 
the vegf gene encoded in their dna. 
They then employed statistical analysis 
to identify any correlation between 
hippocampus differences and vegf dif¬ 
ferences. The study findings suggest 
that variations in vegf might contribute 
to individual differences in hippocam¬ 
pus size and structure. 
These findings build on pioneering 
work conducted by one of the paper’s 
co-authors, Ronald S. Duman, ph.d., 
Elizabeth Mears and House Jameson 
Professor of Psychiatry, professor 
of pharmacology and director of the 
Division of Molecular Psychiatry and 
Abraham Ribicoff Research Facilities. 
Duman recently explored vegf function 
in the brain and found that it helped 
new nerve cells grow, specifically in 
the hippocampus. 
Playing a part in neurogenesis is an 
unconventional role for vegf. The gene 
is known to help cancers grow by lay¬ 
ing down new networks of blood vessels 
that feed malignant cells. Blocking vegf 
function is a main goal in the treatment 
of breast, lung and colorectal cancers, 
among others. 
Joel E. Gelernter, m.d., professor of 
psychiatry and director of the Division 
of Human Genetics in Psychiatry, who 
was examining genetic variations in 
vegf, joined Blumberg and Duman for 
a collaborative effort. 
“We’re trying to understand at a 
basic level of cell signaling how disrup¬ 
tions or alterations could contribute to 
the function of the hippocampus and 
circuits within the hippocampus, and 
how these disruptions influence behav¬ 
ior and illness,” said Duman. Toward 
that end, Gelernter offered up his 
genetic expertise, Duman contributed 
knowledge about the molecular role 
of vegf in the brain from his animal 
studies and Blumberg brought her brain 
imaging know-how to bear. 
The findings of the current study 
complement another recent discovery 
from the research trio. They found that, 
compared to healthy subjects, adults with 
bipolar disorder had significantly smaller 
hippocampus volumes, which were 
linked to variations in the brain-derived 
neurotrophic growth factor (bdnf) 
gene (published online on August 13 
in Neuropsychopharmacology). Duman 
predicts that vegf may behave similarly, 
in that vegf variations may make indi¬ 
viduals either more or less vulnerable to 
stress-related mood disorders. 
To follow up on this prediction, 
Blumberg and co-lead author Fei Wang, 
m.d., ph.d., plan to study vegf genetic 
variations in individuals with mood 
disorders to understand how these gene 
changes may influence both brain struc¬ 
ture and behavior. Ultimately, identi¬ 
fying genetic variants that predispose 
individuals to mood disorders could 
pave the way to patient screening for 
early disease detection and possibly 
smarter treatments. 
—Kara A. Nyberg 
FIX-IT KIT FOR FAULTY GENES 
School of Medicine researchers led by 
Peter M. Glazer, m.d. ’87, ph.d. ’87, hs ’91, 
department chair and the Robert E. Hunter 
Professor of Therapeutic Radiology and 
professor of genetics, have found a new 
approach to gene therapy, opening up the 
possibility of new treatments for inherited 
hematologic diseases. 
In the September 9 issue of the Pro¬ 
ceedings of the National Academy of Sciences, 
the researchers report that they developed 
genetic “repair kits” consisting of chemically 
altered pieces of dna, which bind to human 
genes and trigger the cell’s own repair sys¬ 
tems to fix such mutated genes as the one 
that causes thalassemia, an inherited blood 
disease. The faulty gene was fixed even in 
human bone marrow cells, meaning that the 
genetic repair could be inherited by newly 
generated blood cells. 
The new technique employs small pieces 
of synthetic dna that are easy to insert into 
cells and do not require viruses for delivery. 
—John Curtis 
JUNK DNA AND EVOLUTION 
Humans can handle tools and walk upright 
thanks to a handful of letters in their genome, 
Yale scientists said in a report published in 
Science in September. Evolution, they suggest, 
may have been driven not only by changes in 
genes but also by changes in the sequences 
that control them. 
Some sequences, previously thought of 
as “junk dna” because they do not code for 
proteins, regulate genes that direct human 
development. With colleagues in California, 
Singapore and the United Kingdom, the 
Yale team characterized in mouse embryos 
a human sequence that had changed since 
humans and chimpanzees diverged. This 
sequence drove gene expression at the base 
of the mouse versions of the primordial 
“thumb” in the forelimb and the “great toe” 
in the hind limb. 
“The long-term goal is to find many 
sequences like this and use the mouse to 
model their effects on the evolution of 
human development,” said James Noonan, 
ph.d., assistant professor of genetics and 
senior author of the study. 
—J.C. 
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Books & ideas bookshelf 
John Kao relies on the "implicit 
curriculum of medicine” in his career 
as a consultant on innovation. 
How America can get its groove back 
A medical school alumnus argues that the nation is not 
doing enough to foster innovation. 
John J. Kao, m.d. ’77, m.b.a. ’82, does not even mention his 
medical degree in the biography for his latest book, Innovation 
Nation: How America Is Losing Its Innovation Edge, Why It 
Matters, and What We Can Do To Get It Back. 
Medical school at Yale and a psychiatry residency at McLean 
Hospital were just starting points for a career that has earned 
Kao the designation of “Mr. Creativity” from The Economist. 
Along the way he has played keyboards for Frank Zappa; taught 
at mit and at Harvard, where he earned his business degree; 
started two biotech companies; and was production executive on 
the Palme d’Or-winning film sex, lies, and videotape. Recently he 
founded a nonprofit, the Institute for Large Scale Innovation. 
Despite his distance from hospital corridors, however, Kao 
said he still draws on what he calls “the implicit curriculum 
of medicine,” which taught him, “You work hard, and no one 
works harder than you. You take responsibility and make 
things happen. And you’re it: when someone comes into the 
ER at three in the morning, you’re it. I’ve never forgotten 
those lessons.” 
Lately Kao’s hard work has involved advising corporate and 
government leaders around the world on fostering innovation 
—and warning Americans that they are not doing enough. 
Business Week called his book “scary, insightful, and ultimately 
very useful,” and listed it among the top 10 business books 
for 2007. 
Kao believes that Americans lack a cogent vision of where 
innovation is taking them, even though half of the world’s 
research and development money is invested within this coun¬ 
try. “No country, not even the United States, can afford to be 
without a strategy,” he said. Kao defines innovation as the abil¬ 
ity of individuals, corporations and nations “to continuously 
create their desired future.” If the United States wants to chart 
its own course rather than simply reacting to developments 
elsewhere, it must foster innovation. 
Kao cites Singapore’s innovation strategy as instructive. The 
island nation of 4.5 million has built a huge research complex 
called Biopolis, paid for talented young people to earn doctorates 
in the sciences and recruited researchers and advisors from 
around the world. In his book, Kao quotes former University of 
Washington President Lee L. Huntsman, who has called Singapore 
a “venture capital company masquerading as a government.” 
Like Singapore, each nation should foster innovation 
consistent with its national character and endowments, Kao 
said. Otherwise, he said, “you don’t make the best use of your 
opportunities and resources.” The United States, for example, 
has both strong links between academia and business and 
a mature venture capital industry willing to take chances on 
unproven ideas. “And,” said Kao, “we have a very forgiving 
attitude toward what I would call noble failure.... If you fail in 
European countries or Asia, typically you’re out of the game.” 
America has also benefited by welcoming immigrants: 
half of those with doctoral degrees in computer science, for 
instance, come from abroad. “We’d be stupid to imperil that 
flow of talent into this country,” Kao said. “Many other coun¬ 
tries are stepping up to the plate and making their countries 
highly desirable to immigrant talent.” 
Kao advises physicians who value innovation to seek skills 
and knowledge beyond medicine. For instance, he recommends 
that doctors earn master’s degrees in business or in public 
administration. “These days it’s arguably as important to under¬ 
stand how discoveries get into the marketplace as it is to 
pursue discovery itself. ... The more we can do a variety of 
things in addition to having our core skills, the more we can 
contribute to society.” 
—Cathy Shufro 
Bookshelf focuses on books and authors affiliated with the School of 
Medicine. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
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Freeing 
the 
Human 
Spirit 
A 
Psychiatrist 5 
Journal 
LOUIS B. HERMAN. M.D. 
I Constance A. Bean 
• Lesley- Ann Fein. wr> wn 
BEATING 
LYME 
Undemanding and Treat mg 
This Complex and Often 
Misdiagnosed Disease 
The 
Womans 
Heart gH 
AN OWNER'S GUIDE Hs 
JOHN A. ELEFTERIADES. MO 
TEJtfSA CslTtNCLASSt. MD 
Transgenesis and the Manage¬ 
ment of Vector-Borne Disease 
by Serap Aksoy, ph.d., profes¬ 
sor of epidemiology (microbial 
diseases) (Springer) The author 
explains the reasons for the 
resurgence and spread of vector- 
borne disease. No effective 
vaccines exist for these diseases, 
and only limited therapeutic 
interventions are available to 
treat them in mammalian hosts. 
Aksoy describes the causes of 
the spread of these diseases, 
including habitat change, irriga¬ 
tion practices, atmospheric and 
climate change, insecticide and 
drug resistance and increases 
in global tourism, human traf¬ 
fic and commercial activities. 
The author also explores the 
potential of such molecular 
technologies as transgenesis 
in developing disease manage¬ 
ment strategies. 
Anemias and Other Red Cell 
Disorders 
by Kenneth R. Bridges, m.d.. 
and Howard A. Pearson, m.d., 
professor emeritus of pediatrics 
(hematology/oncology) (McGraw- 
Hill Professional) This resource 
provides a practical framework 
for identifying and managing 
acute, congenital and chronic 
anemias as well as other red blood 
cell disorders. The book describes 
the principles of anemia evalu¬ 
ation and specific deficiencies in 
adults and children. 
Practical Guide to the Evalua¬ 
tion of Clinical Competence 
by Eric S. Holmboe, m.d., hs 
’93, professor (adjunct) of medi¬ 
cine, and Richard E. Hawkins, 
m.d. (Mosby) This guide to 
outcomes-based assessment 
in clinical education describes 
evaluation methods, tools and 
faculty training approaches 
for all medical educators. The 
book can serve as a resource in 
developing, implementing and 
sustaining effective systems for 
evaluating clinical competence 
in medical school, residency and 
fellowship programs. The book 
comes with a dvd. 
Autism Spectrum Disorders in 
Infants and Toddlers: Diagnosis, 
Assessment and Treatment 
by Katarzyna Chawarska, ph.d., 
assistant professor in the Child 
Study Center, Ami f. Klin, ph.d., 
Harris Associate Professor of 
Child Psychiatry in the Child 
Study Center and associate 
professor of psychology, Fred 
R. Volkmar, m.d., the Irving B. 
Harris Professor of Child Psy¬ 
chiatry, Pediatrics and Psychol¬ 
ogy in the Child Study Center, 
and Michael D. Powers, psy.d., 
assistant clinical professor in the 
Child Study Center (The Guil¬ 
ford Press) This book synthesizes 
research on the diagnosis and 
treatment of autism spectrum 
disorders in very young children. 
The authors examine critical re¬ 
search issues and present inno¬ 
vative approaches to assessing 
social, cognitive, adaptive, com¬ 
munications and sensorimotor 
impairments in the first two years 
of life. The book also addresses 
ways to support families in cop¬ 
ing with an early diagnosis and 
in becoming effective advocates 
for their children. The book 
includes case studies and dis¬ 
cusses popular but controversial 
treatments for these disorders. 
Freeing the Human Spirit: 
A Psychiatrist’s Journal 
by Louis B. Fierman, m.d., hs 
’53 (Blue Dolphin) This book 
consists primarily of 21 case 
vignettes intended for readers 
who are involved in or inter¬ 
ested in psychotherapy and 
psychiatric private practice. The 
book also includes an essay on 
the development of nondirec¬ 
tive therapy, an approach that 
the author regards as increasing 
the effectiveness of treatment. 
Beating Lyme: Understanding 
and Treating This Complex and 
Often Misdiagnosed Disease 
by Constance A. Bean, m.p.h. ’50, 
and Lesley Ann Fein, m.d., m.p.h. 
(amacom) The authors offer 
readers an understanding of 
Lyme disease, its history and the 
controversy surrounding its 
diagnosis and treatment. Topics 
include what to do after a tick 
bite, the consequences of mis¬ 
diagnosis, how to get the best 
treatment and what to do if 
insurance won’t cover it. 
The Woman’s Heart: 
An Owner’s Guide 
by John A. Elefteriades, m.d. ’76, 
hs ’81, fw ’83, the William W.L. 
Glenn Professor of Cardiothor- 
acic Surgery, and Teresa Caulin- 
Glaser, m.d. (Prometheus Books) 
In this guide, the authors focus 
on the unique factors affecting 
women’s cardiovascular health. 
Topics include such diseases 
of the heart as mitral valve 
prolapse, symptoms of heart 
disease that women need to 
know, cardiac tests, medications 
and surgery, and the ways in 
which pregnancy and childbirth 
affect women’s hearts. 
Current Diagnosis & Treatment: 
Psychiatry, 2nd ed. 
by Michael H. Ebert, m.d., profes¬ 
sor of psychiatry, Peter T. Loosen, 
m.d., Barry Nurcombe, m.d., 
and James F. Leckman, m.d., the 
Neison Harris Professor of Child 
Psychiatry in the Child Study Cen¬ 
ter and professor of pediatrics and 
psychiatry (McGraw-Hill Medical) 
This reference work addresses 
day-to-day questions about 
psychiatric illness in both adults 
and children. It provides informa¬ 
tion on psychiatry and the law, 
psychological testing, emergency 
psychiatry, evaluation of infants, 
developmental psychology, 
neuropsychopharmacology, psy¬ 
chiatric genetics, psychoanalysis 
and the principles of evaluating 
and diagnosing patients, as well 
as treatment strategies. 
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14 Books & ideas book notes IN CIRCULATION 
HOW TO LAND A 
TOP-PAYING 
FEDERAL JOB 
_ 
LIIV WHITEMAN 
Expert medical help now available to Connecticut 
school nurses via new website 
How to Land a Top-Paying 
Federal Job: Your Complete 
Guide to Opportunities, 
Internships, Resumes and Cover 
Letters, Application Essays 
(ksas), Interviews, Salaries, 
Promotions and More! 
by Lily Whiteman, m.p.h. ’90 
(amacom) This book guides 
prospective applicants through 
every stage of theirfederal job 
search, giving insight into finding 
openings and negotiating a top 
salary as well as suggesting tech¬ 
niques for securing promotions. 
Educating Individuals With Dis¬ 
abilities: ideia 2004 and Beyond 
by Elena L. Grigorenko, ph.d., 
associate professor in the Child 
Study Center and of epidemiol¬ 
ogy (chronic diseases) (Springer) 
This volume discusses the 
identification and assessment 
of learning-disabled students 
today in light of the 2004 
Individuals With Disabilities 
Education Improvement Act 
(ideia). Grigorenko describes the 
ideia in its historical, political 
and legal contexts and considers 
practical issues for school psy¬ 
chologists, neuropsychologists, 
speech-language therapists, 
policy makers and legal profes¬ 
sionals who must deal with 
special education and learning 
disability issues on a daily basis. 
Medical Humanism: Aphorisms 
From the Bedside Teachings and 
Writings of Howard M. Spiro, m.d. 
edited by Robert E. Kravetz, m.d., 
fw ’65 (The Program for the 
Humanities in Medicine) This 
volume gathers many observa¬ 
tions, lessons, admonitions, criti¬ 
cisms, witticisms and comments 
from Spiro’s books, essays and 
papers for the reader’s enjoy¬ 
ment and contemplation. Spiro, 
who served on the School of 
Medicine’s faculty from 1955 until 
his retirement in 2000, speaks 
as an experienced clinician and 
humanist with a broad and 
visionary outlook on medicine. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yah Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu 
School nurse Marcia Wilcox, r.n., didn’t have much luck when 
she used Google to search for information about learning dis¬ 
abilities caused by a rare bone disorder. A teacher at her school 
in Connecticut needed to know whether a new student would 
need extra help as a result of the condition. 
Wilcox contacted Janene Batten, m.l.s., at the Harvey 
Cushing/John Hay Whitney Medical Library, who sent 
Wilcox four journal articles on the condition, “She was able 
to find something a lot quicker than I would be able to,” said 
Wilcox, the sole nurse for about 400 primary school chil¬ 
dren. “Sometimes I have time, and sometimes I don’t.” 
This expert help was available on the “Ask a Librarian” fea¬ 
ture on a new website for Connecticut school nurses that 
Batten established with colleagues Jan Glover, m.l.s., and Lynn 
Sette, m.l.s. They created the site based on a questionnaire 
they had sent in the fall of 2007 to the nearly 2,000 nurses and 
nurse practitioners in Connecticut’s public schools and school- 
based clinics. Just under half the nurses who filled out the 
questionnaire said they were too busy during the school day 
to use the Internet; 44 percent said they lacked knowledge of 
electronic resources. 
The site gives the nurses easy access to 14 databases, in¬ 
cluding PubMed, the biomedical database for clinicians, and 
MedlinePlus. Among other resources is a link to the National 
Library of Medicine’s Drug Information Portal, which provides 
details about 12,000 medications. The site also provides access 
to librarians who can help with difficult searches, as Batten 
helped Wilcox. 
The librarians developed the site over two and a half years 
as part of a $40,000 grant from the National Library of Medi¬ 
cine. They hope that the site, called Connecticut School Nurses 
Information Resources, can serve as a model for others. In June, 
the librarians will present a paper about the project at the 
annual conference of the National Association of School Nurses. 
“Unlike a lot of areas of nursing, school nursing is a very 
solitary practice,” said Joan Cagginello, r.n., m.s., the school 
nurse administrator of the Milford Health Department. The 
site is “invaluable,” she said. 
The site’s url is http://www.med.yale.edu/library/ 
school_nursing/. 
—Cathy Shufro 
In Circulation focuses on activities at the Cushing/Whitney Medical 
Library. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
ON CAMPUS 
An orthopaedic surgeon fights 
for diversity in medicine 
When Claudia L. Thomas, m.d., 
hs ’80, completed her residency 
29 years ago, she was the nation’s 
first black woman to become an 
orthopaedic surgeon—though 
somebody had to inform her of 
her achievement. Thomas, who 
gave the Southwick Lecture for 
the Department of Orthopaedics 
in November, has devoted her 
career to making up for that 
oversight, fighting for diversity 
in both color and gender in medi¬ 
cal schools and in doctors’ offices. 
Although there has been prog¬ 
ress, she said, there’s still a long 
way to go. 
African-Americans make up 
almost n percent of the popula¬ 
tion but just under 2 percent of 
orthopaedic surgeons, and only 
2.3 percent of orthopaedic sur¬ 
geons are women. And dispari¬ 
ties also extend to treatment: 
Whites, for example, are 2.4 
times likelier to get hip replace¬ 
ments than blacks. Race and gen¬ 
der disparities "are killing people,’’ 
Thomas said. 
Thomas, an assistant profes¬ 
sor of orthopaedics at The Johns 
Hopkins University School of 
Medicine, led a diversification 
effort there that increased the 
number of African-American 
orthopaedic residents to 32 per¬ 
cent. "When you have a diverse 
program," she said, “it becomes 
self-perpetuating eventually.” 
—John Dillon 
How climate change affects 
public health 
In 1967 U.S. Surgeon General 
William Stewart, m.d., announced 
that it was time to "close the book” 
on infectious diseases. There was a 
hitch to that announcement, said 
Mary C. Pearl, ph.d. ’72, at a talk 
in November sponsored by The 
Elihu Club and Tropical Resources 
Institute: “No one alerted the bac¬ 
teria and viruses.” 
The diseases that have since 
emerged are deadlier and more 
expensive to fight, said Pearl, 
president of the Wildlife Trust, 
a conservation science group. 
And more than 61 percent of 
these diseases—including sars, 
avian flu, Lyme disease and West 
Nile virus—have jumped from 
animals to humans. They're also, 
she said, the result of human 
damage to the environment. 
In 2006, the Centers for 
Disease Control and Prevention 
declared climate change to be the 
“largest looming public health 
challenge we face,” she said. 
Among its effects are excessive 
heat that stresses the heart; 
pollution that attacks the lungs 
and heart; water- and vector- 
borne diseases; more frequent 
floods and drought; and more 
environmental refugees, lead¬ 
ing to overcrowding, civil unrest 
and ideal conditions for disease 
proliferation. 
“Emerging diseases originate 
where there are lots of people 
living in rapidly changing ecosys¬ 
tems,” Pearl said. "Biodiversity is 
a buffer.” 
—J.D. 
A single-payer system is best Rx 
in a bad economy 
A single-payer system may be the 
best way to provide health care 
coverage in the United States, 
especially when a faltering econo¬ 
my threatens to increase the 
ranks of the uninsured, an expert 
said at the Medical Student 
Council Perspectives on Medicine 
series in October. 
"The employment-based 
approach is increasingly unwork¬ 
able,” said Gordon D. Schiff, m.d., 
associate director of the Center 
for Patient Safety Research and 
Practice at Harvard’s Brigham and 
Women’s Hospital and past presi¬ 
dent of Physicians for a National 
Health Program. Roughly 47 mil¬ 
lion Americans were uninsured in 
2007, a figure that will surely rise 
due to the credit crunch, Schiff 
said. Half of the nation’s 2 mil¬ 
lion personal bankruptcies were 
due to medical expenses, even 
though 76 percent of those filers 
had health insurance. 
It’s time “people got over this 
bogeyman” of government’s inef¬ 
ficiency at managing health care, 
Schiff said. Whereas up to 40 
percent of premiums in private 
plans are spent on nonmedical, 
largely administrative purposes, 
Medicare and Medicaid spend 
only about 2 percent, he said. 
While a single-payer plan 
"isn’t perfect,” Schiff said, "it is 
the only approach that ensures 
universal health insurance for 
everyone.” 
—J.D. 
Noah Webster—from listing 
definitions to tracking disease 
Noah Webster, a 1778 graduate 
of Yale College, is best known 
for his eponymous dictionaries, 
but his lexicographical work is 
far from his sole achievement. 
Webster was also the largely 
unheralded “father of epidemi¬ 
ology—indeed, father of all 
public health in America,” said 
Curtis L. Patton, ph.d., professor 
emeritus of epidemiology. 
Patton, speaking at a celebra¬ 
tion marking Webster’s 250th 
birthday in October, said Webster 
provided “the base upon which 
modern epidemiology is based, 
warts and all.” The “warts” 
stemmed from Webster’s doubts 
over the theory of contagion and 
his belief that meteors and other 
atmospheric conditions aggra¬ 
vated such outbreaks as the yel¬ 
low fever epidemics he studied 
in the 1790s. 
"We may laugh at all this, but 
we didn’t have any idea about 
disease causation at the time,” 
Patton said. Still, Webster knew 
enough to inoculate himself 
against smallpox and to warn of 
the limited benefits of quarantin¬ 
ing people. 
“He didn’t get everything 
right, but he was conscientious 
and careful” about gathering data, 
Patton said. Webster assembled 
enough of that data to write 
A Brief History of Epidemic and 
Pestilential Diseases (1799), which 
became a standard text in medi¬ 
cal schools in the 19th century. 
—J.D. 
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A tortured soul finds redemption in words 
An 1863 graduate of the School of Medicine 
made his mark as a contributor to the 
Oxford English Dictionary while incarcerated 
with schizophrenia. 
By Jenny Blair 
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above After killing a man in London, William 
Minor was sentenced to an asylum in Broadmoor, 
where this undated picture was taken. 
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from medical school, Minor performed autop¬ 
sies on soldiers at Knight Hospital. He published 
his reports in a book, a copy of which is in the 
Medical/Historical Library collection. 
OXFORD: 
AT THE CLARENDON PRESS. 
1888. 
| Alt rights reserved.] 
Some alumni of the School of Medicine 
make groundbreaking medical dis¬ 
coveries. Some become leaders of medi¬ 
cal institutions. William C. Minor, m.d. 
1863, also left his mark: he developed 
schizophrenia, killed a man and became 
a brilliant linguistic scholar while in an 
asylum for the insane. 
Minor graduated from Yale’s medical 
school, which at that time entailed 
two years’ study, as a qualified surgeon. 
After caring for wounded soldiers in 
the Civil War, Minor began to suffer 
from what would much later be defined 
as paranoid schizophrenia. In 1868 
Minor was admitted to a government 
hospital for the insane in Washington, 
D.C., and released from the Army in 
1870. During a stay in London that was 
intended to rest his mind, he shot and 
killed an innocent passerby while in the 
grip of delusional paranoia. The British 
courts judged him not guilty by reason 
of insanity in April 1872; he was then 
placed in Broadmoor, an asylum in 
Berkshire, England, where he began 
to correspond with the editors of the 
nascent Oxford English Dictionary. He 
soon became an invaluable contributor 
to that effort. The chief editor did not 
learn until years into their collabora¬ 
tion that the brilliant and hardworking 
Minor was a mentally ill prison-hospital 
inmate. Minor’s extraordinary life was 
the subject of Simon Winchester’s 1998 
bestselling history, The Professor and 
the Madman, the principal contemporary 
source of information about Minor. 
After graduating from Yale—his 
handwritten m.d. thesis concerned mus¬ 
cular contraction—Minor performed 
autopsies on soldiers at New Haven’s 
wartime Knight Hospital. A small book 
with his detailed and eloquent 
William Minor contributed to the Oxford English 
Dictionary for years before his editor learned he 
was incarcerated in an asylum for the insane. 
reports is still available at the Medical 
Historical Library along with his thesis. 
Post Mortem Examinations Made at 
Knight U. S. A. General Hospital reveals 
haunting glimpses of Minor’s time. 
Most of his autopsy subjects that year had 
fallen ill in the field with now-unusual 
lung ailments, including typhus, typhoid 
pneumonia, pleurisy and “phthisis,” or 
tuberculosis: but others had succumbed 
to the more familiar “alcoholismus 
acutus” or even to choking. Minor also 
published an article in an 1863 issue 
of Yale’s American Journal of Science 
and the Arts regarding the ability of 
certain worms to regenerate after being 
cut apart. 
Years later his erudition and exacti¬ 
tude would serve him well in Broadmoor. 
In the early 1880s—perhaps nine or 
10 years into his incarceration—Minor 
came across a pamphlet that would 
change his life. It had probably been 
placed in one of the many books 
brought to him by his victim’s widow 
(amazingly, the two had become friends). 
The pamphlet called for volunteers to 
compile what was then called A New 
English Dictionary on Historical Principles. 
Minor threw himself into the task, comb¬ 
ing the rare books in his library, then 
mailing the editors vast numbers of quo¬ 
tations demonstrating the words’ mean¬ 
ings and early appearances in English 
literature. Though Minor was plagued 
by vivid hallucinations and delusions, 
the research suited him well and even 
seemed to serve as therapy. He worked at 
it with great success for some 20 years. 
In his declining years, Minor was 
considered less dangerous, and his 
brother arranged his transfer in 1910 to 
the same hospital in Washington, D.C., 
where he had been kept 42 years earlier. 
It was there that he finally received the 
diagnosis of dementia praecox, an early 
term for schizophrenia. A year before 
his death from pneumonia at age 85, 
he was transferred, still delusional, 
to a home for the elderly in Hartford, 
Conn. Minor was buried in New Haven’s 
Evergreen Cemetery in March 1920. 
His obituary in the Yale press made no 
mention of his crime, stating instead 
that while in England “he was found 
to be mentally deranged ... and [in 
Broadmoor] he remained ... gradually 
recovering his mental balance, and 
devoting his time to scholarly pursuits.” 
Though Minor did not in fact recover 
his mental health, the fruits of his 
scholarship done in the throes of schizo¬ 
phrenia can be found throughout the 
Oxford English Dictionary, a basic refer¬ 
ence work in libraries throughout the 
English-speaking world. 
Jenny Blair, m.d. ’04, is a physician and writer 
based in New Haven. 
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As the medical center 
grows, so grows the city 
The ongoing expansion of the medical center fits in with 
New Haven's own plans to undo past urban renewal mistakes. 
By Jenny Blair 
Photographs by Robert Lisak 
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20 As the medical center grows, so grows the city 
On Saturday, April 19, 2008, a month before she was to gradu¬ 
ate from the School of Medicine, Mila Rainof, m.d. ’08, 
left Harkness Dormitory’s exercise room and began walking 
north on York Street. At South Frontage Road, Rainof began 
to cross against the light. It probably seemed safe: as often 
happens at that corner, a large truck was blocking cars on the 
other side as it crossed South Frontage Road on York Street. 
As the truck cleared the road, though, cars bound for the 
expressway burst from behind the truck. Rainof dodged cars 
in two of the three lanes, but the driver of a sports car in the 
third lane did not see her in time, and Rainof was struck just 
a few feet from the curb. 
Rainof died of her injuries the next day. She was 27. 
The intersection at York and South Frontage is one of 
several around the medical center notorious for close calls. 
Located beside the busy Air Rights Garage, its signals are some 
40 years old, installed at a time when a very different vision of 
the medical center’s neighborhood prevailed. The intersection 
serves as a transition point between three lanes of city traffic 
and an on-ramp to the Oak Street Connector, an expressway 
leading to Interstates 91 and 95. And its traffic flow is fre¬ 
quently impeded by trucks backing in and out of the hospital’s 
loading dock. 
A half-century ago, the intersection would have been 
almost unrecognizable. In the mid-1950s, South Frontage Road 
was called Oak Street and marked the boundary between the 
medical campus and the crowded Oak Street neighborhood— 
home to poor Jews and Italian-Americans as well as newly 
arrived immigrants of every nationality. As part of the ambitious 
urban-renewal agenda pursued by Mayor Richard C. Lee and 
funded by government grants, the neighborhood was razed 
in 1957 to make way for an expressway and two frontage roads. 
The new roads brought more traffic into the city but isolated 
the medical campus and separated downtown New Haven 
from the Hill neighborhood. 
previous pace Oncethought 
to be the epitome of urban plan¬ 
ning, the Route 34 Connector never 
completed its planned path as a 
highway to towns in the Naugatuck 
Valley. Instead it divided New 
Haven, separating the Hill neigh¬ 
borhood from downtown and the 
School of Medicine from the rest 
of the university. Now, armed with 
a fresh vision, New Haven officials 
are planning to fill in the highway 
and build mixed-use developments 
that include retail businesses, office 
space and housing. 
But times have changed. City planners now prefer 
houses and shops to medians and on-ramps. New Haven has 
enjoyed an urban renaissance since the mid-1990s, and a 
series of overhauls proposed by Mayor John DeStefano Jr.— 
new buildings and roads behind the medical school; garages, 
restaurants and shopping at Union Station; a redesign of the 
vast and underutilized Long Wharf area; and a relocation of 
Gateway Community College from Long Wharf to downtown— 
will transform the face of the city as completely as Lee’s proj¬ 
ects did a half-century ago. Bruce D. Alexander, Yale’s vice 
president for New Haven and state affairs and campus devel¬ 
opment, said of Lee’s urban projects, “Unfortunately, as well- 
intended as those dollars were, they got spent in ways that 
[mean] we’re now undoing virtually all of them. The Coliseum, 
Chapel Square Mall, the Oak Street Connector—they’re all 
being undone.” 
A cancer hospital brings change 
When Rainof died, plans were already in the works to fix what 
ails York and South Frontage and n other nearby intersections. 
The catalyst was the Smilow Cancer Hospital. Groundbreaking 
for the 14-story, $467 million building on Park Street and 
South Frontage Road took place in September 2006 after a 
protracted fight between the city and local unions on one side 
and Yale-New Haven Hospital on the other. Expected to create 
500 jobs and inject $1 billion into the local economy, it will be 
the largest health care development in state history, according 
to Steve Merz, the hospital’s vice president for administration. 
(Previously, the Children’s Hospital held that record.) 
“The hospital had to expand,” said Merz. In the past 
10 years, he said, the medical center has seen an increase of 
approximately 20 percent in the number of patients discharged 
from the hospital as well as those seen in outpatient clinics. “The 
demand is unbelievable.” In addition to having a higher patient 
census, the hospital’s cancer facilities are spread out over several 
buildings. Administrators feared that the logistical complexity 
that presented for patients might be among the problems threat¬ 
ening the hospital’s National Cancer Center designation. The 
result was Smilow, along with two ancillary buildings. At 55 Park 
Street, a six-story building will house pharmacy and laboratory 
facilities. And a city-block-sized parking garage called Lot E will 
be built at 2 Howe Street. Some employees who park at the Air 
Rights Garage will be asked to park in the new building instead 
to create space for cancer patients. 
21 
Because of the anticipated extra traffic, the streets around 
the medical center received a significant upgrade. Now a traffic 
circle, or roundabout, at the end of the Oak Street Connector 
diverts cars into and out of the Air Rights Garage, keeping traf¬ 
fic off side streets. A loading dock underneath the garage will 
also direct construction vehicles and delivery trucks directly 
from the highway into the garage. Twelve pedestrian-friendly 
traffic lights along the Frontage Road corridors are being 
installed at intersections, including the one where Rainof died. 
And an extra lane has been added to the expressway’s on- 
ramp to discourage drivers from jockeying for position while 
they merge. The changes will also include such measures as 
improved pavement markings and signage. “We are doing 
everything we can to make it as safe as possible for pedestrians 
at the medical center,” Merz said at a review of the plans in 
August; they are expected to be complete in late spring 2010. 
The hospital is no stranger to injury prevention strat¬ 
egies. It co-sponsored the New Haven Safe Streets educational 
campaign, and its trauma center has been named a member 
site of the Injury Free Coalition for Kids, a National Program 
of the Robert Wood Johnson Foundation developed to prevent 
traffic injuries in the hardest-hit areas of the city. 
With a higher percentage of residents who walk to work 
than any other city in New England, New Haven has much at 
stake, so many residents will be watching the changes closely. 
They include Rachel Wattier, a medical student in her fifth year 
and one of Rainof’s classmates. Shortly after Rainof’s death, 
Wattier and other grief-stricken medical students formed the 
Yale Medical Campus Traffic Safety Group. The group brings 
together university personnel, aldermen, police, bicyclists, 
students and other citizens to seek ways to address such neigh¬ 
borhood traffic problems as speeding cars, drivers who run red 
lights and intersections that are inhospitable to pedestrians. 
“A lot of people’s behavior, both as drivers and as 
pedestrians, is due to frustration and urgency,” Wattier said. 
“[Traffic] fatalities are preventable if you reduce speed particu¬ 
larly, and educate people, and improve the infrastructure so that 
it doesn’t allow people to speed comfortably.” 
If the city has its way, the now-forbidding stretch of 
parking lots, housing projects and such massive institutional 
buildings as the School of Nursing, the Tower One/Tower East 
senior housing and the Doctors’ Building between the medi¬ 
cal school and the train station will soon be unrecognizable 
too. Offices, residences, retail shops, and parking structures are 
planned, as well as a network of new and more pedestrian- 
friendly streets. Dean Robert J. Alpern, m.d., Ensign Professor of 
Medicine, says he’s pleased by the timing, as the medical school 
is considering building in that area in a few years. With the 
street restructuring, he said, the streets will “make more sense.” 
Perhaps the most drastic change to New Haven’s inner 
city will be the proposed removal of the Oak Street Connector, 
also known as the Richard C. Lee or the Route 34 Connector. 
As part of a project called Future Forward, Mayor DeStefano 
hopes to tear out the expressway—which carries tens of thou¬ 
sands of cars each day into the downtown area and the medical 
campus—and replace it with an urban boulevard and 10 acres 
of mixed-use development. Similar changes have taken place in 
Milwaukee, Portland, Ore., and San Francisco. “We’re starting 
to see market demand to push the highway back to 1-95 and 
bring a street grid back into service,” said Michael Piscitelli, 
director of the city’s Department of Transportation, Traffic and 
Parking. (Alpern applauds the idea, saying that the school looks 
forward to “being part of a continuous downtown.”) The city 
received a $5 million federal grant in September to research and 
implement the change, and studies will begin early this year. 
West of the Air Rights Garage, along a corridor where 
Pfizer built a vast research facility for clinical trials in 2004 
and where the Lot E garage will be built, New Haven once 
again owns what was until recently state land. The city has 
begun to hold workshops for local would-be retailers as part 
of its plans to develop what is now mostly a wasteland of grass 
and parking lots between the two frontage roads. 
It wasn’t always a wasteland. The Oak Street Connector, 
the Air Rights Garage and Crown Towers, an apartment build¬ 
ing popular with medical students and residents, sit squarely 
atop what used to be the Oak Street neighborhood. Spreading 
over 11 square blocks with 326 buildings, it was either a rank 
slum or a vibrant inner-city quarter, depending on one’s point 
of view. But by the late 1950s it was marked for destruction. 
The city was remaking itself because of the rise of the 
automobile. A post-World War II jump in car ownership meant 
that people could live far from work; this change, along with a 
trucking boom that eclipsed rail freight, meant that cities faced 
vastly increased motor vehicle traffic even as their downtowns 
lost residents to the suburbs. New Haven was no exception. 
When Lee took office in 1954, he and his city planners 
thought big. Funded by grants—during the mayor’s 16-year 
administration, New Haven received more federal and state 
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22 As the medical center grows, so grows the city 
1 
23 
With very little street-level retail business to 
draw passers-by, the area around the medical 
center (6,7,10-12) offers few enticements for 
pedestrians. With both the School of Medicine 
and Yale-New Haven Hospital contemplating or 
implementing new construction, retail is part of 
the mix, as are upgrades to a dozen intersections 
not known for being friendly to pedestrians. 
Among the changes under way are the Smilow 
Cancer Hospital (3-5) and two ancillary buildings, 
a retail corridor along the grassy median that 
divides Legion Avenue (1-2) and a traffic circle (9) 
that brings vehicles directly from the Route 34 
Connector into the Air Rights Garage (8) and 
keeps them off side streets. 
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24 As the medical center grows, so grows the city 
monies per capita for its urban renewal than any other city in 
America—the city poured hundreds of millions of dollars into 
huge projects like the Connector, the Chapel Square Mall and 
the Coliseum. The dense but threadbare and crime-ridden Oak 
Street neighborhood and its poor and immigrant residents did 
not fit the city’s new image. Moreover, it seemed to city leaders 
that bringing in cars would bring life to downtown New Haven. 
Named for what it replaced, the Oak Street Connector is a 1.1- 
mile spike of concrete that protrudes into the city from the two 
nearby interstates; it was intended to be part of a larger freeway 
that would have extended down Route 34 all the way to the town 
of Derby. The first portion (and, as it would turn out, the last) 
was completed in 1959. In addition to the loss of the Oak Street 
neighborhood, Orange and Temple Streets were severed, the Hill 
neighborhood was isolated, and Yale’s medical campus was sepa¬ 
rated from the main campus. Crossing weedy, glass-strewn side¬ 
walks high above a river of rushing cars has for decades been a 
fact of life for many people at the medical center. 
A new approach to urban planning 
The ideas that drove New Haven’s city fathers to replace a 
neighborhood with a freeway were challenged only a few years 
after it was built. In 1961, Jane Jacobs, an urban activist who 
would become perhaps the most influential thinker about city 
planning in North America, published her landmark book, The 
Death and Life of Great American Cities. In stark contrast to pre¬ 
vailing opinions of the time, Jacobs argued that neighborhoods 
should be mixed-use; that buildings should vary in age and 
purpose; that population should be dense; that people walking 
down sidewalks, sitting on porches and looking out windows 
are all-important for safety and a sense of community; and 
that well-intended gargantuan projects actually worsen urban 
quality of life. Jacobs helped prevent the building of a freeway 
across lower Manhattan and, later, a similar project in Toronto. 
Her ideas are at the root of the urban-planning movement 
known as New Urbanism, whose practitioners include two 
Yale graduates, Andres Duany, m.arch. ’74, and Elizabeth 
Plater-Zyberk, m.arch. ’74, co-founders of the Congress for the 
New Urbanism. The movement began in the early 1980s and 
gave rise to such model towns as Seaside, Fla. Jacobs’ think¬ 
ing also helps to explain why Chicago’s Cabrini-Green and 
similar low-income high-rise housing built in that era later 
failed so spectacularly. 
Inspired by Jacobs’ ideas, many area residents have 
criticized the medical center’s infrastructure. Anstress Farwell, 
m.a. ’79, president of the New Haven Urban Design League 
and a 30-year resident of the city, is one of the most vocal critics. 
She laments the uninviting nature of the medical campus, 
with its blank walls, fences along the sidewalk and parking 
structures. There is little housing and there are almost no 
inviting street-level retail stores—Cappuccino’s, a sandwich 
cafe on Congress and Cedar and the Yale Medical Bookstore, 
are recent exceptions—and no reason for pedestrians to take 
a stroll. There is little neighborhood feel. As with many fea¬ 
tures of the city, this situation can be explained in part by the 
dominance of the automobile. 
In recent decades, Farwell said the hospital has rein¬ 
forced the lack of a street connection “and an over-reliance 
on single-occupancy vehicles. All those driveways and aprons 
define the street as related to cars, with pedestrians as a mar¬ 
ginalized presence.” 
As an example, Farwell points to the Air Rights Garage, 
a joint project of the hospital and the city that bookends the 
terminus of the Oak Street Connector and arches over York 
Street. The walk beneath the garage overpass is a bleak and 
noisy stretch of sidewalk lined by fast-food stores, convenience 
stores, a pharmacy and parked ambulances. Built in 1982, the 
garage was intended to be a partial solution to congestion in 
the surrounding neighborhood and was considered a model for 
mixed-use development in its time. The Temple Street Parking 
Garage, built on similar principles, soon followed. 
“The Air Rights Garage was really the only thing that 
made sense,” said Philetus Holt, a lawyer who shepherded the 
Air Rights Garage to completion. A vanpooling initiative by the 
hospital had had few takers, he said. And the region and city 
lacked a strong public transportation system. “People did not 
want to give up their cars.” 
Merz maintains that the hospital is committed to mixed- 
use development, pointing out that more pedestrian-friendly 
features are planned for its newer buildings. “These leed- 
certified, brownfield-redevelopment, mixed-use projects are 
bringing tremendous economic benefit to the city and medical 
center,” he said. 
In recent years, New Haven builders and residents alike 
have learned from the past. The simultaneous accessions to 
power in 1993 of both Yale’s President Richard C. Levin and 
New Haven’s Mayor DeStefano marked the beginning of a 
warmer town-gown relationship that would transform the city 
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yet again. In an era of reduced city prosperity and slipping 
prestige on the part of the university—it was losing money and 
faculty, its physical plant was in disrepair, and undergraduate 
Christian Prince had recently been murdered during a rob¬ 
bery—Yale began to act as a community developer, initiating 
a homebuyer’s assistance program for its employees and buy¬ 
ing up distressed retail properties on Chapel Street and 
Broadway. This change touched off what the media has called 
the New Haven renaissance. Alexander joined Yale in 1998 
after having worked at the Rouse Corp. on such revitalizing 
projects as Faneuil Hall in Boston and Harborplace in 
Baltimore. Asked to locate the epicenter of the renaissance, he 
points to 15 Broadway, where the New York-style 24-hour delica¬ 
tessen Gourmet Heaven set up shop in 2000 at his invitation. 
Barnes & Noble and the clothing stores J. Crew and Urban 
Outfitters soon followed. To encourage lively sidewalk traffic, 
Yale stipulated that retail tenants remain open until 9 p.m. 
“We now have life and activity and a very comfortable environ¬ 
ment for shopping,” Alexander said. “Whenever we have the 
chance to put shops or restaurants on the ground plane of 
buildings that are on city streets where the campus interfaces 
with the community, we try to build in that retail space.” 
The high-end tenants stayed, and developers elsewhere 
took notice. According to Alexander, Yale’s aggressive retail- 
development policies have had the unintended consequence of 
demonstrating to developers that upscale retail and housing 
could succeed in New Haven. Firms are now bidding on the 
chance to develop, for example, the Shartenberg site, a planned 
mixed-use luxury housing development at the corner of State 
and Chapel streets downtown—a dramatic contrast with the 
beginning of the Levin/DeStefano era, when the city had to 
entice developers with perks. 
“We have a really good partnership with the mayor, the 
city administrators and the Board of Aldermen. There’s so 
much power in Yale and the city working together on projects— 
virtually everyone’s come to that recognition,” said Alexander. 
New Haven has also benefited from the biotech boom. 
Investment in Science Park, a former industrial site, and the 
refitting of the former telephone company building at 300 
George Street with wet labs has ensured that many fledgling 
biotech companies born of Yale research have stayed in the city. 
The replacement of the Oak Street Connector with bou¬ 
levards is expected to bring more life to an already revitalized 
downtown. Such a change would reconnect Yale’s medical 
and main campuses for the first time in a half-century. More 
people may be walking or biking to work, and efforts to reduce 
motor traffic are under way. Under a process called trans¬ 
portation demand management, the hospital offers incentives 
to employees not to drive to work, including vanpools and 
subsidies for public transport. Some 3 percent of employees 
participate, removing hundreds of cars from the road. The 
hospital aims to bring the total to 10 percent. The hospital’s 
new buildings will contain street-level retail stores to encour¬ 
age pedestrian life on the sidewalks. Even the planned Lot E 
garage, whose primary purpose is to house 845 cars, will 
contain not only retail and commercial space but also housing. 
“These are all part of our commitment to responsible, smart 
development,” Merz said. “We’re trying to interact with the fab¬ 
ric of the city a little bit better.” 
The city and the medical center will continue their dia¬ 
logue, it seems certain, for decades to come. The hospital’s 
satellite Long Wharf Medical Center opened in 2000, in a part 
of town that will change drastically if DeStefano’s plans go into 
effect. Some employees commute by public transportation, and 
many more might do so if the commute is simplified. Most of 
all, the city’s plans for Route 34, known as Legion Avenue west 
of the Air Rights Garage, will directly affect the medical center, 
and the gradual change of philosophy in urban planning has 
begun to affect the medical center’s vision of itself. 
“Does this vision of us just [building new facilities] 
down Route 34 make sense—having a long corridor of institu¬ 
tional medical services? That was kind of the old vision,” said 
Merz. But the mayor’s dream of a dense mixed-use inner city 
has advantages for the medical center, he said. The reasons 
for that are straight out of fane Jacobs: fewer cars; more retail 
enterprises; a livelier human presence on the sidewalk; and 
better relations with out-of-town visitors and community dwell¬ 
ers alike, who will see a pleasant downtown rather than a grim 
expressway as their welcome to the medical center, ym 
Jenny Blair, m.d. ’04, is a physician and writer based in New Haven. 
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Science and culture in a 
strange land 
As the world gets smaller, the Committee on International Health asks 
whether Downs fellows can find a foreign experience at home. 
By John Dillon 
Illustration by Calef Brown 
In 1966, when the medical school first began offering inter¬ 
national fellowships to medical and public health students, 
the typical fellow was a young man getting his first passport. 
Today’s fellows are much more diverse—they are as likely to 
be female as male, six of the 20 fellows who went abroad in 
2008 weren’t native-born Americans, and because they came 
of age in the era of affordable air travel, all have previously 
visited a foreign country. 
“The profile of the student now interested in getting the 
fellowship has changed,” said Kaveh Khoshnood, m.p.h. ’89, 
ph.d. ’95, assistant professor of epidemiology (microbial dis¬ 
eases) and chair of the Committee on International Health (cih), 
which administers the Downs International Health Student 
Travel Fellowship. “Forty years ago, it was a lot of white kids from 
Kansas who’d never been outside the United States.” 
As the student body changes, the fellowship program 
faces an emerging challenge: balancing the relative importance 
of taking a culture versus taking in a culture. As more people 
come to the United States as refugees or immigrants, do stu¬ 
dents have to travel abroad to gain foreign experience? 
The late Wilbur G. Downs, m.d., m.p.h., a renowned 
Yale virologist, started the fellowship program with the idea 
that students should have a chance to do research in the Third 
World, where their work could do the most good. His experi¬ 
ences in Africa had left him with the deep understanding that 
poverty, malnutrition and infectious diseases, combined with 
the corruption often seen in single-party nation-states, lead to 
grave health consequences. Students would find a Yale mentor 
and a mentor in the host country, travel somewhere they’d never 
been—typically to Asia, Africa or Latin America—and con¬ 
duct rigorous and ethical scientific research. Downs felt that 
they should immerse themselves in the culture during their 
stay, but the program’s new director, Khoshnood, wants to take 
a fresh look at what it means to explore a different culture. 
A longstanding foreign imprint 
Yale alumni, faculty and students have embarked on inter¬ 
national health missions since 1834, when Peter Parker, m.d., 
a medical school graduate and missionary, established the 
Ophthalmic Hospital in Canton (now known as Guangzhou), 
the first Western hospital in China. In 1915 the Yale-China 
Association opened another hospital in Changsha. After World 
War II, medical school faculty were active in the Atomic Bomb 
Casualty Commission’s epidemiological studies in Japan. When 
Yale President Kingman Brewster established a program to send 
students abroad in 1965, Downs secured a $5,000 grant from 
the Rockefeller Foundation to launch the fellowship. Since then 
the program has sent 444 Yale students to scores of resource- 
poor nations and has expanded to include nursing and physi¬ 
cian associate students as well as those from the schools of 
medicine and public health. 
Downs fellows have studied diseases spread by sand 
flies in Peru, hiv transmission among drug users in Vietnam, 
the eating disorder pica among Haitian women of childbearing 
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28 Science and culture in a strange land 
age, and post-traumatic stress disorder (ptsd) among survivors 
of war in East Timor. Though he retired as a professor of epi¬ 
demiology and public health in 1972, Downs remained 
committed to the program until his death in 1991. Curtis L. 
Patton, ph.d., professor emeritus of epidemiology, longtime 
friend, colleague and traveling companion of Downs, took over 
as cih chair until his retirement in 2006. 
“We like to think of it as one of our flagship programs," 
said Paul D. Cleary, ph.d., dean of public health. “We’re proud 
of it, and we try to bolster and promote it.” 
According to Khoshnood, however, the program needs 
to adjust to the changing demographics of the students. As 
an Iranian-American, he personifies the change not just in the 
program, but also in Yale and in academia, where minorities 
make up an increasing portion of the student body. 
“Global health could mean practicing outside the United 
States, but it could also mean working with the immigrant 
population in the United States,” he said. 
He also thinks that the fellowship needn’t be limited to 
developing countries. “We’re not going to send you to the capi¬ 
tals of Europe,” he said, but he sees nothing wrong with, say, 
a Downs fellow working with North African refugees in Spain. 
“I tell the students that this Is a 
great project if you have five 
years and $500,000, but you have 
three months and $5,000.” 
“What if a student wants to go live among them to see if they 
have health issues? These scenarios were raised. We decided to 
table that this year because we couldn’t reach an agreement.” 
And Khoshnood hopes to rethink the program’s reluc¬ 
tance to send students to ancestral homelands or countries they 
already know. “The fact that they are familiar with the culture 
and language is a good thing," Khoshnood said. “Their research 
would benefit from this existing knowledge.” 
One of Khoshnood’s students, Farnoosh Hashemian, 
m.p.h. ’05, a 2004 Downs fellow, convinced the cm to let her 
travel to her native Iran to study the mental health of Kurds 
exposed to chemical weapons during the Iran-Iraq war of 
1980-1988, noting that she would benefit culturally because 
she grew up in Tehran and her work was in the rural Kurdish 
region, a far cry from the life she knew. “Iran is not a homo¬ 
geneous country,” she said. Her work, which found high 
levels of ptsd among those exposed to chemical weapons 
even 16 years after the war ended, was published in 2006 in 
JAMA: The Journal of the American Medical Association—a rare 
feat, Khoshnood said, for a project done in only two months 
and on a shoestring budget. 
Tim Mercer, an m.p.h. candidate and 2008 Downs fel¬ 
low, argued that his two previous trips to Kenya would help 
him to do research there on the lives of street children. “The 
more you visit a foreign place, the more you learn about the 
culture, the more entrenched in it you become,” he said. 
Patton acknowledged that familiarity can help, but 
added, “This is not a fellowship to visit aunts or uncles.” 
The debate continues. Some longtime committee mem¬ 
bers regard the cultural experience as sacrosanct. According to 
Herbert S. Sacks, m.d. ’52, hs ’56, clinical professor in the 
Child Study Center, and a founding member of the cih, one 
goal of the program is to get students out of what he called 
“academic lockstep.” 
“We give them an opportunity to start looking at them¬ 
selves and to reflect about their goals,” Sacks said. “What 
better opportunity to do this but in a contrasting culture? One 
of the questions is, ‘Why do you have to go to Zambia? Why 
not just go to the ghetto areas in New Haven, Bridgeport or 
Hartford?’ I think it’s too easy to go to these areas and work 
eight hours a day and return to your buddies and the routine 
of everyday academic life.” 
Nicole Britten, an m.p.h. candidate whose 2008 Downs 
fellowship took her to Colombia to study tuberculosis trans¬ 
mission among family members, said a balance is crucial. “It 
would be wrong to sacrifice scientific rigor for cultural experi¬ 
ence, but it would be disappointing to have a rigorous project 
with no cultural experience,” she said. Britten said she was 
struck by the hospitality of even her most destitute subjects in 
Colombia. While she required an interpreter for her research, 
“I have also learned how far body language and facial expres¬ 
sions can go in putting a person at ease when talking about 
sensitive issues.” 
Sending students to do research in resource-poor coun¬ 
tries also helps them learn to think on their feet in the face of 
power failures or inadequate water and medical supplies. Erik 
Hett, m.p.h. ’00, who studied disease transmission by tsetse 
flies in Kenya in 1999, learned to trap the flies by putting jars 
near water buffalos, whose scent attracted the insects. He and 
a colleague were extracting dna from the flies with a centri¬ 
fuge when the electricity in their village failed, threatening to 
wipe out their entire day’s work. They drove 20 minutes before 
finding the only working generator in town, at a beauty salon. 
“There were four hairdressers and a few patrons, and we had a 
centrifuge on their only table,” he recalled. 
“We can’t imagine the things they have to deal with,” 
Patton said. “Research has been done on the hood of a car. 
They have to be resourceful.” 
Safety and culture shock 
Each trip by a Downs fellow starts with a research proposal 
submitted in January and reviewed by a Yale mentor. The 
Human Investigation Committee then reviews the proposal to 
ensure that it meets criteria for protecting research subjects. 
Proposals must also pass muster with institutional review 
boards in the host country, which provides yet another lesson, 
this time on how to navigate a foreign bureaucracy. Then the 
Downs committee interviews the student. “They’re not going 
to get exposed to stressful interviews, but the questions are 
designed to help them further refine their proposals and clarify 
their motivations,” Sacks said. 
Khoshnood notes that the final proposals are often far 
removed from the original submissions. “I tell the students 
that this is a great project if you have five years and $500,000,” 
he said, “but you have three months and $5,000.” 
“As young people, we have grand ideas of what we’re 
capable of doing,” said Patton. 
The awardees are announced in early March; last year 
27 students applied for the 20 available fellowships. 
The student must also find a mentor at an academic 
institution or organization in the host country. Often the on¬ 
site mentor is found through personal relationships with Yale 
faculty, and sometimes at the last minute. Khoshnood would 
like to develop “more sustained and long-term partnerships 
with a few institutions rather than one-time student projects.” 
Funding for the fellows’ two- to three-month stays comes 
not just from the Downs fellowship—an endowment that 
covers travel expenses, visas, insurance, immunizations and 
medications and provides a modest stipend—but also from the 
School of Medicine’s Office of Student Research, which pro¬ 
vides an additional $5,000 for research expenses. [See “Downs 
Fellows Cover the World,” p. 39.] 
In 2008 the cih had all applicants take the extra step of 
filling out a one-page statement about how they would protect 
themselves. They needed to learn not only about the political 
climate and the history of the country but also whether there 
were any disease outbreaks that could affect them. They also 
needed an alternate plan in case their first proposal doesn’t 
work out. “We’re not hovering parents, to say the least, but we 
want to make sure we’re not putting anyone in the lion’s 
mouth,” Sacks said. 
“We put them through the hoops of attending to their 
own affairs,” Patton said. “There are things they may not have 
thought of when they first applied, like how to protect yourself 
with words.” 
Food riots in Haiti last summer diverted nursing student 
Eden Garber from her plan to conduct nutritional assessments 
of children there. “It was a bit frustrating,” said Garber, 
who had been studying Creole for two years. After some last- 
minute revisions to her application, she was off to Uganda. 
“Uganda wasn’t on my list of places I want to go before 
I die,” Garber said. Still, she fell in love with the country and with 
the people she worked with. 
Safety is not the only issue confronting Downs fellows. 
Among the elements of culture shock is the realization that they 
often stand apart from the local population. “I was constantly 
hissed at in the street and received a lot of attention from men,” 
said nursing student Jessica Pettigrew, who worked with Haitian 
refugees in the Dominican Republic after the food riots stymied 
her plans to go to Haiti. “Everyone turned and stared at me, so 
I was constantly riddled with a certain self-consciousness. When 
I was doing my fieldwork in the sugar cane fields, there was this 
assumption that we could heal and help everyone.” 
Hett didn’t enjoy being gawked at while he studied tsetse 
flies in Kenya, but he recognized its sometimes discomfiting 
“We can't imagine the things 
they have to deal with.... 
Research has been done on the 
hood of a car.” 
perks. “You get treated like royalty for no reason. Just the color 
of your skin opens up doors,” he said. “It puts you in sort of an 
awkward position. You want to try to get to know people, but I 
guess you could never cross that barrier to get to really know them.” 
Although Rosha Forman, a nursing student who studied 
the practices of midwives in Zambia in 2008, found friends 
quickly in the expatriate community, that wasn’t why she’d 
gone there. “My challenge was to not fall into easy friendships 
with foreigners, but instead to work at my friendships with 
Zambians, as those were the people I was coming to get to 
know,” she said. 
The complexities of foreign research are nothing new. 
One of the earliest Downs fellows, Leonard M. Milstone, m.d. 
’70, hs ’77, research scientist and professor emeritus of derma¬ 
tology, went to Trinidad in 1967 to trap mosquitoes and isolate 
arboviruses. Because English was the common language 
and the Caribbean island was not as poor as other developing 
nations, Milstone said he didn’t experience the disorienta¬ 
tion other Downs fellows have described. The next summer, 
however, Milstone traveled to a Native American reservation 
in New Mexico for a non-Downs research project. Although 
in both locations he lived in Western-style housing and ate 
Western food, he found the Trinidad experience less culturally 
challenging in a way that presages Khoshnood’s approach to 
cultural immersion. “I found the culture on the Indian reserva¬ 
tion in New Mexico far more foreign than the culture I experi¬ 
enced in Trinidad,” Milstone said, ym 
John Dillon is a freelance writer in New Haven. 
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The lost art of the 
physical exam 
Physicians once relied on seeing, hearing 
and touching a patient to make a diagnosis. 
Technology has enhanced and sometimes 
replaced those skills, but many doctors 
lament their decline. 
By Jill Max 
Photographs by John Curtis 
It was a perplexing case: An otherwise healthy 23-year-old man 
was hospitalized with a life-threatening pulmonary embolism, 
but doctors had no clue as to what had caused it. The patient 
underwent every diagnostic study they could think of—CT 
scan, consultation with a hematologist, a coagulation work¬ 
up—but all were negative. Mystified, his doctors recommended 
anticoagulation medication, but it would mean an end to the 
weight lifting, swimming and running that he enjoyed. Still, 
because he didn’t want to risk another serious blood clot, he 
was faced with taking anticoagulants for the rest of his life. 
Luckily, a light bulb went off when Thomas P. Duffy, m.d., 
examined the young man. Noticing that his patient was very 
muscular, Duffy, professor of medicine (hematology), had an 
idea what the problem might be. To confirm his suspicions, 
he performed a simple test known as Adson’s maneuver: With 
the patient’s arm straightened, Duffy placed a finger over the 
pulse at the wrist and then moved the arm behind the young 
man’s back. When he asked the patient to turn his head, the 
pulse disappeared; when he looked forward, the pulse returned. 
During a preclinical clerkship, 
“Learning the Physical Exam,” in 
January 2007, Allison Campbell, 
then a first-year student, peered 
into the ear of classmate Tyler 
Dodds. The course takes students 
through various forms of the 
physical examination. 
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32 The lost art of the physical exam 
Duffy deduced that the man was suffering from thoracic outlet 
syndrome, a compression of the blood vessels beneath the collar¬ 
bone that cuts off blood flow to the arm. Surgery repaired the 
problem, and a few months later the young man suspended 
anticoagulation therapy and resumed his workouts. 
By all accounts, such maneuvers as the one Duffy per¬ 
formed are becoming a rarity in medicine. Time pressures, 
an increasing reliance on technology and limited opportunities 
for bedside teaching have contributed to the demise of the physi¬ 
cal exam. “Diagnosis time has been reduced to the time it takes 
to order an X-ray,” said Lisa Sanders, m.d. ’97, hs ’01, assistant 
clinical professor of medicine and author of “Diagnosis," a 
monthly column in The New York Times Magazine. “The physi¬ 
cal exam will die completely or it will be resuscitated.” 
Bedside diagnosis in Western medicine 
Clinical observation has been a part of medicine since 
Egyptian, Babylonian, Chinese and Indian physicians began 
examining the body thousands of years ago. Clinical rea¬ 
soning and bedside diagnosis first played a role in ancient 
Greece when Hippocrates began measuring body tem¬ 
perature, evaluating the patient’s pulse and palpating the 
abdomen. But it wasn’t until the 19th century that physical 
diagnosis exploded, with such developments as percussion 
and auscultation—the tapping and listening that physicians 
still practice. Sir William Osier, m.d., often described as 
the father of modern medicine, told his students: “He who 
studies medicine without books sails an uncharted sea, 
but he who studies medicine without patients does not go 
to sea at all.” Medical school faculty continue to dole out such 
advice to their students today. 
Although certain diagnostic skills have been under fire 
since a paper presented to the American Medical Association 
in the 1950s discussed the inability of doctors to recognize 
some clinically relevant heart sounds, during the last two 
decades or so physical exam skills have fallen by the wayside. 
“We have technology that allows us to see things we could 
never see before, hear things we could never hear before. 
So in a sense technology has expanded our ability to replace 
a certain sector of the examination with either visual data 
or other kinds of data that weren’t available to us,” said 
Asghar Rastegar, m.d., professor of medicine, who recently 
stepped down as associate chair of medicine after 15 years, 
icu patients, for example, get daily chest X-rays because it’s 
difficult for them to sit up, cough and participate in other 
maneuvers that are necessary for a complete chest exam. 
Although new technologies allow doctors to explore 
parts of the body that they can’t examine any other way, they 
don’t give the whole picture. They can’t feel where an abdomen 
is tender, discern clues from the look on a patient’s face or 
focus on a particular area because of how it feels or what the 
patient says. “The ability to decide by touching the patient and 
examining carefully what the appropriate technologies are to 
diagnose the patient allows technology to become an extension 
of what I’m doing rather than a replacement,” said Rastegar. 
The problem with technology arises when doctors rush 
to order tests without first performing a thorough physical 
exam. Rastegar noted that patients presenting with a change 
in mental status in the emergency department frequently 
undergo a CT scan, which turns out to be normal, only for 
the doctors to find out later that the patients had overdosed 
on a prescribed medication. Doctors may be overly reliant on 
tests because they have confidence in the results; however, 
tests aren’t always accurate. Lyme disease patients, for exam¬ 
ple, often have the classic signs of rash, fever and muscle 
aches, yet the blood test is often negative. “Everyone wants 
to just turn to the back of the book and look up the answer,” 
said Sanders. Tests, she added, are just one more piece of evi¬ 
dence that has to be interpreted by a doctor. 
Physical exams and other tests 
Doctors like Duffy and Sanders, who are experts in the physi¬ 
cal exam and use it regularly, suggest that it can be a valuable 
guide in deciding which tests to order and letting specialists 
know where to concentrate their efforts. “However,” said Aldo 
Peixoto, m.d., associate professor of medicine (nephrology) 
and co-author of Bedside Diagnosis: An Annotated Bibliography 
of Literature on Physical Examination and Interviewing, “it’s 
important to identify items of the exam that are relevant, ask 
questions and use technology to answer the questions about 
how valid and how valuable these maneuvers are.” This, he 
added, allows for optimal use of the physical exam and more 
selective use of technology. Studies have consistently shown 
that the patient’s history and physical are the most important 
factors in arriving at a correct diagnosis, whereas lab tests and 
imaging studies play complementary roles, and that excessive 
reliance on technology hasn’t necessarily improved the quality 
of patient care. 
The tendency to order a series of diagnostic tests, how¬ 
ever, may be a symptom of a larger problem—namely, the lack 
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of time physicians have to devote to their patients. Doctors are 
under pressure from insurance companies to keep exams brief. 
Moreover, the 8o-hour work week for residents means that 
attendings have more clinical responsibilities and less time for 
individual patient care. Ever-shorter hospital stays also affect 
the amount of time doctors spend with each patient. Those 
who were trained before 1980 remember that longer hospital 
stays meant more exposure to patients and unhurried exami¬ 
nations of patients for both residents and physicians. “In my 
generation a patient might be in the hospital for two weeks 
and might educate an entire group of students,” said Duffy. 
Doctors are further removed from their patients because 
rounds have virtually disappeared from the bedside. Patients 
are often discussed at “chart rounds” around conference tables 
due to both a concern for efficiency and respect for patients’ 
privacy. But that change translates to a generation of physi¬ 
cians who have not been as widely exposed to the physical 
exam and are less accustomed to using it. “In an ideal world 
you would be expected to use what you find on a physical exam 
to make clinical decisions, but in practice we very rarely do,” 
said Allison Arwady, m.d. ’08, a resident in medicine and pedi¬ 
atrics. Arwady learned the value of the physical exam during 
a clinical rotation at Mulago Hospital in Kampala, Uganda, 
between her third and fourth years of medical school. She saw 
patients given blood transfusions based on their pallor alone, 
without ever having a complete blood count. “We’ve lost a lot of 
skill here for finding and acting on these things,” she said. 
About 13 years ago, Andre N. Sofair, m.d., hs ’90, 
m.p.h. ’97, associate professor of medicine, realized that the 
teaching that had stuck with him most had taken place at the 
I bedside, not at the blackboard. So he initiated weekly physi¬ 
cal diagnosis rounds for residents and medical students at 
Waterbury Hospital. Sessions take place at the bedside with 
everyone participating, including the patient. Sofair hopes 
to prepare his students for those times in the middle of the 
night when they won’t be able to ask an attending’s advice 
or depend on technology for a diagnosis. For Samit Joshi, 
d.o., m.p.h., hs ’08, an infectious-disease fellow who did his 
residency in Yale’s primary care program and was in Uganda 
with Arwady, being able to identify a problem when you don’t 
have access to a CT scanner or transthoracic echocardiogra¬ 
phy machine highlights why it’s so important to gain profi¬ 
ciency in the physical exam. “You have to rely on a detailed 
neurological or cardiovascular exam or just putting your 
Clinical instructor Jon Fessel guided 
first-year students Isaac Benowitz 
and Nicole Cabbad in the eye exami¬ 
nation in January 2007. The School 
of Medicine has taken several 
steps to reinforce the importance 
of the physical exam—a survey of 
graduates in 2002 found that many 
had never been observed taking a 
history and doing a physical. 
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34 The lost art of the physical exam 
1 
Instruction in the physical exam 
starts in the gross anatomy course 
taken by all first-year students. 
Working with instructors in the 
physical exam course, students 
learn the body’s external land¬ 
marks that will guide them when 
working with patients. In the fall 
of 2008, students Ferrin Ruiz and 
Anant Vasudevan received instruc¬ 
tion from Harry Briggs and Cheryl 
Walters, director of the physical 
exam training course. 
hands on the patient," he said. “That’s faster than getting a 
test result back.” 
It’s also less expensive. Insurance companies are begin¬ 
ning to clamp down on such costly tests as mris unless a physi¬ 
cal exam or some other finding justifies them. It’s a position 
that’s hard to argue with: it’s been estimated that approximately 
80 to 85 percent of diagnoses can be reached via the history 
and physical. But economics aside, there is an intangible ben¬ 
efit to the contact afforded by the physical exam. A physician 
might spend two hours looking at a peripheral blood smear 
or one hour discussing a patient’s case during chart rounds, 
but the patient isn’t aware of those efforts. “Just putting your 
hands on the patient—talking to them while examining 
them—can go a long way in establishing and building a good 
doctor-patient relationship, because the patient thinks you’re 
more attentive to who they are as a person and what their under¬ 
lying diagnosis is,” said Joshi. 
Learning the physical exam 
Medical school would seem the logical place to learn the art 
of the physical exam, but until the late 19th century, most 
U.S. medical schools included virtually no instruction in clini¬ 
cal medicine. It was in 1893, with the opening of The Johns 
Hopkins Hospital in Baltimore, that clinical instruction was 
established as a formal component of medical school cur¬ 
ricula. Osier was a pioneer in this area, advocating clinical 
demonstrations in the third year of medical school and clini¬ 
cal clerkships in the fourth. The current model came into use 
in the 1950s, with schools moving the clerkships to the third 
year and the fourth year devoted to hospital rotations. But 
because these experiences varied so much from institution 
to institution, clinical education came under closer scrutiny. 
Between the 1980s and the early 1990s, five major reports 
focusing on the quality of medical education were issued— 
three by the Association of American Medical Colleges 
(aamc), one by the American Medical Association and one 
by the Josiah Macy, Jr. Foundation—all of which highlighted 
the need to improve clinical skills education. 
Curriculum reform has indeed taken place, although 
it is mostly limited to the first two years of medical school, 
which has traditionally focused on basic science. In 2002, 
about 24 percent of U.S. medical schools included formal 
clinical skills courses, while only 4 percent included such 
courses in the clinical years. During the last five years, there 
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has been a trend toward integrating clinical skills into the 
medical school curriculum, to the point where physical exam 
courses are now required at virtually every medical school in 
the United States, according to M. Brownell Anderson, m.ed., 
senior director for educational affairs at the aamc. “There’s a 
much earlier interaction with patients, trying to make what is 
being learned in the basic science courses correspond to physi¬ 
cal findings,” she said. Students at some schools interact 
with patients in the first few weeks of medical school, while 
others are assigned to patients or families whom they follow 
throughout their four years. Medical schools are also using 
standardized patients (individuals who are trained to follow a 
scripted clinical scenario), a practice that allows students the 
opportunity to learn communication skills along with physi¬ 
cal exam skills. 
Yale is trying to reinforce physical exam skills in a 
number of ways, especially after a survey of graduates in 2002 
revealed that many had never been observed while they took 
a patient history and performed a physical. “A lot of them felt 
ill-equipped, specifically in the focused physical exam, focus¬ 
ing in on an area based on a patient’s chief complaint or 
chief symptom,” said Cheryl A. Walters, m.d., assistant clini¬ 
cal professor of medicine and director of the physical exam 
training course, in which pairs of students work with an 
instructor. Students learn how to perform focused exams of 
organ systems and a sequential head-to-toe, or comprehensive, 
physical examination. Walters also directs the Clinical Skills 
Assessment Program begun in 2003, which evaluates stu¬ 
dents’ skills at the end of their third year in 20-minute visits 
with seven standardized patients. “We have come a long way 
since the teaching model of presenting cases in a conference 
room,” Walters said. “It’s like learning to drive a car. Would 
you show learners complicated skills once, send them out 
alone to practice, and then have them report back on how they 
thought they did?” The students’ comments echoed the results 
of a study Walters published in 2001 that evaluated the physical 
exam skills of more than 2,000 third-year students from eight 
medical schools. Most students, the study found, omitted three 
out of 10 maneuvers critical in evaluating a patient with short¬ 
ness of breath and chest pain. Walters’ course and the assess¬ 
ment program were developed as part of a revamped clinical 
skills program that also includes medical interviewing and 
such courses as end-of-life care and psychosocial skills. These 
courses have moved away from a lecture format to small- 
group, hands-on sessions that give the students an opportu¬ 
nity to practice what they are learning. “We have to work hard 
to reinforce both the approach to patient care and the specific 
physical exam skills that are taught in the preclinical years 
to show students their usefulness and effectiveness at the 
bedside,” said Richard Belitsky, m.d., deputy dean for educa¬ 
tion and the Harold W. (ockers Associate Professor of Medical 
Education. In fact, clinical skills education begins with the 
first anatomy lab, when students work with instructors from 
the physical exam course to locate external landmarks that 
will ultimately help them when they examine patients. 
In a cohort study she completed in 2006, Walters found 
that students in all four years of medical school reliably per¬ 
form the maneuvers on the comprehensive physical examina¬ 
tion. But by the time they enter their clinical years, students 
aren’t as good at employing additional maneuvers that can rule 
in or rule out specific diagnoses. Teaching and learning, 
Walters suggests, may be improved by stressing in the third 
and fourth years the importance of these maneuvers. 
During the first two years of medical school, students 
are a captive audience, but once they begin clerkships and elec¬ 
tive rotations, it is harder to incorporate formal clinical instruc¬ 
tion into their training. Yale has expanded its clinical skills 
program into the third year with such courses as “Breaking 
Difficult News” and “Counseling for Behavioral Change.” 
At the same time, Belitsky is looking for ways to bring more 
of the skills program into the clerkship, including direct obser¬ 
vation of students taking histories and physicals during their 
clinical years of medical school. 
Efforts to ramp up medical students’ clinical skills train¬ 
ing are well timed. After a 40-year hiatus, the United States 
Medical Licensing Exam (usmle) in 2004 added a clinical 
skills component, which had been discontinued in the 1960s. 
The one-day test involving 10 standardized patients is meant 
to reflect a doctor’s typical workday and aims to measure the 
ability of medical students to deal with a variety of patients in 
clinical settings. 
Whether efforts by the usmle, Yale and other academic 
institutions will have an impact on reviving physical exam 
skills remains to be seen. But it’s hard to deny the importance 
of learning those skills and having an opportunity to practice 
them again and again if they are to remain useful. “Medicine 
is learned by the bedside and not in the classroom. Let not your 
conceptions of disease come from words heard in the lecture 
room or read from the book. See, and then reason and compare 
and control,” Osier told his students. “But see first.” ym 
Jill Max is a freelance writer in Trumbull, Conn. 
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36 Faculty 
Asghar 
Rastegar 
A master clinician 
takes on new post 
When Stephen J. Huot, M.D., pro¬ 
fessor of medicine, decided to 
organize a symposium in honor of 
ASGHAR RASTEGAR, M.D., he had 
to fight fierce resistance from the 
honoree himself. “I got an e-mail, 
a phone call [asking me not to],” 
Huot said of the famously humble 
nephrologist, who is stepping down 
as associate chair of medicine to 
serve as co-director of the inter¬ 
national health program. 
In the end, though, Rastegar 
acquiesced. The result was a series 
of tributes from fellow physicians 
celebrating his life, character and 
achievements, with accolades 
ranging from “master clinician” 
to “humanist extraordinaire.” 
Huot, who replaced Rastegar as 
associate chair, traced Rastegar’s 
career from college and medical 
school in Wisconsin and residency 
in Pennsylvania to leadership roles 
at the medical school of Pahlavi 
(now Shiraz) University in his 
hometown of Shiraz, Iran, to Yale. 
Majid Sadigh, m.d., associ¬ 
ate professor of medicine, who 
trained under Rastegar at Shiraz, 
said that Rastegar’s "boundless 
energy” was among the reasons 
the university’s prestige sky¬ 
rocketed in the 1970s. Sadigh 
then gave a spellbinding account 
of not only the complexities of 
practicing medicine in resource- 
poor Iran, but also the violence 
and strife during the Iranian 
Revolution. Rastegar, a democ¬ 
racy activist, left Iran in 1982 
after having been jailed briefly. 
“Why,” Sadigh asked upon seeing 
his mentor imprisoned, “are they 
taking a hero to jail?” Two years 
later, Sadigh and his family were 
refugees themselves, living in a 
camp in Rome, when Rastegar 
secured him an internship in the 
United States. 
Michael 
Kashgarian 
Since joining Yale, Rastegar has 
made wide-ranging contributions 
to residency training, medical stu¬ 
dent education and the education 
of physician associates. “He is 
passionate about his commitment 
to improving the educational 
environment and comfortable 
undertaking the political conver¬ 
sations that need to happen in 
order for that to occur,” said Huot. 
Cary V. Desir, M.D., professor of 
medicine, added that Rastegar’s 
"unyielding desire to help those 
who are less privileged ... will be 
his most long-lasting legacy.” 
At the symposium’s close, 
Rastegar said that he has led a 
“phenomenally privileged life.” 
When he returns to the city of 
Shiraz, he said, he always visits 
the man who ignited his love 
for reading—a bookseller, now 
85, who allowed the 8-year-old 
Asghar to borrow books. He 
acknowledged Donna McCurdy, 
M.D., his mentor at the University 
of Pennsylvania, who allowed 
him to “imagine what I could be”; 
Samuel O. Thier, M.D., former 
chair of medicine, who urged 
him to come to Yale; and Frank 
Bia, M.D., a former professor of 
medicine, and Margaret Bia, M.D., 
professor of medicine, who were 
his interns when he was chief 
resident in Pennsylvania, and who 
helped him build a new life in 
the United States. “My career 
is indebted to people,” he said, 
“who took a chance on me.” 
Pathologist honored 
with symposium 
MICHAEL KASHGARIAN, M.D. ’58, 
HS ’63, was the centerpiece of a 
Yale symposium in October, but the 
words of praise for him wouldn’t 
have been out of place at a fete 
in Hollywood or Cooperstown: 
“a real icon,” a “Renaissance man 
equally at home in town or coun¬ 
try” and “a triple threat.” 
Kashgarian, professor emeritus 
of and senior research scientist in 
pathology, was honored for his 50 
years at the forefront of research 
on kidney disease. At Yale he estab¬ 
lished a diagnostic renal pathology 
and electron microscopy laboratory 
that bears his name. Kashgarian 
was also a pioneer in understand¬ 
ing the process of organ rejection. 
Jon S. Morrow, PH.D., m.d. ’76, 
HS ’77, department chair and 
the Raymond Yesner Professor 
of Pathology and professor of 
molecular, cellular and develop¬ 
mental biology, and a colleague of 
Kashgarian for 30 years, said that 
his “infectious” fascination with 
renal disease inspired others. “He’s 
been a real icon,” Morrow said. 
“He’s profoundly affected the prac¬ 
tice of physiology.” 
Echoing Morrow, former Dean 
Gerard N. Burrow, m.d. ’58, called 
Kashgarian “really a pathological 
triple threat” as a clinician, inves¬ 
tigator and teacher. A skilled 
fisherman, wine expert and bridge 
player, Kashgarian was also a 
beacon outside the classroom. 
“The New York City background 
disappeared into a Yale country 
gentleman,” said Burrow, a friend 
since medical school. 
Although Kashgarian retired in 
July, he continues to work, complet¬ 
ing his remaining research grants. 
He will also continue to serve as 
editor in chief of Yale Medicine. 
Arthur 
Horwich 
Genetics professor 
named to iom 
ARTHUR L. HORWICH, M.D., HS 
’78, the Eugene Higgins Professor 
of Genetics and professor of pedi¬ 
atrics at the School of Medicine 
and a Howard Hughes Medical 
Institute investigator, was elected 
to the Institute of Medicine (iom), 
the National Academy of Sciences 
announced in October. He was one 
of 65 people recognized last year 
by the academy for outstanding 
professional achievements in the 
fields of health and medicine. 
Horwich is an expert on the 
molecular mechanisms of protein 
folding, a process crucial to the 
maintenance of life. When proteins 
misfold, they can aggregate into 
plaques and lead to a variety of 
diseases. More than 20 diseases, 
including such neurodegenerative 
disorders as Alzheimer disease, have 
been linked to misfolded proteins. 
The IOM election was the 
second major honor in a week for 
Horwich, who was also awarded 
the 2008 Louisa Gross Horwitz Prize 
by Columbia University for out¬ 
standing contributions in biology 
and biochemistry. Horwich shared 
the prize with F. Ulrich Hartl, M.D., 
ph.d., of the Max Planck Institute 
of Biochemistry in Germany, and 
Rosalind Franklin, ph.d., who was 
honored posthumously for her work 
on the discovery of the structure 
of dna. Horwich and Hartl were 
honored for their contributions to 
the understanding of the molecu¬ 
lar mechanisms of protein folding. 
NOTES 37 
Benjamin 
Bunney 
Portrait of psychiatry 
chair unveiled 
BENJAMIN S. "STEVE” BUNNEY, 
M.D., professor emeritus and for¬ 
mer chair of psychiatry, returned 
to Yale in October from his home 
in coastal Maine for the unveiling 
of his portrait and a celebration 
of his 20 years as chair. 
“Steve was always a voice of 
clarity and rationality and steadi¬ 
ness,” said William H. Sledge, M.D., 
the George D. and Esther S. Gross 
Professor of Psychiatry, recalling 
a tumultuous time in the depart¬ 
ment some 21 years ago when 
Bunney assumed leadership. With 
Bunney as chair, Sledge said, “we 
continued to progress and evolve 
into truly one of the most out¬ 
standing departments of psychia¬ 
try in the nation and the world.” 
After remarks by John H. Krystal, 
m.d. ’84, the Robert L. McNeil Jr. 
Professor of Psychiatry, who called 
Bunney a “wonderful mentor,” 
the cloth over the painting was 
removed to gasps and applause. 
“This department has been 
blessed with the most amazing 
people,” said Bunney, “so my job 
was very, very easy.... I want to 
thank everyone here for giving 
me such a wonderful career.” 
The portrait by Gerald P. York 
depicts him sitting on a laboratory 
table flanked by scientific images, 
a stethoscope, and a model sailboat 
—symbols of his wide-ranging 
interests. The Sterling Hall of 
Medicine appears over Bunney’s 
shoulder. In keeping with tradi¬ 
tion, the portrait will hang in 
the departmental offices at 300 
George Street alongside those of 
previous chairs of psychiatry. 
Since retiring in early 2008, 
Bunney has made his home in 
Newbury Neck, a peninsula in 
Maine near Acadia National Park. 
Roslyn 
Meyer 
Robert Michael John 
Alpern Donoghue Elefteriades 
Alumna receives 
Yale Medal 
ROSLYN MILSTEIN MEYER, PH.D. 
'77, assistant clinical professor in 
psychiatry, is one of five recipi¬ 
ents of the 2008 Yale Medal, the 
most prestigious award given by 
the Association of Yale Alumni. 
Meyer is well-known in the New 
Haven area for her leadership of 
a wide array of programs and her 
longstanding commitment to 
Yale and the university’s environs. 
Most recently, Meyer has sup¬ 
ported research and treatment 
programs at Yale for melanoma, 
one of the fastest-growing and 
deadliest forms of cancer. With 
a gift of $10 million to the school 
last spring, she and her husband, 
Jerome H. Meyer, m.d. ’72, hs 
’77, lecturer in psychiatry, are 
helping to establish the Milstein 
Meyer Center for Melanoma 
Research and Treatment, which 
will enable the development 
of more investigator-initiated 
clinical trials and improve Yale’s 
ability to design new treatments 
for the often fatal illness. Meyer 
is a trustee of Yale-New Haven 
Hospital, a patient advocate for 
Yale’s NiH-funded Specialized 
Program of Research Excellence in 
Skin Cancer and a co-founder of 
both New Haven’s International 
Festival of Arts and Ideas and 
the Leadership, Education, and 
Athletics in Partnership program. 
She has served as a member of 
the Volunteer Council for Women’s 
Health Research at Yale, a board 
member of the Yale University 
Art Gallery and a trustee of 
Yale’s Joseph Slifka Center for 
Jewish Life. 
Robert J. Alpern, m.d., dean and 
Ensign Professor of Medicine, 
received the John P. Peters Award 
from the American Society of 
Nephrology (asn) in November 
in recognition of his career of re¬ 
search and leadership. The award 
"recognizes individuals who 
have made substantial research 
contributions to the discipline 
of nephrology and have sustained 
achievements in one or more 
domains of academic medicine 
including clinical care, education 
and leadership.” Alpern, a former 
president of the asn, is the 
second Yale faculty member to 
receive the award. Gerhard H. 
Giebisch, m.d., was honored in 
2006. Established in 1983, this 
annual award is named for a 
leader in the discipline of nephrol¬ 
ogy who spent his entire faculty 
career at Yale; Peters was chief 
of the metabolic division in the 
Department of Internal Medi¬ 
cine from 1922 until 1955. 
Michael J. Donoghue, ph.d., 
the G. Evelyn Hutchinson Profes¬ 
sor of Ecology and Evolutionary 
Biology, has been named the first 
Vice President for West Campus 
Planning and Program Devel¬ 
opment. Donoghue recently 
completed a five-year term as 
the director of the Yale Peabody 
Museum of Natural History. 
Donoghue will work with 
faculty to develop specific details 
of new research programs and 
core facilities and will coordinate 
the program for library, museum 
and other initiatives there. 
Yale’s 2007 acquisition of 
the West Campus, formerly the 
Bayer Healthcare complex, is 
part of a $1 billion commitment 
to strengthening science and 
medical research at the univer¬ 
sity. The 136-acre facility in 
nearby Orange and West Haven 
features 17 buildings with more 
than 500,000 square feet of 
state-of-the-art laboratory 
space, in addition to offices, 
warehouses and other facilities. 
Donoghue joined the Yale fac¬ 
ulty in 2000, serving as chair of 
the Department of Ecology and 
Evolutionary Biology from 2001 
to 2002. He also holds faculty ap¬ 
pointments in Yale’s Department 
of Geology and Geophysics and 
in the School of Forestry and En¬ 
vironmental Studies. Donoghue 
has served on dozens of scientific 
committees and has also served 
on the board of directors of New 
Haven’s International Festival of 
Arts and Ideas. 
John A. Elefteriades, m.d. ’76, 
hs ’81, fw ’83, the William W.L. 
Glenn Professor of Cardio- 
thoracic Surgery and chief of 
cardiac surgery, was given the 
Distinguished Fellowship Award 
by the International Academy 
of Cardiology at the XIV World 
Congress on Heart Disease in 
July in Toronto. The award was 
conferred in recognition of "pro¬ 
found contributions to the field 
of cardiovascular medicine.” 
Robert J. Levine, m.d., hs ’63, 
immediate past co-director of 
Yale University’s Interdisciplinary 
Center for Bioethics, received 
The George Washington Univer¬ 
sity Distinguished Alumni Scholar 
Award for 2008. This award was 
presented at a ceremony in 
Washington, D.C., in April. Levine 
is professor of medicine, lecturer 
in pharmacology and director of 
the law, policy and ethics core 
at the Center for Interdisciplinary 
Research in aids. 
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38 Faculty NOTES 
Carolyn Marcella 
Mazure Nunez-Smith 
Carolyn M. Mazure, ph.d., as¬ 
sociate dean for faculty affairs 
and professor of psychiatry and 
psychology, is the 2008 recipient 
of the American Psychological 
Association's Distinguished 
Leadership Award. This award 
recognizes innovative research 
accomplishment and leader¬ 
ship that improve women’s lives 
and advance health outcomes. 
She is the founding director of 
Women's Health Research at 
Yale, which was started in 1998 
in response to the need for 
gender-based research. Mazure 
was also the 2007 recipient of 
the Marion Spencer Fay Award, 
given by the National Board for 
Women in Medicine. 
Charles A. Morgan III, m.d., 
associate clinical professor of 
psychiatry, has received the 
Patriotic Civilian Service Award 
for his service to the John F. Ken¬ 
nedy Special Warfare Center and 
School at Fort Bragg in North 
Carolina. Since 1989, Morgan 
has been researching the factors 
that increase vulnerability to 
Erik Michael 
Shapiro Simons 
developing post-traumatic stress 
disorder during Special Forces 
training and other stressful situa¬ 
tions and working to develop 
preventive strategies that could 
benefit civilians as well as mili¬ 
tary personnel. 
Marcella Nunez-Smith, m.d., 
assistant professor of medicine, 
has received the 2008 Herbert 
W. Nickens Faculty Fellowship 
from the American Association 
of Medical Colleges. The $15,000 
fellowship recognizes a junior 
faculty member who leads efforts 
to remedy inequities in medi¬ 
cal education and health care. 
Nunez-Smith is assistant director 
of the School of Medicine’s Robert 
Wood Johnson Clinical Scholars 
Program, which prepares physician 
leaders to improve the nation's 
health and health care system by 
translating research into action at 
the local, state and national levels. 
Erik M. Shapiro, ph.d., assistant 
professor of diagnostic radiology 
and biomedical engineering, has 
received a $1.5 million Director’s 
New Innovator Award from 
the National Institutes of Health. 
Shapiro, who arrived at Yale in 
2006 and directs the Molecular 
and Cellular Magnetic Resonance 
Imaging Laboratory in the Depart¬ 
ment of Diagnostic Radiology, is 
developing new ways to enhance 
cellular and molecular magnetic 
resonance imaging technology. 
Edward 
Zigler 
These technical advances will 
allow scientists to detect, mea¬ 
sure and manipulate cell migra¬ 
tion in living tissue. 
Michael Simons, m.d. ’84, a distin¬ 
guished heart researcher and phy¬ 
sician, has been named section 
chief of cardiovascular medicine at 
the School of Medicine and Yale- 
New Haven Hospital. 
Simons comes to Yale from 
Dartmouth-Hitchcock Medical 
Center, where he served as 
chief of cardiology, director of 
the cardiovascular center and 
the angiogenesis research center, 
and on the medical center’s 
board of governors. He was also 
professor of medicine and of 
pharmacology and toxicology 
at Dartmouth Medical School. 
While at Dartmouth, Simons 
received the department of medi¬ 
cine’s Excellence in Teaching 
Award. Simons previously served 
as an associate professor of medi¬ 
cine at Harvard Medical School 
and attending cardiologist at Beth 
Israel Hospital in Boston. He was 
also director of Beth Israel’s coro¬ 
nary care unit. 
Simons’ research interests 
include fibroblast growth factor 
signaling in the vascular system, 
regulation of arterial develop¬ 
ment, and branching and 
endothelial signaling. 
Edward Zigler, ph.d., Sterling 
Professor of Psychology emeritus, 
has been selected as the 2008 
recipient of the American 
Psychological Association’s (apa) 
Award for Outstanding Lifetime 
Contribution to Psychology. 
Zigler received the award at the 
apa annual convention in Boston 
in August. Known as the "Father 
of Head Start,” Zigler is one of 
the principal architects of the 
federal Head Start program and 
the founder of the School of the 
21st Century (21C) initiative. 
SEND faculty news to 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
| students 
Downs fellows cover 
the world 
On topics ranging from nutrition 
to contraception, students presented 
their research in October. 
For the first half of his io-week stay in 
Eldoret, Kenya, last summer, Timothy 
Mercer just hung out. “I had to earn 
some credibility and trust,” said Mercer, 
a 2008 Downs fellow who was study¬ 
ing street children in the western 
Kenyan city. His hanging out paid off. 
“I never felt so privileged to be let into 
a social group.” 
Mercer, a public health student, 
described his research in an oral pre¬ 
sentation at the annual fall symposium 
of The Committee on International 
Health—which awards the Downs 
International Health Student Travel 
Fellowship. Eighteen students in nurs¬ 
ing, medicine, public health and the 
Physician Associate Program spent the 
summer conducting research abroad. 
Two other Downs fellows were plan¬ 
ning to travel early this year. The stu¬ 
dents’ projects explored such topics as 
nutrition and food security in Uganda, 
barriers to drug treatment in Cairo, 
emergency contraception in South 
Africa, circumcision as a means of 
preventing hiv/aids infection in Peru, 
and patients’ attitudes toward health 
care in Indonesia. 
In Eldoret, Mercer’s local faculty advi¬ 
sor at Moi University, David Ayuku, 
m.d., had found that about two-thirds 
of the city’s estimated 2,000 street chil¬ 
dren go home at night. Most find it easi¬ 
er to get food and money on the street 
than at home. But on the street they are 
at high risk for hiv/aids infection and 
drug addiction. “Just being a street child 
places you at a greater health disadvan¬ 
tage,” Mercer said. 
Rosha Forman, a student in nursing 
and midwifery, also spent time getting 
to know her subjects as she studied how 
Zambian midwives handled the third 
stage of labor—the period between 
delivery and expulsion of the placenta. 
“You want the placenta to come out and 
you want it to come out quickly—other¬ 
wise you are at risk of hemorrhage,” 
Forman said, adding that postpartum 
hemorrhaging is a leading cause of 
maternal death in the developing world. 
Forman visited four hospitals and seven 
clinics and interviewed 14 midwives. 
“I did a lot of sitting and chatting with 
the midwives,” she said. 
Lauren Graber, a medical student, 
traveled to Kampala, Uganda, at the 
request of a physician there who was 
concerned that a local landfill might be 
the source of high blood lead levels in 
children. “This is a perfect example of 
partnered research, answering a ques¬ 
tion that your host country asks,” said 
Michele Barry, m.d., hs ’77, professor 
of medicine and public health and 
former director of the Yale/Johnson & 
Johnson Physician Scholars in Inter¬ 
national Health Program. Graber, work¬ 
ing with five Ugandan medical students 
and a medical student from Mount Sinai 
Medical Center in New York, tested 165 
children and visited 122 homes. High 
blood lead levels, the students found, 
were correlated less with proximity to 
the landfill than with consumption of 
canned foods and living along busy 
roads. “We really need to learn more 
about how kids are being exposed to lead 
in Kampala,” Graber said. 
—John Curtis 
top Medical student Lauren Graber presented 
the results of her research on lead exposure in 
Kampala, Uganda, in October at the annual 
poster session by Downs fellows. The fellows, 
students in medicine, public health, nursing 
and the Physician Associate Program, spend a 
summer abroad conducting research. 
above At the poster session in the Jane Ellen 
Hope Building, students reported on their re¬ 
search in Africa, Asia and Latin America. Topics 
included nutrition and food security in Uganda, 
barriers to drug treatment in Cairo, the health 
risks faced by street children in Kenya and 
tuberculosis transmission in Colombia. 
For more on the Downs fellowship, see “Science 
and Culture in a Strange Land,"p. 26. 
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40 students 
Auction raises $32,000 for 
New Haven-area charities for 
the hungry and homeless 
“Girls’ Night Out: Join Drs. Bia, Angoff, 
Vining and Hansson to enjoy a dinner 
and the sharing of gossip and wisdom. 
No Y Chromosomes, please.” 
A group of second-year students, 
including auction co-chair Marie A. 
Rymut, bought this evening with four 
female faculty for $650 at the 16th 
Annual Hunger & Homelessness 
Auction on November 13. The auction, 
a traditional blend of fun and charity, 
top Nancy Angoff, associate dean for student 
affairs, entered a bid on a blanket made by first- 
year medical students. 
above Medical student John Binford also bid 
on the blanket, to which many of his first-year 
classmates contributed hand-knit squares. 
right Medical students Nupur Carg and Janice 
Man, right, looked over a list of items at the 
silent auction. 
raised $32,000 for several charitable 
organizations in the New Haven area. 
“This is about giving back,” said 
auctioneer Wade Brubacher, a profes¬ 
sional from Kansas and father of third- 
year medical student Jacob Brubacher, 
in his third appearance at the event. 
“You won’t make much money at it, 
but you’ll feel good.” 
Since its inauguration as an afternoon 
event in Harkness Auditorium, the 
auction has expanded to include a week 
of activities that include a football game 
between first- and second-year medical 
students, a performance of chamber 
music, a panel discussion on hunger and 
homelessness and film screenings. The 
week ends with silent and live auctions 
in Harkness Ballroom and Marigold’s. 
Among the available items at the 
silent auction were works of art, serv¬ 
ices by students and faculty, dinners at 
homes and restaurants, quilts, jewelry, 
“Mediterranean Dinner & Debauchery,” 
concert tickets and homemade brownies. 
The live auction opened with a 
perennial favorite, bidding on a bow 
tie (“Smells faintly of formaldehyde”) 
contributed by William B. Stewart, 
ph.d., associate professor of surgery 
(gross anatomy), who has taught the 
basics of anatomy to first-year students 
for decades. The tie fetched $500 from 
the first-year class in the Physician 
Associate Program, who outbid their 
medical school rivals. 
This year’s proceeds will be donated 
to Christian Community Action, 
Columbus House, Community Soup 
Kitchen, Domestic Violence Services, 
Junta for Progressive Action, Loaves and 
Fishes, New Haven Home Recovery 
and Youth Continuum. 
—John Curtis 
41 
At annual White Coat 
Ceremony, students kick off 
their medical careers 
The ioo students in the Class of 2012 
include 51 women and 49 men, 24 gradu¬ 
ates of Harvard and Yale, 24 members 
of ethnic or racial groups underrepre¬ 
sented in medicine and 26 who were 
born outside of the United States. They 
were selected from 4,139 applicants, and 
46 took time off after college to pursue 
advanced degrees or research, health 
care consulting, teaching or volunteer 
work. “Many have been involved with 
health care programs in various parts of 
the country or other parts of the world,” 
said Richard A. Silverman, director of 
admissions. “This class has real depth 
of experience and a lot of talent. ... It’s 
a pretty hard class to beat.” 
At this year’s White Coat Ceremony 
in August, Dean Robert J. Alpern, m.d.. 
Ensign Professor of Medicine, welcomed 
the new students with thoughts on the 
Yale system of medical education, whose 
tenets include no grades in the first two 
years or class rankings. “Were we trying 
to make it easier for you as students?” 
he asked. “The answer is that we expect 
greater things from you than grades could 
ever engender. We expect you to become 
leaders in the medical world of tomorrow.” 
Frederick D. Haeseler, m.d., director 
of primary care clerkships and asso¬ 
ciate clinical professor of medicine, 
reflected on the art of medicine in the 
ceremony’s keynote speech. Defining 
medicine as having both human and 
scientific components, he said, “When 
physicians connect these two, they are 
practicing the art of medicine.” 
Why did students choose the School 
of Medicine? For Ken Hui, who received 
his undergraduate degree at Yale, it was 
the people. “I thought they’d be really 
nice and really interesting and that’s 
definitely turned out to be the case since 
I’ve been here,” he said. 
Sounok Sen, a graduate of the 
University of Pennsylvania, said it was 
the Yale system, which emphasizes a 
unique student-faculty collegiality and 
Individual responsibility. “I wanted to 
use those values to learn medicine,” 
Sen said. Smiling, he added, “I think we 
have a good group. It’ll be a fun time.” 
—Charles Gershman 
top The Class of 2012, shown here after 
donning their white coats in Harkness 
Auditorium, includes 51 women and 49 men. 
middle Esther Lee donning her white coat 
at the annual rite of entry into medicine. 
above Almost half the class took time 
off between college and medical school for 
research, study, teaching or volunteer work. 
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42 Alumni faces 
Jocelyn Malkin decided to pursue psychiatry, 
despite barriers to women in medicine at 
the time. "I just thought [psychiatry] was the 
living end,” she said. 
The long view of 
psychoanalysis 
Tracing her professional lineage to 
Freud, alumni leader Jocelyn Malkin 
still sees a place forthe couch. 
As a high school student in Manhattan, 
Jocelyn Schoen Malkin, m.d. ’52, 
found her calling during a lecture by 
the prominent psychoanalyst Lawrence 
S. Kubie, m.d. Though Malkin had long 
been interested in emotional issues, 
she said, something clicked that day. 
“I just thought [psychiatry] was the 
living end,” she recalled, using a col¬ 
loquialism of the day. Despite the era’s 
formidable barriers to women in medi¬ 
cine, she made up her mind to become 
an analyst. More than 60 years after 
that decision, she continues to practice, 
teach and advocate for psychoanalysis. 
Malkin, who was elected president of 
the Association of Yale Alumni in Medi¬ 
cine in 2007, has long done things her 
own way. She grew up in Rockaway 
Beach, N.Y. Both her mother, who had 
been admitted to law school but discour¬ 
aged from entering by Malkin’s grand¬ 
father, and her father, an insurance 
salesman, strongly valued education. 
Studying medicine at Yale, though, 
had not been in Malkin’s plans; it was 
the unintended consequence of a lark. 
While an undergraduate at Barnard 
College, she intended to join her then- 
boyfriend at Columbia University’s 
College of Physicians and Surgeons. 
When Yale invited her for an inter¬ 
view, she decided to have some fun. 
“I dressed like I was going to a football 
game. ... like an ‘import’,” she said, 
using Yale slang from the mostly male 
era for a woman brought to campus as 
a date. “Instead of looking like a frump, 
I ... wore a fur coat.” Fritz Redlich, 
m.d., then head of the Department of 
Psychiatry and later dean of the School 
of Medicine, asked her why she would 
make a good medical student. “I said 
I had a sense of humor, so I could toler¬ 
ate an interview like this. ... He loved 
it! ” Yale offered her early admission to 
the Class of 1951. 
Malkin’s acceptance may have sur¬ 
prised her undergraduate advisor at 
Barnard, a female chemistry professor 
who had advised Malkin during her 
freshman year to forget about medical 
school. Fond of dating and partygoing, 
Malkin had earned subpar grades that 
year. But she suspects her appearance 
was also part of the problem. “I didn’t 
look the type,” she said. “In those 
days, you had to look like an old frump, 
and I was having a wonderful time. 
I thanked her and never saw her again.” 
Malkin raised her grades, and by the 
time she was pulling on a fur coat for 
her Yale interview, she was poised to 
graduate from Barnard a year early, Phi 
Beta Kappa and cum laude. 
In 1948, at the end of her first year 
of medical school, after parting from 
her Columbia boyfriend, Malkin mar¬ 
ried Myron S. Malkin, ph.d. ’52, a 
former Marine and a senior in Yale 
College. Unlike most other men she 
dated, he was thrilled that Malkin 
planned to practice medicine. The 
women in his home town, he said, just 
“sit and play mah-jongg.” 
The Malkins graduated in 1952, he 
with a ph.d. in physics and she with an 
m.d., after taking a fifth year. 
In those days eligibility for psycho¬ 
analytic training required completion 
of a medical school internship and a 
43 
psychiatric residency. After complet¬ 
ing a pediatric internship, two years 
of psychiatric residency and a two-year 
public health fellowship at the Child 
Study Center, she applied for a posi¬ 
tion at the newly established Western 
New England Psychoanalytic Institute 
I in New Haven. The young mother was 
advised to “wait until you finish having 
children—you have enough to do.” 
With no positions open to her 
in New Haven, the Malkins agreed 
that any move would have to ben¬ 
efit them both. Malkin, her husband 
and, by then, two children moved to 
Philadelphia in i960, where Malkin 
began training with the Philadelphia 
Association for Psychoanalysis and her 
husband worked on a secret project 
developing re-entry space vehicles. 
Malkin and her husband ultimately 
settled in Bethesda, Md., where she 
has practiced, taught and supervised 
trainees for decades. (While there, 
Myron Malkin went on to head the 
United States’ first space shuttle pro¬ 
gram from 1973 to 1980.) 
Malkin traces her psychoanalytic 
pedigree straight back to Sigmund 
Freud via her Philadelphia supervisor, 
Robert Waelder, ph.d., who had 
undergone analysis by Freud, and her 
Washington mentor, Jenny Waelder- 
Hall, m.d., who had undergone analysis 
by Freud’s daughter Anna. 
Malkin presently chairs a biennial 
seminar in Aspen, Colo., that is attended 
by psychoanalysts from around the 
world. She became active in the Associa¬ 
tion of Yale Alumni in Medicine in 1996 
at her 45th reunion, when she asked 
why there were no women on the execu¬ 
tive committee’s nominating slate; she 
was offered a spot on the committee 
then and there. Her term as president 
ends in June. 
After a 2006 house fire in which 
many of her and her late husband’s docu¬ 
ments and belongings were destroyed, 
Malkin began preparations to move 
to New Haven. She expects to arrive this 
summer and looks forward to continu¬ 
ing active involvement with the psycho¬ 
analytic community and the alumni 
association as well as spending time with 
her children, Martha and Peter, who live 
in Westchester County, N.Y., with their 
families. Malkin’s granddaughter is a 
sophomore in Yale College. 
Despite the waning reputation of 
psychoanalysis and the rise of other 
therapies, Malkin said the older approach 
has a place in modern psychiatry. It was, 
she suggests, greatly oversold in the past. 
“[Psychoanalysis] is like an appen¬ 
dectomy. It’s a great operation, but you 
don’t do it on everybody,” Malkin said. 
“Analysis is the treatment of choice for 
certain kinds of patients, and [for them] 
there’s no better treatment.” She is con¬ 
cerned, though, about the future of 
psychoanalysis. “There are fewer and 
fewer people going into it, and the 
analytic organizations are lowering 
standards to be able to do anything to 
get bodies. ... [But] I think analysis will 
survive, and should survive, as one 
important part of the whole armamen¬ 
tarium available for the treatment of 
mental illness.” 
—Jenny Blair 
Save the date! 
June 5-6,2009 
Reunion Weekend 
Yale School of Medicine 
From art to medicine and 
back—how one physician 
pursued her dreams 
As a high school student in New Britain, 
Conn., Sophie Trent-Stevens, m.d. ’43, 
made up her mind to see and paint 
the far-flung places she saw in exotic 
landscape paintings at the local art 
museum. “I thought that if you were 
an artist you’d go out and see this 
magnificent scenery,” she said. A half- 
century later, after a prestigious medi¬ 
cal career, she did. 
While the 17-year-old knew that she 
wanted to become an artist, her mother 
had other ideas. “Artists starve. You can 
either be a teacher or be a nurse,” her 
mother told her. Neither option suited 
Trent-Stevens, so she decided to go to 
Brown University after a teacher told her 
she could take art classes while earning 
her degree there. 
At Brown, though, she developed 
different ambitions. “Marie Curie was 
a hero at that time. ... I wanted to be 
another Madame Curie,” she said. She 
spent a summer as an animal techni¬ 
cian at a cancer research institute in 
Maine. Back at Brown, an advisor told 
her that if she wanted to make her 
mark in medicine, she ought to pur¬ 
sue an m.d. instead of a ph.d. 
During her years at the School of 
Medicine, the United States became 
involved in World War II. With service¬ 
men falling ill in the South Pacific, 
Trent-Stevens decided to pursue tropi¬ 
cal medicine. After an internship at 
Vanderbilt University, she went to the 
School of Tropical Medicine in Puerto 
Rico. “They had the mosquitoes, they 
had the germs, they had the bugs,” 
she said. Art became, for the moment, 
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44 Alumni faces 
Early in her medical career, Sophie Trent-Stevens 
studied tropical medicine in the Caribbean— 
she made house calls in the Virgin Islands by 
sailboat and on the backs of donkeys. 
less important, though she sketched 
when she could—mostly skulls and 
patients—and occasionally painted 
with a mixture of watercolors and white 
shoe polish. 
After a research fellowship in tropi¬ 
cal diseases at the National Institutes 
of Health and a residency in internal 
medicine in Jacksonville, Fla., Trent- 
Stevens became chief of medicine at 
St. Thomas General Hospital in the 
U.S. Virgin Islands. For nine months, 
she traveled between St. Thomas and 
neighboring St. John by sailboat and 
made house calls on the backs of 
donkeys. She used an old Navy brig 
on St. Thomas as a quiet room for a 
violent patient. She remembers the 
scene of a suicide by hanging; no one 
had thought to cut the victim down, 
which might have saved him. And she 
remembers seeing a priest in full habit 
riding on the back of a donkey, with 
his Bible propped open on the beast’s 
neck. “You saw things that were so dif¬ 
ferent from everyday life that you felt 
you were living in a dream,” she said. 
The vivid images have remained in 
her mind for decades. 
Trent-Stevens returned to 
Connecticut in 1949 and pursued a 
career in internal medicine. She had 
a private practice as well as an associ¬ 
ate professorship at the University 
of Connecticut, and she served as 
senior ward physician at a tubercu¬ 
losis sanatorium in Norwich, the 
Meriden-Wallingford Hospital and 
the Veterans Affairs hospitals in 
Meriden and Newington. She was a 
founding member of the American 
Society of Tropical Medicine and 
Hygiene and played important roles 
in the American Medical Women’s 
Association and the Pan-American 
Medical Women’s Alliance, among 
many other organizations. 
Once she retired from medicine, 
though, Trent-Stevens returned to art. 
In 1982, at the age of 65, she earned 
a master’s degree in art from Central 
Connecticut State University. (She 
noticed that the young art students 
spent a lot of time seeking out free 
food at campus events, and noted, 
“My mother was right.”) She became a 
docent at the New Britain Museum of 
American Art—where she’d seen land¬ 
scape paintings as a child—and pub¬ 
lished reproductions of her paintings in 
Connecticut Medicine, the magazine of 
the Connecticut State Medical Society. 
And—at long last—she began to 
paint the faraway places of her child¬ 
hood fantasies. She painted her former 
workplace, the stunningly beautiful 
island of St. Thomas. She traveled to 
Bora Bora and painted the Pacific island’s 
mountains and the fish she saw from a 
glass-bottomed boat. She painted tropi¬ 
cal flowers in Hawaii, the Matterhorn in 
Europe and a harbor in Maine, where her 
interest in medicine began. 
The large oils and acrylics adorn 
the walls of Trent-Stevens’ home in 
Meriden, which she and her late hus¬ 
band, Ronald Stevens, a colonel in 
the U.S. Air Force, designed and built 
decades ago. Thanks to medicine, 
Sophie Trent-Stevens got her wish and 
became an artist, and she didn’t have 
to starve. 
—Jenny Blair 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public health 
or has followed an unusual path since 
leaving Yale? We’d like to hear about 
alumni of the School of Medicine, School 
of Public Health, Physician Associate 
Program and the medical school’s doc¬ 
toral, fellowship and residency programs. 
Drop us a line at ymm@yale.edu or write 
to Faces, Yale Medicine, 300 George 
Street, Suite 773, New Haven, CT 06511. 
NOTES 45 
Leonard Cleve Ross Holly Robert 
Banco Killingsworth Tonkens Ardito Higgins 
Robert 
Johnson 
I96OS 
Robert L. Johnson, M.D., HS ’64, 
and his wife, Barbara Johnson, 
r.n., have formed a nonprofit 
organization called Village Relief 
Foundation to supply medical 
drugs, books, tapes and instru¬ 
ments to such developing 
countries as Liberia, Zimbabwe, 
Myanmar, New Guinea and Chad. 
Any suggestions for networking 
for gifts and donations to these 
countries are appreciated. "We 
are a hands-on, grass-roots 
organization and make personal 
trips to these countries. Next 
stop: Indonesia.” 
197OS 
Leonard I. Banco, m.d. ’74, has 
been appointed senior vice presi¬ 
dent and chief medical officer at 
Bristol Hospital in Connecticut. 
Banco previously spent 12 years 
at Connecticut Children’s Medi¬ 
cal Center in Hartford. 
Cleve L. Killingsworth, m.p.h. 
'76, has been appointed to the 
board of trustees of the mitre 
Corporation, a nonprofit organi¬ 
zation that provides systems 
engineering, research and 
development, and information 
technology support to the fed¬ 
eral government. Killingsworth 
is chair and ceo of Blue Cross 
Blue Shield of Massachusetts as 
well as a faculty member at the 
Harvard School of Public Health. 
Ross M. Tonkens, m.d. ’74, has 
been hired by mds Pharma 
Services, a provider of drug 
discovery and development so¬ 
lutions based in King of Prussia, 
Pa., to provide medical oversight 
for its Phase lla clinical research 
activities and to direct the 
medical and clinical activities of 
its development and regulatory 
services. Prior to joining mds, 
Tonkens was chief medical 
officer of Regado Biosciences, 
a Duke University biotechnology 
spinoff founded in 2003, and 
was global head of cardiovas¬ 
cular therapeutics at Quintiles 
Inc., a transnational contract 
research organization. 
198OS 
Holly Ardito, m.p.h. ’89, has been 
named director of fee schedule 
and business configuration at 
Network Health in Medford, Mass. 
Ardito previously served as the 
director of client services for 
MedVentive, Inc., a health care 
information technology company 
also based in Medford. 
Sandra C. Castro, m.d. ’84, has 
been named medical director of 
the Children’s Emergency Depart¬ 
ment at Johnson City Medical 
Center in Tennessee. Castro was 
previously the medical director of 
pediatric emergency services at 
Joe DiMaggio Children’s Hospital 
in Hollywood, Fla. 
Robert S.D. Higgins, M.D. ’85, 
surgical director of the heart 
failure and cardiactransplant 
program and professor and chair 
of the department of cardiovas¬ 
cular and thoracic surgery at 
Rush University Medical Center 
in Chicago, is president of the 
Organ Procurement and Trans¬ 
plantation Network/United Net¬ 
work for Organ Sharing board of 
directors. He is serving a one-year 
term that ends in June. 
Donald E. Ingber, m.d. ’84, ph.d. 
’84, Judah Folkman Professor of 
Vascular Biology at Harvard Medi¬ 
cal School and Children’s Hospital 
Boston, was named director of 
the new Hansjorg Wyss Institute 
for Biologically Inspired Engineer¬ 
ing at Harvard in October. The 
institute was founded with the 
largest individual gift in Harvard’s 
history, a $125 million donation 
from Wyss, an engineer who 
led the Swiss medical device 
company Synthes for three 
decades. The institute will bring 
together engineers, scientists and 
clinicians across disciplines and 
will focus on synthetic biology, a 
“living materials program,” and 
biological control. 
Joseph J. Napolitano, m.p.h. ’87, 
ph.d., r.n., was appointed to the 
Pennsylvania State Board of Nurs¬ 
ing in April 2008. Napolitano is a 
program officer at The Dorothy 
Rider Pool Health Care Trust in 
Allentown, Pa., which is commit¬ 
ted to improving the health of 
the citizens of the Lehigh Valley. 
199OS 
Marc Agronin, m.d. ’91, was 
named the 2008 recipient of the 
Clinician of the Year Award by 
the American Association for 
Geriatric Psychiatry for demon¬ 
strating a “profound commitment 
to the field of clinical geriatric 
psychiatry.” Agronin was also 
recently promoted to associate 
professor of psychiatry in the vol¬ 
untary faculty of the Miller School 
of Medicine at the University of 
Miami. Agronin is currently the 
director of mental health services 
at the Miami Jewish Home and 
Hospital at Douglas Gardens. 
Jeffrey M. Dembner, M.D. ’96, 
has been named chair of the 
department of neurosurgery 
at Hoag Memorial Hospital 
Presbyterian in Newport Beach, 
Calif. He continues to be director 
of Newport Neurosurgery, a 
multi-subspecialty neurosurgical 
practice in Newport Beach. 
Jean Hee Park, m.p.h. ’98, j.d., 
was married in September to 
Albert S. Cho, j.d., at Riverside 
Church in Manhattan. She is a 
law clerk in Brooklyn to Marilyn 
Dolan Go, a United States mag¬ 
istrate judge for the Eastern Dis¬ 
trict of New York. Her husband 
is a partner in the Chicago law 
firm Kirkland & Ellis and works 
in the corporate department of 
the firm’s New York office. 
2000S 
David F. Jeng, m.d. ’07, HS ’08, 
has begun a three-year ophthal¬ 
mology residency at Doheny Eye 
Institute, Keck School of Medi¬ 
cine of the University of South¬ 
ern California in Los Angeles. 
Benjamin Negin, m.d. ’04, and 
his wife, Brina, announced the 
birth of healthy twin boys, 
Aaron Isaac Negin and Zachary 
Evan Negin, on July 20. Negin is 
a second-year medical oncol¬ 
ogy fellow at Fox Chase Cancer 
Center in Philadelphia. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yak Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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in Memoriam 
Franklin H. Epstein, M.D. '47, HS 
’49, William Applebaum Professor 
of Medicine at Harvard Medical 
School, considered one of the 
giants of metabolism and nephrol¬ 
ogy, died in Brookline, Mass., 
on November 5. He was 84 and 
actively engaged in biomedical 
research, teaching and clinical 
care until early October. 
During his residency Epstein 
came underthe influence of 
John P. Peters, m.d., regarded by 
many as the leading American 
physician/scientist of that time. 
Epstein eventually succeeded 
Peters as chief of the Division of 
Metabolism at Yale. 
After a fellowship at Boston 
University Medical School in 
cardiology and a period of time 
in the United States Army, Epstein 
returned to the Division of 
Metabolism and the Department 
of Medicine. Epstein was one of 
the first recipients of the Francis 
Gilman Blake Award for outstand¬ 
ing teaching in the biomedical 
sciences. In 1972 he moved to head 
the Thorndike Memorial Labora¬ 
tory and the Harvard Medical 
Unit of Boston City Hospital. One 
year later he joined the Beth Israel 
Hospital as chair and physician-in¬ 
chief of its Department of Medi¬ 
cine. He remained at Beth Israel, 
now the Beth Israel-Deaconess 
Medical Center, until his death. 
Epstein was also a longstanding 
editor of Harrison’s Principles of 
Internal Medicine and of The New 
England Journal of Medicine. 
Epstein received many national 
and international honors for his 
accomplishments in nephrology. 
Roland H. Ingram Jr., m.d. ’60, hs 
’65, died on July 7 in Atlanta, Ga. 
He was 73. Born in Birmingham, 
Ala., Ingram attended the Univer¬ 
sity of Alabama before coming to 
the School of Medicine. After his 
internship at Peter Bent Brigham 
Hospital in Boston, he spent two 
years in Japan with the Atomic 
Bomb Casualty Commission be¬ 
fore returning to Yale to complete 
his training in internal medicine. 
Following a fellowship in pulmo¬ 
nary diseases at Columbia, Ingram 
joined the faculty of the Emory 
University School of Medicine, 
where he received an award as 
the outstanding clinical teacher 
from the Class of 1969. He became 
professor and director of the pul¬ 
monary division at Emory before 
returning to Brigham Hospital in 
Boston. He also joined the Harvard 
faculty, teaching in both the medi¬ 
cal school and the school of public 
health. In 1992 Ingram returned to 
Emory as chief of internal medi¬ 
cine and director of the pulmonary 
division for all Emory hospitals. 
Frank M. Isbell, m.p.h. ’63, died on 
October 6 in Cooperstown, N.Y. 
He was 81. Born in Roanoke, Va., 
Isbell served in the Air Force dur- 
ingthe Vietnam War. He earned 
the Bronze Star Medal for his 
accomplishments at the onset of 
the Tet offensive. After returning 
from Vietnam, Isbell was assigned 
to the Department of Defense, 
Surgeon General’s Office at the 
Pentagon in Washington, D.C. He 
retired from the Air Force in 1970. 
After serving as an administrator 
at Yale-New Haven Hospital, Isbell 
moved to Oneonta, N.Y., in 1973 
to become president of A.O. Fox 
Memorial Hospital. 
Michael W. Lau, m.d. ’45, died on 
August 12 at his home in Los An¬ 
geles. He was 88. Lau, a urologist, 
surgeon and former Navy cap¬ 
tain, grew up in Bronxville, N.Y. 
When his father died in 1931, Lau, 
then n, helped his mother raise 
his young sister. As a teenager he 
washed dishes on a Great Lakes 
freighter. After graduating from 
Washington and Lee University 
in 1941, Lau joined the U.S. Navy 
before attending the School of 
Medicine. Upon graduation he 
joined the Navy Reserve Medical 
Corps and visited the Far East as 
the ship's surgeon on the USS Co¬ 
lumbus. After his marriage in 1952 
he practiced urology in White 
Plains, N.Y., but soon moved to 
Beverly Hills. Lau was on the 
medical faculty at the University 
of Southern California. 
Jose J. Miranda, m.p.h., m.d. ’02, 
died on September 29 in Fayette¬ 
ville, N.C., where he was stationed 
as a major in the U.S. Army. 
He was 33. Born in Puerto Rico, 
Miranda graduated from the Uni¬ 
versity of Kansas with distinction 
in 1997. The same year Miranda 
entered the School of Medicine 
on the United States Army Health 
Professions Scholarship Program. 
He completed his degree in public 
health at Harvard in 2001. After 
graduating from the School of 
Medicine, Miranda completed an 
internship and residency in ortho¬ 
paedic surgery at Eisenhower 
Army Medical Center in 2006. 
George E. Palade, m.d., a Nobel 
laureate who served on the Yale 
faculty and founded the Section 
of Cell Biology, died on October 7 
in San Diego of complications of 
Parkinson disease. He was 95. 
Palade earned his Nobel in 1974 
for his discoveries about the inner 
workings of cells, findings that 
helped launch the field of cell biol¬ 
ogy. He was a pioneer in the use 
of electron microscopy to discover 
and elucidate the functions of such 
tiny structures as the ribosome. 
Born in Jassy, Romania, Palade 
received his medical degree from 
the University of Bucharest in 
1940. He was a member of the 
faculty of that school until 1946, 
when he came to the United 
States for postdoctoral studies. 
Palade came to Yale in 1973, and 
held the Sterling Professorship 
of Cell Biology from 1975 to 1983, 
when the section became the 
Department of Cell Biology upon 
his retirement as chair. 
Palade was elected to member¬ 
ship in the National Academy of 
Sciences, the institute of Medicine 
and the American Academy of Arts 
and Sciences. In 1974, he shared 
the Nobel Prize in physiology or 
medicine with Albert Claude, m.d., 
and Christian de Duve, m.d. 
Palade left Yale in 1990 for 
the University of California, San 
Diego, as professor of medicine 
in residence and dean for scien¬ 
tific affairs. 
Rose Papac, m.d., a longtime 
faculty member of the Section of 
Medical Oncology in the Depart¬ 
ment of Internal Medicine and 
one of the early female pioneers 
in medical oncology, died on May 
10 of cancer. She was 80. Born 
in Montesano, Wash., Papac at¬ 
tended Reed College in Portland, 
Ore., and studied chemistry at 
Seattle University, where she 
graduated summa cum laude. 
In 1949 she was one of the first 
women to be admitted to St. 
Louis University Medical School, 
and she became the first woman 
to complete an internship in the 
department of medicine there. 
In 1954 she moved to Stanford 
University to complete her 
internal medicine residency. 
It was there that she developed 
her interest in and passion for 
oncology; following her residency, 
she was the first American to 
take an oncology fellowship at 
the Chester Beatty Institute in 
London. She continued her fellow¬ 
ship at Memorial Sloan-Kettering 
Cancer Center in New York City. 
In 1963, she joined the Depart¬ 
ment of Medicine at Yale, where 
she stayed until her retirement in 
2006. Papac was one of the first 
women to receive tenure in the 
School of Medicine and the first 
woman to be awarded tenure 
in the Department of Medicine. 
She played a pivotal role in de¬ 
veloping contemporary concepts 
of cancer chemotherapy. 
Marc G. Pypaert, ph.d., director 
of Yale’s Electron Microscopy Core 
Facility and a research scientist in 
the Department of Cell Biology, 
died at Connecticut Hospice on 
July 28 of brain cancer. He was 
45. Pypaert had a diverse and 
prolific scientific career, develop¬ 
ing a high level of expertise in 
membrane cell biology and, in 
particular, in electron microscopy 
of a variety of ceils, especially 
those undergoing mitosis. He 
was an enthusiastic and creative 
photographer who exhibited 
his work at local galleries in the 
City-Wide Open Studios program. 
Born in Ath, Belgium, Pypaert 
received his bachelor’s degree in 
zoology in 1985 from the Facultes 
Universitaires Notre-Dame de la 
Paix in Namur. In 1991, he received 
his ph.d. in biochemistry from the 
University of Dundee in Scotland. 
Following postdoctoral work in 
the United Kingdom, Switzer¬ 
land and Belgium, Pypaert was 
recognized as one of the world’s 
leading experts in quantitative 
immunoeiectron microscopy. 
He was recruited by Yale in 1999. 
He expanded the scope and 
technical capability of the Elec¬ 
tron Microscopy Core Facility, a 
component of the Yale Center for 
Cellular and Molecular Imaging. 
J. Murdoch Ritchie, ph.d., Eugene 
Higgins Professor Emeritus of 
Pharmacology, died on July 10 
in Hamden, Conn., after a long 
illness. He was 83. Born in Aber¬ 
deen, Scotland, Ritchie graduated 
with a degree in math and physics 
from the University of Aberdeen 
in 1944. During World War II, 
he served on a team that was 
instrumental in the development 
of radar. After the war, Ritchie 
earned another bachelor’s degree, 
in physiology, from University 
College London (ucl) in 1949, 
a ph.d. in biophysics in 1952, 
and a D.sc. in biophysics in 1960. 
While at ucl, he met and married 
his wife, Brenda, a physiologist. 
In the early 1950s Ritchie joined 
Alfred Gilman’s department of 
pharmacology at Albert Einstein 
College of Medicine. In 1968 he 
came to Yale as chair of phar¬ 
macology. Ritchie made several 
major contributions to improved 
understanding of the conduction 
of impulses in peripheral nerves, 
in particularthe distribution of 
sodium and potassium channels 
in both myelinated and unmy¬ 
elinated fibers. This research led 
to a better understanding of 
the disease process involved in 
multiple sclerosis. 
Daniel Rowe, m.d., of Hamden, 
Conn., professor emeritus of 
pediatrics and of epidemiology 
and public health and founding 
director of the Yale Health Plan, 
died on July 8. Rowe was a 1948 
graduate of Thomas Jefferson 
Medical College in Philadelphia 
and served in the Army during 
World War II and the Navy during 
the Korean conflict. Rowe came 
to the School of Medicine as the 
director of pediatric outpatient 
services in 1966. While director 
he developed the domestic abuse 
response team program for the 
detection and reporting of child 
abuse, which is still the model 
for child protection in the United 
States. He was the recipient of 
the Francis Gilman Blake Award 
for excellence in teaching in 1968. 
Rowe was named a full profes¬ 
sor of pediatrics in 1970, the year 
he also became director of Yale 
University Health Services. 
The Yale Health Plan was the first 
university hmo in the country. 
Julian A. Sachs, m.d. ’46, died 
on September 1, in the emer¬ 
gency room at the Hospital of 
Central Connecticut in New 
Britain, where he had worked 
for 25 years. He was 86. Sachs 
was one of the hospital’s origi¬ 
nal emergency room physicians 
in 1968. He retired in 1992. He 
was a veteran of the U.S. Army, 
serving as chief of radiology at 
Fort Totten General Hospital in 
New York City and as a transport 
surgeon on a Victory ship. 
Gaston Leonard Schmir, ph.d. ’58, 
professor emeritus of molecular 
biophysics and biochemistry, died 
on July 2 of Parkinson disease. He 
was 75. Schmir was born in Metz, 
France, in 1933 and spent his child¬ 
hood in hiding during World War 
II as his father sought safe havens 
for his Jewish family. He arrived 
in the United States in 1946 and 
joined the Yale biochemistry 
faculty in i960. His research em¬ 
phasis was in the area of enzyme 
mechanisms and related physical- 
organic chemistry. 
Cornell Scott, m.p.h. ’68, chief 
executive officer of the Hill Health 
Corporation in New Haven, died 
on August 25. He was 73. Scott 
came to the Hill Health Center in 
1968 as director of training and 
education and became execu¬ 
tive director in 1972. His 40-year 
tenure was marked by the steady 
development of sites, services 
and programs for the low-income 
population of the New Haven 
area. He received the National 
Association of Community Health 
Centers Lifetime Achievement 
Award in 2002 for his "lifelong 
dedication and exceptional serv¬ 
ice to the American people.” 
Florence S. Wald, r.n. ’41, m.n., 
m.s. ’56, dean emerita of the Yale 
School of Nursing and founder 
of hospice in the United States, 
died on November 8 at her home 
in Branford, Conn. She was 91. 
Born Florence Schorske in New 
York City in 1917, Wald graduated 
from Mount Holyoke College in 
1938. After World War II, she 
became an instructor in the school 
of nursing of Rutgers University. 
After joining the faculty of the 
School of Nursing in 1956, Wald 
served as the school’s fourth dean 
from 1959 to 1966. She married 
Henry Wald, an engineer, in 1959. 
She is credited with bringing the 
hospice movement to the United 
States from England and estab¬ 
lishing the first American hospice 
in Branford in 1971. 
A world-renowned leader in 
nursing research, Wald was 
awarded an honorary doctor of 
law degree from the University 
of Bridgeport in 1967, an honorary 
doctor of humane letters degree 
from Mount Holyoke in 1978 and 
an honorary doctor of medical 
sciences degree from Yale in 1995. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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48 F0ll0W-Up Archives 50 and 25 years ago 
One year later, transplant program is thriving 
On a crisp fall afternoon, Sukru Emre, m.d., chief of organ trans¬ 
plantation and immunology, had just looked in on a 7-month-old 
boy recovering from a lifesaving liver transplant—the surgeon’s 
51st such surgery in less than 14 months. “He’s doing very well 
now and hopefully will go home soon,” Emre said. 
Since Emre came to Yale last year to revitalize the organ 
transplantation section [See "Putting the Fire Back into Yale’s 
Transplant Program,” Autumn 2007], he has also raised the 
number of kidney transplants—the section has done 101 in the 
past year, the highest number in its history—while the liver 
program boasts a best-in-the-nation survival rate of 100 per¬ 
cent six months after surgery. Although infection rates after 
transplants are typically 17 to 25 percent, at Yale the infection 
rate is less than 3 percent. ’’The credit should go to the nurses 
working on those units,” said Emre. Emre and his team were 
also the first in Connecticut to perform such cutting-edge 
liver transplant surgeries as split- and living-donor liver trans¬ 
plantations in both adult and pediatric patients. In split-liver 
transplant, a single liver is sectioned to serve more than one 
recipient. Both procedures allow surgeons to overcome the 
shortage of organs from deceased donors. According to the 
federal Department of Health and Human Services, 19 people 
across the United States die each day awaiting transplants. 
To encourage organ donations, Emre gives talks most weekends 
at hospitals and events sponsored by donorship foundations, 
an outreach that has increased the number of organs available 
and identified Yale as a leader in transplant surgery. 
Emre believes strongly in the team concept; he lists indi¬ 
viduals and departments throughout the hospital and medical 
school who contributed to his section’s renaissance. He also 
thanks team members’ families for making their success possible. 
The section has grown with the addition of six physicians, six 
nurse-coordinators and a nurse-manager. Along with growth has 
come a reorganization that has increased the section’s respon¬ 
siveness to patient needs, Emre said. 
—Colleen Shaddox 
THE SCHOOL OF MEDICINE f 
ALUMNI BULLETIN 
Hunter Radiation Therapy 
Center Dedicated 
—Alumni Bulletin 
January 1959 
Program for Humanities 
in Medicine 
—Yale Medicine 
Spring 1984 
“The new Hunter Radiation Therapy 
Center was dedicated on Friday 
afternoon, October 10. Officials of 
the University and of the Grace- 
New Haven Community Hospital, 
faculty, staff, and guests attended 
the dedication ceremony, which was 
held in Fitkin Amphitheater with 
Dean Lippard presiding. 
“The program was opened with 
a welcome by George S. Stevenson, 
president of the hospital. President 
A. Whitney Griswold spoke briefly 
on “The Medical Center and Yale.” 
This was followed by the introduc¬ 
tion of Mr. Robert E. Hunter of Santa 
Barbara, California, who had made 
a generous gift to Yale for this build¬ 
ing. Mr. Hunter is a Yale alumnus, 
Class of 1911 (Sheffield Scientific 
School). The new center is named in 
memory of his parents, the late Mr. 
and Mrs. Edward S. Hunter.... 
“The four-story, brick-faced 
structure has its entrance on 
Davenport Avenue, and corridors 
connect with the adjoining hospital 
units. High-voltage equipment 
is below ground level. The two- 
million electron volt Van de Graaff 
deep therapy machine was given 
by the Donner Foundation. Three 
other radiation machines of lesser 
voltage are also available, and 
there are facilities for eventual 
inclusion of additional high-voltage 
equipment which may be develop¬ 
ed in the future.” 
“The School of Medicine recently 
received a grant from the Connect¬ 
icut Council for the Humanities 
in support of a new program for 
humanities in medicine. Directed 
by Dr. Howard M. Spiro, profes¬ 
sor of medicine, the program is 
presenting a series of twelve semi¬ 
monthly lectures throughout the 
spring and fall to bring together 
scholars in the humanities and 
members of the medical profession 
in discussions about the influence 
of the arts and letters on medicine 
and health. 
“Speakers include Dr. Robert 
Coles, professor of psychiatry and 
medical humanities at Harvard 
University; Arnold Rampersad, 
professor of English at Rutgers 
University; Arthur Caplan, associate 
for the humanities at the Hastings 
Center; and Dr. Martin Carey, 
associate professor of medicine, 
physiology and biophysics at 
Harvard University. They will dis¬ 
cuss topics as diverse as the phy¬ 
sician as a writer; the effects of 
health and well-being on art and 
visa versa; ethical issues in organ 
transplantation, and creativity 
and illness. 
“The purpose of the series, 
according to Dr. Spiro, is to encour¬ 
age medical students and profes¬ 
sionals to expand their definitions 
of health and disease through 
a better understanding of the 
cultural and intellectual influ¬ 
ences on health and well-being, 
as well as to stimulate scholars in 
the humanities to take a greater 
interest in health related issues. 
The lectures are open to the public 
without charge.” 
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Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
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Share your news on the reverse of this card and mail to: 
Claire M. Bessinger 
Institutional Planning and Communications 
Yale School of Medicine 
300 George Street, Suite 773 
New Haven, CT 06511 
Please include a photograph. 
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A LIFELONG LOVE OF YALE 
The relationship between Nicholas P.R. Spinelli, m.d. ’44, and Yale 
began in 1937, when he entered Yale College as a freshman. This 
early acquaintance blossomed through his years at the School of 
Medicine; in his career as a physician and educator; in his role as 
a leader of alumni; and in his later years, in philanthropy. 
Those who knew him say the same thing: No one loved the 
Yale School of Medicine more than Nick Spinelli. That love was 
expressed in many ways, most recently with a $4.5 million bequest 
that will support a professorship in neurology and a scholarship 
fund for medical students. 
Spinelli, who died in November 2007 at the age of 86, en¬ 
dowed the faculty position in the name of Harry M. Zimmerman, 
m.d., a neuropathologist during Spinelli’s student days who became 
the founding director of the Albert Einstein College of Medicine in 
the Bronx, N.Y. Spinelli funded the scholarships in keeping with his 
long practice of helping medical students. “He used to worry about 
how much it cost students to become a doctor, and said he didn’t 
know how they did it,” said his sister, Viola J. Spinelli, m.p.h. '65. 
Spinelli graduated from Yale College in 1941, began medical 
school later that year and, along with his classmates, was inducted 
into the Army. Upon his graduation in 1944, Spinelli served as 
an Army physician in Germany. In 1968 a heart condition forced 
Spinelli to give up his career as an internist, but he continued 
working as director of medical education at Bridgeport Hospital. 
He retired at age 65 and served as alumni director at the School 
of Medicine from 1985 to 1990. 
He received numerous awards, including the Yale Medal, 
; the university’s highest honor, and both the Distinguished Alumni 
Service Award and the Peter Parker Medal from the School of Medi¬ 
cine. But no award could match the satisfaction Spinelli received 
from his interactions with students and residents, said his sister Viola. 
—Michael Fitzsousa 
Nicholas Spinelli sponsored many students 
at the medical school, including several from 
Thailand. Kanya Suphapeetiporn graduated 
from the medical school in 2002 with both an 
m.d. and a ph.d. After a residency in Brooklyn, 
N.Y., she returned to Thailand. 
Yale Medicine 300 george street, suite 773, new haven ct 06511 
yalemedicine.yale.edu 
winter 2009 
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Rock ‘n roll, genes 
and mice 
n scientists 
me artists 
' ' 
Dean sii spring 2009 
200 Years of Medicine at Yale 
Cast your votes for the most significant events and personalities of the 
school’s first two centuries 
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on the cover In 1895medical 
students posed for a photo at an 
unknown location. Some wrote the 
year on the soles of their shoes with 
chalk, while others showed maca¬ 
bre humor by posing with skulls. 
Photograph courtesy of 
Cushing/Whitney Medical Library 
inside cover WhentheClass 
of 1954 posed for a photo on Match 
Day in the Historical Library, the 
student body largely comprised 
white men, although women had 
been in the school since 1916. In 
that year Louise Farnam, Helen 
Scoville and Lillian Nye became 
the first women to gain admission 
to the medical school. One thing, 
however, stood in their way—the 
lack of proper bathroom facilities. 
Farnam’s father, Henry Farnam, 
a professor of economics at Yale 
College, paid to provide “suitable 
lavatory arrangements.” With a 
few exceptions, until the 1960s no 
class counted more than 10 percent 
women among its members. The 
Class of 1998 was the first at the 
School of Medicine with more 
women than men. In almost every 
year since then, women have 
outnumbered men and become a 
ubiquitous presence on the wards 
and in laboratories. 
Photograph courtesy of 
Cushing/Whitney Medical Library 
inset At Commencement in 
2008, not only were there more 
women than men in the graduat¬ 
ing class, but the makeup of the 
student body reflected broader so¬ 
cietal changes, with more students 
from racial and ethnic minorities 
and, in an increasingly common¬ 
place sight, parents who brought 
their children to the ceremony. 
Yale Medicine 
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2 Letters 
Yale Medicine 
1 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or less) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Make premed courses 
more relevant 
One of the benefits that are sure 
to result from making the pre¬ 
med curriculum more relevant 
to medical practice [“Reform of 
Premed Education Underway,” 
Yale Medicine, Winter 2009] is 
that it will attract more students 
into primary care. 
Most medical schools are 
research-based and naturally 
favor students with outstanding 
aptitudes in basic science. This 
has produced many advances 
and well-trained specialists, and 
society has benefited immensely. 
The focus on specialization, how¬ 
ever, has also led to a serious 
shortage of primary care doctors. 
The lack of access to primary 
care has prompted policymakers 
to consider giving authority to 
nurse-practitioners to practice 
some aspects of primary care 
independently. 
In my 34 years of practice as a 
primary care doctor, I have found 
almost no use for the intense 
exposure I had in premed to cal¬ 
culus, organic chemistry, physics, 
invertebrate biology and physical 
chemistry. This is not to say that 
these courses were worthless, but 
they could have been abbreviated 
and simplified. 
I can remember several students 
in my premed class who struggled 
through the basic sciences. Their 
grades in the sciences were aver¬ 
age and they did not do well on the 
mcats. Turned down by medical 
0 
Online: Yale Netcasts 
Additional content for articles 
in this issue of Yale Medicine 
is available online at iTunesU, 
or by pointingyour browser 
toyalemedicine.yale.edu. 
schools at home, many attended 
foreign medical schools, as I did. 
The point is that the move to 
make premed courses more 
relevant is a good one. Perhaps 
students with the abilities to be 
good general practitioners will 
not be weeded out and eventu¬ 
ally the primary care physician 
shortage will be corrected. 
Edward J. Volpintesta, m.d. 
Bethel, Conn. 
Thanks for the photos 
from a fan of the big dig 
My 2-year-old son would like 
to thank you for the wonderful 
photos in your Winter 2009 issue 
["As the Medical Center Grows, 
So Grows the City,” Yale Medicine, 
Winter 2009]. He is a BIG fan 
of “dig, dig” and the ongoing 
projects at the medical center 
have given him much enjoyment 
over the past year. 
Sandra J. Bishop-Josef, ph.d. 
Assistant Director, Edward Zigler 
Center in Child Development and 
Social Policy; Associate Research 
Scientist, Child Study Center, Yale 
School of Medicine 
Article on physical exam 
recalls Klatskin’s skill 
I just received the Winter 2009 
edition of Yale Medicine and 
enjoyed a number of articles, 
including the roast of Yale’s 
"pathological triple threat.” Both 
I and my father, Wilbur G. Downs, 
m.d., m.p.h., much enjoyed 
our acquaintance with Michael 
Kashgarian, m.d. ’59, hs ’63. 
There was considerable 
mention of the Wilbur Downs 
International Health Travel 
Fellowship Program, as well as 
a nice piece about Curtis Patton, 
ph.d., professor emeritus of 
epidemiology. 
I myself am a fan of the 
Oxford English Dictionary and 
I’ve read The Professor and the 
Madman.... and so I enjoyed 
the article on William Minor. 
Additionally, as a practitio¬ 
ner of ER medicine, I am acutely 
aware of how technology has 
served to erode our physical 
exam skills. The article by Jill 
Max was very apropos and I 
admit I had forgotten about the 
Adson maneuver. One of the 
professors of my era, Gerald 
Klatskin, m.d., could percuss out 
a liver edge or a heart border 
such that a student across the 
room could hear it. 
Monty Downs, m.d. '70 
Kapaa, Hawaii 
Writing award for 
Yale Medicine editor 
In February we learned that 
John Curtis, managing editor of 
Yale Medicine, had received the 
Award for Excellence in General 
Staff Writing from the Group 
for Institutional Advancement 
of the Association of American 
Medical Colleges. Curtis received 
the award for his feature article 
in the Winter 2008 issue, "On 
the Wards in Uganda." To report 
on an ongoing collaboration 
between Yale and Makerere 
University in Kampala, Curtis 
spent two weeks shadow¬ 
ing Yale attendings, residents 
and medical students as they 
worked alongside Ugandan 
colleagues at the government- 
run Mulago Hospital. He also 
accompanied them on field 
trips to camps for internally 
displaced persons in northern 
Uganda and to the fishing 
village of Kasensero on Lake 
Victoria, where Uganda’s aids 
epidemic began. 
starting point 3 
World events bring change to Yale and to Yale Medicine 
Changes—some long-planned, others arising of necessity—are in the air for Yale Medicine. For 
more than a year we’ve been contemplating a redesign of the magazine. In the nine years since 
the last redesign, as some sections and pages have begun to show their age, we have seen a need 
to bring variety and flexibility to them. Our first step will be to survey our readers to ask what you 
like—or don’t like—about the magazine. Many of you should expect to receive a survey, by mail 
or e-mail, in the coming weeks. 
Then came word last December that the global economic crisis had reached the university, 
reducing its endowment by a quarter and requiring cuts in spending. In February came another 
announcement—the crisis was more severe than anticipated and belts would have to be pulled 
even tighter. 
The School of Medicine is not immune to these events. To meet requests to reduce spend¬ 
ing, we are scaling back on Yale Medicine. We are still looking at ways to cut back, but options 
include shrinking the magazine from our current size of 48 pages for the winter and spring 
issues and 64 for the autumn issue to a standard 32 pages for all three issues. Or we may cut 
back from three issues a year to two. These changes will drive our redesign; and sadly, we’ll see 
the reduction or elimination of certain pages and sections. 
Despite these changes we will continue to produce what we consider a first-rate publica¬ 
tion, with compelling stories about the medical school and the issues and events that affect it. 
We hope that Yale Medicine will continue to engage you and help you to maintain your ties to 
the School of Medicine. 
John Curtis 
Managing Editor 
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chronicle news from cedar street 
A first term marked 
by progress and growth 
With kudos from Yale’s president 
and his peers, Robert Alpern signs on 
for another five-year term as dean. 
When Robert Alpern was appointed 
dean in 2004, his vision for the School 
of Medicine was to build programs in 
education, research and clinical care to 
rival the best in the world. “Yale already 
has many outstanding programs in 
these three arenas that are likely among 
the best, but no medical school is perfect 
in all aspects,” he said in an interview 
from Dallas, where he was then dean 
of the University of Texas Southwestern 
Medical School. “We will identify our 
priorities for program improvement and 
then move forward.” 
Coming to Yale with a reputation 
for being at once easygoing and ambi¬ 
tious, the new dean rallied faculty, set 
priorities and vowed to build an already 
formidable institution into something 
even greater. In the dozen years preced¬ 
ing his arrival, the medical school had 
slipped from third to nth in the annual 
U.S. News and World Report survey and 
from third to eighth in funding by the 
National Institutes of Health. By March 
2009, however, it had moved back up 
several rungs on both lists. 
While Alpern discounts rankings as 
often-flawed indicators of quality, he rec¬ 
ognizes that they reflect how the school 
is perceived. Much more important are 
the real accomplishments of the faculty; 
by that yardstick, he said, the school is 
“soaring.” He credits his leadership team 
and says that the real proof of quality can 
be seen in the creation of new programs 
that lift Yale above its peers. Among them 
are multidisciplinary groups focused on 
cellular neuroscience, neurodegeneration 
and repair, stem cell biology, human and 
translational immunology, and cell biol¬ 
ogy. The school has also seen continued 
growth in areas where it already excelled, 
such as genetics, immunobiology and 
internal medicine. 
Alpern has also expanded the clini¬ 
cal practice and the school’s capacity 
to conduct clinical research. In 2006, 
the School of Medicine won a land¬ 
mark grant under the nih Clinical and 
Translational Science Awards (ctsa) 
Program. The $57 million grant—Yale’s 
largest ever—has been critical in build¬ 
ing infrastructure linking the school’s 
research base to the clinical practice. 
One of the clinical initiatives is a 
new transplant program with outstand¬ 
ing liver and kidney components. A new 
chief of cardiology arrived last summer 
and is building the section’s strength in 
interventional cardiology, heart failure, 
electrophysiology and basic research. 
The Smilow Cancer Hospital is set to 
open in the fall, and in February Alpern 
named a new director for Yale Cancer 
Center. Five biomedical institutes and 
three new core facilities are planned for 
the West Campus. 
In announcing Alpern’s second term 
in February, Yale President Richard 
C. Levin said that faculty and staff are 
enthusiastic in their support for the 
dean. Levin went on to say that Alpern 
had “transformed the school’s relation¬ 
ship with Yale-New Haven Hospital 
(ynhh), a profound change that will 
have a lasting impact on the school’s 
clinical mission.” 
“To take a school as good as Yale 
and make it better is exciting, and we’ve 
come a long way,” Alpern said. “The 
reason I’ve signed on for another five 
years is to continue that ascent.” 
—Michael Fitzsousa 
o 
Online: Yale Netcasts 
Robert Alpern: Vision for the School of Medicine 
In his five years as dean, Robert Alpern has over¬ 
seen an expansion of the medical school’s space, 
the addition of new programs and an increase in 
grants and contracts from the National Institutes 
of Health. In February, he was appointed to a 
second five-year term. “To take a school as good 
as Yale and make it better is exciting, and we’ve 
come a long way,” Alpern said. 
Yale obesity expert lauds 
New York tax dedicated to 
health programs 
When Kelly Brownell, ph.d., published 
an op-ed piece in The New York Times in 
1994 pioneering a tax on junk food, he 
became the focal point of a nasty contro¬ 
versy. Rush Limbaugh lashed out at the 
notion of the government telling people 
what to eat, and Brownell accumulated 
“a very thick file of angry letters. I got 
things from people saying, ‘We know 
where you live and we’re going to drive 
you right into the New Haven Harbor,’ ” 
Brownell said. 
But he stood firm, and this year he 
has seen a glimmer of hope in New 
York Gov. David Paterson’s recent pro¬ 
posal for an 18 percent tax on non-diet 
soda and sugary beverages containing 
less than 70 percent real fruit juice. 
Paterson’s plan is the highest tax ever 
proposed on food, and the estimated 
$404 million in revenue it could gener¬ 
ate in its first year would fund public 
health programs, including obesity 
prevention. If the proposal survives 
a comprehensive legislative and public 
review of Paterson’s budget, it could be 
adopted as early as April. 
“It’s a whole new kettle of fish right 
now,” said Brownell, professor of psychol¬ 
ogy and epidemiology, and director of the 
Rudd Center for Food Policy and Obesity 
at Yale. He cited the troubled economy, 
mounting research linking soft drink 
intake to health issues and a growing 
concern about child obesity. “I think the 
social situation has changed enough that 
these taxes are going to happen at some 
point. Once the door opens, 1 would 
expect there will be a flood of others 
wanting to go through it.” 
The tide may be turning already. 
While many New Yorkers and repre¬ 
sentatives of the beverage industry 
are highly critical of Paterson’s tax, 
Brownell has had calls from advocates 
in two other states that he said may soon 
go public with similar proposals. 
Over the years, the “fat tax” has also 
surfaced as a “snack tax,” a “Twinkie 
tax” and a “miracle tax diet,” but rarely 
has it gotten off the legislative floor. 
California, Maine and Maryland all 
passed taxes of about 4 to 5 percent, 
and all later repealed them, mostly in 
response to food industry resistance. 
Smaller taxes on junk food in more than 
a dozen other states have been too insig¬ 
nificant to drive down consumption 
or spark a fight with the food industry, 
Brownell said. 
New York’s proposed soda tax is 
exactly the kind of food tax Brownell 
Kelly Brownell 
favors, because the potential revenue 
would be dedicated to health-related pro¬ 
grams, and he applauds Paterson’s bold 
approach. “I give the governor credit 
for proposing a large tax and not pussy¬ 
footing around. It makes sense to tackle 
this aggressively,” he said. 
More than any other food category, 
sugared beverages have been linked to 
poor diet, a higher rate of obesity and 
increased risk of diabetes. Studies also 
suggest that an 18 percent increase in 
price would drive consumption down by 
about 15 to 18 percent. “If consumption 
of sugared beverages goes down, that 
could have a whopping effect on public 
health,” Brownell said. 
—Kathy Katella 
Online: Yale Netcasts 
Kelly Brownell: Human Food Cravings 
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6 chronicle 
Internal medicine continues 
outreach with focus on “human 
infrastructure” abroad 
For nearly three decades, the School of 
Medicine’s international health program 
has provided career-changing experi¬ 
ences for medical residents by sending 
them to developing countries. Now Yale 
is taking the Yale/Johnson & Johnson 
Physician Scholars in International 
Health Program a step further by 
developing “human infrastructure” 
at partner sites. 
Rather than helping only American 
doctors develop a sense of global citizen¬ 
ship and commitment to caring for the 
poor, the program has made ambitious 
plans to build the long-term capabilities 
of its sites abroad. The program, which 
typically sent American doctors to as 
many as 15 foreign sites, now focuses on 
only six. A sense that Western institu¬ 
tions had profited asymmetrically from 
a brain drain from developing coun¬ 
tries—a realization prompted in part by 
increased international communication 
among researchers in the aids era— 
drove the change. 
“It became clear that we as faculty 
and Yale as an institution have an obli¬ 
gation ... to people all over the world,” 
said Asghar Rastegar, m.d., new director 
of the international health program, 
which has partnered with Johnson & 
Johnson since 2001. Based in part on 
Rastegar’s own experience as a faculty 
member at Shiraz University in Iran, 
the redesign emphasizes bilateral ben¬ 
efits and long-term in-depth commit¬ 
ment. Physicians in the program now 
serve in the host country as both learn¬ 
ers and teachers; and they bring equip¬ 
ment and materials with them, helping 
the site itself expand its capacity to care 
for the sick. In turn, the host countries 
send physicians on learning trips to 
the United States. 
The pilot program, developed by 
Majid Sadigh, m.d., associate professor 
of medicine, is in Kampala, Uganda, at 
Mulago Hospital, the teaching hospital 
of Makerere University. The hospital 
has a ward staffed full time by Yale fac¬ 
ulty and residents working side by side 
with their colleagues from Makerere, 
and sends physicians to New Haven 
for specialty training. Fred Okuku, 
m.d., a resident physician, spent six 
months at Yale learning to perform 
mammograms and ultrasounds, then 
Asghar Rastegar 
returned to Uganda with the training 
and equipment—a mobile mammogra¬ 
phy van—to diagnose early-stage breast 
cancer. The inexpensive cancer treat¬ 
ment available at Mulago—surgery— 
will save lives that would otherwise have 
been lost to a late diagnosis. 
Though the program has slimmed 
from 15 sites to just six, those six—in 
Eritrea, Honduras, South Africa, 
Uganda, Liberia and Indonesia—are 
being transformed by the new philoso¬ 
phy. At Tugela Ferry, South Africa, a site 
directed by Gerald H. Friedland, m.d., 
professor of medicine, and devoted to 
research on and care of patients with 
hiv and tuberculosis, the husband-and- 
wife team of Scott Heysell, m.d., m.p.h., 
and Tanya Thomas, m.d., is spending a 
year at the local hospital. In war-ravaged 
Liberia, Yale has joined five American 
medical schools in a collaboration with 
the John L. Kennedy Medical Center. 
And Rastegar is working with Eritrea’s 
first medical school to develop an inter¬ 
nal medicine residency there. 
The international health program 
outreach continues to expand, sponsor¬ 
ing classes in international medicine for 
medical, nursing and physician associ¬ 
ate students interested in global health. 
These projects, said Michele Barry, m.d., 
hs ’77, a longtime co-director of the 
program who stepped down in March to 
become senior associate dean for global 
health at Stanford University, will bring 
fresh hope to caregivers in the sites’ low- 
resource communities. “I think there 
is a role for us to really stop the brain 
drain—to stop people like Bred Okuku 
from thinking he only has a hospice,” 
Barry said. 
—Jenny Blair 
7 
Recommendations for rest 
periods for residents meets 
with skepticism 
For decades, doctors in training have 
endured long hours and sleepless nights 
during residency. Due to concerns that 
their resultant fatigue might harm 
patients, in 2003 an 8o-hour limit 
on weekly duty hours, along with a 
30-hour limit on work periods, became 
mandatory for hospitals approved by 
the Accreditation Council for Graduate 
Medical Education. But a recent report 
by the Institute of Medicine (iom) rec¬ 
ommends stricter duty-hours rules that 
would allow residents more rest, while 
calling for stronger enforcement of exist¬ 
ing rules. 
Issued in December, the iom report 
is the work of a committee of physicians 
and sleep experts that examined studies 
on the relationships among duty hours, 
sleep physiology and patient safety, 
including some research done since the 
2003 changes. The committee concluded 
that the evidence was “nascent... but 
sufficient to recommend action now.” 
It proposed, among other changes, that 
residents working 30-hour periods pause 
on or before the 16th hour for five hours’ 
rest, and that they be granted an uninter¬ 
rupted 48 hours each month to catch up 
on sleep. The 80-hour weekly maximum 
would remain in effect, as would such 
other 2003 rules as 10 hours off after a 
work day. 
Yale educators, however, have reserva¬ 
tions about the report. Peter N. Herbert, 
m.d. ’67, hs ’69, senior vice president 
of medical affairs at Yale-New Haven 
Hospital, called it “disappointing,” citing 
the scarcity of evidence that scheduling 
of duty hours affects patient safety. “It 
reflected, to many of us, a confusion 
about what their purpose was,” Herbert 
said. “It would probably be much more 
worthwhile to look at what work hours 
and schedules do to resident education.” 
“We’re certainly philosophically on 
board with believing that rested, clear- 
thinking people provide better care,” 
said Stephen J. Huot, ph.d. ’81, m.d. 
’85, hs ’87, chair of the primary care 
internal medicine residency. But, he 
said, these well-intended changes might 
actually jeopardize patients, since they 
would require more frequent handoffs of 
patient care and might diminish access 
to care at some medical centers. 
Academic neurosurgeons greeted 
the report with dismay. Neurosurgical 
operations last longer than other types 
of surgery, said Dennis D. Spencer, 
m.d., hs ’77, chair of the department, 
requiring longer and more flexible 
duty hours. “The 16-hour shift with 
the 10-hour-at-home rule means that 
our chief residents will never be able 
to come back to the hospital and see 
patients they may have operated on, or 
they will be unable to come to the hos¬ 
pital the next day,” Spencer said. “They 
will never learn responsibility for their 
patients and they will erode the mentor/ 
student bond with attending faculty 
who are attempting to give them more 
responsibility. This destroys one of the 
main competencies we are supposed to 
be teaching—professionalism.” 
Though the iom committee esti¬ 
mated that the cost of adopting its rec¬ 
ommendations could reach $1.7 billion 
annually, it recommended that these 
changes be adopted within two years. 
Whether or not the new rules are 
adopted, the culture change alone 
implied by a 16-hour work period—a 
move toward shift work—has some 
physicians worried. Continuity of care 
and teaching a physician to “own” a 
patient, said Dean Robert}. Alpern, 
m.d., Ensign Professor of Medicine, are 
valuable lessons. “This focus on work 
hours has removed that culture from 
medicine,” he said. “Nobody seems to 
be concerned about where we’re headed 
with this loss in continuity of care.” 
“We need to figure out how to 
continue to instill a sense of complete 
responsibility for the care of your 
patient—putting the patient’s needs 
above your own needs and do so in an 
educational system that allows you to 
still function as a person,” said Huot. 
-J.B. 
MEDICAL CAMPUS GETS GREEN AWARD 
The Amistad Street Building has received a 
gold “greenness” rating from the U.S. Green 
Building Council’s Leadership in Energy and 
Environmental Design program. Among 
the “green” features is a 7,500-gallon tank 
that recycles storm water collected from 
the roof. Additional features include labora¬ 
tory cabinetry made from wood produced 
in sustainable forests, a heat recovery system 
and energy-efficient bulbs and occupancy sen¬ 
sors that help cut-electricity use. Recycling of 
renovation debris reduced construction waste 
by 70 percent. 
The project, which provides laboratory 
space for the Interdepartmental Program 
in Vascular Biology and Therapeutics, the 
Yale Stem Cell Center and the Human and 
Translational Immunology Program, was 
built around the existing shell and core of 
the building. 
“This project presented all the challenges 
one typically finds when striving to build 
sustainably in an existing building,” said 
Virginia Chapman, director of construction 
and renovation for the School of Medicine’s 
facilities office. “But we made it work—and 
work rather well.” 
—Charles Gershman 
ECONOMIC SITUATION WORSENS FOR YALE 
In an e-mail to the Yale community in Feb¬ 
ruary, President Richard C. Levin said the 
deteriorating economic situation would re¬ 
quire budget cuts beyond those he had called 
for in December. “The mounting evidence 
suggesting a prolonged recession has caused 
us to recognize that we need to take a more 
aggressive approach to budget reductions for 
the coming fiscal year,” Levin wrote. 
Levin called for cuts in all 2009-2010 bud¬ 
gets by an amount equal to 7.5 percent of the 
salaries and benefits of all non-faculty staff 
and a 7.5 percent reduction in non-salary 
expenditures, up from the 5 percent he had 
called for in December. These measures could 
save $37 million in next year’s operating bud¬ 
get, Levin said. But, he added, "... if external 
con ditions deteriorate significantly, we may 
be required to take further action next year.” 
—John Curtis 
Y
al
e 
M
ed
ic
in
e 
s
p
ri
n
g
 
2
0
0
9
 
Rounds MEDICINE AND HEALTH AT YALE 
Pediatric aids clinic 
reports success 
Drug protocols and other measures 
prevent Hiv-positive births in New 
Haven for more than 12 years. 
Born Hiv-positive, for 20 years “John” 
relied on the Yale Pediatric aids Clinic 
to keep him healthy. That meant visits 
every three months and treatment that 
was literally hard to swallow. But John 
says he “loved every minute” of his time 
at the clinic because he could rely on the 
staff, even when the problem was not 
medical. For example, the clinic helped 
him find housing as a teen when his 
mother left the state. 
Now a junior at Southern Connecticut 
State University, he is making plans for 
graduate school. He calls to let everyone 
Pediatrician Warren Andiman has been treat¬ 
ing children with aids since the earliest days 
of the epidemic. Thanks to a protocol he has 
established, not a single baby has been born 
Hiv-positive in New Haven in more than 12 years. 
at the clinic know what’s going on in his 
life, but he gets his hiv care at an adult 
clinic, where he is likely to visit three 
times a year. Increasingly sophisticated 
blood testing lets doctors fine-tune his 
medications to prevent resistance to 
antiretrovirals. 
As patients like John transition into 
adult care, few new cases replace them. 
No woman known to be Hiv-positive has 
passed on the virus to her baby in New 
Haven since 1996. The protocols for 
preventing mother-to-child transmission 
are so effective that the only Hiv-positive 
infants delivered in the city over the 
past 13 years were born to mothers who 
had not been not diagnosed themselves. 
“We have literally been putting 
ourselves out of work,” said Warren A. 
Andiman, m.d., fw ’76, professor of 
pediatrics and epidemiology and pub¬ 
lic health, and medical director of the 
Pediatric aids Program. An infectious 
disease specialist, Andiman began car¬ 
ing for Hiv-positive infants in 1982. 
In the first few years, his young patients 
died protracted and miserable deaths, 
often by age 6. “There’s no way to de¬ 
scribe what it was like,” he said. 
Today mother-to-child transmis¬ 
sion is a rarity in the developed world. 
Nationwide, the rate is less than 2 per¬ 
cent, which Andiman attributes to “will 
and money.” 
Widespread hiv testing allows doc¬ 
tors to identify women who may pass the 
virus on to their babies. Any Hiv-positive 
pregnant woman in the area gets referred 
to Yale’s High-Risk Maternity Program 
or a parallel program at the Hospital 
of St. Raphael, both of which work 
closely with the Pediatric aids Program. 
Such measures as giving mothers 
antiretrovirals during the pregnancy 
and administering azt to mothers dur¬ 
ing labor and to newborns have proven 
successful, along with, in certain cir¬ 
cumstances, performing caesarean sec¬ 
tions and discouraging breast feeding. 
Connecticut mandates that every 
pregnant woman be offered hiv test¬ 
ing twice. She can be offered testing 
again during labor. If she refuses, 
a newborn can be tested over her 
objections. In practice, almost all the 
mothers welcome testing. 
During an Hiv-positive woman’s 
pregnancy, older children or sex part¬ 
ners may be diagnosed and get treat¬ 
ment. The woman will be connected 
with the adult aids clinic and social 
workers will address a wide range of 
practical and emotional issues. “It’s 
a sort of seminal period, a moment 
when all kinds of worthwhile stuff can 
happen," said Andiman. 
So much good stuff has happened at 
the Pediatric aids Clinic that Andiman 
expects it to close in the next couple 
of years. The few remaining patients 
can be transitioned to the Pediatric 
Infectious Disease Clinic, “aids is an 
infectious disease just like many other 
infectious diseases,” Andiman said. 
—Colleen Shaddox 
A revitalized trauma section 
increases staff and improves 
care in emergency cases 
On February i6, 2007, Quinnipiac 
University senior Benjamin Shapiro 
was driving down a secondary road in 
Hamden, Conn., at about 1 a.m. when 
his car slid across four lanes of traffic, 
crashed through a chain-link fence, 
flipped over a concrete barrier, slid down 
an embankment and landed in the 
Mill River. He spent the next 20 min¬ 
utes submerged in icy water. 
“When they pulled him out of the 
water there was no heartbeat, no pulse, 
nothing,” said Shapiro’s stepmother, 
Joan Abrams. Shapiro had suffered a 
brain injury, the bones in the left side 
of his face were crushed and his left 
eyeball was hanging by a tendon. 
Doctors put his chances of survival 
at well below 10 percent. 
The Department of Surgery’s Section 
of Trauma, Surgical Critical Care and 
Surgical Emergencies, which was 
recently revamped under the direction 
of Kimberly A. Davis, m.d., was pre¬ 
pared to deal with an emergency of 
this magnitude. 
“Everyone who is a full-time mem¬ 
ber of this section is board-certified or 
eligible in both general surgery and 
surgical critical care,” said Davis, who 
took over as section chief in June 2006. 
“With attending-level surgeons in the 
hospital at all times, we can take care 
of anything that comes our way, 24/7.” 
This also means faster evaluation and 
response times and improved commu¬ 
nications between caregivers as well as 
with family members. 
“With Kim’s appointment, our 
Level 1 trauma center has become a 
comprehensive acute care service, where 
physicians are able to function in all 
three areas: urgent general surgery, 
critical care and trauma, and that has 
made a huge difference in our service 
to the community,” said Tucker Leary, 
vice president of administration at 
the hospital. 
Under Davis, the number of surgeons 
has nearly doubled, to seven full-time 
surgeons providing trauma, critical care 
and emergency surgery. Davis is plan¬ 
ning to fill an eighth position soon. She 
also initiated a weekly meeting to review 
cases and discuss what worked and what 
might have been handled differently. 
And the investment is paying off. 
The year before Davis’ arrival, the sec¬ 
tion evaluated 2,550 patients and admit¬ 
ted 1,650. In 2007-2008, 3,800 trauma 
patients were evaluated and 2,400 were 
admitted. The survival rate of trauma 
center patients is 95.6 percent, above the 
national average of 94 percent. 
One of those survivors is Shapiro, 
who spent nine days in a medically 
induced coma, followed by surgery to 
rebuild his face and save his eye. He 
was able to return to Quinnipiac as a 
full-time student and graduated with his 
class that May. 
“I look back on the day of my acci¬ 
dent and as horrible as it was, I view 
it as the single best day of my life,” he 
said. “Now, whenever someone says to 
me, ‘How are you doing?’ I can always 
say, ‘Great.’ ” 
—Jennifer Kaylin 
A newly revamped trauma section has seen a 
doubling of the number of surgeons who provide 
trauma, critical care and emergency surgery and 
an increase in the number of patients evaluated 
and admitted. 
LOST IN TRANSLATION 
Even as the number of Americans with limited 
English-language proficiency has continued 
to grow, many physicians try to get by with 
their own limited foreign-language skills or by 
relying on a patient’s friend or family member, 
according to research conducted in part by the 
School of Public Health. 
The study, published online in the Journal 
of General Internal Medicine in December, 
found that increasing the use of interpreters 
by hospital physicians will require “substan¬ 
tial" changes in hospital practice. “Residents 
found it difficult to change their practice, 
despite misgivings about the quality of care 
provided,” said Lisa Diamond, m.d., m.p.h., 
a Robert Wood Johnson Foundation Clinical 
Scholar and lead author of the study, who 
is now at the Palo Alto Medical Foundation 
Research Institute in California. Research has 
shown that language barriers can lead to 
decreased access to preventive services, poor 
understanding of instructions for medications, 
longer hospital stays and an increased risk of 
medical errors and misdiagnoses. 
—John Curtis 
ELDERLY WANT SAY IN TREATMENT 
Elderly patients with multiple medical con¬ 
ditions want to be involved in their treat¬ 
ment decisions, Yale researchers reported 
in the Journal of the American Geriatrics 
Society in October. 
About 65 percent of older Medicare benefi¬ 
ciaries have at least two chronic conditions, and 
24 percent have four or more. These patients 
face what are called “competing outcomes”— 
complex choices presented when the treat¬ 
ment for one condition could worsen another. 
Medicine for elevated cholesterol, for example, 
may cause leg cramps that prevent a patient 
from doing exercises that reduce arthritis 
symptoms. 
Study author Terri R. Fried, m.d., associ¬ 
ate professor of medicine (geriatrics), and 
her team conducted 13 focus groups with 66 
people age 65 and older who had an average 
of five chronic conditions and took an average 
of seven medications. When faced with com¬ 
peting outcomes, Fried said, “They chose the 
treatment option that would maximize the 
likelihood of their most desired outcome.” 
—J.C. 
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IO Findings from the bench 
A molecule that puts 
the brakes on appetite 
Yale scientists find a family of 
phospholipids that curb the desire 
to eat in rats and mice. 
That heaping pile of golden crisp French 
fries looks delectable, but polishing 
off the plate may be a tall order. New 
research from Yale scientists sug¬ 
gests that a family of phospholipids 
tells the brain when an animal has 
had its fill of fat—findings that help 
explain the physiologic mechanism 
that wards off a deep-fried feeding 
frenzy. And these phospholipids, called 
N-acylphosphatidylethanolamines, 
or napes, may hold the key to new 
treatments for obesity. 
The human body has several built- 
in systems that keep us from stuffing 
\ 1 / , 
ourselves silly. Leptin, for example, tells 
the brain to put the brakes on eating 
when fat stores are abundant. Now a 
team led by Gerald I. Shulman, m.d., 
ph.d., the George R. Cowgill Professor 
of Physiological Chemistry, professor 
of medicine and of cellular and molec¬ 
ular physiology and a Howard Hughes 
Medical Institute investigator, has identi¬ 
fied a new class of appetite-suppressing 
molecules—the napes—that become 
synthesized in rats after a high-fat 
meal, as reported in November in the 
journal Cell. 
The researchers teased apart the 
function of napes by synthesizing the 
most physiologically abundant nape 
and injecting it into rodents. They found 
that the higher the concentration of the 
phospholipid, the less the rodents ate. 
Furthermore, like someone sitting back 
after a feast, the NAPE-injected mice 
lounged about and groomed themselves 
even though they ate only a mini-meal. 
Shulman’s group discovered that 
napes, like certain other chemicals 
that help to control appetite, exert their 
effects via the central nervous system. 
They appear to be synthesized in the 
small intestine after a high-fat meal 
but they then get dumped into the 
blood and lymphatic system, putting 
them on a fast track to the brain. When 
Shulman’s team injected nanomolar 
amounts of nape directly into rodent 
brains, it slashed the animals’ appe¬ 
tites by more than 50 percent and shut 
down the activity of npy neurons, 
which stimulate appetite. 
On a roll, the researchers decided to 
treat the rats with nape for five straight 
days. They found that the rodents ate 
30 percent less food and shed a signifi¬ 
cant amount of weight. 
The race is now on to see whether 
these rodent findings translate to 
humans. Shulman’s team is investigating 
nape regulation in humans following 
feeding, and the researchers soon plan 
to treat monkeys with napes to observe 
the effects on appetite. Provided those 
studies pan out, Shulman is eager to see 
whether napes can reduce food intake in 
humans. If they do, napes could serve as 
the basis of novel appetite-suppressant or 
obesity-fighting drugs. “Obesity is a major 
health problem, and we have very few 
treatments available,” Shulman said. “We 
are always looking to better understand 
appetite regulation, and napes may be a 
new physiological regulator of appetite.” 
—Kara A. Nyberg 
“Dry cleaning" effect—research 
shows how mice, and people, 
work on autopilot 
By watching mice navigate a custom- 
designed swimming pool, Christopher 
Pittenger, m.d., ph.d., assistant profes¬ 
sor of psychiatry, has discovered an 
ongoing competition between one part 
of the brain devoted to active seeking 
and another part devoted to mindless 
cruising. These two sections of the 
brain, his research shows, can inhibit 
each other, depending on the task at 
hand or, in this case, at paw. The com¬ 
petition, which likely occurs in people 
as well, may explain why it can be so 
hard to alter set routines, and could 
explain the power of such unwanted 
habits as drug addiction or obsessive- 
compulsive behaviors. 
Pittenger’s study found that two 
parallel learning and memory systems 
| that reside in different parts of the 
brain can block each other’s functions. 
The striatum powers up when—as if 
on autopilot—we embark on a well- 
known route like driving to work. The 
hippocampus comes into play when 
we need to think about where we’re 
going, as when we’re looking for a new 
address or detouring for an errand. (The study found that when one system 
is impaired, the other is enhanced: in 
mice, injuring the striatum made the 
animals worse at locating a visual target 
in a water maze, but better at more 
active hippocampus-based navigational 
skills, and vice versa. 
This reciprocal inhibition may 
explain the difficulty many people 
1 have in breaking from an entrenched 
routine. “This is why I cannot, for the 
life of me, remember to drop off my 
dry cleaning on the way to work,” said 
Pittenger, whose findings were pub¬ 
lished in October in Proceedings of the 
National Academy of Sciences. 
“When you have driven the same 
route many times and are doing it 
on autopilot, it can be really difficult 
to change. If I’m not paying enough 
attention right at that moment, if I am 
thinking about something else, I just 
sail right on by.” 
On a more serious note, the findings 
may also help explain the behavioral 
peculiarities seen with some brain dis¬ 
eases. Alzheimer disease, for example, 
destroys hippocampal function. That 
may be why many people with this 
disease fall back on old behaviors, like 
repeatedly returning to a previous 
address, thinking it is still home. Other 
diseases, including obsessive-compulsive 
disorder (ocd) and Parkinson disease, 
involve striatal malfunction. Pittenger’s 
new results emphasize that this striatal 
malfunction is likely to lead to changes 
in the function of the hippocampus, too, 
which may either compensate for or 
exacerbate the symptoms of the disease. 
Understanding the connections 
between memory systems may offer 
new ways to treat serious behavioral 
problems. “A lot of psychiatric diseases 
are characterized by recurrent, mal¬ 
adaptive patterns of thought or behav¬ 
ior,” says Pittenger, who is also director 
of the Yale Obsessive-Compulsive 
Disorder Research Clinic. “People with 
ocd or drug addiction just keep doing 
the same thing and can’t seem to stop, 
no matter how hard they try.” 
Treatment for ocd often includes 
cognitive behavioral therapy, which works 
by engaging a more reflective thinking 
mode to try to control automatic behav¬ 
iors. Pittenger speculates that the process 
may work by recruiting one brain region 
to overcome an excess in the other. If so, 
it might be possible to develop drugs to 
make cognitive therapy more effective by 
enhancing or balancing the activities of 
the striatum or hippocampus. 
It’s quite a leap from mice paddling 
in a pool to human disease, Pittenger 
said, but learning how basic normal 
memory systems work in animals is an 
important first step. 
—Pat McCaffrey 
BIOMARKER FOR LUNG CANCER RISK 
A genetic variation could explain why some 
people have a greater risk of developing lung 
cancer, Yale scientists reported in the journal 
Cancer Research in October. 
“Only 10 percent of smokers will develop 
lung cancer in their lifetime, and genetic test¬ 
ing to determine the population of smokers 
who are most predisposed to develop the dis¬ 
ease is needed to help guide better evaluation 
for these people,” said Joanne B. Weidhaas, 
m.d., ph.d., assistant professor of therapeutic 
radiology at Yale. She was senior author of the 
study, in collaboration with Frank Slack, ph.d., 
associate professor of molecular, cellular and 
developmental biology. 
“We looked for the effects of genetic vari¬ 
ations within a human oncogene known to be 
affected by tiny rna molecules called micro- 
RNAs,” said Slack, explaining their discovery of 
the biomarker. These variations, called single 
nucleotide polymorphisms, predicted a signifi¬ 
cant increase in non-small-cell lung cancer risk 
in people with a moderate smoking history as 
well as in nonsmokers. 
—John Curtis 
YALE PAPER AMONG BEST OF 2008 
An article by Yale scientists on the formation of 
cell membranes has been named one of the top 
scientific papers of 2008 by the journal Nature. 
The paper, published in Cell in March 2008, 
explored how cells shape their membranes 
into tubes, spheres and other curved struc¬ 
tures that they need in order to move, com¬ 
municate and reproduce. Scientists including 
Vinzenz M. Unger, ph.d., associate professor 
of molecular biophysics and biochemistry, 
m.d./ph.d. student Adam Frost and Pietro De 
Camilli, m.d., the Eugene Higgins Professor 
of Cell Biology and Neurobiology, established 
how banana-shaped proteins called f-bar 
domains form curved scaffolds that allow cell 
membranes to assume those forms. 
Using a combination of cryoelectron 
microscopy and cell biology experiments, 
the team found that f-bars accumulate side 
by side on flat membranes until attractive 
forces cause them to turn onto their tips en 
masse and pull the now-curved membrane 
into shape. 
—Peter Farley 
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Books & ideas bookshelf 
Uncovering the toxins in our daily lives 
A new book by a lecturer in public health describes what’s 
safe and what’s not in household products. 
Toxicologist Gary Ginsberg, ph.d., has good news about the 
environmental contaminants we encounter in our daily lives. 
“One of the major myths is that the environment is worse 
than it’s ever been,” said Ginsberg, the senior toxicologist at 
the Connecticut Department of Public Health and a lecturer at 
the Yale School of Public Health. “As a matter of fact, a lot of 
things are better now than they ever were.” 
For instance, pesticides used in farming are less hazardous 
and less persistent than the banned chemicals of the 1950s, 
1960s and 1970s. Paint and gasoline no longer contain lead. 
Asbestos has been phased out of building materials, and intact 
asbestos can be safely left in place. And although a stagger¬ 
ing number of people are worried about mold in homes and 
schools, Ginsberg said that humans have lived with mold for 
millennia, and the fungus is unlikely to cause lung damage. 
“It’s a crop you don’t want to grow in your house, but it’s some¬ 
thing you shouldn’t freak out about.” 
Still, research and reporting regularly bring to light serious 
risks from toxic chemicals, said Ginsberg, “and the headlines 
don’t answer the specifics of your situation." To help the public 
distinguish between major and minor risks, Ginsberg collabo¬ 
rated with health department colleague Brian Toal, m.s.p.h., to 
write a guide, What’s Toxic, What’s Not, published in 2006. 
“Rather than answer questions one phone call at a time, we 
decided we would try to put it all together in a somewhat ency¬ 
clopedic but accessible way,” said Ginsberg. He and Toal con¬ 
sidered a range of potential hazards: hormones in hamburgers, 
carcinogens in bubble bath, toxic fumes from overheated Teflon 
and volatile chemicals in toilet cleansers and drain uncloggers. 
(Ginsberg said that using harsh cleaners is “like using the 
atom bomb to clean the bathroom.” He recommends hot water 
and detergent instead.) The authors discuss power lines, toxic 
waste dumps and cancer clusters. 
Ginsberg cites the top five risks Americans face as radon 
gas, indoor air pollution, mercury in fish, lead paint and carbon 
monoxide. The book advises readers to test for carcinogenic 
radon gas at home and to vent appliances and woodstoves prop¬ 
erly, to burn only dry hardwoods and to clean chimneys regu¬ 
larly. Because most fish contain mercury, the book suggests no 
g Cary Ginsberg is the co-author of 
^ What’s Toxic, What’s Not, an acces- 
1 sible guide to the risks of common 
5 household products. 
more than two fish meals per week, with only one containing 
farmed fish. People living in houses more than 30 years old 
should watch for chipping paint, especially on windowsills. 
Occupants of houses built before 1987 should test their drink¬ 
ing water for lead, and all children should get blood tests for 
lead at ages 1 and 2. 
Ginsberg himself buys such products as dish soap and 
shampoo at the health food store rather than the supermarket. 
Dangers in supermarket items include volatile organic com¬ 
pounds in cleaning products as well as reproductive toxins and 
carcinogens in cosmetics. “There’s no gatekeeper at the super¬ 
market, and the Consumer Product Safety Commission doesn’t 
regulate these things,” Ginsberg said. 
With each new headline in the media, Ginsberg gets new 
questions. For example, consumers have begun worrying about 
plastic baby bottles and water bottles containing Bisphenol A 
(bpa), a chemical used since the 1950s to make polycarbonate 
plastics that was developed in the 1930s as a synthetic estro¬ 
gen. Recent animal studies have shown that bpa can disrupt 
the endocrine system. The Canadian government announced 
in October 2008 that it is banning polycarbonate baby bottles 
containing bpa. To provide information about such emerging 
issues, Ginsberg has established a website: whatstoxic.org. 
He also hosts a radio show, Greener Living with ‘Dr. G,’ which 
can be heard (locally or on the Internet) on wtic-am, Saturdays 
from 4 to 6 p.m. 
—Cathy Shufro 
Bookshelf focuses on books and authors affiliated with the School of 
Medicine. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
BOOK NOTES 
High Risk Obstetrics: 
The Requisites in Obstetrics 
and Gynecology 
by Edmund F. Funai, m.d., associ¬ 
ate professor of obstetrics, gynecol¬ 
ogy and reproductive sciences, 
Mark Evans, m.d., and Charles 
J. Lockwood, m.d., chair and the 
Anita O’Keefe Young Professor 
of Obstetrics, Gynecology and 
Reproductive Sciences (Elsevier) 
This volume offers guidance for 
assessing and managing high-risk 
pregnancies. The book includes 
tables that present differential 
diagnoses and recommendations 
on lab values and treatments. 
Case studies and illustrations ac¬ 
company coverage of antepartum 
care, medical complications of 
pregnancy, fetal disorders, fetal 
surveillance, intrapartum compli¬ 
cations and puerperal disorders. 
Stoeiting’s Anesthesia and 
Co-Existing Disease, 5th ed. 
by Roberta L. Hines, m.d., hs ’77, 
chair and the Nicholas M. Greene 
Professor of Anesthesiology, and 
Katherine E. Marschall, m.d., 
assistant professor of anesthesiol¬ 
ogy (Elsevier) This edition has 
been updated to reflect the lat¬ 
est information to help clinicians 
avoid or manage complications 
stemming from pre-existing 
medical conditions. Organized by 
r 
UNCEBTAIN 
ABT 
HERVIN B. 
NULAND 
TRAUMA-CENTERED 
GROUP 
PSYCHOTHERAPY 
FOR WOMEN 
HADAR UJSIN. MD 
DAVID READ JOHNSON. PHD 
Essential 
Otolaryngology 
Head & Neck Surgery 
disease, the new edition provides 
guidance on definition, current 
pathophysiology and pre-, intra- 
and postoperative factors of the 
disease process, anestheticjudg- 
ment and management. It pro¬ 
vides case studies that exemplify 
howto overcome a wide range of 
challenges, and it examines spe¬ 
cific anesthesia considerations 
for special populations, including 
pediatric and geriatric patients. 
Motion Preservation Surgery of 
the Spine: Advanced Techniques 
and Controversies 
by James J. Yue, m.d., associate 
professor of orthopaedics and re¬ 
habilitation, Rudolph Bertagnoli, 
m.d., Paul C. McAfee, m.d., and 
Howard S. An, m.d. (Elsevier) This 
book provides an introduction to 
motion preservation surgery and 
discusses surgical considerations 
and cervical total disc arthro¬ 
plasty. The text examines the 
advantages and disadvantages 
of the full range of nonfusion 
technologies and presents step- 
by-step, illustrated operative 
guides to achieve optimal out¬ 
comes. The book is accompanied 
by a dvd featuring three hours of 
surgical video. 
Dermatopathology: 
Diagnosis by First Impression 
by Christine J. Ko, m.d., assistant 
professor of dermatology and 
pathology, and Ronald J. Barr, 
m.d. (Wiley-Blackwell) This guide 
introduces a simple and effec¬ 
tive way to approach a slide and 
focuses on a selection of com¬ 
monly tested entities, showing 
low- to high-power views. Major 
differences among diagnoses 
that are sometimes confused are 
emphasized on “Key Differences” 
pages. The book contains minimal 
text and should be used as a 
companion to dermatopathology 
textbooks and as a pictorial refer¬ 
ence and study tool. 
The Uncertain Art: 
Thoughts on a Life in Medicine 
by Sherwin B. Nuland, m.d., clini¬ 
cal professor of surgery (gastro¬ 
enterology) (Random House) This 
volume is a collection of essays 
about the mix of expertise, intui¬ 
tion, sound judgment and chance 
that plays a part in a doctor’s 
practice and life. Drawing from 
history and his own experiences, 
Nuland includes topics ranging 
from the primitive procedures 
doctors once practiced with good 
intentions—such as grave rob¬ 
bing and prescribing cocaine as 
an anesthetic—to gene therapy, 
the adoption of Eastern practices 
like acupuncture and the complex 
moral and ethical quandaries con¬ 
fronting healers that arise from 
such innovations as cloning. 
Trauma-Centered Group 
Psychotherapy for Women: 
A Clinician’s Manual 
by Hadar Lubin, m.d., assistant 
clinical professor of psychiatry, 
and David R. Johnson, ph.d., 
associate clinical professor of psy¬ 
chiatry (Routledge) This manual 
is a theory-based, field-tested 
model of group therapy for 
traumatized women. It includes 
clinical examples, a session-by- 
session guide for clinicians and 
a workbook for clients. Topics 
include managingtraumatic 
re-enactments, a developmental 
theory of trauma and post- 
traumatic stress disorder and 
guidance in handling difficult 
treatment and clinical situations. 
The authors also discuss the use 
of testimonials and ceremonial 
structures to heighten the thera¬ 
peutic impact. 
The Marshall Plan: Lessons 
Learned for the 21st Century 
edited by Eliot Sorel, m.d., fw 
’75, and Pier Carlo Padoan, m.d. 
(oecd Publishing) This book ex¬ 
amines the historical, diplomatic, 
economic and strategic aspects 
of the European Recovery 
Program—popularly known as 
the Marshall Plan—that brought 
Europe out of the chaos, hunger, 
poverty and desperation of 
World War II. Contributors ad¬ 
dress 21st-century applications 
of lessons learned from the 
Marshall Plan. 
Essential Otolaryngology: 
Head and Neck Surgery, 9th ed. 
by K. J. Lee, m.d., associate 
clinical professor of surgery (oto¬ 
laryngology) (McGraw-Hill) This 
otolaryngology primer delivers 
the latest critical information to 
help treat conditions involv¬ 
ing the head and neck, such 
as sinusitis, sensory disorders, 
cancer and sleep disorders. This 
edition contains new chapters 
on cysts and tumors ofthe jaw, 
tnm classification in otolaryn¬ 
gology, head and neck surgery, 
and malignant melanoma. 
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14 Books & ideas book notes IN CIRCULATION 
HOW TO 
THINK LIKE A 
RADIOLOGIST 
the 
NURSING HOME 
guide 
Non-lnvasive Management of 
Gynecologic Disorders 
edited by Aydin Arici, m.d. ’50, 
professor of obstetrics, gynecol¬ 
ogy and reproductive sciences, 
and Emre U. Seli, m.d., assistant 
professor of obstetrics, gynecol¬ 
ogy and reproductive sciences 
(Informa Healthcare) This text 
provides information on currently 
available options for gynecologic 
disorders suitable for nonsurgical 
management. It offers guidance 
to physicians on how and when 
to choose more conservative mo¬ 
dalities and howto differentiate 
between the variety of treatment 
options available. The authors take 
an evidence-based approach to 
topics including management of 
ectopic pregnancy, pregnancy loss 
and termination, infertility, chronic 
pelvic pain, endometriosis and 
dysfunctional uterine bleeding. 
How to Think Like a Radiologist: 
Ordering Imaging Studies 
by Tara Marie Catanzano, m.d., 
assistant professor of diagnostic 
radiology (Cambridge University 
Press) This pocket guide provides 
guidance in choosing which type 
of imaging study best answers 
the clinical question posed. The 
book addresses imaging studies 
by modality, body region and 
type of study in bulleted outline 
format. It discusses general 
considerations for each modal¬ 
ity—including advantages and 
disadvantages—as well as patient 
preparation and requirements for 
each type of examination. 
The Nursing Home Guide: 
A Doctor Reveals What You Need 
to Know About Long-Term Care 
by Joshua D. Schor, m.d. ’85 
(Berkley/Penguin) The author 
guides the reader step by step 
through the process of placing a 
loved one in a nursing home or 
long-term care facility. He covers 
such topics as questions to ask 
about medications, meals and ac¬ 
tivities; deciding whether assisted 
living may be a viable alternative; 
determining whether a family 
member needs long-term or 
subacute care; and knowing your 
rights and getting the informa¬ 
tion you need. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu 
Library initiative links Third World doctors and 
researchers to journals 
Just seven years ago, clinicians and scientists in the developing 
world could get hold of—on average—only two international 
medical journals, according to the World Health Organization 
(who). And in the poorest countries, fewer than half of the doc¬ 
tors and researchers could put their hands on a single journal. 
Now, through a who program called hinari, they have 
electronic access to 6,000. The program makes journals and 
databases available to health care professionals in 3,600 hos¬ 
pitals, medical schools and other institutions in 108 countries 
from Afghanistan to Zimbabwe. Subscription rates range from 
nothing in the poorest countries to $1,000 annually per institu¬ 
tion in more affluent countries. 
Yale librarians including Kimberly Parker, m.i.l.s,, have 
played crucial roles in developing hinari. Parker headed the 
electronics collection for Yale’s library system when the project 
was conceived in 2001; researchers from resource-poor coun¬ 
tries had told who officials that without access to biomedical 
information they could not be members of the international 
research community. Within months, several major publishers 
had agreed to donate access to their journals, and hinari was 
launched in January 2002. Last spring Parker took over as pro¬ 
gram manager of hinari in Geneva. 
Yale librarians continue to contribute. When a researcher in 
Ecuador peruses a journal, or a gynecologist in Vietnam reads 
about screening for anemia, each depends upon the support 
of Yale librarian Daniel Dollar, m.l.s., and his staff, who make 
sure that links work and add journals and databases to the ever- 
expanding system. “They actually have access to more journals 
than we do,” said Dollar. 
Because of hinari, Parker said, more scientists “are con¬ 
tributing to the global conversation in important ways, often 
on topics the rest of us are ignoring.” 
Senegalese urologist Mohamed Jalloh, m.d., depends on 
hinari to search the medical literature and find such clinical 
information as drug dosages. Just three years out of residency, 
Jalloh says he has had 13 articles published. “It is very impor¬ 
tant for us to have access to good-quality peer-reviewed publica¬ 
tions,” he said. 
—Cathy Shufro 
In Circulation focuses on activities at the Cushing/Whitney Medical 
Library. Send suggestions to Cathy Shufro at cathy.shufro@yale.edu. 
ON CAMPUS 
Connecticut lags in long-term 
care for elderly and disabled 
Connecticut has made inroads 
into shifting long-term care 
for the elderly and people with 
disabilities from institutions to 
community-based programs, but 
according to a Yale researcher it 
lags behind many other states. 
“Connecticut is making important 
progress, but there’s a long way 
to go,” said Leslie Curry, ph.d., 
m.p.h., a research scientist at the 
School of Public Health who spoke 
at a session in the Aging Research 
Seminar Series in February. 
Spurred by a 1999 U.S. 
Supreme Court ruling, states 
have begun to shift long-term 
care from nursing homes to 
community-based options, 
largely because nursing home 
care is about twice as costly 
as community-based care and 
because people prefer commu¬ 
nity settings. With $56 million 
in federal grants, Connecticut 
has increased the proportion 
of Medicaid clients receiving 
community-based care from 46 
percent in 2002 to 51 percent in 
2006, Curry said. 
Nationally, though, Connecti¬ 
cut “is not a leader,” and Curry 
said the state needs to stream¬ 
line its organization, increase 
community-based options and 
enhance consumer-directed 
models of care in order to reach 
its goal of having 75 percent of 
Medicaid recipients who need 
long-term care in community- 
based settings by 2025. 
—John Dillon 
Zimbabwe cholera outbreak has 
roots in corruption 
When cholera struck Zimbabwe 
last summer, international aid 
poured into the African country. 
Despite those resources, how¬ 
ever, fatalities increased among 
those infected. “One in 20 peo¬ 
ple was dying, and 80 percent of 
those deaths were preventable," 
said Chris Beyrer, m.d., m.p.h., 
professor of epidemiology at 
the Johns Hopkins Bloomberg 
School of Public Health, at a talk 
at the School of Public Health in 
February. Beyrer investigated the 
health care system in Zimbabwe 
last year on behalf of Physicians 
for Human Rights. 
The reasons for the epidemic 
and its high mortality rates, 
Beyrer said, stem from the cor¬ 
ruption of President Robert 
Mugabe’s administration, which 
enriched itself at the public’s 
expense. “I have never seen a 
health care system collapse so 
extreme,” Beyrer said. Public 
hospitals and clinics shut their 
doors, and for political reasons, 
the government had handed 
over public water supplies to 
cronies. As a result, untreated 
sewage flowed into reservoirs 
of drinking water. 
“If you want to create a 
cholera epidemic, this is the way 
to do it,” Beyrer said. “It is very 
hard to imagine a public health 
solution to these problems 
without addressing the politics.” 
—John Curtis 
Physicians must know how to 
blow the whistle on torture 
Physician complicity in torture 
at Guantanamo and Abu Ghraib 
reveals a serious gap in medi¬ 
cal education, said former Yale 
professor Barbara Burtness, m.d., 
now chief of head and neck medi¬ 
cal oncology at Philadelphia’s 
Fox Chase Cancer Center. 
Speaking at the Program 
for Humanities in Medicine in 
January, Burtness said that phy¬ 
sicians and other health care pro¬ 
viders had abetted such tortures 
as waterboarding, granted medi¬ 
cal clearance for harsh interroga¬ 
tions, permitted forced feeding, 
offered privileged information 
on prisoners’ phobias, withheld 
care and falsified death cer¬ 
tificates. In Iraq, she said, “they 
medically approved biopsychoso¬ 
cial interrogation plans.” 
“I wondered,” said Burtness, 
“Were they people I had gone to 
medical school with, or people 
I had trained?” 
Medical students, she said, 
should learn standards for 
treatment of prisoners and 
understand such ethical codes 
as the Declaration of Tokyo, 
which addresses torture. They 
should recognize signs of tor¬ 
ture and understand that, if 
they participate in abuse, they 
could be accused of war crimes. 
Physicians should also know 
how to blow the whistle: just 
as they carry notes on how to 
measure blood gases, she said, 
they should carry phone num¬ 
bers for reporting torture. 
—Cathy Shufro 
Parental consent needed for 
genetic screening 
Most of the 4.3 million babies 
born in the United States each 
year are screened without paren¬ 
tal consent for up to 50 genetic 
disorders that may cause such 
severe conditions as mental 
retardation. But at a pediatric 
grand rounds in February, Lainie 
Friedman Ross, m.d., ph.d. 
’96, the Carolyn and Matthew 
Bucksbaum Professor of Clinical 
Medical Ethics at the University 
of Chicago, argued for changing 
the recommendations governing 
parental consent. 
"If we had parental consent 
for these tests it would show 
respect for parental autonomy 
in health care decisions for 
their children, which is required 
for all other health care, and it 
would also allow us to enroll the 
children in research protocols,” 
Ross said. “That is the only way 
we will learn the natural his¬ 
tory of these very rare diseases, 
understand who needs to be 
treated and develop effective 
treatments for them.” 
Ross also questioned the 
current policies of the American 
Academy of Pediatrics and the 
American College of Medical 
Genetics, which proscribe test¬ 
ing children for adult-onset 
conditions like breast cancer. 
Some parents want the infor¬ 
mation early for psychosocial 
reasons. While predictive test¬ 
ing should be discouraged, Ross 
maintained that parents, not 
physicians, should have the final 
say in testing children. 
—Alix Boyle 
v
a
le
 
M
ed
ic
in
e 
s
p
ri
n
g
 
2
0
0
9
 
16 capsule 
Cautionary tales for WWII GIs 
The Medical Historical Library’s art collection includes graphic posters that warned soldiers 
and sailors of the dangers of venereal diseases. 
By Colleen Shaddox 
Posters that warned enlisted men of the dangers 
of unprotected sex were part of a larger educa¬ 
tional campaign to stem the spread of sexually 
transmitted diseases during and after World 
War II. The posters, which were prominently 
displayed at military bases, were intended as re¬ 
minders that would buttress messages imparted 
through filmstrips and lectures. The messages 
took different approaches, some warning 
against prostitution and cautioning, as in the 
poster at right, that “They don’t wear labels.” 
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She’s no idealized oil painting. The 
lines around the mouth tell you she’s 
been around the block. She might have 
stepped out of a dime detective novel, 
a wrong number who conned some 
farm boy into giving up his heart and 
his wallet. She is literally falling out of 
her too-tight dress. One hand rests on 
a cocked hip while a cigarette smolders 
in the other. Her hennaed hair is tightly 
curled. She arches a plucked brow and 
forms her rouged lips into a bitter pout. 
“Danger Disease Ahead!” the poster 
warns, fust in case the message is too 
subtle, a large orange banner at the bot¬ 
tom spells it out: “Gonorrhea Syphilis.” 
This unnamed woman was created to 
warn World War II servicemen about 
venereal disease (VD). 
The Medical Historical Library’s 
holdings include etchings by Rembrandt, 
portraits of the world’s most eminent 
physicians stretching back to Hippocrates 
and reverent depictions of kings healing 
scrofula with the “royal touch.” It may 
seem incongruous that a graphic—in 
both senses of the word—and cautionary 
portrayal of a loose woman would find 
a home here. For several years, however, 
the library has been adding to its collec¬ 
tion of public health posters. 
“What is represented in art, or fine 
art... is limited,” explained Susan 
Wheeler, curator of prints and drawings. 
“Moving into public health posters 
allowed us to represent more medical 
subjects in the collection.” 
In 2004, just as the library had made 
a strategic decision to acquire more 
posters, it received a large gift of turn-of- 
the-century French advertising and pub¬ 
lic health posters from collector William 
H. Helfand, who has since made addi¬ 
tional gifts. Posters were often produced 
in large numbers, explained Wheeler, 
and so copies reside in many attics and 
garages. As websites catering to collec¬ 
tors begin to spring up, owners realize 
that they are storing a saleable commod¬ 
ity, and more posters become available. 
The library is adding its posters to the 
Medical Digital Library so that they will 
be widely accessible. 
An exhibit in the Cushing Rotunda 
through the winter featured a trio of 
posters produced by the U.S. Navy 
during World War II to warn sailors 
about sexually transmitted diseases. 
Some other subjects addressed in the 
collection include hygiene, nutrition, 
aids, tuberculosis, cancer, polio and 
children’s health. All the posters have 
a common purpose: to change human 
behavior. So their images and lan¬ 
guage are strong and direct. 
The library’s selection of World War 
II anti-VD posters is a prime example. 
A sailor leans against the ship’s rail with 
“VD” painted in huge orange letters 
on the back of his T-shirt. The caption 
reads, “Nothing to be proud of.” In 
another poster, a sailor paints “VD” in 
the same bright orange across the deck 
of a battleship. “Don’t smear your ship,” 
the poster implores. The caution against 
letting down one’s comrades is a recur¬ 
rent theme, explained Wheeler. 
The wartime military gave every 
serviceman training about preventing 
venereal disease and access to prophylac¬ 
tics. When men were infected, they were 
urged to see military doctors as soon as 
possible. A number of posters warned 
against “quacks” and home remedies. 
“Rapid treatment centers” gave prosti¬ 
tutes access to drugs to halt transmission. 
The anti-VD campaign was effective. 
By the end of the war, the infection rate 
among servicemen was no higher than 
that of the civilian population. 
In April and May, the library will 
feature early Soviet posters, again on the 
theme of venereal disease. The library 
has acquired a complete set of posters 
from the Soviet campaign of 1928, so 
viewers can get a full picture of the mes¬ 
sages that Russian public health officials 
were sending. 
Colleen Shaddox is a freelance writer in 
Hamden, Conn. 
wxm 
dont smear your ship 
The posters used a variety of approaches to 
convey their message. The one at far left 
called to mind family and the possibility of lost 
dreams. A specific concern was that after the 
war soldiers would bring disease home. The 
poster at left depicted VD as an enemy to be 
conquered through prevention. And the posters 
above, part of a series, invoked shame and 
guilt. Soldiers and sailors could not let their 
buddies down by getting sick—incapacitated 
servicemen could not be part of the team. 
^'|ig| 
Nearly 200 years ago, in October 1810, the Connecticut 
legislature passed a bill establishing the Medical Institution of 
Yale College, a joint venture between Yale and the Connecticut 
State Medical Society. The resulting institution then consisted 
of four professorships appointed by the Corporation of Yale 
College after nomination by a joint committee of the corpora¬ 
tion and the medical society. The fledgling medical school 
opened its doors in 1813 with those four professors, an adjunct 
professor and a student body of 37. The course of studies con¬ 
sisted of a few months of lectures in a classroom. Only three 
students would graduate with medical degrees in 1814. 
Next year the medical school will mark the start of 
its third century with a series of special events and exhibits 
and the publication of a book looking at the personalities and 
forces that shaped medicine at Yale. 
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20 
Yale Medicine would like readers’ opinions about those 
influences, as well as their recollections of medical school life 
over the last half century or so. Was Milton C. Winternitz, m.d., 
the so-called “steam engine in pants” who established the Yale 
system of medical education, the most dynamic of all deans? 
Was his educational philosophy the driving force behind the 
school’s extraordinary growth in reputation? Was Paul B. 
Beeson, m.d., the most exemplary clinician, or was it John 
P. Peters, m.d.? 
We’d like to hear from you. On the following pages are 
10 questions about the history of the School of Medicine and 
your experiences here compiled by the editors of Yale Medicine. 
Please take a moment to detach or copy these pages, check off 
your favorites or nominate your write-in candidates—along 
with your comments and reminiscences—and return it in the 
envelope provided inside the back cover of this magazine. 
(There’s also a Web version of this survey at yalemedicine.yale. 
edu/bestofyalemed.) There are many significant events, find¬ 
ings and discoveries to choose from, but we ask that you select 
only one response per question, or write in your nominees 
for the “best of the Yale School of Medicine.” 
So whether you feel that the neuro rotation in third year 
or that role in drag during the second-year show was the pin¬ 
nacle of your medical school experience, take a few minutes 
to look back and share your memories, as well as your nomi¬ 
nations for the medical school’s best of everything, ym 
>ry. This l3b features 3n exhi 
astern that removes noxious 
dors, computer terminals st 
:ate their bodies 
tion. One thing 
the study of 
jires exploration 
The best of two centuries 
The editors of Yale Medicine would like your opinions on the most significant events and personalities to shape the 
medical school since its founding in 1810. To start the ball rolling, we’ve suggested a few contenders, but these are 
just suggestions. We hope the collective wisdom of thousands of alumni, faculty and former house officers on our 
mailing list will produce other candidates and sharpen our focus when it comes to describing the forces that have 
made Yale School of Medicine great over the years. Your votes will be counted and your comments included in a 
follow-up article in Yale Medicine in time for the school’s Bicentennial celebration in 2010-2011. 
In addition to voting, please tell us the thinking behind your choice in the space provided for comments. 
We’ve also included several questions about the best aspects of Yale School of Medicine as you experienced them 
during your student years. 
Please complete this survey online at yalemedicine.yale.edu/bestofyalemed, or fill out the questionnaire that 
follows and return it in the envelope provided inside the back cover of this magazine. 
Contact information: 
NAME STREET ADDRESS 
1. What event in the history of Yale School of Medicine had 
the greatest impact in shaping the school? 
□ Founding in 1810 
□ Admission of women in 1916 
□ Creation of the Yale system in the 1920s 
OTHER 
□ _ 
2. What was the greatest scientific advance made at the 
medical school? 
□ John Peters' transformation of clinical chemistry into 
a discipline of precise, quantitative indicators 
of disease 
□ Dorothy Horstmann’s finding that the polio virus 
enters the central nervous system through the 
bloodstream, paving the way for the Salk vaccine 
□ The first antiviral drug, discovered by William Prusoff 
COMMENTS 
OTHER 
□ _ 
COMMENTS 
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3. What was the medical school’s greatest clinical advance? 
Discovery and successful testing of the therapeutic 
properties of nitrogen mustard, the first anticancer drug 
First successful use of penicillin in the United States 
□ Introduction of fetal heart monitoring in the 1950s 
OTHER 
□ _ 
COMMENTS 
5. Who was the greatest personality to shape the school? 
□ Founding faculty member Nathan Smith 
□ Milton Winternitz, dean from 1920 to 1935 
□ Vernon Lippard, dean from 1952 to 1967 
OTHER 
□ _ 
COMMENTS 
7. Which basic science class impressed you the most? 
9. Which extracurricular activities were the most enjoyable? 
4. Who among the faculty possessed the most extraordi¬ 
nary scientific mind? 
□ John Fulton 
□ Dorothy Horstmann 
□ George Palade 
OTHER 
□ _ 
COMMENTS 
6. Who was the medical school’s most outstanding clinician? 
□ John Peters 
□ Edith Jackson 
□ Paul Beeson 
OTHER 
□ _ 
COMMENTS 
8. What was your most valuable clinical experience at Yale? 
10. What is your favorite memory of medical school? 
23 
top left When Dorothy 
I Horstmann applied to Yale for a 
; fellowship during World War II, her 
interview did not go well. Francis 
Cillman Blake, the acting dean, 
told her “how the last woman he 
| had on the house staff did some- 
K thing awful,” she recalled. “If a 
I woman on the house staff did 
not live up to expectations it was 
remembered for the next 50 years,” 
she told him, "but if the person was 
a man, it was forgotten by the next 
year.” Blake left the hiring decision 
up to John Paul, a young pathologist 
who had co-founded the Yale 
Poliomyelitis Study Unit in 1931. 
Horstmann was hired and she 
paved the way for a polio vaccine 
with her discovery that the virus 
enters the nervous system through 
the bloodstream. Horstmann, 
shown here in her lab in the 
1970s, was the first woman to be 
appointed a full professor at the 
medical school. 
top right Women have become 
a ubiquitous presence in classrooms, 
clinics and laboratories over the 
years. Sarah Henry, a research asso¬ 
ciate in neurology, works in the lab 
of neurologist Jana Preiningerova, 
who studies multiple sclerosis, mri 
analysis and cell-based therapies 
for multiple sclerosis. 
above left The Class of 1949 
was the first to stage a show that 
mocked the medical school and its 
faculty. The “Four Years for What 
Follies" was the brainchild of Wil¬ 
liam Anlyan, who wrote the script, 
played piano and directed the pro¬ 
duction. Over the years what had 
been a fourth-year show became 
a second-year show. As always, 
the students mock their professors 
and classmates and draw the plot 
from current events. 
above right “The Great ST 
Depression," presented in Febru¬ 
ary by the Class of 2011, 60 years 
after the first student production, 
depicts faculty, administrators and 
students struggling to make ends 
meet in the face of a financial crisis. 
In one scene, students moonlight¬ 
ing at a fast-food joint, played by 
Adam Kaufman, Lauren Graber and 
Henry Park, try to treat a choking 
victim played by Mei Elansary. 

scientist built a better mouse 
By inserting human system genes into mice, 
immunobiologtetd&chard Flavell and hfsteatgp 
are creating a mouse with a working human 
immune system. Their goal is a system for test¬ 
ing vaccines and therapies against diseases that 
kill millions. 
Story by Michael Fitzsousa 
Photograph by Frank Poole 
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26 How a rock ’n’ roll scientist built a better mouse 
previous pace Richard Flavell 
chairs his department and over¬ 
sees multiple research projects, 
yet he still finds time for his other 
passion, rock ’n roll. 
In March 2006, eight healthy volunteers in London received an 
experimental drug that showed promise for treating rheuma¬ 
toid arthritis and other autoimmune diseases. In animal tests, 
the drug, named TGN1412 by its developer, the German biotech 
company TeGenero, caused T-cells to proliferate, especially a 
subset known as regulatory T-cells. These cells calmed the 
immune system, leading TeGenero to believe its candidate 
molecule would ease symptoms in diseases in which the body 
is attacked by its own sentinels. 
That was the hope. But when TGN1412 was tested in 
humans, disaster ensued. The six young men who received the 
drug (two volunteers were given a placebo) became severely 
ill within 90 minutes, suffering headaches, shivering, searing 
pain, swelling and nausea. Within 12 hours, one was on a ven¬ 
tilator and all six were admitted to intensive care. Then their 
organs—kidneys, lungs and livers—began to fail and their T-cell 
counts, instead of proliferating, dropped to dose to zero. 
What went wrong? Writing in The New England Journal 
of Medicine later in 2006, the intensive care team that rescued 
the six men reported that TGN1412 had launched a “cytokine 
storm”—the rapid and overwhelming release of toxic immune 
system molecules. Nothing in the animal studies had suggested 
this reaction was possible, and the human subjects had received 
only one-50oth of the dose that had proved harmless to mice. 
Although Richard A. Flavell, ph.d., was not involved in 
this near-fatal clinical trial, its lessons were not lost on him 
and on other scientists who use animal models to understand 
human biology and pathology. Studies in lower organisms— 
from yeast, worms and fruit flies up the chain to nonhuman 
primates—are powerful precursors to research in people, 
says Flavell, the department chair and Sterling Professor 
of Immunobiology at Yale and a Howard Hughes Medical 
Institute (hhmi) investigator. The vast majority of genes in 
flies have human homologues, and the genomes of mammals 
and primates are closer still to our own genome. But what 
works in mice may not work in humans. 
Human molecules in a mouse 
Since the 1980s, Flavell had been engineering mice by “knock¬ 
ing out” specific genes or inserting them, with great effect. 
His group’s work led to the development of a vaccine against 
Lyme disease and to a more detailed understanding of other 
disorders, including diabetes, lupus, asthma, Crohn disease 
and multiple sclerosis. But Flavell and his colleagues asked 
whether there might be a better way: “What if there was an 
experimental animal with a human immune system? How 
much easier would it be to predict what would happen?” 
When the Bill and Melinda Gates Foundation announced 
its Grand Challenges in Global Health in 2003, with a goal 
of creating new vaccines for diseases in the developing world, 
Flavell and several of his collaborators realized that such an 
experimental mouse would be an invaluable tool. Their pro¬ 
posal was among 1,500 submitted to the Gates Foundation 
and one of 43 funded in the first round of grants in 2005. 
Flavell’s group at Yale and his collaborators in Switzerland and 
New York received $17 million. Their goal is to generate mice 
in which human immune system genes replace those of the 
mouse “so that they can support the development and function 
of human immune cells engrafted into the mice. This should 
permit reliable assessments of weakened live vaccines prior to 
human trials,” according to the Gates program. 
While this “human immune system mouse” builds 
on previous advances by other scientists, it represents a major 
shift in thinking. “Nothing of this kind of grand vision has 
been attempted before,” says David G. Schatz, ph.d., a faculty 
colleague. Flavell’s group is inserting into mice the cytokines 
and other molecules that immune cells use to summon other 
cells, the markers that establish identity and mediate transplant 
acceptance or rejection, and the receptors on which cells rely to 
recognize viruses and bacteria. 
So far, Flavell’s group has successfully altered or inserted 
nine human immune system genes into the experimental mouse. 
“I think we’ll have a usable system in 15 months,” he says. 
An unusual path 
When Flavell was recruited to Yale in 1988 to head the medical 
school’s newly established Section of Immunobiology, he came 
with an unconventional pedigree: educated at the University 
of Hull in the north of England, Flavell had trained and taught 
at universities in Europe before leaving academia for a job in 
business. Scientists do that all the time. But after six years 
running the research division at Biogen, one of the early bio¬ 
tech companies that emerged in the 1980s, Flavell returned 
to academia. That’s much less common, and often difficult to 
accomplish after so much time out of the funding stream that 
supports academic scientists. 
Twenty years later, immunobiology at Yale is considered 
one of the top programs by its peers. It was ranked No. 1 among 
immunology graduate programs in the Chronicle of Higher 
Education’s 2006 Faculty Scholarly Productivity Index, which 
counts scholarly publications, citations, grant dollars, awards 
and honors in its assessment of the best departments in the 
United States. Flavell has authored a number of highly cited 
papers and has been recognized with science’s top honors: he 
was made a member of the Royal Society in 1984 and elected 
to the National Academy of Sciences in 2002 and the Institute 
of Medicine in 2006. 
Immunobiology’s rise at Yale may have resulted in part 
because of—rather than in spite of—Flavell’s unconventional 
approach to his career and to science. For example, he leads 
one of the larger university-based lab groups in the world, but 
while he is a scientist with significant clout, he is anything 
but a top-down leader. “Richard couldn’t care less where a good 
idea comes from, as long as it’s a good idea. He’s very good at 
gathering information, building consensus and then making 
a decision,” says Schatz, professor of immunobiology and an 
hhmi investigator. “It’s very inclusive.” 
No prima donnas 
This congenial atmosphere may stem from a decision Flavell 
and his Yale departmental co-founders—colleague Alfred 
Bothwell, ph.d.; former professor H. Kim Bottomly, ph.d. 
(now the president of Wellesley College); and Bottomly’s late 
husband, Charles Janeway Jr., m.d.—made at the beginning. 
”We wanted to have outstanding people working in comple¬ 
mentary areas using different approaches,” Flavell says. “But 
there was one other thing that was really essential—no prima 
donnas. So we hired people who were outstanding but were all 
easy to get along with.” 
The department now numbers 13 primary faculty and 
close to 200 researchers overall, including faculty with second¬ 
ary appointments as well as research scientists and postdocs. 
Flavell’s own lab has more than 40 people working on a com¬ 
bination of projects funded by hhmi, the National Institutes 
of Health and the Gates Foundation. 
Flavell has trained several dozen young scientists from 
around the world who rotated through his lab as postdocs. In 
selecting them he has looked for “a combination of creativity 
and the ability to get something done.” Most have gone on to 
highly productive careers in the United States and abroad. For 
example, Lena Alexopoulou, ph.d., who earned her doctorate 
in Greece before doing her postdoc at Yale, is now a group leader 
at the Centre d’lmmunologie de Marseille-Luminy in France. 
In 2001 she and Flavell published a paper in Nature showing for 
the first time that toli-like receptors (tlrs, molecules at the core 
of the innate immune response) play a role in the recognition of 
viruses. With more than 1,000 citations, the paper is one of the 
most highly referenced in the rapidly expanding tlr field. 
Alexopoulou says that Flavell’s mentoring launched her 
career and gave her an appreciation for how to manage people 
in her own lab. “He knows how to motivate people,” she says. 
Ricftard Ravel - Madyn Raves - fca Mefcrao • Tama? Boursaian - Ba PrvSxx* • Leonard Kaczmare* 
In Concert—June 27,8:00 PM 
Bethesda/Chevy Chase Rescue Squad Hall 
5020 Battery Lane (Battery & Old Georgetown Rd.) 
301-652-0077 
All NIHers welcome! 
For almost as long as he’s been at 
Yale, Richard Flavell has played 
guitar in the “lab rock” band, the 
Cellmates. Colleagues and band 
members have included former 
pharmacology chair Leonard 
Kaczmarek on guitar, former cell 
biology chair Ira Mellman on 
bass and Flavell’s wife, Madlyn, 
on keyboards. The Cellmates 
have recorded such science rock 
songs as “She’s a Knockout” and 
“Molecular Millionaire.” 
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28 How a rock ’n’ roll scientist built a better mouse 
“He gives people a chance to develop their own ideas and proj¬ 
ects. He provides you with everything you need that he can 
offer you—connections, money, scientific information—and 
he’s very open to new ideas.” 
As a result, says Deputy Dean Carolyn W. Slayman, 
ph.d., “any wonderful young postdoc ... would just die” for a 
slot in Flavell’s lab. “He’s got a terrific knack for doing transla¬ 
tional research and training people in it. And that’s led to an 
amplification factor—there are more scientists doing this kind 
of extraordinary work by virtue of Richard training others.” 
By translational work, Slayman means conducting 
fundamental scientific studies and applying that knowledge to 
clinical questions. Flavell explains: “I would say a high propor¬ 
tion of it is curiosity-driven, pursuing such basic questions as 
'How does the body work?’ But we always study this using dis¬ 
eases that matter. And what we try to do is to force ourselves to 
ask the question, ‘Is this an important problem?’ 
“We want to study only important problems,” he says, 
meaning problems that are fundamental or relevant to human 
disease. “You can spend your life doing unimportant things and 
in both cases you will spend just as much energy and get just as 
tired and as frustrated—and you’ll be a lot less productive.” 
Finding motivation 
In the late 1950s, when he was a rock ‘n’ roll-crazed teenager 
in the English county of Norfolk, no one would have mistaken 
Flavell for a budding academic. “I was a totally unmotivated 
student, except for the one thing I was interested in at the 
moment,” he says. “First it was French, then it was history. 
Anything I was obsessed about, I was the best student in the 
class. For the rest I was in the bottom 25 percent.” 
That changed when he nearly failed his O-level exams, 
an essential step on the road to a university education in 
Britain. Raised in a family of teachers (his father was a school 
principal and a pilot during World War II), Flavell says the 
shock of a poor grade roused him from his scholarly indiffer¬ 
ence. Around the same time, thanks to an exceptional teacher, 
he discovered chemistry. After earning bachelor’s and doctoral 
degrees in biochemistry at Hull, Flavell did postdoctoral work 
in the Netherlands and Switzerland and then joined the fac¬ 
ulty of the University of Amsterdam. From the Netherlands, 
he moved to London, where he was head of the Laboratory of 
Gene Structure and Expression at the National Institute for 
Medical Research at Mill Hill. 
Then came an offer to join a commercial enterprise, the 
biotechnology startup Biogen, in Cambridge, Mass. “It was a 
very difficult decision, because I was totally satisfied with what 
I was doing. ... And along comes this crazy opportunity, which 
was also great because it was at a time when a new industry 
was being created.” It was exciting, Flavell says—“You’re alter¬ 
nately up in the clouds or on the precipice”—but when then- 
Yale Dean Leon E. Rosenberg, m.d., came looking for someone 
to head the medical school’s new program in immunobiology, 
he decided he was ready for a return to academia. Biogen’s 
next phase of growth, in which it would bring its first drugs to 
market, was a decade-long proposition. “I thought, ‘Do I want 
to commit the next 10 years to doing that?”’ he says. “I decided 
that I wanted to be more of a scientist and less of a manager.” 
At Yale, Flavell has struck a balance between the pursuit 
of basic biological questions and the pursuit of solutions to the 
causes of human disease. During its 20 years, the immunobi¬ 
ology department has opened major new areas of understand¬ 
ing, in particular discoveries establishing that the long-ignored 
innate immune system plays a much more significant role 
in the body’s defenses than previously thought. Overturning 
assumptions that had stood for decades, department members 
Janeway and Ruslan Medzhitov, ph.d., demonstrated in Nature 
in 1997 that the innate response is the activating factor for the 
adaptive immune system’s release of T- and B-cells. 
“It was like saying there are only four planets in the 
solar system and then one day somebody comes along and says, 
no, there are eight,” says Schatz. In the dozen years since the 
Medzhitov-Janeway paper appeared in Nature, a new branch of 
immunology research has been established, with hundreds of 
scientists looking for drug and vaccine targets among tlrs. 
To help speed the clinical application of its basic immu¬ 
nology findings, the department launched a new program in 
2007 called Human Translational Immunology (hti), bring¬ 
ing together scientists from across the medical school and uni¬ 
versity to focus exclusively on research that could lead to better 
treatment of disease. The group studies the immune compo¬ 
nents of a wide range of disorders, including autoimmune dis¬ 
eases, cancer and the immune rejection of transplanted organs. 
A better mouse 
In the three years since the Gates project began, Flavell’s group 
has made steady progress toward developing a mouse with a 
functional human immune system for the purposes of testing 
vaccines. His collaborator in Switzerland, Marcus Manz, m.d., 
of the Institute for Research in Biomedicine in Bellinzona, 
established the basis for the project in 2004, when his group 
created a mouse with human T-cells, B-cells and natural 
killer cells (NI< cells target and destroy other cells that are 
infected with viruses or bacteria or are cancerous). To do this, 
they began with an immunodeficient mouse lacking ragi or 
RAG2—genes needed for generation of B-cells and T-cells—and 
lacking the receptor required for the growth of the NK cells. 
When they injected human stem cells from umbilical cord 
blood into the liver of the mouse, those stem cells found their 
way to the bone marrow and began to develop into mature 
human immune cells. 
“It is hard to believe that a human system may settle 
down in the organism of a mouse, yet the evidence points 
that way,” Manz’s colleague Elisabetta Traggiai, ph.d., said in 
2004. “Two months since the transplant into the mouse, we 
have observed fully fledged human cells capable of reacting to 
human viruses and vaccines.” 
One problem that emerged, says Elizabeth E. Eynon, 
ph.d., who manages the Gates project as a research scientist 
I in Flavell’s group, was that the human cells did not mature 
properly. They did not have the expected longevity, they did 
not multiply in sufficient numbers and they did not interact 
with other cells as expected. 
Eynon says those problems can be attributed to the lack 
of human growth factors and other molecules required by the 
T-cells and B-cells to develop correctly but not present in the 
mouse. “We tested to see how much alike a number of differ¬ 
ent factors were in the mouse and human and found about a 
dozen with significant differences,” she says. Thus began the 
current effort to “knock in” the genes for those molecules and 
create the support system the human immune cells will need 
to thrive in the mouse. 
In that work, the project has drawn on the expertise of 
Sean Stevens, ph.d., and others at Regeneron Pharmaceuticals 
in Tarry town, N.Y. Regeneron created a highly efficient tech¬ 
nology for knocking out genes and inserting human replace¬ 
ments into mouse dna. Eynon says they are now working on 
introducing genes for the human major histocompatibility 
complex, which the body relies on to recognize foreign cells. 
“What we hope to have [by July 2010] is a mouse that 
pretty nearly recapitulates the basic, fundamental immune 
responses that are human. All the appropriate cells will be 
there in the appropriate amounts, the cells will live a long time 
and the immune response will be functional,” she says. “It 
certainly won’t be the perfect mouse, but we think that it will 
make enough of an improvement to make this a useful model, 
not only for our lab but for other groups as well.” ym 
Michael Fitzsousa is director of communications at the School of Medicine. 
a 
Online: Yale Netcasts 
Richard Flavell: Mouse With a 
Human Immune System Could 
Revolutionize Research 
Online: Yale Netcasts 
Ruslan Medzhitov: Arming the 
Immune System 
; 
Roots, Rock, Regale 
When a young Richard Flavell and 
his bandmates were playing par¬ 
ties and clubs in England in i960, 
they dressed in smart suits and 
thin ties and soaked up every bit 
of American blues and R&Bthey 
could get their hands on—includ¬ 
ing the music of Little Richard, Jerry 
Lee Lewis and Elvis Presley. Last 
May, Flavell was thrilled to meet a 
more famous contemporary of the 
English music scene, when Sir Paul 
McCartney visited Yale to receive 
an honorary degree. 
At a reception in New Haven, 
Flavell told McCartney about his 
days playing clubs in Norwich, 
England, where early Beatles 
collaborator Tony Sheridan was a 
performer. Flavell remembers a 
conversation with Sheridan, who 
had just come back from Hamburg 
and a series of gigs with a new 
band from Liverpool. 
“They’ve got a funny name,” 
Sheridan told Flavell. “You should 
remember them. They’re going to 
do well.” 
McCartney, says Flavell, was 
amused. 

become artists 
^ r 
• ^ 
An ongoing exhibit of interesting scientific images 
raises the question of what constitutes art. 
By Jenny Blair 
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32 When scientists become artists 
previous pace Inthisview 
of human tonsil tissue, scientists 
used green labels to locate naive B 
lymphocytes, red for mature B cells 
and blue for a chaperone molecule. 
They then captured the image with 
a confocal microscope. 
Image by Cecile Chalouni 
above Purkinje cells from an 
adult mouse, located in the cer¬ 
ebellum and among the largest 
neurons in the brain, were stained 
red for acetylcholine receptors 
and green for DNA. The image 
was captured with a Zeiss Laser 
Scanning meta microscope. 
Outside a third-floor elevator at the Brady Memorial Laboratory, 
four unusual prints are displayed on the wall. Each is a square 
filled with a dense and intricate pattern that resembles televi¬ 
sion static; the prints are identical except for different bright 
hues. Their striking texture and colors invite a long examina¬ 
tion. They would not look out of place in an art gallery. 
Or would they? The patterns represent a dna microar¬ 
ray, and they were created by scientists working with David F. 
Stern, ph.d., professor of pathology, and by Terry Dagradi, a 
photographer and image specialist in information technology 
at the medical school who curated the display. The images are 
just a few of the many that Dagradi solicited from School of 
Medicine researchers as part of an ongoing project sponsored 
by the Office of Facilities Operations to display interesting sci¬ 
entific images in the corridors of the medical school. The Stern 
images are among the few that Dagradi altered (she added 
color), but in each case she played an artist’s role herself in 
choosing, framing and arranging the images. “There is a pat¬ 
tern and a rhythm” to these images, said Dagradi. “Somebody 
made a visual decision.” 
Along with facilities manager Lorraine Roseman, 
Dagradi had already co-founded and curated ArtPlace, a project 
that since 2000 has shown the work of local artists, includ¬ 
ing many medical school faculty, on the walls of the Yale 
Physicians’ Building (ypb) on Howard Avenue. But unlike 
in the ypb galleries, which exhibit portraits, landscapes and 
abstracts in various media, the laboratory images were made 
in the course of scientific research—mostly with microscopes. 
For example, in the Bridge Gallery at The Anlyan Center 
(tac), which runs along a second-floor walkway that connects 
the center with Brady Memorial Laboratory across the street, 
passersby are momentarily arrested by a fluorescent tick; by a 
protein rendered as writhing arrows, bulges and ribbons; by 
a 15-day-old mouse fetus, its snout and nail beds picked out 
in delicate blue, a portrait as tender as the sight of a sleeping 
child; by a set of neurons done in soft blues, pinks and greens 
that look like impressionist pastels, the cells seeming to strain 
upward like so many flowers in a Monet painting. Images like 
these straddle an uncertain boundary between scientific rep¬ 
resentation and the fine arts, and for some viewers they raise 
the question, what is art? 
For as long as scientists have made observations, they 
have illustrated them. Andreas Vesalius, the 16th-century pio¬ 
neer of the study of anatomy, took apart and reassembled the 
33 
human body in allegorical poses; Robert Hooke, the English 
polymath and contemporary of Isaac Newton, drew a flea 
seen under a microscope; John James Audubon, the 19th- 
century American naturalist and ornithologist, painted birds 
at a Louisiana plantation. The stunning images that resulted 
might be called ancestors of the ones at the medical school. 
“When I look at those 17th-century images, I don't 
hesitate to think of them as artworks,” said Jonathan Gilmore, 
ph.d., assistant professor of philosophy and a critic for publi¬ 
cations including Art in America and Artforum. “[Hooke is] 
not just showing you these things as they looked under the 
microscope—he’s saying something about how marvelous or 
wondrous they are.... There’s no reason not to call that art.” 
That quality of wondrousness is one reason why such 
images still seem so much at home in galleries; moreover, 
what Yale is doing isn’t new. Princeton University, for example, 
has become noted for its Art of Science competitions, in 
which organizers ask researchers to submit scientific images. 
More than a hundred Princetonians entered the first contest 
in 2005. The results, displayed in both a gallery and online, 
were so breathtaking that they caught the attention of Wired 
and Science and answered the contest’s challenge: “Science Is 
Boring, Art Is Stupid, Prove Us Wrong.” 
“What’s interesting to us is that these marvelous images 
... come out of a process that is not really directed at making 
something beautiful,” said Gilmore. 
The portrait of the fluorescing tick is the work of Ruth 
R. Montgomery, ph.d., senior research scientist in medicine 
(rheumatology). She is also director of the confocal microscopy 
facility at the Department of Internal Medicine, where images 
are integral to her research. “As a person interested in how 
cells function, I’ve always taken pictures of them as part of 
displaying the research questions,” she said. “You learn as a 
skill of the trade how to get a good image that can be used in 
manuscripts and in slides to demonstrate your point.” 
Montgomery studies what tick saliva does to human 
macrophage cells. “We were trying to trace a fluorescent 
marker through the tick to show which compartment of the 
tick it ended up in,” she said, describing an image that graced 
not medical school hallways, but the cover of the Journal of 
Experimental Medicine in June 2006. “We never did find the 
actual molecule we were looking for, so we didn’t really prove 
the point that we wanted to, but we got this cool picture. ... 
I figure [the display in tac is] my one and only art opening for 
my lifetime.” 
Vali Gazula, ph.d., an associate research scientist in 
pharmacology, made several images of a mouse cerebellum. 
Because they were not intended for scientific publication, he 
manipulated their colors to make them more striking. “Since 
this is for art,” he said, “I can put some dye more, some dye 
less, make [them] visually appealing.” Gazula said he some¬ 
times uses leftover reagents to create images in addition to 
the ones he needs for his research. “When Terry asked me for 
Ticks from the Ixodes family, the 
vectors for Lyme disease, were 
microinjected with fluorescent 
dyes to label surface structures 
and midgut ceils. The images of 
the living ticks were made by la¬ 
ser scanning confocal fluorescent 
microscopy 24 hours after the 
dyes had been injected. 
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34 When scientists become artists 
top Another view of Purkinje cells 
from an adult mouse cerebellum. 
above Stains on this human 
colon section show actin filaments 
in green, an adhesion molecule on 
membranes of the colon’s epithelial 
cells in red and the nuclei in blue. 
these pictures, I already had a lot of pictures, because I wanted 
to put them on my computer as screen savers.” 
Yet the native of Hyderabad, India, does not think 
of himself as an artist. He thinks of art in a more traditional 
sense and dislikes abstract art. His favorite artist is a 19th- 
century Indian painter, Raja Ravi Varma, who painted episodes 
from the Indian literary epics in an academic European style. 
One reason why the question “Is this art?” is so impor¬ 
tant, said Gilmore, is that the answer has some bearing on 
how we respond to the images. “If the scientists making 
them thought of themselves as creating works of art, that 
says that we should interpret them, perhaps look for meaning 
in them.” Such works also get a pass on manipulation and 
enhancement—in art, anything goes. But the same is not 
true of images intended to demonstrate a scientific point; and 
indeed, other scientists whose works are on display deny hav¬ 
ing manipulated their images. 
“Was it modified? No, not at all,” said Marc Pelletier, 
ph.d., a former postdoctoral fellow who now runs a biotech 
company in Cleveland, of his transmission electron microscope 
image. It depicts a molecule of apolipoprotein A-i, part of the 
high-density lipoprotein type of cholesterol. As the image cap¬ 
tion points out, the micrograph is reminiscent of the work of 
the Russian painter Wassily Kandinsky, a pioneering abstract 
artist of the early 20th century. “I framed it in the scope to have 
the look of the Kandinsky,” he explained. 
Though Pelletier didn’t alter or shape his image as an 
artist probably would, that nod to Kandinsky was an act of 
craftsmanship. In general, however, if a scientist never intend¬ 
ed an image as art, it may not be. “Whether something is a 
work of art or not—that question has to be sensitive to the con¬ 
text in which it was created,” said Gilmore. “That doesn’t mean 
that these can’t be works of art made by, say, the person who 
collated them and put them together and used them.” In some 
cases—and in a long tradition of “found” art—Dagradi herself 
may be the artist. She chose images that were intended only to 
demonstrate a scientific point and, by making a visual decision 
of her own, elevated them to the status of art by displaying or 
altering them. 
“I think that one should be at least careful about iden¬ 
tifying the scientists—those who just happened to have these 
images around [and] made them for research purposes—as 
artists, because the concept of art didn’t enter into the process 
by which they made these things,” said Gilmore. We some¬ 
times honor people who create visually interesting objects, he 
explained, by calling them artists. “Are those people artists 
in the sense in which Rembrandt was an artist? Probably not. 
I think that would be a mistake.” 
Of all the scientists represented in Yale Med’s galleries, 
Cecile Chalouni, ph.d., a former associate research scientist in 
the Department of Cell Biology who now works at Genentech 
in San Francisco, may be the most at home in the art world. 
Trained as an immunologist, she chose her field in part for the 
opportunities for imaging it affords; she was already an experi¬ 
enced aesthetic photographer when she began her doctoral 
studies. One of her microscopic images won a contest in Nature 
Cell Biology and three others appeared in the 40th edition of 
Gray’s Anatomy, while her fine-art photography has been dis¬ 
played in exhibitions in the United States and France. 
Both science and art, said Chalouni, feature connec¬ 
tions between very different things. What shows up in a frog’s 
immune system is often seen in a human’s as well, while an 
artist may create a visual image based on a piece of music. 
“This is something for me that is totally amazing—that you 
translate and make bridges between senses.” 
Asked if the images she chooses for display were orig¬ 
inally done for the sake of beauty or for science, she said they 
were done for both. Like Gazula, Chalouni occasionally makes 
and saves extra images in the course of her work. “The images 
I kept have the scientific information I’m looking for, and pos¬ 
sibly aesthetic elements. What is important to remember is that 
a less beautiful image can be scientifically more interesting 
than a very beautiful image.” That is, dendritic cells like the 
one on tac’s wall—a blue many-armed star—may be visually 
appealing, but a micrograph of simple round lymphocytes may 
be more striking to a scientist if it illustrates an important dis¬ 
covery. To a scientist, the beauty of an image may be more than 
visual. Yet, as artists have always known, the visual element 
makes for powerful demonstrations and may be the most effec¬ 
tive mode of scientific communication. 
“A fundamental driving force in science is to look for the 
beauty in nature,” said Pelletier. “So scientists ... should have 
an eye to explore that nature.” If the images in Brady and tac 
are any indication, Yale scientists’ eyes are wide open. 
Pioneering scientific image-makers like Hooke who 
looked through their microscopes were filled with wonder at 
what they saw, and their modern-day counterparts—as well as 
many nonscientists—continue to gaze upon the natural world 
with awe and appreciation. “Sometimes there’s no urgency in 
deciding whether or not these are works of art,” said Gilmore, 
“because these things are just incredibly marvelous to look at 
in their own right.” ym 
This embryonic mouse is about 
15 days old. A marker has been 
inserted and blue dye will stain 
any site in which the lacZ gene is 
normally expressed. In this image, 
the dye marks hair follicles that are 
forming, the nails and the epithe¬ 
lium around the nose and mouth. 
Jenny Blair, m.d. ’04, is a physician and writer based in New Haven. 
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36 Faculty 
Thomas Lynch 
Lung cancer expert to 
lead cancer center 
THOMAS J. LYNCH JR., M.D. 
’86, a lung cancer expert at 
Massachusetts General Hospital 
(mgh) and Harvard Medical School, 
was named director of Yale Cancer 
Center (ycc) in February. Dean 
Robert J. Alpern, M.D., Ensign 
Professor of Medicine, announced 
the appointment, which was effec¬ 
tive April l. Lynch will also serve 
as physician in chief of the new 
Smilow Cancer Hospital at Yale- 
New Haven. 
In accepting the new post, 
Lynch said that he wants the cancer 
center to be known for discovery; 
personalized cancer therapy; the 
importance of compassionate 
patient- and family-centered care; 
and a commitment to quality, safety 
and outcomes measurement. 
"One of the reasons why we’re 
not curing cancer today is that 
we need to better understand the 
biology of cancer,” said Lynch, who 
served as chief of hematology/ 
oncology at mgh Cancer Center. 
“Yale is well-positioned for that, 
with expertise in immunobiology, 
genetics and tumor biology. At 
Yale, the scale is right for an inte¬ 
grated cancer program between 
science and clinical medicine. 
You have laboratories where fun¬ 
damental discoveries are being 
made—within a couple hundred 
feet of clinics where patients are 
being treated—and people who 
are active in the pursuit of both 
clinical excellence and scientific 
discovery.” 
As part of that integration of 
science and clinical medicine, Lynch 
will oversee a new institute for can¬ 
cer biology at the university’s 136- 
acre West Campus. He will recruit 
a director and a team of scientists 
specializing in cell signaling, cancer 
immunology, and drug develop¬ 
ment and target acquisition for the 
new institute. 
NOTES 
Michael Caplan Mark 
Hochstrasser 
Other major plans for YCC and 
Smilow Cancer Hospital include 
recruitment of clinicians and trans¬ 
lational researchers, a significantly 
expanded clinical trials network 
and a program that will provide 
molecular profiling services to 
enable targeted therapies. 
As director of the MGH Thoracic 
Oncology Center, Lynch made 
important contributions to devel¬ 
opmental therapeutics and defining 
the optimal treatment for patients 
with lung cancer. He has pioneered 
the use of molecular testing for 
mutations in the epidermal growth 
factor receptor gene to select 
patients who can benefit from tar¬ 
geted lung cancer therapies. 
Lynch succeeds Richard L. 
Edelson, M.D. ’70, chair and the 
Aaron B. and Marguerite Lerner 
Professor of Dermatology, who 
became ycc director in 2003. 
Edelson will continue as chair and 
professor of dermatology. 
Several faculty members have 
been named to endowed chairs 
in recent months. Michael J. 
Caplan, m.d. ’87, ph.d. ’87, fw 
'89, known for his research on 
the sorting and function of ion 
proteins in polarized epithelial 
cells, was named the c.n.h. Long 
Professor of Physiology. His 
laboratory focuses on identifying 
the proteins that interact with 
ion transporters to determine 
their localization and trafficking 
properties. He is currently the 
interim chair of the Department 
of Cellular and Molecular Physiol¬ 
ogy. Mark Hochstrasser, ph.d., 
was named the Eugene Higgins 
Professor of Molecular Biophysics 
and Biochemistry. Hochstrasser’s 
research, which lies at the 
intersection of biochemistry and 
genetics, attempts to understand 
protein turnover at the molecular 
level—particularly the ways in 
which specific proteins are rapidly 
degraded within eukaryotic cells, 
even while most proteins are 
spared. David J. Leffell, m.d., 
newly designated the David Paige 
Smith Professor of Dermatology, 
specializes in the diagnosis and 
treatment of melanoma and 
other skin cancers using the Mohs 
micrographic technique. Leffell, 
who is also chief executive officer 
of Yale Medical Group, has served 
as deputy dean for clinical affairs 
at the School of Medicine since 
2005. David A. McCormick, PH.D., 
was named the Dorys McConnell 
Duberg Professor of Neurobiolo¬ 
gy. McCormick studies the cellular 
and network mechanisms of the 
brain’s cortical function in relation 
to attention, working memory, 
sleep-related activity and visual 
perception. Scott A. Strobel, ph.d., 
was named the Henry Ford II 
Professor of Molecular Biophysics 
and Biochemistry. His labora¬ 
tory employs such technologies 
David Leffell David 
McCormick 
as organic synthesis and X-ray 
crystallography to study reactions 
catalyzed by rna. 
Three neuroscientists have been 
named to endowed chairs funded 
by an alumnus of the Yale College 
Class of 1928. Angus C. Nairn, fw 
’82, ph.d., who was named the 
Charles B.G. Murphy Professor 
of Psychiatry, is noted for his 
research on the molecular actions 
of dopamine in the basal ganglia. 
Nairn has extensive experience 
in enzymology, protein chemistry 
and the molecular biology of 
signal transduction, particularly 
with respect to the role of protein 
phosphorylation in the nervous 
system. Marina R. Picciotto, ph.d., 
was named the Charles B.G. 
Murphy Professor of Psychiatry. 
She specializes in molecular neuro¬ 
science, behavioral pharmacy, 
mouse genetics and translational 
neuroscience. The goal of her 
research is improved understand¬ 
ing of the role of single molecules 
in complex behaviors related to 
addiction, depression and learn¬ 
ing. Jane R. Taylor, ph.d., was 
named the Charles B.G. Murphy 
Associate Professor of Psychiatry. 
She specializes in brain research 
related to drug addiction and 
such psychiatric disorders as 
adhd, depression, schizophrenia 
and Tourette syndrome. 
Vikki Abrahams, ph.d., assistant 
professor of obstetrics, gynecol¬ 
ogy and reproductive sciences, 
has received a 2009 Albert McK¬ 
ern Scholar Award for Perinatal 
Research. The two-year award of 
$100,000 peryear will fund her 
proposal, "Human Endogenous 
Retroviruses: A Novel Biomarker 
for Pre-eclampsia.” The award is 
funded by a bequest from Albert 
McKern, m.a. ’13, M.D., an Aus¬ 
tralian who studied engineering 
Scott Strobel Angus Nairn 
at Yale before entering medi¬ 
cal school at the University of 
Edinburgh. 
Joshua A. Copel, m.d., professor of 
obstetrics, gynecology and repro¬ 
ductive sciences and of pediatrics, 
has been named president-elect 
of the Society for Maternal-Fetal 
Medicine (smfm) for the coming 
year. The appointment begins 
in February 2010. The smfm is a 
nonprofit organization of more 
than 2,000 members dedicated 
to improving care for pregnant 
women and their fetuses. The 
society’s primary objectives are to 
promote and expand education 
in maternal-fetal medicine and 
to encourage the exchange of 
new ideas and research concern¬ 
ing the most recent approaches 
and treatments for obstetrical 
problems. Copel received the Dru 
Carlson Award for Research in 
Ultrasound and Genetics from the 
smfm in 2007. 
Walter S. Gilliam, ph.d., assistant 
professor in the Yale Child Study 
Center and director of its Edward 
Zigler Center in Child Develop¬ 
ment and Social Policy, received 
the Priscilla Canny Research 
Award in December at Connecti¬ 
cut Voices for Children's 8th annu¬ 
al First for Kids awards ceremony. 
He was recognized for providing 
consultation to state and federal 
decision makers. Connecticut 
Voices also praised his dedica¬ 
tion to research on translating 
early-childhood policies into 
effective services and improving 
the quality of pre-kindergarten 
and child care services, as well as 
studying the impact of early- 
childhood programs on children’s 
school readiness. Gilliam was 
a principal investigator of the 
National Pre-Kindergarten Survey, 
the first-ever national study of the 
Joshua Copel Marina Jane Taylor 
Picciotto 
Walter Gilliam 
implementation of state-funded 
pre-kindergarten programs. 
Robert Heimer, ph.d., professor of 
epidemiology (microbial diseases) 
and pharmacology, will work and 
lecture in Russia this year with 
support from a 2009 Fulbright 
Scholarship. Heimer’s project, 
"Delphi Analysis to Explore the 
Origins of the hiv Epidemic 
Among Russian Drug Users,” will 
be conducted at Kazan State Medi¬ 
cal University in Kazan, Russia, 
from March through July. Heimer’s 
research efforts include investiga¬ 
tion of the mortality and morbid¬ 
ity associated with injection drug 
use. He is director of the Interdisci¬ 
plinary Research Methods Core at 
Yale’s Center for Interdisciplinary 
Research on aids and director of 
the Yale office of the Connecticut 
Emerging Infections Program. 
Gregory L. Larkin, M.D., professor 
of surgery (emergency medicine) 
and associate chief of emergency 
medicine, has been awarded a 
two-year American Foundation 
for Suicide Prevention Distin¬ 
guished Investigator Award for 
his study, "Suicide Clusters Across 
the Globe: Geospatial Trends 
in America, Ireland and New 
Zealand.” This award extends a 
recent grant Larkin received from 
the New Zealand Ministry of 
Health to examine suicide clusters 
in that country. Larkin has also 
recently formed and been named 
as chair of the Task Force on 
Emergency Medicine and Suicidal 
Behavior of the International As¬ 
sociation for Suicide Prevention. 
Gil Mor, m.d., and Alessandro 
Santin, m.d., members of Yale 
Cancer Center, received more 
than $5 million in federal and 
foundation grants in January to 
improve detection of ovarian 
cancer and to find a cure for the 
disease. Santin received $1.7 mil¬ 
lion, including two grants from 
the Italian National Institutes 
of Health and another from the 
National Cancer Institute (nci) for 
$346,000 per year for five years. 
Although Santin’s NCi-funded 
research is focused on thera¬ 
peutic vaccination strategies for 
the treatment of HPV-infected 
cervical cancer patients, he also 
studies therapies for the manage¬ 
ment of chemotherapy-resistant 
ovarian cancer. 
Mor will use an nci grant of 
$314,000 per year for the next 
five years to better understand 
the mechanism by which ovarian 
cancer cells resist cell death. 
Another newly awarded five-year 
nci grant totaling $1,715,000 will 
fund Mor’s research on the ways 
in which tumors influence the 
immune system to promote their 
own growth and progression. Mor 
also has three foundation grants 
that include $150,000 per year for 
three years from the Janet Burros 
Memorial Foundation; $50,000 
per year for three years from the 
Sand Foundation; and $50,000 
from the Adler Foundation. 
Pasquale Patrizio, m.d., direc¬ 
tor of the Yale Fertility Center 
and professor of obstetrics, 
gynecolo-gy and reproductive 
sciences, addressed the Italian 
Parliament in Rome in January on 
a 2004 Italian law that restricts in 
vitro fertilization (ivf) practices. 
According to Patrizio and other 
experts, the law has led to fewer 
pregnancies and higher rates 
of multiple births. The law limits 
insemination to three eggs 
per patient—if all three eggs 
result in fertilization, all three 
embryos must be transferred for 
implantation. The law also bars 
genetic screening to prevent the 
Gregory Larkin Majid Sadigh 
transfer of embryos with lethal 
or severely disabling diseases. As 
a result, fewer Italian women are 
getting pregnant through ivf on 
their first try, causing them to 
go through multiple ivf cycles. 
Patrizio hopes that he convinced 
the legislature that the law does 
a disservice to Italian women and 
also encourages couples to seek 
fertility treatments in countries 
with less restrictive legislation. 
Majid Sadigh, m.d., associate 
professor of medicine, was 
nominated by medical students 
forthe Humanism in Medicine 
Award presented annually by the 
Association of American Medical 
Colleges. The award recognizes a 
medical school faculty physician 
who exemplifies the qualities of a 
caring and compassionate mentor 
in the teaching and advising of 
medical students. The candidate 
must also possess the desirable 
personal qualities necessary to 
the practice of patient-centered 
medicine. Although Sadigh was 
not named this year’s recipient, 
he received a plaque in honor of 
his nomination. In addition to 
his duties at Waterbury Hospital, 
Sadigh directs the Makerere 
University-Yale University col¬ 
laboration that sends medical stu¬ 
dents and physicians to Muiago 
Hospital in Uganda for rotations. 
The students wrote in their nomi¬ 
nating statement that Sadigh 
"has been a source of inspiration 
and guidance to the many medi¬ 
cal students he has encountered, 
both on this continent and on 
continents far away.” 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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38 students 
At Commencement, 
the PA Program’s history 
Alfred Sadler, the first director of 
Yale’s Physician Associate Program, 
described its early days in the 1970s. 
When Yale’s Physician Associate Pro¬ 
gram was launched in 1971, 28 of the 30 
members of the Class of 2008 had not 
yet been born. At their Commencement 
in December the graduates got a history 
lesson along with their diplomas. The 
lesson came firsthand, delivered by the 
co-founder and first director of the Yale 
program, Alfred M. Sadler Jr., m.d. 
Physician associate programs have 
their roots in emergency care, and Yale’s 
began as an experiment. “We were 
designing the curriculum as we went 
along,” Sadler said. 
The Class of 2008 reflects the 
growth of the program in both num¬ 
bers and scope. Whereas Yale’s first 
graduating class of just five students left 
with a certificate in physician associate 
studies in 1973, this year’s class—like 
others since 1999—earned a master’s 
degree in medical science, the m.m.sc. 
Dean Robert J. Alpern, m.d., Ensign 
Professor of Medicine, said the program 
was lengthened from two years to 28 
months under his tenure, “which is why 
we’re having Commencement on this 
freezing day” in December. 
Sadler said the Yale program came 
into being when he and his twin 
brother organized regional emergency 
above The 30 members of the physician 
associate Class of 2008 heard about the history 
of the Yale program from one of its founders, 
Alfred Sadler Jr., who addressed the class at 
Commencement in December. 
right Graduates Adam Cohn, Song Jin 
Comstock and Rachelle Concepcion read the 
professional oath of physician associates. 
medical services in Connecticut, creat¬ 
ing a model that was copied nationwide. 
Meanwhile, Jack Cole, m.d., chair of 
surgery, had received a grant from the 
Commonwealth Fund to start a trauma 
program within the Department of 
Surgery. He and Sadler had both noticed 
that the military had produced army 
medics competent to treat trauma 
alongside doctors, and that “these pro¬ 
fessionals were actually practicing 
medicine,” Sadler said. The two men 
then convinced Yale to create “the 
medical school’s first experiment in 
nonphysician education.” 
Sadler, who directed the program 
until 1973, spearheaded legislation to 
authorize physician associates to practice 
medicine in the state of Connecticut. As 
inaugural president of the Association of 
Physician Assistant Programs, he helped 
develop accreditation standards for the 
profession and worked with the National 
Board of Medical Examiners to create 
the first national board examination. 
Yale has since graduated 895 stu¬ 
dents from the program. Today there are 
142 programs nationwide, Sadler said. 
At the Commencement ceremony 
William B. Stewart, ph.d., associate 
professor of surgery (gross anatomy), 
and Shanta E. Kapadia, m.b.b.s., lecturer 
in surgery (gross anatomy), received the 
Didactic Instruction Award from stu¬ 
dents. Gerard J. Kerins, m.d., geriatrics 
section chief at the Hospital of Saint 
Raphael, received the Clinical Instruction 
Award for a clinical rotation site that pro¬ 
vides exemplary teaching. The Jack Cole 
Society Award, for contributions 
in support of the physician associate 
profession, went to Paul P. Possenti, pa-c, 
lecturer in surgery (trauma). 
Adam Cohn, pa ’08, received the 
Dean’s Award for Academic Achievement. 
Arielle Macher, pa ’08, received the 
Dean’s Award for Clinical Excellence, 
and Lauren Myers, pa ’08, received the 
Dean’s Humanitarian Award. 
—John Dillon 
below The Class of 2011 took affectionate 
potshots at faculty in February with their second 
year show, “The Great ST Depression.” Ripped 
from the headlines, the show’s plot revolved 
around efforts to keep the School of Medicine 
functioning during an economic decline. 
U.S. economy in free fall! 
Yale endowment down! 
Med school scrambles for $$$! 
Carrying on a 6o-year-old tradition, the 
second-year class mocked its teachers 
and mentors with irreverence and affec¬ 
tion at their show in February, “The 
Great ST Depression.” 
The show’s 16 sketches centered 
on a loose plotline based on current 
events: the School of Medicine has lost 
its endowment and the dean is laying 
off faculty and eliminating financial 
aid. Entering survival mode, faculty and 
students must get part-time jobs—at 
s’wings or the Cedar Street food carts, 
for instance—or as Dean Robert J. 
Alpern, m.d., Ensign Professor of 
Medicine, suggests in one sketch, by 
holding up and robbing s’wings, a 
Crown Street eatery. 
The cast of characters was famil¬ 
iar. Associate Dean for Student Affairs 
Nancy R. Angoff, m.p.h. ’81, m.d. 
’90, hs ’93; Alpern; and Margaret J. 
Bia, m.d. (played by Larissa Chiulli, 
Derek Kennedy and Lauren Hackney, 
respectively) all received considerable 
skewering. Standout moments included 
the song “Docta Bia,” based on abba’s 
“Mamma Mia” and Jennifer Lopez’s 
“Jenny from the Block”; a video sketch 
featuring Shanta E. Kapadia, m.b.b.s., 
dishing up Indian food at a cart on 
Cedar Street; and the song “My Goodies/ 
Rizzilicious,” featuring Matthew 
Singleton on stage and Carl Berdahl as 
the voice of Lawrence J. Rizzolo, ph.d., 
based on Ciara and Petey Pablo’s “My 
Goodies” and Fergie’s “Fergilicious.” 
Other highlights included a 14- 
member orchestra; a video parody in 
which David L. Katz, m.p.h. ’93, m.d., 
played an overadrenalized juice fanatic; 
and a video screening of the Class 
of 2011s class prank—a parody of a 
Saturday Night Live sketch about bodily 
functions in which faculty made faces 
of delight or disgust. “Our faculty had 
a great sense of humor and recognized 
that we only make fun of them out of 
love and respect,” said Patricia Peter, one 
of the show’s two executive producers. 
Planning for the show began last 
summer, and about 90 of the class’ 
100 members participated. “We’re very 
proud of how collaborative it was,” said 
co-producer Janet Chiang. Henry Park 
directed the show. 
—Charles Gershman 
above left Gisella Weissbach-Licht, played by 
Lauren Graber, chastises faculty members James 
Jamieson, played by Ben Goldberg, and Michael 
O’Brien, portrayed by John Thomas, for spending 
too much money and getting the medical school 
into a financial crisis. 
above right A highlight of the show was 
“My Goodies/Rizzilicious,” featuring Matthew 
Singleton as anatomy professor Lawrence 
Rizzolo. The number was based on Ciara and Petey 
Pablo’s “My Goodies” and Fergie’s “Fergilicious.” 
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40 Alumni faces 
Alum finds fascination in 
disease and the end of life 
Robert Buckingham’s career has taken 
him around the world as he studies 
hiv/aids, prostitution and hospice care. 
Robert Buckingham, ph.d. ’78, saw 
a lot of people die when he served in 
the U.S. Navy during the height of the 
Vietnam War. But he was more drawn 
to illness-related mortality, even in 
Robert Buckingham, an epidemiologist at New 
Mexico State University’s College of Health 
and Social Services, works around the world on 
aids prevention among sex workers and has 
been instrumental in developing hospice care. 
combat zones. “In my travels through¬ 
out Southeast Asia during the war, 
I saw a lot of disease and death,” he 
said. “I got fascinated with diseases.” 
Buckingham’s career has run on the 
tracks of disease and death ever since. 
Usually the tracks are parallel, but they 
have also diverged and intersected, fre¬ 
quently taking him back to the places in 
Southeast Asia where his interest was 
first sparked. 
For Buckingham, an epidemiolo¬ 
gist and professor of health science at 
New Mexico State University’s College 
of Health and Social Services, the 
intersection became personal as he 
entered the School of Public Health in 
the 1970s. His mother had just died of 
breast cancer, “so I was interested in the 
care she got—and the lack of care.” His 
frustration over the hospital’s aggressive 
attempts to keep her alive instead of alle¬ 
viating her suffering led him to become 
involved in palliative treatment. 
At the same time, the late Florence 
S. Wald, r.n., the former dean of the 
School of Nursing, was trying to estab¬ 
lish the first inpatient hospice in the 
United States. Under Wald’s tutelage, 
Buckingham helped to write a grant 
proposal that led to funding for hos¬ 
pice care. In researching his doctoral 
dissertation, he came to the conclusion 
that care for the dying was better in a 
hospice than in a hospital. 
The Connecticut Hospice opened 
in Branford in 1974. Today there are 
about 8,000 hospices around the 
world (including more than 4,500 
in the United States), according to 
Stephen Connor, ph.d., vice president 
of research and international relations 
at the National Hospice Foundation. 
Buckingham had a hand in developing 
about 90 of them. “Bob is remark¬ 
ably intelligent and capable,” Connor 
said. “He certainly is someone well- 
regarded in the field.” 
Buckingham moved on to other 
areas of public health, notably hiv/ 
aids prevention among sex workers. 
He returned to Thailand as the aids 
epidemic spread and has since studied 
condom use among prostitutes in that 
country’s commercial sex industry and 
started a pediatric hospice for children 
with aids there. He spent the 2000-2001 
academic year “developing programs for 
commercial sex workers as well as treat¬ 
ment programs for workers who were 
Hiv-positive.” Before his research began, 
only 11 percent of sex workers’ clients 
had used condoms. His study, published 
in the journal AIDS Care in 2005, found 
that the rate had risen to 51 percent. It 
wasn’t ideal, but in some brothels as 
many as 89 percent of the workers’ cli¬ 
ents use condoms, and overall the hiv 
rate in Thailand has “decreased signifi¬ 
cantly,” he said. Buckingham concluded 
that more focus needs to be put on 
native Thai patrons, who are less likely 
to use condoms than Western or other 
Asian customers. 
Buckingham is trying to transfer 
that model of hiv prevention to pros¬ 
titution in Latin America. One such 
place is Ciudad Juarez, Mexico, just 
across the border from El Paso, Texas, 
and not far from his campus in Las 
Cruces, N.M. “When you see poverty 
you see prostitution, and when you 
see prostitution you see disease,” he 
said. He has encountered little opposi¬ 
tion from the authorities, even though 
Mexico is a heavily Roman Catholic 
country. “We usually don’t get interfer¬ 
ence,” he said. “We’re trying to help.” 
Most recently, Buckingham has 
been asked by the government of 
Honduras to form the country’s first 
health commission. The need for 
health care is acute, especially for peo¬ 
ple living on the islands off the coast 
where care is “nonexistent,” he said. 
“What we’re doing is a simple needs 
assessment affecting the country.” He 
plans to get the project in full swing 
while on sabbatical in 2009-2010. 
Honduras also has a disproportionately 
high share of Central America’s hiv/aids 
cases—some estimates have it as high 
as 60 or 70 percent—so Buckingham 
will work to promote condom use there. 
He will also likely be working with the 
dying, because he helped to establish a 
hospice in that country. 
His work with hospices and sex 
workers isn’t all that divergent, he 
said—in fact, the two tracks crossed 
one day in Thailand. He was inter¬ 
viewing prostitutes when a woman, 
wrongly assuming that he was a physi¬ 
cian, begged him to care for her sick 
infant. “I said, ‘I can’t take care of 
your baby,’ and gave it back to her. She 
said, “No, no!’ and just ran away. We 
brought it to the medical school. Sure 
enough, the baby was Hiv-positive. 
Word went out that I found a place for 
these dying kids.” 
Buckingham helped set up a hos¬ 
pice there, too. “Life is weird some¬ 
times,” he said. 
—John Dillon 
An international traveler 
makes himself at home in the 
world’s great libraries 
Wherever Stanley Simbonis, m.d. ’57, 
travels, he visits the local library. If it’s 
Athens, you’ll find him in the Gennadius 
Library at the American School of 
Classical Studies, or the archeological 
library at the British School at Athens, 
where he reads about the origins of 
language and writing. This research, 
of course, occurs after his annual six- 
week course in the Greek language at 
the University of Athens. 
“The library is the heart and soul 
of the university,” said Simbonis, 
who is, not surprisingly, a trustee of 
the Cushing/Whitney Medical Library. 
“It’s the guts of the university, the 
crown jewel. How can you do without 
it? It’s been a storehouse of knowledge 
throughout the ages." 
If it hadn’t been for libraries, Simbonis 
might never have made it to the School 
of Medicine. 
Born in Manhattan in 1928 to emi¬ 
grants from Greece, Simbonis lived in a 
tenement apartment in the Bronx with 
his mother and brother; his father died 
when he was 8. Simbonis loved to look 
at the handful of books in his home 
until he discovered the public library on 
Washington Avenue; then he started to 
read everything from Churchill to cal¬ 
culus. At 13, when he finished school for 
the day, he wandered into the libraries 
and classrooms of Fordham University, 
where a chemistry professor allowed 
him to sit in on classes. 
Simbonis’ junior high school sci¬ 
ence teacher steered him to the Bronx 
High School of Science, which still 
enjoys a reputation as one of the best 
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Alumni faces 
Wherever Stanley Simbonis travels, he always 
makes a point of visiting the local library. “The 
library is the heart and soul of the university,” 
said the retired pathologist, who is still an associ¬ 
ate clinical professor at Columbia University’s 
College of Physicians and Surgeons. “It’s been a 
storehouse of knowledge throughout the ages." 
college preparatory high schools in the 
country. He grew restless, however, in 
part because the school had no sports or 
even a gym at that time, and he dropped 
out at age 16. 
“My original dream was to be a cen¬ 
ter fielder for the Yankees and then I 
tried to become a musician,” he recalled. 
“Medicine was my third choice.” 
In the 1940s, trying out for a profes¬ 
sional baseball team did not require 
an agent or experience. Simbonis just 
showed up at Yankee Stadium. He also 
took a crack at the Dodgers. Neither 
team hired him, so he knocked on 
doors all along Broadway to audition as 
a big band drummer. “I could barely 
keep a beat,” he said. He did, however, 
meet bandleaders Louis Prima and 
Harry James. 
Still uncertain of his career path, he 
took on three menial jobs, delivering 
newspapers on Wall Street at 5 a.m., 
running mail for a ship’s broker and 
washing dishes at the Horn & Hardart 
automat. “The dishwashing really woke 
me up,” Simbonis said. “I thought, 
‘What the hell am I doing here? It’s obvi¬ 
ous that I have to go to school.’ The GI 
Bill sounded pretty good.” 
Simbonis enlisted in the Marine 
Corps on September 2,1945, the day 
the Japanese surrendered to the Allied 
forces, and began to pursue his high 
school equivalency degree. Because he 
took more than a dozen of the academic 
classes the Marines offered, he was 
called to the Marine Corps school in 
Washington, D.C., to teach English. 
Simbonis planned to go to Columbia 
University and live at home after leaving 
the service, but his mother had remar¬ 
ried and moved to New Haven. He 
followed her to the city and enrolled in 
Yale College. Simbonis lived off campus 
above the Sisk Funeral Home on Howe 
Street, where he earned $25 a month 
and a free apartment for answering the 
telephone in the middle of the night. 
He majored in zoology and earned his 
undergraduate degree in 1953. 
Simbonis then entered the School 
of Medicine, where he took an interest 
in pathology because it allowed time for 
research. After graduating he worked in 
the New York University lab of biochem¬ 
ist Severn Ochoa, m.d., who won the 
1959 Nobel Prize for medicine or physi¬ 
ology for his discovery of an enzyme 
that can synthesize rna. “Ochoa was 
brilliant, but also fun-loving,” Simbonis 
remembered. “He bought a red sports 
car with his prize money.” 
After stops at Columbia University 
and Holy Name Hospital in Teaneck, 
N.J., Simbonis settled down at St. 
Joseph’s Hospital in Paterson, N.J., 
where he became chair of pathology. 
He retired in 1992 but remains an 
associate clinical professor of pathol¬ 
ogy at Columbia University’s College 
of Physicians and Surgeons, where he 
still audits classes. 
Teaching, he said, was his greatest 
contribution to pathology. “I hope I was 
able to convey to students how to exam¬ 
ine slides and specimens, and then think 
fiercely on how to synthesize the ma¬ 
terial at hand to arrive at reasonable 
conclusions,” Simbonis recalled. “It 
wasn’t an easy task but it was really 
worth the effort.” 
Since 1975 Simbonis has lived in a 
historic brownstone in Greenwich 
Village, where he is active in neighbor¬ 
hood preservation. Divorced, he has no 
children. He travels widely and owns 
an apartment in Athens. He also has 
a vacation home on Fire Island, N.Y., 
which he has willed to the School of 
Medicine. The home will be sold upon 
his death and the proceeds divided 
between the library and a scholarship to 
be set up in his name. It will be a fitting 
gift from a lover of libraries. 
—Alix Boyle 
43 
A life in public health takes an 
alumnus around the world and 
back to Brooklyn 
Research, teaching and other projects 
have exposed Michael A. Joseph, m.p.h. 
’96, ph.d., to Zimbabwean health crises, 
the Bedford-Stuyvesant-Crown Heights 
aids epidemic and tuberculosis (TB) 
affliction in South African provinces. 
No matter where he has traveled, how¬ 
ever, he has always returned to suny 
Downstate Medical Center in Brooklyn, 
where his interest in public health began. 
Joseph’s wide-ranging path wasn’t 
what he’d imagined growing up in 
Brooklyn. Although he had planned to 
become a doctor, the premed courses 
at Brooklyn College turned him away 
from medicine. He switched his major to 
health science and secured an internship 
at Downstate. Assisting the late Rachel 
G. Fruchter, m.p.h., ph.d., then-associate 
professor of obstetrics and gynecology, in 
researching gynecological cancers among 
minority and immigrant women, he 
said, “allowed me as an undergraduate to 
see a research project from inception 
to completion.” It also connected him to 
the institution that would become his 
professional touchstone. 
“By my second epi course, I fell in 
love with the hands-on detective work 
linking an exposure to a health outcome,” 
recalled Joseph, who was encouraged 
by professors to pursue an m.p.h. At the 
School of Public Health he served as 
a teaching assistant during his second 
year, where his love affair with teaching 
began and spurred him toward a ph.d. 
Joseph’s master’s thesis was based on 
his analysis of Fruchter’s data. 
For his doctoral work, he went to 
the University of Michigan and assisted 
in the teaching of master’s-level bio¬ 
statistics and epidemiology courses. 
There, he said, “I was trained by the 
best of the best in epidemiology: Sioban 
Harlow, Sherman James and David 
Schottenfeld.” He continued exploring a 
theme from his Downstate internship—- 
minority health—for his dissertation, 
“Risk Factors for Lower Urinary Tract 
Symptoms in African-American Men.” 
Strong family ties lured Joseph back 
to Brooklyn after he had completed 
his doctorate and was looking for a 
faculty position. When he heard about 
Michael Joseph initially planned to become a 
doctor, but instead he went into public health. 
His studies and his work have taken him around 
the country and to Africa, but he has always re¬ 
turned to his home in Brooklyn, where he focuses 
on aids and tuberculosis. 
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44 Alumni faces 
Downstate’s new public health gradu¬ 
ate program emphasizing urban and 
immigrant health—a marriage of the 
themes that have guided his career—it 
seemed like a natural fit. “At a well- 
established public health school. I’d have 
less input, less room for innovation and 
growth,” he reasoned. “This was an 
opportunity to serve as a role model for 
a diverse student population.” Joseph’s 
lectures explore factors “prohibiting 
minority and underserved populations 
from engaging in healthy behaviors— 
including economic inequality, lack of 
employment opportunity, poverty and 
our failing health care system.” 
Dedicated to both teaching and 
minority health, Joseph was invited on 
tlrree occasions to teach an intensive 
biostatistics and epidemiology course to 
public health students at the University 
of Zimbabwe in Harare. “Africa is 
plagued by many infectious diseases, 
so students are in the field tackling out¬ 
breaks. What I teach here over 14 weeks, 
I had to teach there in two, from 9 to 5 
daily. It was exhausting but quite fulfill¬ 
ing,” he said. Through Downstate’s hiv 
Center for Women and Children, he 
was invited in 2008 to train hiv and TB 
researchers at South Africa’s University 
of the Free State in Bloemfontein. “They 
had a wealth of data but needed assis¬ 
tance carrying out the next steps—con¬ 
ducting appropriate analysis or writing 
a manuscript for publication.” 
An assistant professor of epidemi¬ 
ology, Joseph is the junior principal 
investigator on a grant from the Centers 
for Disease Control and Prevention, 
in which Downstate faculty collabo¬ 
rate with the Arthur Ashe Institute for 
Urban Health to target sexual behaviors 
that put heterosexual African-American 
men at risk for hiv infection. In 2006, 
Joseph and his wife-to-be, Lauretta 
Ansah, used funding from the National 
Black Leadership Commission on 
aids to support a ministry to edu¬ 
cate the members of Bedford Central 
Presbyterian Church about the disease. 
“For years, the black church was silent 
about the aids epidemic because of 
stigma. Many in the black community 
still believe it’s largely a homosexual dis¬ 
ease,” said Joseph. 
Joseph always reaches out to peers. 
At Michigan, he mentored several stu¬ 
dents, including members of the Public 
Health Students of African Descent, a 
student-run group that was established 
over 21 years ago. He tutored master’s- 
level students struggling with epidemi¬ 
ology or biostatistics. He also co-founded 
the Black Young Professionals’ Public 
Health Network, also known as ‘The 
network.’ The network presents 
such programs for black attendees at 
American Public Health Association 
conferences as “Is Hip Hop Healthy 
for African American Females?” Poster 
sessions showcase research in health 
disparities by minority public health 
students and young professionals. 
To Pascal J. Imperato, m.d., m.p.h., 
dean and Distinguished Service 
Professor of Downstate’s Graduate 
Program in Public Health, “Michael 
is extremely skilled in teaching epi¬ 
demiological concepts [so that students 
are] engaged and encouraged to reach 
beyond their own perceived limits. 
His introductory epidemiology course 
is one of the most popular in the 
graduate program.” Joseph’s students 
consistently give him top ratings as 
teacher, mentor and role model. 
After interviewing at Downstate 
in 2004, Joseph remembers thinking, 
“They loved me, I loved them, it’s a great 
fit.” For his work there, he was inducted 
into Delta Omega, the public health 
honorary society. MicJiael Joseph knows 
he’s in the right place. 
—Carol Milano 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine, Physician Associate Program 
and the medical school’s doctoral, fellow¬ 
ship and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 300 George Street, Suite 
773, New Haven, CT 06511. 
NOTES 45 
Lionel Nelson 
196OS 
Lionel M. Nelson, m.d. ’69, writes 
from Camp Stryker in Baghdad, 
where he is a colonel in the 
Army and the brigade flight 
surgeon with Task Force 449: 
"I have been here a month now, 
and have fallen into the routine. 
The day starts at o dark 30 with 
my usual exercise routine.... no 
different than home. I get to 
fly about once a week, usually 
something to attend to at one 
of our forward operating bases 
where we keep air crews, and a 
good excuse to get outside the 
wire and see some green fields. 
Parts of the Iraqi countryside 
along the rivers are quite beauti¬ 
ful. Otherwise, most of the day 
is a combination of staff duties 
(coordination, reports, briefs, 
etc.), supervising medical care 
for the task force personnel and 
overseeing the medical portion 
of our medevac operations. I 
have a staff of 25, with several 
physicians to help me with this. 
Operational tempo remains 
quite heavy, but threat level is 
relatively low at this time. I came 
out of retirement (21 years in, 
mostly as a reservist, and retired 
for five years) to do this. The 
need for flight surgeons with ex¬ 
perience is significant. The Army 
asked, and I volunteered. I will 
be here about 90-120 days, and 
have temporarily closed my ent 
practice in San Jose, Calif., for 
that time. Although I have had 
other deployments in the past, 
this is my first time in Iraq. It is 
great to be back around the avia¬ 
tors. Helicopter crews, particularly 
the Apache and medevac folks, 
are full of bravado and practi¬ 
cal jokes. I am glad to have the 
opportunity to be here and help 
take care of these very dedicated 
and brave Americans.” 
Juanita 
Merchant 
Martin Wand, m.d. ’67, was 
elected vice chair with succession 
to chair of the American Board of 
Ophthalmology. Wand is also the 
chair of the council and trustee 
of the 27,000-member American 
Academy of Ophthalmology. 
He specializes in glaucoma and 
remains in full-time practice with 
an eight-physician subspecialty 
group in Connecticut. 
197OS 
Laura M. Finkelstein, m.p.h. ’79, 
and Lawrence N. Rothbart were 
married on November 17, at the 
River Cafe in Brooklyn. Finkelstein 
is a quantitative and qualitative 
market research consultant based 
in Brooklyn, where she works 
with financial service companies, 
advertising agencies and consumer 
packaged-goods companies. 
Rothbart is a lawyer in Manhat¬ 
tan specializing in matrimonial 
and family law. 
198OS 
Juanita Merchant, m.d. ’84, 
ph.d. '84, professor of internal 
medicine and of molecular and 
integrative physiology at the 
University of Michigan Medi¬ 
cal School, was named to the 
Institute of Medicine of the 
National Academy of Sciences 
in October. She was also named 
an Outstanding Woman in Sci¬ 
ence for 2008 by the American 
Gastroenterological Associa¬ 
tion Foundation for Digestive 
Health and Nutrition, in honor 
of her contributions to digestive 
disease science. 
199OS 
Michael A. Coady, m.d., m.p.h. 
’97, has been named cardiac 
surgeon at The Miriam Hospital 
in Providence, R.l. He is also chief 
of surgery at Landmark Medical 
Center in Woonsocket, R.l. 
2000S 
James M. Kessler, m.d., m.p.h. '01, 
was married to Jessica A. Bassik 
in Kings Point, N.Y., in November. 
Kessler is a third-year radiology 
resident at Jacobi Medical Center in 
the Bronx. He graduated summa 
cum laude from the American 
Jewish University in Los Angeles. 
He received a master’s degree in 
public health from Yale and a medi¬ 
cal degree from Johns Hopkins. 
His wife is a third-grade teacher at 
Public School 75 in Manhattan. 
John Strasswimmer, m.d., ph.d., 
hs ’03, was part of a group that 
traveled to Malawi in September 
to assess the surgical needs of 
albino patients and to determine 
how dermatologic surgeons can 
help. Strasswimmer is a Mohs 
surgeon in Delray Beach, Fla. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Annual Giving 
Daily Impact 
When you make an annual gift to the School 
of Medicine, it goes to work immediately— 
providing essential support for financial aid, 
teaching, student research, and all aspects 
of academic and cultural life at the School. 
You are also helping to build Yale’s future, 
because every annual gift counts toward the 
Yale Tomorrow campaign goal. 
Your generosity makes a difference—today 
and for years to come. 
y A l e »tomorrow 
THE CAMPAIGN FOR YALE UNIVERSITY 
www.yale.edu/giveMedicine 
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in Memoriam 
Rebecca L. Calderon, M.P.H. ’81, 
ph.d. '86, died on December 21 
at her home in Chapel Hill, N.C., 
after an 18-month struggle with 
lung cancer. Since 2004 Calderon 
served as director of the human 
studies division of the National 
Health and Environmental Effects 
Research Laboratory at the Envi¬ 
ronmental Protection Agency. 
William A. Clermont, R.N., M.P.H. 
'57, died on December 22 at Fort 
Pierce Hospice House in Fort 
Pierce, Fla. He was 92. Clermont 
served as a medic in the U.S. 
Army in England during World 
War II and was a hospital admin¬ 
istrator at Alice Hyde Memorial 
Hospital in Malone, N.Y. 
Charles H. Crothers, m.d. ’44, hs 
’48, died on January 10 of cancer 
at his home in Van Buren, Ind. 
He was 88. Crothers practiced 
pediatric medicine in Connecticut 
for more than 40 years. After 
serving in the U.S. Army in the 
Philippines, he returned to 
Grace-New Haven Community 
Hospital in 1948, where he was 
chief resident and assistant 
professor of pediatrics. In 1952 
he began a private practice in 
New Britain, Conn. 
Nicholas D. D’Esopo, M.D. ’36, 
died on December 12 at his home 
in Woodbridge, Conn. He was 99. 
During the 1940s D’Esopo conduct¬ 
ed studies that led to the develop¬ 
ment of combined chemotherapy 
for the treatment of tuberculosis. 
From 1953 until 1985, he was chief 
of the pulmonary disease service at 
the West Haven VA Medical Center. 
He was also a clinical professor of 
internal medicine at the medical 
school until 2004. 
Rocko M. Fasanella, m.d. ’43, 
chief of ophthalmology at 
Yale from 1951 to 1961, died on 
February 11. He was 92. Fasanella 
established the ophthalmology 
residency program and headed 
the section when it was still 
within the Department of Sur¬ 
gery. He laid the foundation for 
ophthalmology's growth into a 
freestanding department with 
its own full-time faculty. He is 
known for a surgical technique 
that bears his name and is still 
widely performed, the Fasanel- 
la-Servat procedure for drooping 
eyelid, which was developed 
with Javier Servat, m.d. His 
popular textbook, Management 
of Complications in Eye Surgery, 
was a must-read in the 1960s 
and 1970s. 
Francis R. Fekety Jr., M.D. ’55, died 
at Parkcliffe Alzheimer's Commu¬ 
nity in Toledo, Ohio, on January 
6. He was 79. After service in the 
U.S. Public Health Service and a 
teaching appointment at Johns 
Hopkins University, Fekety estab¬ 
lished and was named chief of the 
Infectious Diseases Division of the 
Department of Internal Medicine 
at the University of Michigan 
Medical School. He was on the 
faculty there from 1967 until his 
retirement in 1995. 
Joanne E. Finley, m.d., m.p.h. ’51, 
died on October 15 in Baltimore, 
Md. Finley was the commissioner 
of health in New Jersey from 1974 
to 1982 and deputy secretary of 
health for the state of Maryland 
from 1983 to 1984. 
Dennis R. Hamilton, m.p.h. ’71, 
died on September 16 in New 
Hampshire of a heart attack. 
He was 66. A resident of New 
Haven, Hamilton was in New 
Hampshire working on a photo 
exhibit for Amman Imman, a 
project started by Ariane Kirtley, 
m.p.h. ’04, to bring water to 
remote areas of the African coun¬ 
try of Niger. Although retired, 
Hamilton was active in New Ha¬ 
ven’s progressive community and 
was associate director of Amman 
Imman. An accomplished pianist, 
Hamilton often played at his 
friends' birthday parties. 
Edward H. Hon, m.d., hs '55, died 
on November 6 at his home in 
Bradbury, Calif. He was 89. Hon 
worked with Orvan Hess, m.d., 
to invent electronic fetal heart 
rate monitoring at Yale in the 
1960s. Born in China to Austral¬ 
ian parents in 1917, he grew up 
in Australia and came to the 
United States in 1945 to attend 
Loma Linda Medical School, then 
known as the college of Medical 
Evangelists of the Seventh-Day 
Adventist Church. Hon and Hess 
published their landmark paper 
on fetal electrocardiography 
in Science in 1957. Hon received 
numerous awards, including the 
Distinguished Service Award of 
the American College of Obstetri¬ 
cians and Gynecologists. 
Robert F. Hustead, m.d. ’54, died 
on December 6 from complica¬ 
tions of pneumonia in Baltimore, 
Md. He was 80. Hustead was a 
longtime resident of Wichita, 
Kan., and a world-renowned an¬ 
esthesiologist. From 1957 to 1959 
he was a captain in the U.S. Army 
and served at the Edgewood 
Chemical Biological Center in 
Aberdeen, Md. In 1959 he became 
an instructor in anesthesiology at 
Johns Hopkins University School 
of Medicine, where he started 
the anesthesiology department. 
In 1961 he moved to Kansas City 
to take a position as assistant 
professor at the University of 
Kansas School of Medicine. He 
patented numerous medical 
devices and invented the Hustead 
epidural needle, used to eliminate 
childbirth pain. 
W. Raymond James, m.d. ’44, 
died on December 16 at his home 
in Essex, Conn. He was 89. After 
an internship in Los Angeles and 
a residency at Columbia Pres¬ 
byterian Hospital in New York, 
James and his wife moved to 
Essex in 1948, where he practiced 
medicine. A proponent of region¬ 
alization and special education, 
he served on the Essex Board 
of Education and the Region 4 
Board of Education. He was also 
a health officer in area towns 
and won awards for his efforts 
to clean up the polluted lower 
Connecticut River. 
Mildred H. January, m.d. ’35, died 
on January 5 in West Hartford, 
Conn., after a long period of 
failing health. She was 101. After 
postgraduate training January 
specialized in psychiatry and 
psychoanalysis. She maintained 
a private practice in Hartford, 
Conn., and was affiliated with 
clinical settings in Stamford, New 
Britain, New Haven and Hartford. 
Edward M. Kenny, m.p.h. ’63, 
died on November 26 of prostate 
cancer. He was 78. Kenny was the 
assistant administrator at Stam¬ 
ford Hospital from 1963 to 1965; 
assistant administrator at Man¬ 
chester Memorial Hospital from 
1965 to 1967; executive director 
of Manchester Memorial Hospital 
from 1967 to 1983; and presi¬ 
dent and ceo of the Greenwich 
Hospital Association from 1984 to 
1991. He served for more than two 
decades in the U.S. Army Medical 
Service Corps and retired with 
the rank of lieutenant colonel in 
1979. He was a recipient of the 
Connecticut Hospital Association 
T. Stewart Hamilton, m.d., Annual 
Award for Distinguished Service 
and was a member of the boards 
of Workers’ Compensation Trust, 
Opportunity House (for autistic 
residents) and Milford Hospital. 
James M. Lansche, M.D., hs ’53, 
died on November 2 in Poca¬ 
tello, Idaho. He was 78. Lansche 
became the first neurosurgeon in 
Pocatello when he moved there 
from California in 1972. He was 
chief of staff at the Bannock Re¬ 
gional Medical Center and served 
on several professional boards, 
including the State Board of 
Medical Discipline, as well as in 
numerous civic and professional 
organizations. After retiring in 
1992, he spent much of the year 
at his cabin on Henry’s Fork of 
the Snake River. 
Anthony Lovell, m.d. ’67, died 
on November 15 at his home in 
Springfield, Mass., of a glioblas¬ 
toma. He was 68. Lovell had 
recently retired after 35 years as 
a cardiologist in Springfield. The 
son of a lobsterman on Cape Cod, 
Lovell earned money for college 
and medical school by shell 
fishing and commercial fishing. 
Long interested in serving the 
community, he helped initiate 
one of the region’s first cardiac 
rehabilitation programs at the 
Springfield ymca. 
John L. Mahoney, M.D. ’63, HS ’69, 
died on October 5 of prostate can¬ 
cer at his home in Oakland, Calif. 
He was 71. After an internship at 
Seton Hall University Medical Cen¬ 
ter in New Jersey, Mahoney joined 
the U.S. Marine Corps as a captain 
and instructor in neuropsychiatry. 
In 1973 Mahoney took a position 
as staff psychiatrist at Highland 
General Hospital in Oakland. He 
also started a private practice, 
consulted at senior living centers 
and in 1999 became staff psychia¬ 
trist at San Ouentin State Prison. 
In 2004 he transferred to Solano 
State Prison. He retired in 2006. 
Hugh J. McLane, m.d. ’46, died at 
his home in the Laurel Lake Re¬ 
tirement Community in Hudson, 
Ohio, on January 11. He was 85. 
After attending Amherst College 
and the School of Medicine, 
McLane served in the U.S. Army 
Medical Corps in Berlin from 
1947 to 1949. He completed his 
residency in internal medicine at 
Henry Ford Hospital in Detroit. 
He practiced internal medicine 
in Fond du Lac, Wis., for more 
than 40 years and retired in 
1992. He served as president of 
the Fond du Lac Medical Society 
and president of the Wisconsin 
Heart Association. 
Allan R. Oseroff, m.d. ’76, PH.D., 
died on October 16 in Buffalo, N.Y. 
He was 65. Oseroff was chair of 
dermatology at the University of 
Buffalo and at the Roswell Park 
Cancer Institute in Buffalo. He 
was internationally recognized for 
the photodynamic treatment of 
skin cancer. 
Frederic M. Richards, ph.d., a 
structural biologist and an in¬ 
novative leader in the study of 
the relationships between protein 
structures and their biological 
functions, died of natural causes 
at his home in Guilford, Conn., on 
January 11. He was 83. 
Richards, professor emeritus 
of molecular biophysics and 
biochemistry, was instrumental 
in the development of molecu¬ 
lar biophysics and structural 
biology at Yale and nationwide. 
His most paradigm-shifting 
experiment, published in 1958, 
provided the first evidence that 
a protein peptide’s ability to 
form a three-dimensional struc¬ 
ture is an intrinsic property of its 
amino acid sequence. 
Richards obtained his ph.d. at 
Harvard in 1952. He pursued post¬ 
doctoral research attheCarlsberg 
laboratory in Copenhagen, Den¬ 
mark, and at Cambridge University 
in England. In 1955 he joined the 
biochemistry faculty at Yale and 
in 1963 merged the departments 
of biochemistry and biophysics to 
form the Department of Molecular 
Biophysics and Biochemistry, with 
a mandate to move the depart¬ 
ment into the new field of molecu¬ 
lar biology. Between 1963 and 1967 
and from 1969 to 1973, as chair of 
this new department, Richards 
initiated the development of one 
of the major centers in the world 
for the study of biophysics and 
structural biology. 
Richards was a member of the 
National Academy of Sciences the 
American Academy of Arts and 
Sciences, and the American Philo¬ 
sophical Society. He was awarded 
the Connecticut Medal of Science 
in 1995. 
Samuel Ritvo, m.d. ’42, a faculty 
member at the Yale Child Study 
Center for nearly six decades, died 
on December 3 while hospital¬ 
ized for treatment of lymphoma 
in Maryland. He was 91. Ritvo 
graduated from Harvard College 
in 1938. He trained in pediatrics at 
the University of Minnesota and 
in pediatrics and psychiatry at Co¬ 
lumbia University in New York. He 
joined the Yale faculty in 1950 as 
part of the reorganization of what 
became the Child Study Center 
and held the rank of clinical profes¬ 
sor of psychiatry from 1965 until 
his retirement in 2007. The first 
director of training in child psy¬ 
chiatry at Yale, Ritvo was a training 
and supervising analyst at the 
New York Psychoanalytic Institute 
and the Western New England 
Institute of Psychoanalysis in New 
Haven. A highly respected teacher 
and clinician, Ritvo trained genera¬ 
tions of child psychiatrists. 
Jerome H. Shapiro, m.d. 48, died 
on October 14 in Bedford, Mass., 
from complications of Alzheimer 
disease. He was 84. Shapiro 
served in the U.S. Army during 
World War II and completed his 
medical education following his 
discharge. He was president of 
the Massachusetts Radiological 
Society, the New England Roent¬ 
gen Ray Society and the American 
College of Radiology (acr). He 
received the acr gold medal in 
1992 and a gold medal from the 
Radiological Society of North 
America in 1996. 
Ellis J. Van Slyck, m.d. ’47, died 
on December 20 in Grosse 
Pointe, Mich. He was 84. After 
his residency and service in the 
U.S. Army Medical Corps during 
the Korean War, Van Slyck joined 
the hematology division at 
Henry Ford Hospital in Detroit. 
He authored or co-authored 80 
publications about his specialty, 
cancer and hematologic disorders. 
From 1981 to 1983 he chaired the 
medical advisory board of The 
Children’s Leukemia Foundation 
of Michigan. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu 
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48 F0ll0W-Up Archives 50 and 25 years ago 
A student-run free clinic grows and thrives 
The idea was simple—free primary health care for the uninsured. 
Five years ago students in medicine, nursing and public health 
and in the Physician Associate Program opened the haven Free 
Clinic in partnership with the Fair Haven Community Health 
Center (fhchc). [See “Students Reach Out to the Uninsured at 
Free Medical Clinic in Fair Haven,” Yale Medicine, Autumn 2006.] 
Supervised by faculty from the schools of medicine and nurs¬ 
ing, the students saw three or four patients a week. Now haven 
serves more than 20 patients a week during its Saturday morning 
hours. Unlike the fhchc, which has a sliding scale, haven does 
not charge for its services or for medications. 
Since its beginnings five years ago, the student-run clinic 
has added services to meet the needs of its growing patient 
population, said Susan Mathai, a fourth-year medical student 
and one of haven’s directors. In response to student observa¬ 
tions of unmet mental health needs among female patients, 
a support and educational group for women has been started. 
A new program for latent tuberculosis patients is improving 
medication adherence, haven's expanded capacity and services 
have been made possible by a variety of gifts and grants from 
members and friends of the medical school community and 
such philanthropic organizations as the Community Foundation 
for Greater New Haven and the Gilead Foundation. 
Along with more services have come more opportunities 
for students to learn about the challenges of caring for low- 
income patients, haven has drawn on the fhchc professional 
staff, volunteers from the medical school community and full¬ 
time faculty members to serve as attending physicians. According 
to Frederick Haeseler, m.d., associate clinical professor of medi¬ 
cine and haven’s medical student advisor, faculty volunteers 
value the opportunity to teach committed students and help 
care for patients in need. 
"A lot of good things are possible,” said Mathai. 
—Colleen Shaddox 
THE SCHOOL Of MEDICINE 
ALUMNI BULLETIN 
Alumni Day 1959 
—Alumni Bulletin 
May 1959 
“Those who attended the February 
Alumni Day activities at the School 
of Medicine were privileged to hear 
a stimulating panel discussion on 
‘Recent Advances in Cardiovascular 
Surgery at Yale.’ This program was 
arranged and moderated by Dr. 
William W.L. Glenn, associate direc¬ 
tor of surgery, who heads the sec¬ 
tion of cardiovascular surgery.... 
“The growth of cardiovascular 
surgery at Yale has been possible 
through the integrated efforts and 
cooperation of various depart¬ 
ments in the School of Medicine, 
and it was not possible to include 
all who have been active in this 
important field.... 
“Recent advances in the diag¬ 
nosis of heart disease in the adult 
were reviewed by Dr. Allan V.N. 
Goodyer ('42), associate professor 
of medicine, who heads the cardio¬ 
vascular section of the Department 
of Medicine. He was followed by 
Dr. Richard L. Barach (’49), assis¬ 
tant professor of radiology, who 
presented a remarkable motion 
picture taken during fluoroscopy 
to illustrate cineangiography in the 
diagnosis of congenital heart dis¬ 
ease. Features of various anomalies 
amenable to right heart bypass 
were discussed by Dr. Marie J. 
Browne, clinical fellow in rheumatic 
fever and heart disease, of the 
Department of Pediatrics. 
“In conclusion, Dr. Glenn con¬ 
tributed some observations on the 
breadth and scope of cardiac sur¬ 
gery. A pump oxygenator (heart- 
lung machine) currently being used 
in open heart surgery was dem¬ 
onstrated. As a special bonus, Dr. 
Alexander Mauro, assistant profes¬ 
sor of physiology, was called upon 
to describe a newly developed elec¬ 
tronic cardiac pacemaker.... which 
recently underwent its first clinical 
trial successfully." 
... In Progress: Cancer 
—Yale Medicine 
Summer/Fall 1984 
“The National Cancer Institute 
recently awarded a grant of 
$421,000 for support for three 
years of research being conduct 
by Dr. Sara Rockwell on the use 
of perfluorochemical emulsions 
as adjuncts to radiotherapy. Thi 
target for this research is impro 
treatment of those solid tumor; 
which are resistant even to the 
of current treatment. ... 
"In preliminary studies, Dr. 
Rockwell and her colleagues hav 
found that infusing laboratory 
animals that have breast cancer 
sarcomas with Fluosol and havin 
them breathe oxygen before ant 
during radiotherapy increases th 
number of tumor cells killed b 
radiation, but does not increaS 
the toxicity of the radiation to tl 
blood-forming cells of bone mar 
row. Further studies will examin 
the effect of Fluosol treatment t 
other tumors and other normal 1 
sues, to evaluate whether this a| 
in combination with radiotheraf 
has the potential for effective tr 
ment of solid tumors in humans 
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FROM A DONOR IN THE ANATOMY LAB, A FINAL LESSON 
Four first-year medical students in the anatomy lab watched closely 
in February as Shukrulla Ghofrany, m.d., lecturer in surgery (gross 
anatomy), hunted for the .22-caliber bullet in the body of the donor 
they’d been studying since the fall. An X-ray showed that it was 
lodged near the 12th vertebra, and Ghofrany was struggling to find 
the shell, which had gone untouched for 73 years. 
“The bullet is intact, so we know it didn’t hit bone,” said William 
B. Stewart, ph.d., chief of the section of anatomy and experimental 
surgery, as he studied the X-ray. 
While Ghofrany probed, student Rany Woo methodically 
kneaded the donor's kidney. “What’s that?” she asked. Moments later, 
she held the bullet in her gloved hand as classmates crowded around. 
The students couldn’t have known it, but the man who donated 
his body after learning he had incurable lymphoma would have taken 
great satisfaction from this scene. C. Charles Peterson, “Chuck” to family 
and friends, “loved to teach,” said his widow, Carolyn. 
Peterson was 7 years old when his playmate accidentally shot 
him with a gun the boys had found in a neighbor’s bedroom. The doc¬ 
tors left the bullet because Peterson was unbothered by it. 
Peterson lived a full life until his death in December 2007 at 
the age of 80. He married and had five children, served in the Naval 
Air Corps as a night carrier pilot, initiated an after-school computer 
program while teaching in Missouri in the 1960s, wrote and taught 
a hands-on science program for the American Association for the 
Advancement of Science, and was vice president of Middle East pro¬ 
grams for Sikorsky Aircraft. 
Peterson shared his wish to donate his body with his family, 
who, after some agonizing, agreed. “Dad was a teacher and a scien¬ 
tist, and furthermore, he loved to work,” son Charles said. “This is the 
very thing he’d want, that after he died, he'd have a job to do.” 
—Jennifer Kaylin 
First-year medical students Josh Au, Chineme 
Enyioha, Rany Woo and Kenneth Ike examined 
the .22-caliber bullet they found in the body of 
their anatomy lab donor. The donor had been 
shot accidentally by a playmate 73 years earlier, 
but the bullet was never removed. 
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Embrace the past. Explore the future. 
I ft] I ill L for a weekend of celebration! 
Yale School of Medicine Alumni Reunion Weekend 
June 4-6,2009 
PROGRAM HIGHLIGHTS 
Thursday June 4 
• 14th Annual Vale Surgical Society Spring Reunion 
An Evening to Honor Robert Weiss, md 
• 5th Annual Yale Physician Associate Alumni Spring Reunion 
The State of the Yale Physician Associate program with Assistant Dean Mary L. Warner, pa- 
Friday June 5 
• Campus Tours: 
Historical Library Tour and Discussion 
Guided Walking Tour of the Yale Medical School Campus 
• Welcome Reception and New England Lobster Dinner 
Greeting by Dean Robert J. Alpern, md 
Saturday June 6 
• Reunion Symposium: 
Biological Therapies in Cardiology, Michael Simons, md ’84 
Oxygen and the Biology of Cardiovascular Disease, Frank J. Giordano, md 
• State of the School with Dean Robert J. Alpern, MD 
• Afternoon Campus Tours: 
Historical Library Tour and Discussion 
Tour of Yale's West Campus 
Hard Hat Tour ofSmilow Cancer Hospital 
• Class Dinners and Photos 
ALSO THIS SPRING 
Monday May 4 — New York 
• Yale’s Vision for Medical Education: Affirming Values, Defining Priorities and 
Renewing the Curriculum, Richard Belitsky, md, Deputy Dean for Education 
The Yale Club of New York, 50 Vanderbilt Avenue, New York 
Thursday May 7 — Chicago 
• An evening with Richard A. Silverman, Director of Admissions 
MK The Restaurant, 868 North Franklin, Chicago 
For additional information about Reunion Weekend contact Mary Meehan, Director of Alurnni Affairs, 
(203) 436-8540 or email mary.meehan@yale.edu. 




